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Alzheimer’s disease (AD) has a long preclinical stage characterised by the accumulation 
of brain pathology, which is estimated to begin several decades before the onset of 
symptoms. A significant proportion of older adults harbour such pathology, although 
many of them may not develop dementia during their lifetimes. Growing evidence 
suggests that subtle cognitive decline occurs during this preclinical period, but many 
unanswered questions remain about the nature and timing of changes in different 
cognitive domains, and associations with life-course predictors.  
This thesis is based on data from Insight 46, a neuroimaging sub-study of the MRC 
National Survey of Health and Development (the British 1946 birth cohort). In this 
population-based sample of 502 adults aged ~70 years, cognitive performance was 
assessed using standard and novel tests, and associations were investigated between 
cognition, life-course predictors, genetic risk factors for AD and brain pathologies, with a 
particular focus on -amyloid.   
The key finding was that participants with elevated levels of -amyloid showed poorer 
performance across a range of cognitive domains – some of which have received little 
attention in previous studies – including non-verbal reasoning, intra-individual variability 
in reaction time, visuomotor integration and memory. Other important results include: 
independent effects of childhood cognitive ability, educational attainment and adult 
socioeconomic position on later-life cognition; an association between white matter 
pathology and slower processing speed; associations between larger whole brain 
volume and faster performance on several diverse timed measures; and evidence that 
APOE-ε4 carriers may be advantaged on tests of short-term memory after accounting 
for the detrimental effect of -amyloid. 
These results have implications for the interpretation of cognitive data measured in later 
life, and for the use of cognitive assessments to detect and track subtle cognitive decline 





This thesis is based on data from Insight 46, a neuroimaging study of 502 members of 
the MRC National Survey of Health and Development (NSHD, the British 1946 birth 
cohort). All participants were born during the same week in March 1946 and have been 
studied ever since, with a rich dataset of measures of physical and mental health, 
cognition and lifestyle. As the NSHD is the world’s longest continuously-running birth 
cohort study, it is a unique resource for the scientific community and its outputs have had 
a substantial influence on health policy, and will continue to do so. With participants now 
in their early 70s, this is an ideal time to investigate the emergence of neurodegenerative 
diseases, as participants are predominantly cognitively healthy but a significant 
proportion are expected to show evidence of accumulating brain pathologies. This study 
focuses on β-amyloid pathology, which is critical to the development of Alzheimer’s 
disease (AD), the most common cause of dementia. As the prevalence of this 
devastating disease continues to rise rapidly, there is a pressing need for better 
understanding of its early preclinical stage – the stage during which future disease-
modifying treatments are most likely to be effective. In particular there is a need for 
greater insight into the nature and timing of the earliest subtle changes in cognition, and 
how these changes can best be measured. 
One of the main aims of this thesis was to investigate whether subtle differences in 
cognition could be detected between individuals with and without β-amyloid pathology 
(measured by β-amyloid positron emission tomography (PET) imaging). The results 
provide novel evidence that such differences are indeed detectable in cognitively-normal 
70-year-olds across a variety of cognitive domains, including non-verbal reasoning, 
consistency of reaction time, visuomotor integration and memory. This has implications 
for our understanding of the earliest cognitive changes associated with AD, as the 
dominant narrative is that memory is the earliest domain to be affected, whereas these 
results suggest that other cognitive domains may also see very early changes. The 
results may also influence the design of future clinical trials, as sensitive cognitive tests 
are required to judge the effectiveness of potential disease-modifying treatments, and 
some of the novel computerised cognitive tests described here may be good candidates 
for outcome measures in such trials. 
The results also showed that childhood cognitive ability, educational attainment and 
socioeconomic position each have independent effects on cognitive performance at age 
70. This is consistent with previous reports that education and other cognitively-
stimulating activities have an influence on cognitive trajectories across adulthood, and 
may have implications for public health efforts to reduce risk of later-life cognitive decline. 
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Dissemination of results to the research community is in progress and will continue 
through publication in scientific journals and presentation at international conferences, 
and public engagement activities will allow research outputs to be shared more widely. 
Data-sharing agreements are in place so that other researchers can request Insight 46 
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1.1. Alzheimer’s Disease  
There are 50 million people living with dementia globally (World Health Organization, 
2019). In addition to the incalculable human impact, the economic cost is staggering – in 
the UK alone the estimated current cost is £26 billion per year, and this is projected to 
more than double by 2040 (Prince et al., 2014). The most common cause of dementia is 
Alzheimer’s disease (AD), accounting for about two-thirds of cases (ARUK Dementia 
Statistics Hub).  
AD was first described in 1907 by Alois Alzheimer, a psychiatrist in Frankfurt, who 
reported memory loss, paranoia and disorientation in his patient Auguste D. After her 
death he produced a detailed characterisation of the neurofibrillary tangles he observed 
in her neurons, and described aggregations of a “peculiar substance” we now know to 
be β-amyloid, hereafter referred to as Aβ (Ryan, Rossor and Fox, 2015). These 
pathological hallmarks – extracellular β-amyloid plaques and intracellular neurofibrillary 
tangles containing hyperphosphorylated tau – are the basis for histopathological 
diagnosis of AD today, and are accompanied by atrophy (loss of neuronal cells) in 
selective brain regions which mainly correspond to the clinical presentation of symptoms. 
A typical presentation is characterised by progressive memory impairment and 
disorientation, corresponding to medial temporal lobe atrophy (Braak and Braak, 1991), 
but a variety of atypical non-amnestic presentations occur (Jones and Thompson, 2017). 
As the disease progresses and atrophy spreads, the cognitive and functional impairment 
becomes more global. While post-mortem confirmation of pathology is still the gold 
standard for a definitive diagnosis, new technologies have emerged which allow 
detection of Aβ, tau pathology and neurodegeneration in vivo. These innovations have 
made it possible to study the progression of pathological changes, and revealed that 
these changes begin around 20-30 years before the onset of symptoms, with Aβ 
pathology being the first to accumulate (Jack et al., 2013; Palmqvist et al., 2018). This 
period of pathological changes in the absence of symptoms is referred to as the 
preclinical stage of AD, and is discussed in greater detail later (section 2.2). 
The causes of AD on an individual level are poorly understood, apart from for a very 
small minority of patients who carry autosomal dominant mutations for familial 
Alzheimer’s disease (FAD), accounting for less than 1% of cases of AD (Bateman et al., 
2010). For sporadic AD, the biggest known risk factor is age: 95% of people living with 
dementia in the UK are over the age of 65, and the prevalence rises steadily in older 
20 
 
age, reaching about 40% among those aged 95 and above (Prince et al., 2014). Other 
risk factors include the APOE gene, which is discussed later (section 2.6.1) and lifestyle 
factors such as smoking, hypertension and obesity (Norton et al., 2014). 
There are currently no disease-modifying treatments available for AD and the field has 
suffered from a series of disappointing failures from clinical trials of drugs that have 
targeted Aβ pathology. 
 
 
1.2. Preclinical Alzheimer’s Disease  
As AD has such a long preclinical window, this may be the most beneficial time to provide 
disease-modifying therapies. While some secondary prevention trials (i.e. targeting 
asymptomatic individuals with evidence of Aβ deposition) are already underway, many 
important questions remain. We still lack understanding of the timing and sequence of 
the pathological changes that occur, influences on their progression, and factors 
affecting how and when this leads to cognitive decline – especially on an individual level. 
Over the last decade, much effort has been directed towards creating standardised 
criteria for defining preclinical AD. These criteria are designed to serve as a framework 
for research, with the ultimate aim of providing an evidence base for designing 
appropriate and successful clinical trials in this population. These criteria are discussed 
in more detail in section 2.2. 
Although individuals with preclinical AD are, by definition, cognitively normal, there is 
increasing evidence that subtle changes in cognition can be detected during this period 
(see section 2.3). A key research question is how these changes relate to the preclinical 
disease process and how they can best be measured. Sensitive cognitive tests are 
crucial for identifying individuals at risk of AD and for use as outcome measures in clinical 
trials. Indeed, the US Food and Drug Administration have recently approved cognition 
as a sole end-point for such trials, where previously they required evidence of functional 
improvement as well – a requirement clearly unworkable for a population with no 
functional impairment (Kozauer and Katz, 2013). In addition, using sensitive cognitive 
tests in observational studies could increase our understanding of the factors which 
affect an individual’s risk of cognitive decline – such as demographic factors, physical 




1.3. The MRC National Survey of Health and Development 
My PhD project sits within the Insight 46 study, a neuroimaging sub-study of the MRC 
National Survey of Health and Development (NSHD, also known as the British 1946 Birth 
Cohort). The NSHD was established in 1946 to address concerns about infant and 
maternal health, specifically why the national fertility rate was falling and whether this 
could be attributed to the quality and cost of obstetric and midwifery services. Ninety-one 
percent of all mothers who gave birth in England, Scotland and Wales during one week 
in 1946 (n = 13687) were interviewed at their 8-week check-up and the findings were 
influential in designing maternity services within the new NHS. 5362 babies from this 
sample were enrolled to form the original NSHD cohort, stratified by socioeconomic 
position in order to investigate the effects of social inequality (Wadsworth et al., 2006).  
Between 1946 and 2015 there have been 24 data collection waves, focussing initially on 
childhood development and educational attainment, then shifting to physical and mental 
health, lifestyle and cognition across adulthood. Further details on the cognitive 
measures – of particular relevance to this thesis – are provided in section 3.2.1. The 
results of the NSHD have had a substantial impact on policy, including influencing the 
debate about comprehensive education and social mobility, providing pivotal evidence 
that smoking during pregnancy is harmful, and drawing attention to the unfolding obesity 
crisis (Pearson, 2016). High rates of participation have been maintained through the use 
of home visits for data collection and by keeping in regular contact with study members 
(Stafford et al., 2013; Kuh et al., 2016). At the most recent data collection wave in 2014-
2015, the target sample was 2816 study members, i.e. 52% of the original cohort. The 
remainder were no longer active for the following reasons: died (18%), permanently 
withdrawn (12%), living abroad (11%), lost to follow-up (7%) (Kuh et al., 2016).  
The NSHD is the world’s longest continuously-running birth cohort and aims to become 
a complete cradle-to-grave study. With participants now entering their eighth decade, the 
cohort provides a unique opportunity for understanding neurodegeneration in the context 
of ageing, and the complex factors and interactions that influence its progression. 
 
1.4. Insight 46  
Insight 46 is a neuroscience sub-study of the NSHD, run jointly by the Dementia 
Research Centre and the MRC Lifelong Health and Ageing Unit (both at University 
College London). Combining intensive cognitive and clinical assessment with collection 
of neuroimaging, blood and genetic biomarkers, Insight 46 aims to identify investigate 
life-course and genetic influences on brain health and cognition, with a particular focus 
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on AD. This will provide a critical evidence base for future therapeutic trials in the 
preclinical stage of AD. As the study members were aged ~70 at the time of recruitment 
into Insight 46, the prevalence of dementia was expected to be low – around 3% (Prince 
et al., 2014) – but a sizeable minority of participants were expected to be in the preclinical 
stages of AD, with meta-analytical data suggesting significant Aβ pathology in around 
15-25% of individuals at this age (Jansen et al., 2015).  
Participants recruited to Insight 46 were invited to University College London (UCL) for 
assessments at two time-points with an interval of approximately two years. Data 
collection included cognitive tests, clinical history and examination, Aβ positron emission 
tomography (PET), brain magnetic resonance imaging (MRI), and other biomarker and 
genetic measures. Further details on recruitment and data collection are provided in 
sections 3.1and 3.2 and in the protocol paper (Lane et al., 2017). Baseline assessments 
were conducted between May 2015 and January 2018. Follow-up assessments began 
in January 2018 and will be completed around the summer of 2020. 
 
1.5. Scope of PhD 
My research focuses on analysing the cognitive data collected during the baseline Insight 
46 assessments, with the ultimate aim of understanding more about subtle cognitive 
changes that may be associated with preclinical AD pathology, in particular Aβ plaques. 
The following chapter introduces the background to the unanswered questions in this 
field, reviews the relevant literature, and leads to a statement of my specific research 





2. BACKGROUND AND RESEARCH QUESTIONS 
 
2.1. Rationale 
Research into the relationship between preclinical AD pathology and changes in 
cognition is based on the understanding that individuals do not suddenly become 
cognitively impaired, but rather there is a gradual process of cognitive decline, during 
which time cognitive performance initially remains within the normal range. Jessen et al. 
produced a figure to illustrate this, which I have used as a basis for structuring my review 
of the literature (Figure 2-1): I have annotated the figure with the letters A-D to highlight 
four important questions, which are explained below.  
 
 
Figure 2-1. The course of cognitive decline through preclinical AD to dementia  
The questions for my literature review are indicated by the labels A to D – see text for a full 
explanation. This figure is reprinted from Jessen et al. (2014) with permission from Elsevier. (The 
letters A to D are my own addition.) Jessen et al. designed this figure to draw attention to the 
concept of Subjective Cognitive Decline (SCD), which describes the phenomenon of some older 
adults reporting concerns about declining memory and cognition, despite showing no evidence of 
any objective cognitive impairment. My research focuses on objective measures of cognition, so 





A – What is preclinical AD? To investigate whether the cognitive tests used in Insight 
46 can detect subtle cognitive decline in the preclinical stage of AD, preclinical AD must 
be defined. The main scope of this question is to review the development of criteria for 
defining preclinical AD in clinical and pathological terms, as well as to review evidence 
relevant to the application of these criteria to the Insight 46 cohort, such as the 
prevalence of preclinical AD at age ~70 years. However, as becomes clear from the 
debates and controversies surrounding these criteria, this question also has a more 
philosophical dimension relating to classification of disease in apparently asymptomatic 
individuals. This question is reviewed in section 2.2. 
B – What is the evidence that subtle cognitive changes are detectable in preclinical 
AD? Cognitive impairment can be defined as the point when a participant’s cognition is 
below the normal range for their age, sex and education. This is represented in Figure 
2-1 by the vertical line labelled “Impairment on a cognitive test” which intersects the 
cognitive trajectory (smooth purple line) at the point where it drops out of the green 
shaded area. But there is evidence that cognition begins to decline among so-called 
cognitively-normal individuals who are in the preclinical stage of AD, before reaching the 
point of impairment, as indicated by the vertical line labelled “Onset of decline in cognitive 
performance”. In aiming to detect and measure subtle cognitive changes in preclinical 
AD, the Insight 46 cognitive battery is targeting the region between these two vertical 
lines. Evidence from previous studies with similar aims is reviewed in section 2.3.  
C – Which predictors of individual differences in cognitive performance are most 
important to account for? Some of the variation between individuals in terms of 
cognitive performance can be explained by factors such as age and education. These 
factors need to be accounted for in order to define the normal range of cognitive 
performance for a certain population (represented in Figure 2-1 by the green band). 
Accounting for this predictable variation between individuals should increase the 
sensitivity of cognitive tests to detect subtle cognitive changes associated with preclinical 
AD within this normal range. This question is reviewed in section 2.4.  
D – Which cognitive measures are most sensitive to subtle cognitive decline in 
preclinical AD? In Figure 2-1, the vertical line labelled ‘Onset of decline in cognitive 
performance’ illustrates the point at which subtle cognitive decline becomes detectable, 
even though performance is still within the normal range. With more sensitive cognitive 
measures, this vertical line could move to the left as subtle differences could be detected 
earlier. Some approaches to enhancing the sensitivity of cognitive measures are 




These four questions are now reviewed in the following four sub-sections. Each sub-
section ends with a summary of the implications for my research. 
 
2.2. What is preclinical AD? 
 
2.2.1. Development of research criteria for preclinical AD 
As mentioned in section 1.1, the advent of technologies to measure in vivo biomarkers 
of AD pathology has led to a reconceptualization of AD as a continuum with a long 
preclinical stage. Efforts to create standardised biomarker-based criteria for preclinical 
AD have been led by two main groups: the International Working Group for New 
Research Criteria for the Diagnosis of AD (IWG) and the US National Institute on Aging 
– Alzheimer’s Association (NIA-AA). The evolution of these criteria over the last ten years 
reflects the progress that has been made in understanding the biology of AD, the new 
biomarker measures that have become available, and the ongoing debates about how 
the disease should be conceptualised. A chronological summary of the various iterations 
of the IWG and NIA-AA criteria for preclinical AD is provided in Table 2-1. It is important 
to note that both sets of criteria have been conceived as frameworks for research and 
are not recommended for use in clinical practice.  
All the biomarkers currently included in criteria for preclinical AD are derived from 
neuroimaging or cerebrospinal fluid sampling. Blood-based biomarkers for AD are in 
development but require further work (Zetterberg, 2019) and are not discussed further. 
Technical details about the biomarkers referred to in Table 2-1, and their relative 
advantages and disadvantages, are not discussed here, but further details are provided 
in section 3.2.2 for the biomarker measures that are used in the analyses presented in 






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   


















































































































































































































































































































































































































































































































































































































































The impact of biomarkers on conceptualisation of AD is immediately obvious from Table 
2-1, as it can be seen that the IWG’s 2007 diagnostic framework was the first to require 
the presence of one or more abnormal biomarkers in addition to evidence of an episodic 
memory impairment for a diagnosis of AD (Dubois et al., 2007), and by 2018 the 
influential NIA-AA criteria have now removed clinical symptoms from the framework 
completely. 
It can be seen from Table 2-1 that both the IWG and NIA-AA have arrived at a very 
similar definition of AD, stating that it begins when there is evidence of both tau and Aβ 
pathology. One key area of difference has been around the classification of cognitively-
normal individuals who show only evidence of Aβ pathology (but normal tau). The 
influential NIA-AA 2011 criteria designated these individuals as being in Stage 1 of 
preclinical AD, whereas all iterations of the IWG criteria have opted for the more cautious 
designation of “Asymptomatic at risk for AD”. However, the gap between these two 
positions has been narrowed by the updated NIA-AA 2018 criteria, as such individuals 
are now referred to as showing “preclinical Alzheimer’s pathologic change” and the label 
of “preclinical AD” is reserved for those with evidence of both Aβ and tau pathology (as 
in the IWG criteria). Another important difference is the classification of cognitively-
normal individuals who show only evidence of tau pathology (but normal Aβ). IWG 
includes these individuals in their “Asymptomatic at risk for AD” category whereas NIA-
AA considers such individuals to show “Non-Alzheimer’s pathologic change”. 
It is no coincidence that these differences relate to the earliest stages of pathologic 
change in cognitively-normal individuals, as the earliest stages are obviously particularly 
challenging to characterise, and are the focus of the most contentious ongoing debates 
within AD research. Major issues include 1) to what extent the amyloid hypothesis should 
remain the dominant model of AD and how it may be integrated with other models; 2) 
the significance of terminology. These issues are discussed in the following sub-sections, 
with a focus on those which are most relevant to the investigation of associations 
between biomarkers of Aβ pathology and cognition in Insight 46. As the NIA-AA 2018 
criteria are the most recent and most influential, the current debates and discussions 
focus more on them. 
 
2.2.1.1. Dominance of the amyloid hypothesis 
The amyloid hypothesis contends that the accumulation of Aβ plaques between neurons 
– arising from an imbalance between the production and clearance of β-amyloid – is the 
primary cause of AD. This hypothesis has dominated the field for the last 25 years 
(Selkoe and Hardy, 2016). Pivotal evidence for the amyloid hypothesis came from the 
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discovery of the genetic mutations causing FAD, all of which are in the amyloid precursor 
protein (APP) or the presenilin genes (PSEN1 and PSEN2) involved in generating Aβ. 
These mutations result in over-production of Aβ, and a similar phenomenon is seen in 
Down’s Syndrome due to the duplication of chromosome 21 which contains the APP 
gene. Further compelling evidence for the amyloid hypothesis will not be described in 
detail here, but includes 1) the observation that accumulation of Aβ pathology begins 
several years before the appearance of tau pathology and neurodegeneration (Bateman 
et al., 2012; Jack et al., 2013; Pletnikova et al., 2018); 2) the well-documented neuronal 
toxicity of Aβ in animal studies (Selkoe and Hardy, 2016); 3) evidence that the APOE-ε4 
allele – the biggest risk factor for AD after age (see section 2.6.1) – impairs clearance of 
Aβ (Selkoe and Hardy, 2016).  
Criticism of the amyloid hypothesis is rooted in the universal failure of drug trials targeting 
Aβ in patients with AD or mild cognitive impairment (MCI). Some argue that the amyloid 
hypothesis is too linear and simplistic (e.g. Edmonds et al., 2015), and the time has come 
– or indeed is long overdue – to embrace other models of AD. Proposed alternatives will 
not be discussed here, but some examples are listed to illustrate the complexity and 
diversity of models of AD, and to highlight the contrast with the apparent simplicity of the 
IWG and NIA-AA criteria, which are firmly based on the amyloid hypothesis: 1) systems-
based models that focus on the wider consequences of pathology for brain systems such 
as cholinergic deficits (Tang, Lutz and Xing, 2018) and the effects of these “systems 
failures” on diverse clinical symptoms such as cognition, sleep and depression (Medina 
et al., 2017); 2) cellular models which focus on the complex cellular alterations which 
underline the long preclinical phase (De Strooper and Karran, 2016); 3) holistic 
approaches that focus on the biological mechanisms of diverse risk factors for AD such 
as ageing, genetics and lifestyle (Morris, Clark and Vissel, 2018); 4) the vascular 
hypothesis which focuses on vascular dysfunction including changes to the integrity of 
the blood-brain barrier and cerebral blood flow (de la Torre, 2018; Sweeney et al., 2019); 
5) the calcium hypothesis which focuses on the consequences of alterations to neuronal 
calcium signalling (Alzheimer’s Association Calcium Hypothesis Workgroup, 2017); 6) 
the neuroinflammation hypothesis which focuses on dysfunction of microglial cells 
(Heneka et al., 2015). 
This decision to focus on AD pathology in isolation from other processes and systems 
causes some to question the validity of the criteria in real life, and also raises concerns 
that the dominance of these criteria may divert research effort away from other potentially 




2.2.1.2. Significance of terminology 
The criteria for preclinical AD raise an immediate issue about terminology. As noted 
earlier, the term “preclinical AD” does not have the same meaning in the IWG and NIA-
AA criteria, and it can be seen in Table 2-1 that both groups have evolved their definition 
of this term over the last few years. Consequently, the literature on preclinical AD shows 
a lack of consistency, with the terms “preclinical”, “prodromal”, “presymptomatic” and “at-
risk asymptomatic” being used with overlapping but non-equivalent meanings by 
different authors. “Prodromal” is usually applied to cover the period immediately 
preceding the onset of dementia, when patients might meet criteria for MCI (e.g. Visser 
et al., 2012), whereas “preclinical” generally covers the cognitively-normal stage before 
this. Although both sets of criteria now require evidence of both Aβ and tau pathology for 
a classification of preclinical AD, the fact that that NIA-AA 2011 criteria required only 
evidence of Aβ pathology has resulted in numerous studies describing a “preclinical AD” 
group based purely on elevated levels of amyloid (e.g. Dang et al., 2018; Harrington et 
al., 2018; Slot et al., 2018). The term has also been used by some authors to describe 
APOE-ε4 homozygotes (Caselli et al., 2014) or individuals with MCI (Kirova et al., 2015).  
The issue of terminology is important because of concerns about the consequences of 
labelling people with “preclinical Alzheimer’s Disease”. While the criteria are explicitly for 
research purposes only, it has been argued that they will inevitably filter through into 
clinical practice, which could result in a significant proportion of older adults being 
diagnosed with preclinical AD, even though many of them may never go on to develop 
clinical symptoms (Boenink, 2018; McCleery et al., 2018, 2019; Morris, Clark and Vissel, 
2018). This would raise a number of ethical, societal and economic issues, especially 
given the current dearth of evidence-based treatment or management options available 
to individuals meeting the criteria. Some of the authors behind the NIA-AA criteria have 
pointed out that there is not the same concern over the terms “precancerous lesion” or 
“pre-diabetes”, arguing that the unease over the term “preclinical AD” reflects the 
continued fear and stigma surrounding dementia, as well as the fact that progression 
from preclinical AD to dementia cannot currently be predicted with any accuracy on an 
individual level (Sperling, Mormino and Johnson, 2014). The prospect of causing 
significant anxiety to otherwise healthy people is concerning, and its implications are 
hard to predict (Stites, Milne and Karlawish, 2018).  
Another contentious issue of terminology is raised by the definition of “Alzheimer’s 
disease” in the NIA-AA criteria. The authors make clear that their usage of this term is 
purely biological and implies nothing about clinical symptoms. Although they provide 
alternative terminology to describe the clinical presentation of AD – either “AD with 
dementia” for individuals meeting the biomarker criteria or “Alzheimer’s clinical 
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syndrome” for individuals with unknown biomarker profiles – critics argue that the 
common usage of the term AD (as a descriptor for the clinical symptoms) is likely to 
persist, so it would be more appropriate to create a new term for the biological entity or 
simply use the A/T/N categories (Louie, 2019; McCleery et al., 2019). In addition, it is 
important to remember that most clinics around the world do not have the resources to 
investigate biomarkers. Also, the value of a broad commonly-understood term in public 
perception should not be underestimated as it underpins efforts to raise awareness and 
support patients and carers.  
While attending a feedback session on the proposed NIA-AA 2018 criteria at the 
Alzheimer’s Association International Conference 2017, I observed that the debates 
around terminology were marked by a strength of feeling that stems from the 
fundamental nature of the issues raised. It may be informative to note that these issues 
are rooted in a wider question that has received much attention from philosophers of 
science, namely “What is disease?”. The extensive literature on this question will not be 
reviewed here, but some points of interest are listed below to indicate why the 
controversies surrounding criteria for preclinical AD have no easy resolution. 
i) The identification of AD pathology in a substantial proportion of older adults 
raises the issue of the blurred boundary between ageing and disease. If such 
pathology is common, then to what extent can it be considered distinct from 
so-called “normal” ageing (Lock, 2013)?   
ii) Related to this, gerontologists debate the question of whether there is such a 
thing as “healthy ageing” or whether senescence (biological ageing) itself 
should be considered as a disease process (Bulterijs et al., 2015; Gladyshev 
and Gladyshev, 2016; Janac, Clarke and Gems, 2017). 
iii) This debate follows from the fact that it has proved impossible to agree on a 
definition of disease. No theory can draw a meaningful distinction between 
diseases and other states of sub-optimal health (e.g. injury, disability, 
malnutrition, frailty) (Murphy, 2015) or account satisfactorily for 
presymptomatic disease (Broadbent, 2014). Competing concepts of disease 
broadly fall into naturalist and constructivist camps, which disagree in 
essence over whether diseases exist in nature or are constructed based on 
human normative judgements (Murphy, 2015). 
iv) As illustrated by the concerns around of the NIA-AA criteria, these abstract 
concepts have potentially far-reaching implications for the way individuals 
view their health and identity, and the priorities of medical research, treatment 




2.2.2. Expected prevalence of preclinical AD in Insight 46 
A significant proportion of cognitively-normal older adults meet criteria for preclinical AD, 
with one meta-analysis putting the figure at 22% (Parnetti et al., 2019). The increasing 
accumulation of brain pathology throughout older age is well-documented. For example, 
one study estimated that the prevalence of Aβ pathology increases from 10% at age 50 
to 44% at age 90 (Jansen et al., 2015), and another study based on the ATN biomarker 
framework (see Table 2-1) found that more than 90% of people have at least one 
abnormal biomarker by the age of 85 (Jack et al., 2017). Previous studies provide a basis 
for estimating the expected prevalence of preclinical AD in Insight 46 participants (aged 
~70 years at the time of recruitment) and the estimated risk of progression to cognitive 
impairment. 
Based on a meta-analysis of nearly 3000 cognitively-normal older adults who underwent 
either Aβ-PET or cerebrospinal fluid (CSF) sampling, the prevalence of Aβ pathology at 
age 70 is around 15-25% (Jansen et al., 2015). Consistent with this, in a more recent 
population sample of 322 70-year-olds from Sweden who underwent CSF sampling, 23% 
had evidence of Aβ pathology (Kern et al., 2018). The prevalence of preclinical AD in the 
Swedish sample was 10%, according to IWG 2016 and NIA-AA 2018 criteria, meaning 
that less than half of individuals with Aβ pathology also showed evidence of tau 
pathology. 
According to a meta-analysis of studies investigating risk of progression to MCI or 
dementia in older adults, over intervals ranging from 1.3 to 10.4 years, the estimated risk 
of progression for those with Aβ pathology alone was 20%, whereas the risk for those 
with both Aβ and tau pathology was 38% (Parnetti et al., 2019). A study of participants 
(n=599) in the Australian Imaging Biomarkers and Lifestyle (AIBL) study found a similar 
result, with an 18% risk of progression for Aβ+ participants over 8 years (measures of 
tau were not available) (Dang et al., 2018). These studies suggest that the risk of 
progression is low to moderate over a timescale of up to 10 years, and therefore it may 
be expected that many older adults with Aβ pathology will not develop symptoms in their 
lifetime. A recent study of cognitively-normal older adults stratified by sex and biomarkers 
of preclinical AD produced the following estimates of lifetime risk of AD dementia for 70-
year-olds: females with no AD pathology = 17%; males with no AD pathology = 11%; 
females with Aβ pathology only = 27%; males with Aβ pathology only = 20%; females 
with Aβ pathology and neurodegeneration = 39%; males with Aβ pathology and 




2.2.3. Implications for my research 
The Insight 46 protocol includes Aβ-PET but does not include a measure of tau 
pathology, so current criteria for preclinical AD cannot be fully applied. When data 
collection and analysis began, it may have seemed reasonable to follow other studies in 
defining a “preclinical AD group” based on Aβ pathology alone, as per the NIA-AA 2011 
criteria. However, with the publication of the updated 2018 criteria it has becomes clearer 
that this term is not justified according to current consensus. Therefore Insight 46 
participants whose Aβ pathology is above normal levels will simply be referred to as Aβ+. 
The term suggested for Aβ+ in the NIA-AA 2018 criteria – “preclinical Alzheimer’s 
pathologic change” – would not add additional clarity in this context, because it implies 
that tau pathology is absent, whereas in fact it is unknown. The same argument applies 
to the “asymptomatic at-risk” label favoured by the IWG group, which has the additional 
disadvantage of being a potential misnomer in the context of my aim to detect subtle 
cognitive changes. The concerns discussed in section 2.2.1.2 about the significance of 
terminology provide a further reason to stick to the simple descriptor of Aβ+, rather than 
applying disease terminology to healthy individuals. 
However, preclinical AD remains the consensus term to describe the research area that 
my project focuses on, and, according to current understanding, Aβ pathology plays a 
critical – if not primary – role in the development of AD dementia. Therefore, if Aβ+ 
participants show cognitive differences from Aβ- participants in Insight 46, it will be 




2.3.  What is the evidence that subtle cognitive decline is detectable 
in preclinical AD? 
As discussed above, the current criteria for preclinical AD are purely biological, but there 
is intense interest in understanding their relationship to cognitive decline. Being able to 
detect and track the earliest changes in cognition is of prime importance to clinical trials 
that seek to reduce the risk of conversion to MCI or dementia in individuals who are 
accumulating AD pathology. 
Studies that have compared cognitive performance in older adults with and without 
preclinical AD pathology are reviewed below. This review only considers objective 
cognitive measures; there are reports that preclinical AD pathology may also be 
associated with subjective cognitive decline (Jessen et al., 2014)  and subtle changes in 
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behaviour (Caselli et al., 2018), but these are not discussed. Another important evidence-
base relevant to subtle cognitive decline in preclinical AD comes from studies of 
presymptomatic FAD mutation carriers (e.g. Wang et al., 2015), which are not reviewed 
here, but such studies are considered in subsequent chapters where relevant to specific 
tasks in the Insight 46 cognitive battery.  
This section provides a general overview of the relationship between preclinical AD 
pathology and cognition, but does not discuss specific cognitive domains and tests. For 
the cognitive domains tested in Insight 46, more detailed discussions of the current 
evidence for pathology-related changes are provided in the introductions to the relevant 
chapters (4 to 8). As the Insight 46 cognitive battery was already in place before my 
involvement with the study, this review was not undertaken to inform the selection of 
cognitive tests, but rather to establish the consistency and magnitude of Aβ-related 
effects on cognition reported in other studies.  
The evidence for differences in cognition between cognitively-normal older adults with 
and without preclinical AD pathology was comprehensively evaluated in 2017 in a 
systematic review (Mortamais et al., 2017) and two meta-analyses (Baker et al., 2017; 
Duke Han et al., 2017). The findings of these three publications are summarised first, 
followed by a discussion of studies published between 2017 and April 2019.  
 
2.3.1. Summary of systematic reviews and meta-analyses of cognitive 
changes in preclinical AD 
Mortamais et al. (2017) summarised evidence of associations between cognition and the 
following three biomarker measures: structural brain changes, functional brain changes 
and amyloid burden. Most of the included studies did not claim to define a “preclinical 
AD” group, but investigated populations who were “at risk” of clinical AD due to the 
presence of the APOE-ε4 allele, amyloid deposition, or other markers of 
neurodegeneration such as hippocampal atrophy. The authors concluded that cross-
sectional studies generally have not observed associations between cognition and 
biomarkers of preclinical AD, although there were some positive results for episodic 
memory tests. However, they found more consistent evidence for associations between 
cognitive decline and amyloid burden in longitudinal studies with follow-ups of at least 2 
years, particularly for tests of episodic memory and for global cognitive composites.  
Baker et al. (2017) conducted a more focused meta-analysis of the effect of Aβ pathology 
on cognition in cognitively-normal older adults, as an update to a previous meta-analysis 
(Hedden et al., 2013). They concluded that in cross-sectional studies (n = 30) there was 
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evidence that Aβ+ groups showed small impairments (standardised effect sizes in the 
range d = 0.15 to 0.32) in global cognition, visuospatial function, processing speed, 
episodic memory and executive function. In longitudinal studies (n = 14) there was 
evidence that Aβ+ groups showed small to moderate cognitive decline (standardised 
effect sizes in the range d = 0.24 to 0.30) in episodic memory, visuospatial function, 
semantic memory and global cognition. Effect sizes were moderated by type of Aβ 
measure (PET or CSF), type of analysis, inclusion of covariates, and exclusion criteria 
used. 
Duke Han et al. (2017) conducted a similar meta-analysis of 61 cross-sectional studies 
comparing cognitive performance of Aβ+ and Aβ- cognitively-normal older adults 
(classified using PET or CSF), and concluded that Aβ+ individuals showed evidence of 
small impairments in global cognitive function, memory, language, visuospatial ability, 
processing speed, attention, working memory and executive functions (standardised 
effect sizes in the range d = 0.04 to 0.20). They conducted a second meta-analysis of a 
subset of studies comparing Aβ+ individuals with and without tau pathology or 
neurodegeneration (corresponding to Stages 1 and 2 of the NIA-AA 2011 criteria – see 
Table 2-1) and concluded that Aβ+ individuals with tau pathology or neurodegeneration 
were more impaired on memory measures than those without the additional pathology 
(d = 0.46). 
 
2.3.2. Studies published between 2017 and April 2019  
Between 2017 and April 2019, I appraised new publications in the field on a weekly basis. 
Some key themes from studies published during this period are highlighted below. 
Further studies have reported results consistent with the conclusions of the reviews 
discussed above, namely that cross-sectional differences in cognition between Aβ+ and 
Aβ- individuals are small and not observed in all studies, but Aβ+ individuals are 
consistently observed to show faster cognitive decline (Donohue, Sperling, et al., 2017; 
Harrington, Lim, Ames, Hassenstab, Laws, et al., 2017; Mormino et al., 2017; Baker et 
al., 2018; Rabin et al., 2018). Several studies have replicated the finding of Duke Han et 
al. that the poorest cognition and greatest cognitive decline is seen in Aβ+ individuals 
who have additional tau pathology and/or neurodegeneration (Soldan et al., 2016; Bilgel 
et al., 2018; Ho and Nation, 2018; Sperling et al., 2018). 
However, several studies have provided evidence that even sub-threshold amounts of 
Aβ pathology (below the cut-off for Aβ+) may have a detectable effect on cognition. One 
approach to studying sub-threshold Aβ pathology is to identify “amyloid accumulators” – 
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initially Aβ- individuals whose Aβ levels are rising at repeated assessments. Three 
separate cohorts of amyloid accumulators have shown evidence of declining memory 
(but not executive function) (Farrell et al., 2018; Landau et al., 2018; Leal et al., 2018), 
even in middle-aged adults (Farrell et al., 2018). Grothe et al. (2017) found similar results 
with an alternative approach that does not require longitudinal assessment: they 
developed a 4-stage model of Aβ deposition based its pattern of progressive 
accumulation in different brain regions and found an association between higher stage 
and poorer episodic memory (but not executive function) in cognitively-normal older 
adults. They noted that the staging system accounts for sub-threshold amyloid 
accumulation, as most individuals in stages 1 and 2 would be classified as Aβ-. A third 
approach is to investigate associations between cognition and a continuous measure of 
Aβ, the standard uptake volume ratio derived from Aβ-PET (SUVR, see section 3.2.2). 
In a study of 1164 cognitively-normal adults aged 50-95 years, Knopman et al. (2018) 
reported that higher SUVR was associated with lower scores on a global cognitive 
composite across its full range, including at values below the cut-point for Aβ+. Similarly, 
in a study of adults aged 40-89, Farrell et al. (2017) reported that higher SUVR predicted 
greater cognitive decline over 4 years and was a better predictor than the dichotomous 
Aβ+/ Aβ- classification.  
Taken together, these results suggest that subtle cognitive changes begin very early, 
decades before the onset of dementia. Indeed, recent preliminary estimates from the 
large Alzheimer’s Disease Neuroimaging Initiative (ADNI) suggest that memory decline 
may begin about 20 years before dementia, at around the same time as amyloid 
accumulation reaches the threshold for positivity (which is about 10 years after changes 
are seen in CSF markers of Aβ and tau) (Palmqvist et al., 2018). However, it is important 
to remember that these memory declines are likely to be so subtle that they would initially 
have little or no impact on daily life; a recent analysis of nearly 3000 cognitively-normal 
individuals concluded that it is not until age 70 that Aβ+ individuals are more likely to 
have a low score (defined as below the 10th percentile) on verbal memory tests, 10 to 15 
years after the onset of Aβ+ (Jansen et al., 2018). 
  
2.3.3. Implications for my research 
The above evidence suggests that subtle cognitive decline is detectable in cognitively-
normal people with biomarker evidence of Aβ pathology. There is solid basis for the 
hypothesis that Aβ+ Insight 46 participants may have poorer cognitive performance at 
baseline, but previous cross-sectional studies have reported mixed results, so there is a 
need for greater understanding about the magnitude and nature of Aβ-related effects on 
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cognition. The evidence suggests that early changes may be detectable in multiple 
cognitive domains, with episodic memory receiving the most attention, but there is a need 
for better characterisation of the profile of subtle impairments that may emerge. 
Given recent evidence that sub-threshold Aβ pathology may have detectable effects on 
cognition, I decided to use the continuous measure of Aβ (SUVR) in my analyses as well 
as the dichotomous Aβ+/ Aβ- classification (see section 3.2.2). 
 
 
2.4. Which predictors of individual differences in cognitive 
performance are most important to account for? 
As mentioned in section 2.1, accounting for factors associated with predictable variation 
in cognition between individuals should make it easier to detect subtle cognitive 
differences that may be associated with preclinical AD pathology. Three of the most 
obvious – age, sex and education – are highlighted in Figure 2-1, and discussed briefly 
below. As extensive research has been conducted on predictors of cognitive function 
across the life-course in the NSHD, Insight 46 has the advantage of being able to account 
for predictable variation in the cognitive performance of its participants; a summary of 
these key predictors follows in section 2.4.2. 
 
2.4.1. Factors that have been shown to predict cognitive performance in 
other samples of older adults 
This section contains some brief comments on the effects of age, sex and education on 
cognition in older adults. For each of the cognitive tests used within Insight 46, more 
detailed summaries of the literature on sex differences, ageing effects, and associations 
with education can be found in the introductions to the relevant chapters (4 to 8).  
Most cognitive functions decline with age – notably memory, attention, processing speed 
and executive functioning – although there is considerable variability between individuals 
and some aspects of cognition are generally improved or maintained with age, such as 
semantic knowledge and procedural skills (Glisky, 2007). The association between age 
and accumulation of AD pathology means that these two factors can confound each 
other in analyses if not accounted for. For example, several studies have reported that 
the estimation of ageing effects on cognition in older adults is substantially reduced when 
accounting for brain pathology, particularly for measures of memory, although stronger 
ageing effects on executive function remain (Hassenstab et al., 2016; Hedden et al., 
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2016; Harrington, Lim, Ames, Hassenstab, Rainey-Smith, et al., 2017; Hohman et al., 
2017; Harrington et al., 2018). 
Sex differences in cognition are a widely-researched and somewhat controversial topic. 
The commonly-held view is that males tend to perform better on spatial tasks and women 
on verbal tasks, although this is a simplification of a complex picture (Andreano and 
Cahill, 2009). Reports of superior verbal memory in women and superior visuospatial 
abilities in men are discussed in Chapters 4 and 5 respectively, in the context of verbal 
and visual memory tasks used in Insight 46. However, it is important to note here that 
sex differences in cognition are of particular interest to the field of Alzheimer’s research 
because women are disproportionately affected by the disease, making up 65% of those 
living with dementia (Prince et al., 2014). Whether or not this can be fully explained by 
women’s longer life expectancy has not yet been conclusively established (Medeiros and 
Silva, 2019). There is evidence of sex differences in the relationships between risk 
factors and the development of dementia, including APOE-ε4 (Neu et al., 2017), lifestyle 
factors (Norton et al., 2014; Xu et al., 2015; Podcasy and Epperson, 2016), and 
childhood intelligence (Snowdon et al., 1996; Whalley et al., 2000; McGurn et al., 2008; 
Russ et al., 2017; Huang et al., 2018).  
Associations between education and cognitive performance are widely observed across 
the life-span. For example, the US Alzheimer’s Disease Centers’ program has provided 
normative data for over 3000 clinically-normal older adults (~60-90 years) on cognitive 
tests that are widely-used in Alzheimer’s research, showing that more years of education 
predicted better performance on all tests (Weintraub et al., 2009; Shirk et al., 2011). 
Similarly, a study of over 7000 adults with normal cognition or MCI (age range ~40-90 
years) found a verbal memory advantage for those with higher education (Jansen et al., 
2018). The degree to which educational attainment reflects cognitive ability is a matter 
of ongoing debate (see below), but it is clear that accounting for some measure of prior 
cognitive ability is important when seeking to identify subtle cognitive impairment or 
decline associated with preclinical AD. This may be particularly necessary when studying 
individuals with a high baseline level of cognitive ability, because they may experience 
significant decline over a long period before their performance falls below the normal 
range for their age (Rentz et al., 2004, 2007). 
 
2.4.2. Factors that have been shown to predict cognitive performance 
across adulthood in the NSHD cohort 
Cognition has been assessed throughout childhood and adulthood in the NSHD. Details 
of the cognitive measures collected at different time-points are provided in section 3.2.1. 
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Measures of childhood cognitive ability have proved consistently predictive of cognition 
in middle age and later life (Richards and Sacker, 2003; Richards et al., 2004, 2019; 
Davis et al., 2017; Philippou et al., 2018) as well as a range of physical health parameters 
such as grip strength, standing balance and chair rise speed (Kuh et al., 2009; Cooper, 
Richards and Kuh, 2017), healthy dietary choice and exercise (Richards, Stephen and 
Mishra, 2010; Philippou et al., 2018), and mental health outcomes (Koike et al., 2017). 
Path models of cognition at ages 53 and 69 in the NSHD have shown that childhood 
cognitive ability has both direct and indirect effects on later-life cognition, with the indirect 
effects coming from its associations with educational attainment and adult 
socioeconomic position (defined according to occupational complexity), which are 
themselves predictors of cognition (Richards and Sacker, 2003; Richards et al., 2019). 
Importantly, educational attainment and adult socioeconomic position also showed 
independent effects on later-life cognition at both ages, unaccounted for by childhood 
cognitive ability. Childhood cognitive ability, educational attainment and adult 
socioeconomic position were all partly explained by mother’s educational attainment and 
father’s socioeconomic position, but neither of these two variables showed a direct path 
to the later-life cognitive measures (Richards and Sacker, 2003; Richards et al., 2019). 
The finding of an independent effect of education on later-life cognition makes an 
important contribution to the debate about the extent to which general cognitive ability, 
or IQ, determines cognitive function throughout life, suggesting that education has a 
causal influence on subsequent cognition (Richards and Sacker, 2011). This issue is 
covered in more depth when discussing the results of my analyses (see Chapter 10). 
 
2.4.3. Implications for my research 
One of the key advantages of Insight 46 is that participants were all born during the same 
week, so the problem of disentangling the effects of age and brain pathology is 
essentially avoided. However, because there is a range in “age at assessment” due to 
data collection being carried out over 2.6 years (see section 3.6), potential ageing effects 
cannot be ruled out so should still be accounted for.  
Insight 46 also has a unique advantage afforded by the availability of the life-course 
factors discussed above (childhood cognitive ability, educational attainment and adult 
socioeconomic position): predictable variation in cognition can be accounted for much 
more robustly than in most other studies which use educational attainment as a proxy 
for prior cognitive ability. This should increase the sensitivity of the cognitive measures 
to detect subtle differences that may be associated with Aβ pathology, as well as 
providing an opportunity to investigate and quantify the effects of childhood cognitive 
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ability, educational attainment and adult socioeconomic position on cognitive measures 
that are widely-used in research studies and clinical trials in preclinical AD. 
 
2.5. Which cognitive measures are most sensitive to subtle 
cognitive decline in preclinical AD? 
When the Insight 46 cognitive battery was designed, two approaches for improving the 
sensitivity of cognitive measures were adopted: 1) cognitive composites; 2) 
computerised tests with fine-grained outcome measures. A brief background to these 
two approaches is provided below.  
 
2.5.1. Cognitive composites 
A cognitive composite is a single score formed by combining scores from multiple 
cognitive tests. Cognitive composites are being used as outcome measures in several 
current clinical trials in preclinical AD (Weintraub et al., 2018) and the US Food and Drug 
Administration has recently indicated openness to cognitive composite end-points 
(Kozauer and Katz, 2013). The rationale for their use in this context is that they may be 
sensitive to cognitive decline when effects are too small to be detectable on individual 
tests; several studies have demonstrated that composites are particularly sensitivity to 
cognitive decline in cognitively-normal individuals meeting criteria for preclinical AD (e.g. 
(Ayutyanont et al., 2014; Langbaum et al., 2014; Mormino et al., 2017). In the context of 
clinical trials, an advantage of using a cognitive composite as a single outcome measure 
(rather than multiple cognitive outcomes) is that it reduces the likelihood of type 1 errors 
due to multiple comparisons (Ayutyanont et al., 2014; Langbaum et al., 2014; Jonaitis et 
al., 2019).  
There are two main approaches to composites – either to design them based on a priori 
hypotheses about which cognitive domains are affected earliest in the disease process 
(e.g. Donohue et al., 2014; Lim, Snyder, et al., 2016; Soldan et al., 2016; Bateman et al., 
2017; van Bergen et al., 2018; Wang et al., 2018) or to derive them empirically from 
cognitive data (e.g. (Ayutyanont et al., 2014; Langbaum et al., 2014; Donohue, Sun, et 
al., 2017). 
Further details of a widely-used composite – the Preclinical Alzheimer Cognitive 
Composite (PACC, (Donohue et al., 2014)) – are provided in Chapter 4, along with a 




2.5.2. Computerised tests 
Computerised tests offer scope to generate a range of precise outcome measures such 
as reaction times in milliseconds. Other advantages of computerised tests are ease of 
scoring, greater standardisation between testers, and the potential for presentation of 
items to be adapted automatically according to a participant’s performance (Silverberg 
et al., 2011). Computerised assessments offer the potential for remote testing, which can 
be of great value in studies seeking to screen or recruit large numbers of people, such 
as the PROTECT study which aims to administer repeated online cognitive assessments 
to at least 50,000 older adults over ten years (http://www.protectstudy.org.uk). It also 
allows the measurement of cognitive function in real-world environments (Sliwinski et al., 
2018).  
Even for relatively simple tasks where responses could be scored manually, 
computerised administration can provide additional information on the process by which 
an individual completes a task. For example, eye-tracking measures could be recorded 
during a visual recognition task (Bott et al., 2018), or a digital pen could reveal 
organisational strategies for completing a drawing task (Davis et al., 2014). Evidence 
suggests that the earliest stages of cognitive decline are characterised by the adoption 
of compensatory strategies (Jessen et al., 2014), so these kind of ‘process measures’ 
are potentially useful for detecting individuals who may be working harder or thinking 
longer to achieve the same result, perhaps before showing more overt decline (Davis et 
al., 2014).  
The field of cognitive assessment in preclinical AD is increasingly moving towards using 
computerised assessments for the reasons mentioned above (Silverberg et al., 2011; 
Rentz et al., 2013; Ritchie et al., 2017; Hassenstab et al., 2018). 
 
2.5.3. Implications for my research 
Given that cognitive composites and computerised assessments are increasingly being 
used in preclinical AD research, it is important to evaluate how these measures compare 
to individual scores from standard paper-and-pencil cognitive tests in Insight 46. This 
should contribute to the evidence base on the most sensitive cognitive measures to use 





2.6. Other influences on cognitive decline 
It is important to be aware that other brain pathologies influence cognitive performance, 
as well as Aβ pathology. The rich dataset of biomarker and genetic measures collected 
in Insight 46 provides the opportunity to investigate some of these other pathologies and 
genetic risk factors. My aim in including some of these variables in my models of 
cognitive performance was partly to increase the sensitivity of my analyses to the effects 
of Aβ by accounting for potential confounding effects of other variables, but also to 
generate new evidence about their associations with cognition. The three variables that 
are explored throughout this thesis are APOE-ε4, whole brain volume and global white 
matter hyperintensity volume (WMHV). As these variables are not the primary focus of 
my research, I have not conducted a comprehensive review of evidence for their 
associations with cognition, but some introductory comments are provided below. 
 
2.6.1. APOE-ε4 
The strongest genetic risk-factor for sporadic AD is the apolipoprotein gene (APOE), 
which occurs in three different alleles: ε2, ε3 and ε4. Each person has 2 copies, with the 
most common combination being ε3/ε3 (60% of the population (Alzheimer’s Society, 
2016a)). The ε4 allele is associated with increased lifetime risk of developing AD in a 
dose-dependent manner: ε4-heterozygotes have a fourfold increase in risk, and ε4-
homozygotes have a tenfold increase in risk (compared to ε3-homozygotes) (Alzheimer’s 
Society, 2016a). The mechanism for this increased risk is understood to relate to reduced 
clearance of Aβ in APOE-ε4 carriers, resulting in accumulation of a higher burden of Aβ 
plaques (Kline, 2012). Among older adults, APOE-ε4 carriers are around twice as likely 
as non-carriers to be Aβ+, with around 50% of ε4 carriers aged ~50-90 years estimated 
to be Aβ+ (Rowe et al., 2007; Jack et al., 2017). 
The interactions between APOE-ε4 and Aβ on cognition are yet to be fully understood. 
Many studies investigating associations between APOE-ε4 and cognition have not 
included measures of Aβ, making it impossible to know whether Aβ may account for 
cognitive deficits observed in ε4-carriers, although evidence for such deficits is mixed 
(see O’Donoghue et al. (2018) for a review). Several studies that were able to account 
for Aβ have reported that Aβ- ε4-carriers seem to experience normal cognitive aging, 
suggesting that Aβ is necessary for memory decline (Lim, Laws, et al., 2016; Lim et al., 
2018). However, there is evidence that Aβ and APOE-ε4 may interact such that clinically-
normal Aβ+ ε4-carriers experience faster memory decline than Aβ+ non-carriers 
(Mormino et al., 2014; Lim et al., 2015) and have a higher risk of progression to MCI or 
dementia (Dang et al., 2018). 
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Beneficial effects of APOE-ε4 have also been reported, particularly during youth, with 
growing evidence that APOE-ε4 is associated with a diverse range of survival 
advantages including resistance to certain infections, increased fertility, increased fitness 
in infancy and slightly superiority in some aspects of cognition (Duke Han and Bondi, 
2008; Zetterberg et al., 2009; Tuminello and Duke Han, 2011; Smith, Ashford and 
Perfetti, 2019). This is an example of antagonistic pleiotropy – the principle that some 
genes have both beneficial and detrimental effects, with the detrimental effects generally 
manifesting after reproductive age (Austad and Hoffman, 2018). However, the putative 
beneficial effects of APOE-ε4 on cognition in earlier life are controversial and the 
literature has not yet reached a consensus (see reviews in (Tuminello and Duke Han, 
2011; O’Donoghue et al., 2018)). 
 
2.6.2. White matter hyperintensity volume (WMHV) 
White matter hyperintensities are commonly seen on brain MRI scans of older adults and 
reflect lesions caused by cerebral small vessel disease (Prins and Scheltens, 2015). 
White matter lesions are considered to be the primary pathology of vascular dementia – 
the second most common type of dementia after AD (Alzheimer’s Society, 2018) – but 
are also commonly seen in patients with AD (Prins and Scheltens, 2015; Alosco et al., 
2018). Greater WMHV in cognitively-normal older people is associated with increased 
risk of dementia (Debette and Markus, 2010; Payton et al., 2018) and with decline in 
cognition, particularly processing speed and executive function, although the 
associations with cognition generally appear to be weak (Gunning-Dixon and Raz, 2000; 
De Groot et al., 2002; Oosterman et al., 2004; Prins et al., 2005; van Dijk et al., 2008; 
Prins and Scheltens, 2015; Kaskikallio et al., 2019). 
 
2.6.3. Whole brain volume 
Loss of brain volume, or atrophy, occurs gradually with age, but accelerated atrophy is 
a feature of neurodegenerative diseases that tracks closely with the progression of 
symptoms (Fox and Schott, 2004). Accelerated atrophy typically occurs relatively late in 
the AD pathological continuum, some years after accumulation of Aβ and tau pathology 
(Jack et al., 2013). Therefore, evidence of significant atrophy is not expected among 
Insight 46 participants as they are at an age when those who are destined to develop 
dementia are still likely to be many years from symptoms (Prince et al., 2014).  
Aside from atrophy, another area of interest is whether brain volume is associated with 
cognitive ability at younger ages. This possibility has received attention in the long-
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running debate about the neural basis for differences in intelligence (McDaniel, 2005), 
and two recent studies of large samples of young adults have reported that larger brain 
volume is weakly associated with better cognition, notably in terms of faster processing 
speed (Magistro et al., 2015; Takeuchi et al., 2017). 
 
 
2.7. Research Questions and Hypotheses 
 
2.7.1. Research Questions 
My research sought to address three broad questions: 
i) What are the patterns of performance on each cognitive test?  
If the cognitive tests used in Insight 46 are to have future application as markers 
of preclinical AD, it is important to confirm that the tasks work appropriately in this 
age group (e.g. are there any floor or ceiling effects?) and to describe the normal 
range of performance. As the computerised tests have several different 
conditions (e.g. easier and harder levels) and outcomes, (e.g. speed and 
accuracy), identifying key outcome measures that may be particularly sensitive 
to subtle cognitive decline requires an understanding of patterns of performance 
across the various aspects of each task, such as “Is there a trade-off between 
speed and accuracy?” or “To what extent is memory recall affected by the number 
of items to be remembered?”. 
 
ii) What are the relationships between demographic and life-course predictors 
and performance on the cognitive tests? 
As discussed in section 2.4, I sought to understand more about predictors of 
cognitive performance at age ~70 by investigating the effects of childhood 
cognitive ability, education, adult socioeconomic position, age at assessment, 
and sex. As well as aiming to generate novel evidence about predictors of 
performance on the specific cognitive tests used in Insight 46, the purpose of this 
was to be able to account for predictable variation between individuals, which 
may increase the sensitivity of the tests to detecting subtle cognitive changes 




iii) What are the relationships between biomarkers and genetic risk factors for 
AD and performance on the cognitive tests?  
As discussed in section 2.6, I aimed to investigate whether the following 
measures were associated with cognitive performance: Aβ pathology 
(dichotomous amyloid status and continuous SUVR), whole brain volume, global 
WMHV and APOE-ε4. 
 
2.7.2. Hypotheses 
Overarching hypotheses are listed below. Specific hypotheses for each cognitive test are 
stated in the relevant chapters (4-8): 
 
i) Higher childhood cognitive ability, educational attainment and adult 
socioeconomic position will show independent associations with better cognitive 
performance. 
ii) As the sample size of Insight 46 (n = 502) is large for a neuropsychological study, 
subtle sex differences in cognition will be detectable. 
iii) Participants with elevated Aβ deposition will show evidence of subtle cognitive 
deficits.  
iv) WMHV and whole brain volume will show evidence of weak associations with 
cognition, particularly processing speed.  
v) Composite and computerised measures will be more sensitive to brain pathology 
than standard paper-and-pencil cognitive tests. 
Given the mixed evidence for effects of APOE-ε4 on cognition independent of Aβ (see 
2.6.1), I did not make an overarching hypothesis about the effects of APOE-ε4, but I 
made a specific hypothesis for one of the cognitive tasks where previous studies have 





3. GENERAL METHODOLOGY 
 
3.1. Recruitment and data collection 
The target sample for Insight 46 was NSHD participants who had a specific set of life-
course data available including attendance at a clinic visit at age 60-64, at least one 
measure of childhood cognition, and various measures of physical health and lifestyle 
during adulthood – full details have been published in the protocol paper (Lane et al., 
2017). Additionally, participants were required to be willing to attend a clinic-based visit 
at UCL and to have no contraindications to MRI or PET, such as severe claustrophobia, 
or metal within the body (e.g. pacemakers and intracranial clips). Participants were sent 
an invitation by post and then screened by telephone if interested. A recruitment flow-
chart is provided in Figure 3-1 and further details have been published (Lane et al., 2017; 
James et al., 2018). 
502 participants were recruited to Insight 46 and attended a baseline assessment 
between May 2015 and January 2018. Ethical approval for Insight 46 was granted by the 
National Research Ethics Service (NRES) Committee London (14/LO/1173). All 
participants gave written informed consent.  
The study protocol included: cognitive tests; a clinical interview with a neurologist; a 
structured physical and neurological examination; assessment of visual, auditory and 
olfactory function; self-administered questionnaires measuring subjective cognitive 
decline, anxiety, dental health, handedness and sleep; collection of blood and urine for 
clinical and genetic biomarker identification; neuroimaging comprising simultaneous 
acquisition of β-amyloid PET and MRI data. Each participant had an informant who 
completed the AD8 interview, a brief screening tool for dementia (Galvin et al., 2005). 
Further details are provided in section 3.2 and in the protocol paper (Lane et al., 2017). 
While all assessments were typically completed on one day, 62 participants had to have 
their scans rescheduled for a later date, with a median interval of 49 days (IQR = 26 – 
77; range = 1 – 216). For the purpose of calculating age at assessment, the date of 






























Figure 3-1. Flowchart of recruitment and data acquisition 
The specific dataset refers to a set of life-course data which formed the original criteria for 
Insight 46 eligibility – see text for further details. To reach our target sample size, these criteria 
were relaxed to remove the requirement for a previous measure of lung function, smoking or 
physical exercise, enabling recruitment of a further 62 individuals. Details of the biomarker 
measures are provided in section 3.2.2. 
a In most cases, this was due to erroneous segmentation of vascular abnormalities such as 
stroke or demyelination. 
FLAIR = fluid attenuated inversion recovery MRI; MR = magnetic resonance; PET = positron 
emission tomography  
Active sample at 
age 69               
n = 2689 
Available specific 
dataset                    
n = 1322 
Willing to attend 
London-based clinic 
n = 779 
Invited for study 
participation            
n = 841  
Attended 
research centre                         
n = 502 
Completed 
scan                 
n = 471 
No scan  
n = 31 
Did not attend 
research centre          
n = 339 
Unknown 
willingness   
n = 302 
Not willing to attend 
London-based clinic     
n = 241 
Incomplete 
dataset               
n = 1367 
n=62 
Complete 
biomarker data    
n = 445 
Failed acquisition of PET data n=8 
MR images failed quality control n=3 
FLAIR images failed quality control n=2 
White matter segmentation failure 
a
 n=11 
No APOE data available n=2 
Claustrophobia n=25 
PET/MRI incompatibility issues n=4 
Recent illness n=1 
Withdrawal before being rescheduled n=1 
Incomplete 
biomarker data     
n = 57 
Refusals n=204 
Temporary refusals n=28 
Not eligible n=69 
Non-response n=12 
Deaths notified n=3 




3.2. Materials and measures 
 
3.2.1. Cognitive Battery 
As my research focuses on the cognitive data, the methods for its collection, processing 
and analysis are described in detail in this section.  
The cognitive battery was designed to have the following characteristics: 1) to be 
complementary to prior NSHD cognitive assessments, the most recent of which included 
the Addenbrooke’s Cognitive Examination III (Hsieh et al., 2013), a word-list learning 
task and a timed letter search task (Silverwood et al., 2014); 2) to have a total duration 
of less than 90 minutes; 3) to include standardised cognitive tests to allow results to be 
compared with normative data; 4) to include experimental computerised cognitive tests 
that might be more sensitive to subtle cognitive decline; 5) to be informed by a review of 
protocols and results of current large-scale initiatives and clinical trials in preclinical AD 
(including the A4 trial (Sperling et al., 2014) and the Alzheimer’s Prevention Initiative 
(Reiman et al., 2011)).  
An overview of the cognitive tests in the Insight 46 battery is provided in Table 3-1. Four 
of these tests are standardised clinical neuropsychological tests that have been widely 
used in studies of preclinical AD and the others are more novel tests. To facilitate 
comparison of the Insight 46 battery with the cognitive tests administered previously in 
NSHD, I compiled a table which was included in the Insight 46 protocol paper (Lane et 
al., 2017); an updated copy is included here which contains more citations of recent 
relevant publications (Table 3-2).  
The order of tests within the Insight 46 cognitive battery was designed to allow for the 
necessary delay times between the various recall trials of the memory tests (Table 3-3).  
Chapters 4 to 9 of this thesis present my work analysing and interpreting the results of 
these cognitive tests, with the exception of the Instructionless Eyetracking and Irrelevant 
Distractor tests. These two tests were only performed on sub-samples of the Insight 46 
cohort because the Irrelevant Distractor test was dropped from the battery and replaced 
by the Instructionless Eyetracking test in February 2017 (mid-way through data 
collection). This change was made because many participants found the Irrelevant 
Distractor test very difficult due to its fast presentation speed: 3% of participants declined 
to attempt the task after struggling with the practice, and 48% of those who attempted it 
had error rates of greater than or equal to 50% (the level that would be achieved by 
chance) in at least one part of the task. Therefore, in view of the fact that the task was 
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unpopular with participants and seemed unlikely to yield informative results, I decided 
along with my supervisors to remove it. The Instructionless Eyetracking test was chosen 
as a replacement based on evidence that eye movement patterns may reveal early 
changes in  memory, attention, visuospatial and executive processes (Pereira et al., 
2014; Primativo et al., 2017)  Data from the Instructionless Eyetracking test have not yet 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 3-3. Order and timings of the Insight 46 cognitive battery 
Cognitive test Mean duration (minutes) 
Circle-tracing pre-exposure 8 
Logical Memory Immediate Recall 2 
Matrix Reasoning 10 
Instructionless Eyetracking (or Irrelevant Distractor for 
participants tested before 08/02/17) 
13 
Logical Memory Delayed Recall 1 
FNAME-12 trials 1 and 2 8 
Choice Reaction Time and Response Inhibition 10 
FNAME-12 trial 3 3 
Digit-Symbol Substitution 3 
“What was where?” 10 
Circle-tracing and Serial Subtraction 10 
FNAME-12 trial 4 4 
 




3.2.2. Biomarker measures and genetic risk factors 
Full details of biomarker measures collected in Insight 46 are provided in the protocol 
paper (Lane et al., 2017). Details are provided below for only those variables which I 
have used in subsequent analyses.  
β-amyloid PET and MRI data were collected simultaneously during a 60-minute scanning 
session on a Biograph m MR 3 T PET/MRI scanner (Siemens Healthcare, Erlangen), 
with intravenous injection of a β-amyloid PET ligand, 370 MBq florbetapir F18 (Amyvid). 
Aβ deposition was quantified using a global Standard Uptake Volume Ratio (SUVR), 
using 10 minutes of static steady state Florbetapir data ~50 mins post-injection. The 
SUVR was calculated from a cortical grey matter composite (composed of frontal, 
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temporal, parietal, and cingulate regions), with a reference region of eroded subcortical 
white matter. Aβ-PET attenuation correction was performed using pseudo-CT correction. 
Due to technical issues, only console attenuation correction was available for 26 
participants. For these participants a pseudo-CT corrected value was imputed based on 
their console value.  
A cut-point for Aβ positivity was determined using a mixture model to define two 
Gaussians, and using the 99th percentile of the lower (Aβ negative) Gaussian, at SUVR 
> 0.6104. This gives a dichotomous variable of amyloid status: Aβ+ (elevated levels of 
β-amyloid) or Aβ- (normal levels of β-amyloid). 
Volumetric T1-weighted and FLAIR (fluid attenuated inversion recovery) MR images 
underwent visual quality control, before being processed using automated pipelines 
(Lane et al., 2017). Whole brain volume was generated from high resolution 3D T1-
weighted MRI using automated segmentation with manual editing (Leung et al., 2011). 
Total intracranial volume (TIV) was calculated using statistical parametric mapping 
(SPM) software (SPM12; http://www.fil.ion.ucl.ac.uk/spm) (Malone et al., 2015). Global 
white matter hyperintensity volume (WMHV) was generated from T1-weighted and 
FLAIR MRI using Bayesian Model Selection (BaMoS), an automated segmentation 
algorithm based on a multivariate Gaussian mixture model (Sudre et al., 2015), followed 
by visual quality control, generating a global WMHV including subcortical grey matter but 
excluding infratentorial regions. 
APOE genotyping was conducted at LGC, Hoddesdon UK. For the analyses presented 
in this thesis, participants were classified into two categories based on the presence of 
the APOE-ε4 allele: ε4-carriers and non-carriers. 
 
 
3.2.3. Major neurological and psychiatric conditions 
Participants were coded as having a major neurological or psychiatric condition 
according to the criteria in Table 3-4. Participants not meeting any of these criteria are 
hereafter referred to as cognitively normal and represent a sample who might be 
considered eligible for a clinical trial of cognitively healthy individuals, free from possible 
confounding comorbidities. This does not imply that all participants with a major 
neurological or psychiatric condition necessarily had a measurable cognitive impairment.  
58 
 




3.2.4. Life-course data 
As discussed in sections 2.4.2 and 2.4.3, three key predictors of life-time cognition 
among NSHD participants are childhood cognitive ability, educational attainment and 
adult socioeconomic position. These variables are defined as follows, using definitions 
used in many previous analyses from the NHSD (e.g. Richards and Sacker (2003); 
Rawle et al. (2018)). 
Childhood cognitive ability was measured at age 8 using four tests of verbal and non-
verbal ability devised by the National Foundation for Education Research (Pigeon, 1964) 
(see Table 3-2). The sum of scores from these four tests was standardised into a z-score 
representing overall cognitive ability. If these data were missing, the standardised score 
 Clinical evidence of dementia, Parkinson’s disease and other neurodegenerative 
disorder 
 Psychiatric disorder requiring anti-psychotic medication 
 Depression requiring electroconvulsive shock therapy 
 Epilepsy requiring active treatment 
 Radiological evidence of traumatic brain injury or major neurosurgery 
 Clinical diagnosis or radiological features of multiple sclerosis  
 Clinical diagnosis of stroke, or radiological evidence of cortical ischaemia or 
haemorrhage consistent with previous cortical stroke  
 Radiological evidence of possible brain malignancy 
 Mild cognitive impairment (MCI) defined as follows, based on published criteria 
(Petersen et al., 2013):   
o No clinical evidence of dementia  
o AND participant concern regarding their cognition (memory or cognitive 
difficulties more than other people the same age, or if they felt they would 
seek medical attention regarding their difficulties) and/or informant 
concern regarding the participant’s cognition (AD8 score ≥ 2)  
o AND objective evidence of either an amnestic (Logical Memory delayed 
recall ≥ 1.5 SD below the mean) and/or non-amnestic deficit (Digit-
Symbol Substitution score ≥ 1.5 SD below the mean). These cognitive 
tests were chosen for defining a cognitive deficit on the basis of their 




from the tests at age 11 was used (or if this was missing, the standardised score from 
the tests at age 15). Note that these scores were standardised for the full cohort 
(N=5362) rather than the Insight 46 sample. 
Educational attainment was recorded at age 26. Highest educational or training 
qualification achieved was classified using the Burnham scale (Department of Education 
and Science, 1972) and grouped into five categories: no qualification, below O-levels 
(vocational), O-levels and equivalents, A-levels and equivalents, higher education 
(degree and equivalents). 
Adult socioeconomic position (SEP) was derived from participants’ own occupation 
at age 53, or earlier if this was missing. Occupations were coded according to the UK 
Registrar General’s Standard’s Occupational Classification, then classified into six 




3.3. Completion rates and reasons for missing data 
Completion rates for the biomarker measures and reasons for missing biomarker data 
are shown in Figure 3-1.  
Figure 3-2 shows completion rates for cognitive assessments and Table 3-5 gives the 


















Figure 3-2. Venn diagram of completion rates for Insight 46 cognitive tests  
As shown here, 470 out of 502 participants completed all of the cognitive tests. There were no 
missing data for the Logical Memory, MMSE, Matrix Reasoning and Choice Reaction Time tests, 




Table 3-5. Reasons for missing cognitive data 




Technical problems 11 
Participant unable due to tremor in hands 3 
Participant declined to complete task 4 
Lack of time* 1 
Response Inhibition Data file not saved 1 
“What was where?” 
Not administered due to technical problems  10 
Participant started the task but declined to 
complete it 
1 
Participant had recently had hand surgery 
and could not operate the touchscreen 
1 
Lack of time* 4 
FNAME-12 
Technical problems 1 
Data from this task are partially missing – the 
fourth trial was administered in place of the 
third trial, because the time elapsed since the 
second trial was already 30 minutes.* 
1 
Digit-Symbol Participant declined to attempt this task 1 
 
* Three participants took longer than usual to complete tasks due to neurological conditions 




3.4. Processing of cognitive data 
Test scores collected on paper (MMSE, Matrix Reasoning, Logical Memory, Digit-
Symbol, FNAME-12) were inputted into XNAT, a customised web-based database 
(www.xnat.org). XNAT was also used to record reasons for any missing data. After 
consultation with the various authors of the computerised cognitive tests, I wrote 
programmes in Stata v15 (StataCorp, 2017) to clean the data and generate the outcome 




3.5. Data analysis 
Chapters 4 to 8 report the results of the cognitive tests administered to Insight 46 
participants. In each chapter, analyses are split into two parts. Part 1 addresses the first 
and second research questions posed in section 2.7, namely “What are the patterns of 
performance on each cognitive test?” and “What are the relationships between 
demographic and life-course predictors and performance on the cognitive tests?”. Part 2 
addresses the third research question posed in section 2.7, namely “What are the 
relationships between biomarkers and genetic risk factors for AD and performance on 
the cognitive tests?”. My approach to these analyses is described below in sections 3.5.1 
and 3.5.2, followed by an explanation of the statistical models for the computerised tests 
(section 3.5.3).  
 
All analyses were conducted in Stata v15 (StataCorp, 2017). Results were considered 
statistically significant if the chance of a false positive finding was below 0.05. 
 
3.5.1. Patterns and predictors of performance 
Most of the computerised cognitive tests generate trial-by-trial outcome data (e.g. 
reaction time for each individual response). In order to explore patterns of performance 
in as much detail as possible, these trial-by-trial data were used rather than summary 
scores, and relationships between different task outcomes (e.g. speed and accuracy) 
were explored. 
For analyses investigating the effects of demographic and life-course predictors on 
cognition, all participants were included. The rationale for including all participants (rather 
than excluding those with a major neurological or psychiatric condition) was to be able 
to describe the predictors of cognition in as representative a sample as possible. 
Neurological and psychiatric conditions are not uncommon among older people, and 
their inclusion takes advantage of a key strength of Insight 46: it is a population-based 
sample, likely to be more representative of the general population than most studies in 
ageing and AD research (see section 10.3.1 for a discussion of the representativeness 
of Insight 46 and comparison with other studies). However, as many neurological and 
psychiatric conditions affect cognition, it is important to account for these effects which 
may confound the effects of other predictors (for example, a lifelong condition affecting 
cognition is likely to be associated with lower childhood cognitive ability and educational 
attainment). Therefore, a dichotomous factor coding for the presence of a major 
neurological or psychiatric condition (yes vs. no) was included in all analyses. While the 
different neurological and psychiatric conditions are associated with different profiles of 
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cognitive impairment, it was not appropriate to compare one condition against another 
due to the very small numbers of participants with each condition (see section 3.6). 
Multivariate models were used since I was interested in determining the independent 
effects of each predictor (e.g. the effect of educational attainment accounting for 
childhood cognitive ability and all other predictors). Predictors in the models were sex, 
age at assessment, childhood cognitive ability, education, adult socioeconomic position 
and presence of a neurological or psychiatric condition. (See section 3.2.4 for definitions 
of variables.)  Education was treated as a continuous variable with values of 1 to 5 
corresponding to the five categories defined in section 3.2.4. Similarly, adult 
socioeconomic position was treated as a continuous variable with values of 1 to 6. 
 
3.5.2. Associations with biomarkers and APOE-ε4 
The second analysis section of each chapter investigates associations between 
cognitive performance and the following biomarkers measures: Aβ pathology, whole 
brain volume, WMHV and APOE-ε4. (See sections 2.6 and 3.2.2 for background and 
definitions of these measures). In terms of Aβ pathology, I chose to focus primarily on 
amyloid status (Aβ+ vs. Aβ-), since it identifies those whose Aβ burden is abnormal and 
is integral to standard criteria for preclinical AD (see section 2.2). However, I also reran 
all analyses using SUVR, the continuous measure of Aβ burden, instead of dichotomous 
amyloid status, in recognition of the fact that the cut-point for Aβ+ is arbitrary and sub-
threshold accumulation of Aβ may have an impact on cognition (see section 2.3.3). To 
check whether associations between SUVR and cognition were sensitive to the inclusion 
of the imputed SUVR values (see section 3.2.2), these analyses were additionally rerun 
excluding the 26 participants with imputed data. 
Participants meeting criteria for major neurological or psychiatric conditions (see section 
3.2.3) were excluded from these analyses, as the aim was to investigate whether the 
cognitive tests may be sensitive to pathology in cognitively-normal individuals. The 
cognitively-normal sub-sample represents a non-demented, non-MCI population free 
from known possible confounding comorbidities, who might be considered eligible for a 
clinical trial targeting preclinical AD.  
Since I was interested in determining the relative contributions of each biomarker to the 
cognitive outcome measures, and I know that they are not necessarily independent, 
multivariate models were used so that the reported effects of each biomarker are 
adjusted for all the others. The models also included the factors tested in the first section 
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(sex, age at assessment, childhood cognitive ability, education and adult socioeconomic 
position).  
 
3.5.2.1. Selection of summary outcome variables 
As the computerised tests are complex with many trials and various different conditions 
and outcomes, I aimed to identify a few summary outcomes for each test that capture 
the key aspects of performance. Reducing the data to a small number of summary 
outcomes is desirable as it allows me to describe associations between biomarkers and 
participants’ overall pattern of performance (as opposed to their trial-by-trial 
performance) and enables key outcomes to be compared across the different cognitive 
tests in the Insight 46 battery in a standardised manner. It is important to be able to 
compare the magnitude of subtle cognitive deficits associated with Aβ pathology across 
different cognitive tasks and domains, as this may deepen our understanding of the 
nature and timing of cognitive decline associated with accumulation of pathology – this 
is addressed in Chapter 9. Some of the computerised tests have obvious summary 
outcomes, such as mean RT, but for other tests the most meaningful summary outcome 
depends on the pattern of results across different conditions of the task, such as 
discrepancies in performance between easy and hard conditions. In choosing summary 
outcomes, I prioritised those which showed promise in sensitivity to Aβ pathology.  
 
3.5.3. Statistical models 
 
3.5.3.1. Computerised cognitive tests 
I reviewed the statistical approaches of previous studies that have used the 
computerised cognitive tests in the Insight 46 battery and discussed the various models 
with Jennifer Nicholas (study statistician) in order to decide on the best approach for 
modelling the outcomes of each test. As each computerised task contains various 
different conditions, there are repeated measures on each participant, so models must 
account for the fact that repeated measures within a participant are likely to be 
correlated.  
Some previous papers on the “What was where?” and Circle-tracing tasks chose to use 
repeated measures analysis of variance (ANOVA) where each participant was given a 
mean score for each condition and these mean scores were entered into the model (e.g. 
(Pertzov et al., 2012, 2015; Vaportzis et al., 2015b). Other analyses have used 
Generalised Estimating Equations (GEE), which are similar to standard regression but 
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enable repeated measures to be accounted for by specifying an appropriate correlation 
structure (see below), and using robust standard errors to account for the fact that the 
assumed correlation structure may not be entirely accurate (e.g. (Say et al., 2011)). 
Disadvantages of the ANOVA approach are that information is lost by the reduction of 
data to mean scores, particularly information about within-participant variability, and it is 
heavily reliant on the assumption that the outcome is normally distributed. In contrast, 
GEE models allow analysis of the full trial-by-trial data (e.g. reaction times for every 
individual response) and are also more flexible, being able to accommodate different 
distributions of outcome variables, so I chose to adopt a GEE approach. 
For continuous outcomes (e.g. reaction time), GEE linear models were used with an 
exchangeable correlation structure, which assumes that each response is equally likely 
to be correlated with each other response within-subject. For continuous outcomes with 
skewed distributions, appropriate transformations were first applied so that the data more 
closely approximated the normal distribution (e.g. log-transformation of reaction time 
data). For dichotomous outcomes (e.g. correct vs. incorrect response), GEE logistic 
models were used with an independent correlation structure. The GEE method accounts 
for the fact that the assumption of this correlation structure is likely to be violated (as 
repeated responses within-participant are likely to be correlated rather than totally 
independent) by estimating the within-participant correlations and using this to calculate 
adjusted estimates of the p values and confidence intervals.  
 
3.5.3.2. Paper-and-pencil cognitive tests and summary scores 
For analyses of the paper-and-pencil tests or the summary outcome variables from the 
computerised tests (see section 3.5.2.1), each participant had a single score, so 
repeated measures were not an issue. Where the distribution of these scores 
approximated to the normal distribution, linear regression was performed. Examination 
of residuals was performed to check model fits. For outcomes with skewed distributions, 
appropriate transformations were considered (e.g. log-transformation or square-root 
transformation). For outcomes where a transformation was not appropriate but skew was 
still a concern, bootstrapping was used to produce bias-corrected and accelerated 95% 
confidence intervals from 2000 replications. For outcomes that were derived from 
multiple binary responses (e.g. percentage of correct responses across a task where 
each response was either correct or incorrect), GEE logistic regression was performed 




3.5.3.3. Consideration of correction for multiple comparisons and 
multicollinearity of predictors 
Although each model contained several predictors (e.g. sex, education, amyloid status), 
corrections for multiple comparisons were not applied. This was felt to be appropriate 
because my analyses were testing specific hypotheses about the effects of each 
predictor based on the literature, with the purpose of replicating and extending previous 
findings. The assumption underlying the practice of correcting for multiple comparisons 
is that the first explanation for non-null findings is chance, which may lead to errors of 
interpretation (Rothman, 1990). Correction for multiple comparisons is appropriate in 
scenarios where the result will be used to justify a decision with significant impact (e.g. 
in a clinical trial with multiple primary outcome measures where a drug may be licensed 
based on a positive effect on any one outcome measure) or when a large exploratory 
analysis is conducted without prior hypotheses (e.g. a genome-wide association study 
where thousands of genes are compared and it is statistically likely that numerous false 
positives would be detected). Where significant results are detected in this thesis, they 
are interpreted cautiously with reference to previous literature.  
Models were not checked for multicollinearity through variance inflation factors, but this 
was not felt to be a concern as correlations between the predictors were modest at most. 
For example, Spearman’s correlations between childhood cognitive ability, education 
and adult socioeconomic position are as follows: childhood cognitive ability and 
education ρ = 0.50, p < 0.0001; education and adult socioeconomic position ρ = 0.51, 
p < 0.0001; childhood cognitive ability and adult socioeconomic position ρ = 0.29, 
p < 0.0001. 
 
3.6. Participant Characteristics 
Forty-nine out of 502 participants met criteria for a neurological or psychiatric condition 
(see section 3.2.3), leaving 453 participants classified as cognitively-normal. Prevalence 








Parkinson’s disease or other neurodegenerative disorder 5 
Psychiatric disorder requiring anti-psychotic medication 2 
Depression requiring electroconvulsive shock therapy 2 
Epilepsy requiring active treatment 7 
Traumatic brain injury or major neurosurgery 2 
Multiple sclerosis 3 
Cortical stroke 18 
Brain malignancy 1 
Mild cognitive impairment (MCI) 11 
 
Note: although 49 participants met criteria for neurological or psychiatric conditions, the 
numbers in this table add up to 54 because some participants had more than one condition. 
 
As detailed in Figure 3-1, 445 participants had complete biomarker data. Of these, 406 
were classified as cognitively-normal. Of these, 18.3% were classified as Aβ+, which is 
around the expected prevalence for this age (Jansen et al., 2015). 
Table 3-7 shows the participant characteristics for the full sample (n = 502, used for the 
first section of analyses in Chapters 4 to 8) and the sub-sample of cognitively-normal 
participants with complete biomarker data, stratified by amyloid status (n = 406, used for 
the second section of analyses in Chapters 4 to 8). 
Chi-square, t-tests and rank-sum tests were used as appropriate to test whether the Aβ+ 
and Aβ- groups differed in their characteristics. As expected, Aβ+ were more likely to be 
APOE-ε4 carriers (χ2 = 41.6, p < 0.0001) but there was no evidence of statistically 
significant differences in any other characteristics (sex: χ2 = 0.52, p = 0.47; age at 
assessment: t = 0.33, p = 0.74; education: z = 0.73, p = 0.47; childhood cognitive ability: 
t = -0.35, p = 0.72; adult socioeconomic position: z = -1.31, p = 0.19; WMHV: z = -0.68, 
p = 0.50, whole brain volume: t = -0.61, p = 0.54).   
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Table 3-7. Participant characteristics  
 
All participants 
Cognitively-normal a participants 
with complete biomarker data 
 Aβ+ Aβ- 
N 502 74 332 
Sex: % female 49 46 51 
Age at assessment:  
mean, SD, (range) 
70.7, 0.68 
(69.2 to 71.8) 
70.6, 0.66 
(69.4 to 71.8) 
70.6, 0.70 
(69.2 to 71.8) 
Educational attainment: %    
None 15.5 17.6 15.4 
Below O-levels (vocational)  5.2 6.8 4.2 
O-levels or equivalent 24.9 25.7 26.2 
A-levels or equivalent 35.7 32.4 35.2 
Degree or equivalent 18.7 17.6 19.0 
Childhood cognitive ability 
(z-score) b :  
mean, SD, (range) 
0.39, 0.74 




(-1.59 to 2.47) 
Adult SEP: %    
Unskilled 1.0 1.4 0.6 
Partly skilled 4.8 2.7 5.4 
Skilled manual 9.4 9.5 9.3 
Skilled non-manual 21.3 16.2 22.0 
Intermediate 52.2 55.4 51.8 
Professional 11.4 14.9 10.8 
SUVR: median, IQR, (range) 0.55, 0.51 to 0.58 
(0.45 to 0.87) c 
0.67, 0.64 to 0.71 
(0.61 to 0.87) 
0.53, 0.51 to 0.56 
(0.47 to 0.61) 
WMHV (ml):  
median, IQR, (range) 
3.1, 1.6 to 6.8 
(0.3 to 33.7) d 
3.3, 1.8 to 6.8 
(0.3 to 33.7) 
2.9, 1.5 to 6.4 
(0.3 to 32.8) 
Whole brain volume (ml): 
mean, SD, (range) 
1100, 99 
(819 to 1494) e 
1118, 103 
(819 to 1326) 
1098, 97 
(860 to 1494) 
APOE genotype: % 
f g   
ε4-carriers 29.6 60.8 22.9 
non-carriers 70.4 39.1 77.1 
 
a Defined as the absence of major neurological or psychiatric conditions (see section 3.2.3); b Z-scores for 
childhood cognitive ability were based on the full NSHD cohort of N=5362, so the mean for Insight 46 
participants indicates that they had higher childhood cognitive ability on average than their peers not 
recruited to this sub-study. c n=462 due to missing data; d n=455 due to missing data; e n=468 due to missing 
data; f n=500 due to missing data. g The full breakdown of APOE genotypes was as follows: 14% ε2/ε3, 2% 
ε2/ε4, 56% ε3/ε3, 25% ε3/ε4, 3% ε4/ε4.  
Aβ = β-amyloid; IQR = interquartile range; SD = standard deviation; SEP = socioeconomic position; SUVR 




4. STANDARD COGNITIVE TESTS 
 
This chapter focuses on the paper-and-pencil cognitive tests within the Insight 46 
cognitive battery. A paper based on this chapter has been accepted for publication in 




Emerging evidence that subtle cognitive decline begins in the preclinical phase of AD 
has led to efforts to develop sensitive cognitive measures to detect and track this decline. 
One such measure is the Preclinical Alzheimer Cognitive Composite (PACC), composed 
of four cognitive tests which measure global cognition, episodic memory and executive 
function (Donohue et al., 2014). It is the primary outcome measure in the A4 trial 
(Donohue et al., 2014), the first clinical trial in Aβ+ cognitively-normal older adults. 
Several variations of the PACC have been tested (Sperling et al., 2014; Lim, Snyder, et 
al., 2016; Donohue, Sperling, et al., 2017; Donohue, Sun, et al., 2017; Mormino et al., 
2017; Papp et al., 2017; Merluzzi et al., 2019) and a revised version is under 
development (Hassenstab et al., 2017). The standard cognitive tests included in the 
Insight 46 battery (see section 3.2.1) were chosen to allow computation of the PACC, 
complemented by a test of non-verbal reasoning (WASI Matrix Reasoning) that was 
chosen for its similarity to aspects of the cognitive tests completed in childhood. 
Cognitively-normal Aβ+ older adults have shown faster decline on the PACC than Aβ- 
individuals, over intervals of around 3 years (Donohue, Sperling, et al., 2017; Mormino 
et al., 2017). However there are mixed results when comparing Aβ groups at baseline, 
with some studies finding lower PACC scores in Aβ+ participants (Donohue, Sperling, et 
al., 2017) but some finding no difference (Donohue et al., 2014; Burnham et al., 2016; 
Soldan et al., 2016; Buckley et al., 2017; Mormino et al., 2017; Rabin et al., 2018). One 
reason for this could be that cross-sectional analyses struggle to account for the wide 
variation that exists between individuals in terms of their overall cognitive abilities 
(beyond adjusting for age, sex and educational attainment), whereas longitudinal 
analyses account for this variation by effectively using each participant as their own 
control. The better we can account for predictable variation between individuals at 
baseline, the greater the likelihood that outcomes such as the PACC will be sensitive 
enough to detect differences in cognition associated with preclinical disease pathology, 
if such differences exist.  
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Insight 46 is uniquely placed to address this, since data are available on participants’ 
cognition since childhood. While it is well-established that higher educational attainment 
is associated with better performance on most cognitive tests in older age (Weintraub et 
al., 2009; Shirk et al., 2011; Gaertner et al., 2018; Jansen et al., 2018), the life-course 
determinants of performance on the PACC are unknown, and the effects of childhood 
cognitive ability and adult socioeconomic position on PACC score have never been 
investigated before. 
There is also a need to understand more about possible sex differences on the PACC. 
As discussed in section 2.4.1, women are at greater risk of AD (although this may be 
explained by greater longevity) but the relevance of sex differences to the detection of 
subtle cognitive decline in preclinical AD is unclear. There is consistent evidence that 
women tend to perform slightly better than men on the Digit-Symbol Substitution test of 
processing speed included within the PACC (Royer, 1978; Roivainen, 2011; Gaertner et 
al., 2018) as well as on tests of verbal memory (Andreano and Cahill, 2009). Normative 
data for over 3000 cognitively-normal older adults reported an advantage for women on 
three of the four sub-tests included within the PACC (Digit-Symbol Substitution, Mini 
Mental State Examination, and Logical Memory story recall – see section 4.2.1 below for 
description of sub-tests), although the authors concluded that the differences are small 
and may not have clinical relevance (Weintraub et al., 2009). 
Consistent with the approach outlined in section 3.5, I aimed first to characterise the 
performance of Insight 46 participants on the paper-and-pencil cognitive tests including 
the PACC with respect to sex, childhood cognitive ability, education and adult 
socioeconomic position. I then explored whether cognitive performance was influenced 
by amyloid status, whole brain volume, white matter hyperintensity volume (WMHV), and 




4.2.1. Stimuli and Procedure 
 
The original PACC (Donohue et al., 2014) is composed of four cognitive tests – the Mini 
Mental State Examination (MMSE) (Folstein, Folstein and McHugh, 1975), Logical 
Memory IIa from the Wechsler Memory Scale Logical Memory (Wechsler, 1987), Digit-
Symbol Substitution test from the Wechsler Adult Intelligence Scale-Revised (Wechsler, 
1981), and the Free and Cued Selective Reminding Test (FCSRT) (Grober et al., 2008). 
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We replaced the FCSRT with the 12-item Face-Name test (FNAME-12) (Papp et al., 
2014), to avoid potential overlap with a similar word-learning memory test administered 
to the NSHD cohort at multiple time-points throughout adulthood (Rawle et al., 2018). 
FNAME-12 is similar to FCSRT in terms of being an episodic memory test of immediate 
and delayed recall, is moderately correlated with FCSRT free recall scores (Papp et al., 
2014) and is also relatively challenging for cognitively-normal populations. Two previous 
studies have reported that FNAME is sensitive to Aβ deposition (Rentz et al., 2011; 
Sanabria et al., 2018). 
Participants also completed the Matrix Reasoning test from the Wechsler Abbreviated 
Scale of Intelligence (Wechsler, 1999) – a measure that was chosen for its similarity to 
aspects of the cognitive tests completed in childhood. 
The MMSE is a 30-point composite screening tool for cognitive impairment which is 
widely used within clinical practice. 
Digit-Symbol Substitution is an index of executive function and psychomotor speed. 
The score is the number of items completed correctly within 90 seconds. 
Logical Memory IIa assesses free recall of a short story, which the participant is asked 
to recall immediately and after a delay of approximately 20 minutes. The exact delay 
duration is recorded so that it can be accounted for in analyses, as it may affect 
performance (Montgomery et al., 2017). 
The Face-Name test (FNAME-12) assesses associative memory for face-name and 
face-occupation pairs. Two versions exist: FNAME-12A and FNAME12-B. This study 
used FNAME-12A. Participants are shown 12 unfamiliar face-name and face-occupation 
pairs (e.g. “Sarah, Reporter”), with 8 seconds to study each one. They are then 
presented with each face and asked to recall the associated name and occupation. This 
process is repeated with a second learning phase and a second recall test. After a ~10-
minute delay they are again shown each face and asked to recall the names and 
occupations (the third recall test). After a ~30-minute delay participants are shown 12 
sets of three faces and asked to identify each previously learned face from the two 
distractors (facial recognition) and to recall the name and occupation (the fourth recall 
test). If they cannot recall the name and/or occupation, they are asked to select the 
correct answer from three options comprising: the correct answer, a distractor (a 
name/occupation that belongs with a different face in the set), and a name/occupation 
that did not feature in the set. The summary outcomes are FN-N (total names recalled, 
max. 48), FN-O (total occupations recalled, max. 48) and FNAME-total (FN-N + FN-O, 
max. 96) – these outcomes are based on the four recall tests. Precise administration 
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times were recorded for a sample of 50 participants to check that the delay times 
conformed to expectations: the mean delay times were 10.0 mins and 35.5 mins.  
The Matrix Reasoning test assesses non-verbal reasoning, an aspect of fluid 
intelligence. Participants are shown a matrix of geometric shapes and are required to 
select the missing piece from five options. There are 32 matrices, graded in difficulty, 
and the test is discontinued when participants make four consecutive errors (or four 
errors within five consecutive items), as specified in the manual (Wechsler, 1999). 
The four components of our version of the PACC were: MMSE total score, Logical 
Memory delayed recall score, Digit-Symbol Substitution score and FNAME-total. 
Following the method described in previous studies (Lim, Snyder, et al., 2016; Buckley 
et al., 2017; Mormino et al., 2017; Papp et al., 2017; Rabin et al., 2018), the four 
components were converted into z-scores based on the full Insight 46 sample, and then 
averaged. A higher PACC score indicates better performance. Two participants did not 
complete the FNAME test and one did not complete the Digit-Symbol Substitution test 
(see section 3.3). For these three participants, their PACC score was the average of the 
z-scores for the three tests they completed. This is consistent with a previous study which 
required at least 2 out of the 4 components to be present (Soldan et al., 2016). Excluding 




Out of 502 participants, 499 completed all cognitive tests and three were missing one 
test score as mentioned above (see section 3.3 for reasons for missing data). Participant 
characteristics are reported in section 3.6.  
 
 
4.3. Patterns and predictors of performance  
 
4.3.1. Statistical Analyses 
 
To investigate the relationship between cognitive outcomes and demographic factors, all 
participants were included (n=502), as explained in section 3.5. Raw scores from each 
cognitive test were standardised to z-scores based on the full Insight 46 sample to allow 
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comparison of effect sizes across different cognitive tests. Multivariable linear regression 
models were run where the outcome was the z-score on a particular cognitive test and 
the predictors were sex, age at assessment, childhood cognitive ability, education, adult 
socioeconomic position and presence of a neurological or psychiatric condition (including 
MCI). For outcomes with skewed distributions (MMSE and Matrix Reasoning), 
bootstrapping was used to produce bias-corrected and accelerated 95% CIs from 2000 
replications. For the Logical Memory delayed recall score, the model contained an 
additional factor of delay duration (time elapsed between the immediate and delayed 
recall). Mean delay duration was 24.6 minutes (SD = 4.66) and there was no evidence 
that this was associated with performance (regression coefficient = -0.006, 95% CIs -
0.024 to 0.012, p = 0.53), but it was included in the models as per standard practice. 
 
4.3.2. Results  
 
Descriptive statistics for each test are given in Table 4-1.  
On average, Insight 46 participants performed at the expected level for their age on the 
MMSE, Digit Symbol and Logical Memory tests, according to normative data (Shirk et 
al., 2011). On the Matrix Reasoning test, their performance (mean = 24) was above the 
expected level based on normative data (sample mean for 70- to 74-year-olds is 16 
(Wechsler, 1999)) but comparable to a sample of healthy older adults recruited by 
Washington University (mean = 24 (Emery, Hale and Myerson, 2008)). To date, only two 
studies have published FNAME-12 data (Papp et al., 2014; Kormas et al., 2018) and 




Table 4-1. Descriptive statistics for the standard cognitive tests 
 
a n=501 due to missing data. b n=500 due to missing data.  
FN-N = names recalled; FN-O = occupations recalled; PACC = Preclinical Alzheimer Cognitive 
Composite
 
mean SD median range 
MMSE (max. 30) 29.3 1.0 30 22, 30 
Matrix Reasoning (max. 32) 24.0 4.9 25 4, 32 
Digit-Symbol a (max. 93) 47.6 10.4 48 19, 82 
Logical Memory: Immediate (max. 25) 12.8 3.5 13 4, 22 
                               Delayed (max. 25) 11.5 3.7 12 0, 23 
FNAME-12 b: FN-N (max. 48) 27.0 11.7 28 0, 47 
                      FN-O (max. 48) 38.2 8.0 40 1, 48 
                      Total (max. 96) 65.3 18.3 67 3, 95 
                      Facial Recognition (max. 12) 12.0 0.2 12 9, 12 
                      Names recognition (max. 12) 10.3 1.8 11 3, 12 
                      Occupations recognition 
                      (max. 12) 
11.6 0.9 12 4, 12 
PACC (mean of z-scores) -0.00 0.73 0.07 -3.49, 1.72 
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Results of the multivariable regression models exploring associations with demographic 
and life-course predictors are reported in Table 4-2. On average, participants with 
neurological or psychiatric conditions (including MCI) scored significantly lower on all 
tests (Table 4-2). The analyses were rerun excluding the participants with MCI to check 
that these differences could not be explained by circularity in the definition of MCI (since 
low scores on the Logical Memory or Digit-Symbol Substitution tests formed part of the 
MCI criteria); the results were unchanged except that the differences were no longer 
statistically significant on MMSE and Matrix Reasoning. 
Females scored significantly higher than males on all measures except Matrix Reasoning 
(Table 4-2); the greatest difference was on the FNAME-12, particularly in recalling 
names.  
As expected across this narrow age range (2.6 years – reflecting the time it took to collect 
the data, since participants were all born in the same week) there was no evidence of 
age effects on cognition, except on the Matrix Reasoning test where older age was 
associated with slightly poorer performance (Table 4-2).  
Higher childhood cognitive ability was associated with better performance on every 
cognitive outcome (Table 4-2, Figure 4-1). Higher educational attainment and higher 
adult socioeconomic position were independently positively associated with the majority 
of cognitive outcome measures, including the PACC. Higher educational attainment 
showed a notable positive association with the Matrix Reasoning task. 
All these effects were maintained when excluding participants with neurological or 
psychiatric conditions, except that the following two associations were directionally but 
no longer statistically significant: Logical Memory Delayed and adult socioeconomic 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4-1. Preclinical Alzheimer Cognitive Composite (PACC) score against 
childhood cognitive ability   
Scatter plot shows the raw data, colour-coded by clinical group. Alzheimer’s disease dementia is 
distinguished from other neurological or psychiatric conditions for interest. The blue line is the line 
of best fit from the multivariable regression model (adjusted for sex, age at assessment, 
education, adult socioeconomic position and presence of neurological or psychiatric conditions), 
and the navy lines are its 95% confidence intervals. For an explanation of the childhood cognitive 
ability variable, see section 3.2.4. 
 
 
4.4. Associations with biomarkers and APOE-ε4  
 
4.4.1. Statistical Analyses 
 
Following the format laid out in 3.5, the second part of this chapter aims to investigate 
associations between performance on the standard cognitive tests and biomarkers of AD 
in cognitively-normal participants for whom complete biomarker data are available. The 
number of participants meeting these criteria was 406 (see section 3.3). 
The z-score on a particular cognitive test was the outcome and amyloid status, whole 
brain volume, WMHV and APOE genotype were included as predictors in multivariable 
regression models to examine the effects of each biomarker adjusted for all the others. 
78 
 
To adjust for the correlation between whole brain volume and head size, total intracranial 
volume was included in all models, as were the demographic and life-course factors 
investigated in the first analysis (sex, age at assessment, childhood cognitive ability, 
education and adult socioeconomic position). Interactions were investigated between 
amyloid status and brain volume, and amyloid status and WMHV. 
The models were additionally rerun replacing dichotomised amyloid status with a 
continuous measure of Aβ (SUVR) to test whether increasing Aβ deposition was 
associated with differences in performance. To check whether associations between 
SUVR and cognition were sensitive to the inclusion of the imputed SUVR values (see 
section 3.2.2), the analyses were rerun excluding the 26 participants with imputed data. 
 
4.4.2. Results  
 
Results of the multivariable regression models are reported in Table 4-3. Results for 
the demographic and life-course factors (sex, age at assessment, childhood cognitive 
ability, education and adult socioeconomic position) are not reported as they are 
essentially unchanged from the first analysis section (4.3.2).    
On average, Aβ+ participants scored lower than Aβ- participants on every cognitive 
measure (Table 4-3, Figure 4-2). The unadjusted differences were only statistically 
significant for the MMSE and Matrix Reasoning (Figure 4-2A), but in the multivariable 
model adjusting for demographic, life-course and biomarker factors, the differences were 
also statistically significant for Logical Memory immediate recall and PACC (Figure 4-2B, 
Table 4-3). 
Replacing dichotomised amyloid status with the continuous SUVR revealed weak 
associations between higher SUVR and poorer performance on MMSE (regression 
coefficient -1.21, 95% CIs -2.39 to -0.10), Logical Memory immediate recall (regression 
coefficient -1.87, 95% CIs -3.22 to -0.52) and PACC (regression coefficient -1.09, 95% 
CIs -1.90 to -0.29). Similar trends were observed on the other tests but did not reach 
statistical significance. These results were unchanged when the analyses were rerun 
excluding the 26 participants with imputed SUVR data. 
The only outcome which showed an association with whole brain volume was Digit-
Symbol Substitution, where larger whole brain volume was associated with better 
performance (Table 4-3). 
Digit-Symbol Substitution and PACC showed associations with WMHV, where higher 
WMHV was associated with poorer performance (Table 4-3). 
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On average, APOE-ε4 carriers performed better than non-carriers on Logical Memory 
immediate recall (after adjustment for the detrimental effect of Aβ and all other 
confounders). There was a trend in the same direction on Logical Memory Delayed recall 
(p = 0.06) (Table 4-3).  
There was no evidence of interactions between amyloid status and whole brain volume, 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4-2. Performance of β-amyloid positive and β-amyloid negative individuals 
on the standard cognitive tests: means and 95% confidence intervals 
A = unadjusted means; B = adjusted means predicted from the multivariable regression models 
(adjusted for age at assessment, sex, childhood cognitive ability, education, adult socioeconomic 
position, whole brain volume, total intracranial volume, white matter hyperintensity volume and 







In this large population-based sample of older adults of approximately the same age, I 
investigated predictors of performance on a range of cognitive measures including the 
Preclinical Alzheimer Cognitive Composite (PACC). The key findings are that childhood 
cognitive ability was strongly associated with all cognitive scores, significant sex 
differences in cognition were observed, and Aβ positivity and white matter hyperintensity 
volumes (WMHV) were associated with lower PACC scores among cognitively-normal 
participants. These results are discussed in the following sub-sections. For a discussion 
of strengths and limitations that apply to all the analyses presented in this thesis, such 
as considerations relating to the generalisability of the sample, see Chapter 10. 
 
4.5.2. Demographic and life-course predictors 
 
4.5.2.1. Associations with childhood cognitive ability, education and adult 
socioeconomic position  
Childhood cognitive ability was consistently an important predictor with a notable effect 
on every cognitive outcome. My finding that educational attainment and adult 
socioeconomic position were associated with many cognitive outcomes, independent of 
childhood cognition, is consistent with previous NSHD analyses which have shown that 
these factors are only moderately correlated and all have direct and indirect influences 
on cognition across the life-course ((Richards and Sacker, 2003; Richards et al., 2019) 
– see section 2.4.2). It is also consistent with evidence that education and occupational 
attainment may have protective effects on later life cognition (Stern, 2012). This is 
discussed in more detail in Chapter 10, as similar effects were found on other cognitive 
tests that feature in later chapters. 
 
4.5.2.2. Sex differences 
The finding of an advantage for women on the sub-tests of the PACC is consistent with 
previous studies (Weintraub et al., 2009; Shirk et al., 2011; Gaertner et al., 2018; Jansen 
et al., 2018). The effect size of sex on PACC score was large enough to be potentially 
clinically meaningful (0.4 SD), suggesting that accounting for sex differences on the 
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PACC may be important. As the FNAME test was the component where females had the 
greatest advantage, versions of the PACC which include a different memory test may be 
less susceptible to sex differences. However, sex differences have also been reported 
on the FCSRT (the test used in the original PACC, which we replaced with FNAME) 
(Mura et al., 2017). Sex differences are discussed further in Chapter 10. 
 
4.5.2.3. Associations with age 
The interpretation of the association observed between older age at assessment and 
lower Matrix Reasoning score is unclear. While scores on this test are known to decline 
with age (Wechsler, 1999; Bugg et al., 2006; Emery, Hale and Myerson, 2008), the effect 
size of the association in Insight 46 (-0.17 z-score units) equates to -0.83 points on the 
test per year, which is incompatible with the much lower rate of decline across adulthood 
reported by others (Wechsler, 1999; Emery, Hale and Myerson, 2008). I considered the 
possibility that associations between age and cognition in Insight 46 could be explained 
by recruitment bias – this is discussed in Chapter 10.  
 
4.5.3. Associations with biomarkers and APOE-ε4 
 
In cognitively-normal participants (i.e. excluding those who fulfilled dementia or MCI 
criteria and those with another neurological or psychiatric condition), Aβ positivity was 
associated with poorer performance on the PACC. Statistically significant differences 
were also observed on several individual tests assessing a range of cognitive domains: 
memory (Logical Memory Immediate), non-verbal reasoning (Matrix Reasoning), and a 
global measure of cognitive state (MMSE). Previous studies have tended not to find a 
difference in PACC score between Aβ+ and Aβ- individuals at baseline, with differences 
only emerging after longitudinal assessment (Donohue et al., 2014; Burnham et al., 
2016; Soldan et al., 2016; Buckley et al., 2017; Mormino et al., 2017; Rabin et al., 2018), 
although a difference at baseline has been reported before in a sample where the Aβ+ 
group were slightly older and less educated than the Aβ- group (Donohue, Sperling, et 
al., 2017). These results add to accumulating evidence for subtle cognitive differences 
associated with Aβ deposition, even at an age when those who are destined to develop 
dementia are still likely to be many years from symptoms (Prince et al., 2014). 
In cognitively-normal participants with a generally low burden of white matter disease, I 
also found an independent association between WMHV and PACC score which, to my 
knowledge, has not been reported before. This suggests that the PACC may be a 
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sensitive, rather than a specific, marker of cerebral pathology – an important 
consideration for clinical trials.  
Controlling for childhood cognitive ability, education and adult socioeconomic position, 
as well as other brain pathologies and APOE genotype, enabled detection of a difference 
in PACC score between Aβ+ and Aβ- participants, whereas the unadjusted group 
difference was not statistically significant. This may be partially explained by negative 
confounding effects, whereby one or more factors that predicted higher PACC score also 
had weak positive associations with Aβ positivity. This was indeed the case for childhood 
cognitive ability and adult socioeconomic position, which were slightly higher in Aβ+ 
individuals (although differences were not statistically significant). Such differences may 
well be due to chance but can suppress the association between Aβ and cognition when 
not adjusted for. Another factor may have been that adjustment for these variables 
reduced the unexplained residual variance in PACC score, thus increasing the ability to 
detect smaller differences between the groups. Combined together, the demographic, 
life-course and biomarker factors accounted for one third of the variance in PACC score 
among cognitively-normal participants. 
Fluid intelligence measures themselves are not usually considered candidates for 
detecting subtle cognitive decline in preclinical AD, so my finding that Aβ positivity was 
associated with poorer performance on the Matrix Reasoning test, to a greater degree 
than the PACC, (accounting for childhood cognitive ability etc.) is interesting. It is 
consistent with evidence that non-verbal IQ declines early in presymptomatic FAD 
mutation carriers (Fox et al., 1998). As a high-level test involving multiple domains 
(including visuoperceptual, working memory, and executive function), Matrix Reasoning 
is rather different to the tests comprising the PACC, and its potential as a marker of 
cognitive decline merits further investigation.  
The Digit-Symbol test was the single test most sensitive to overall brain health, showing 
associations with WMHV and whole brain volume in cognitively-normal participants, and 
being the task on which participants with neurological or psychiatric conditions were most 
disadvantaged. Negative effects of WMHV on processing speed are well established, 
consistent with subcortical damage (Gunning-Dixon and Raz, 2000; Oosterman et al., 
2004; Prins et al., 2005; van Dijk et al., 2008; Prins and Scheltens, 2015). The Digit-
Symbol task may be particularly sensitive to brain pathologies because good 
performance on this task requires multiple cognitive functions, including visuomotor 
skills, executive functioning, working memory and attention, hence people with an 
impairment in any one of these areas might perform badly (Jaeger, 2018). The fact that 
the Digit-Symbol task is timed may also contribute to its sensitivity at detecting small 
differences in performance. 
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The finding that APOE-ε4 carriers showed evidence of better short-term memory on the 
Logical Memory immediate recall test – a measure on which Aβ positivity was associated 
with poorer performance – is consistent with the model of antagonistic pleiotropy 
discussed in section 2.6.1, whereby APOE-ε4 may have both beneficial and detrimental 
effects. This is discussed in greater detail in Chapter 10.  
 
4.5.4. Comments on the Face-Name Associative Memory Exam 
(FNAME-12) 
 
Few studies have published results of the FNAME test. Two previous studies found a 
sex difference on FNAME which was reduced in older adults (Alegret et al., 2015) and 
attenuated in postmenopausal women (Rentz et al., 2017). Here, I found a significant 
sex difference in 70-year-olds. It has been argued that one potential benefit of the 
FNAME test is, in contrast to many other memory tests, its reported lack of association 
with education (Kormas et al., 2018), although this has been contradicted in one study 
(Papp et al., 2014). In the current study which benefits from prospective collection over 
the life course, I found that childhood cognitive ability, education and adult 
socioeconomic position were all significant predictors of FNAME scores.  
A recent consensus statement on recommended outcomes in preclinical AD from the 
European Prevention of Alzheimer’s Dementia project (EPAD) raised concerns about a 
ceiling effect on this task in healthy populations, recommending the use of the “Favorites 
test”, a refinement of FNAME designed to reduce the ceiling effect by pairing faces with 
unrelated words (Ritchie et al., 2017). These results from Insight 46 suggest that 
FNAME-12 is sufficiently challenging for 70-year-olds, despite scores on the occupations 
sub-scale being somewhat skewed towards the top end. Indeed, for some participants 
who particularly struggled with recalling names and required encouragement, the 16-
item FNAME might have been stressful. 
Two previous studies reported an association between Aβ deposition and FNAME 
performance, specifically on the FN-N outcome (recall for names) (Rentz et al., 2011; 
Sanabria et al., 2018). While my results followed this trend, differences between Aβ+ 
and Aβ- participants did not reach statistical significance, and the FN-N outcome did not 





In summary, these data show that childhood cognitive ability, education and adult 
socioeconomic position all independently influence cognitive performance at age 70, 
which has implications both for the interpretation and analysis of cognitive data 
measured in later life. These results provide evidence that the PACC can be used to 
detect subtle cross-sectional differences in cognition associated with Aβ deposition and 
white matter disease in cognitively-normal older adults at an age where dementia 









Visual memory binding describes the ability to integrate multiple features of an object in 
memory, such as colour and shape, or object and location. This vital aspect of both short- 
and long-term memory is reported to be impaired in AD at an early stage (Parra et al., 
2009, 2010, 2011, 2017; Fernández et al., 2018). Furthermore, evidence from studies of 
presymptomatic carriers of mutations causing familial Alzheimer’s disease (FAD) 
suggests that subtle deficits in visual memory binding may be one of the earliest 
detectable changes in cognition in the preclinical stage of AD (Parra et al., 2010, 2011, 
2015; Liang et al., 2016). A recent review concluded that although memory generally 
declines with age, a specific deficit in binding is not seen in healthy ageing once this 
general decline is accounted for (Schneegans and Bays, 2019), which strengthens the 
case for investigating the potential of memory binding tasks as specific markers for early 
change associated with AD pathology. 
The study by Liang et al. (2016) used the “What was where?” task, a computerised visual 
short-term memory binding task that requires participants to recall the identity and 
location of objects (Pertzov et al., 2012, 2013, 2015). One notable feature of this task is 
that it incorporates memory for locations as a continuous analogue measure (the 
distance between the location reported by the participant and the true location), in 
contrast to most memory measures which are made up of binary responses (correct vs. 
incorrect). This approach is based on a recognition that failure to recall an item correctly 
does not mean that its representation in memory has been entirely lost, and this may 
make the localisation measure particularly sensitive to small differences in performance 
(Pertzov et al., 2013; Ma, Husain and Bays, 2014). In the “What was where?” task, a 
‘binding error’ is captured when a participant correctly recalls the identity of an object but 
mislocalises it to the location of a different object held in memory. Liang et al. (2016) 
reported that presymptomatic FAD mutation carriers tended to make more binding errors 
than controls, despite having unimpaired memory for objects and locations.  
While it is well-established that the hippocampus plays a key role in associative learning 
and memory (Mayes, Montaldi and Migo, 2007), the role of medial temporal lobe 
structures in visual short-term memory binding is still subject to debate (Parra et al., 
2009, 2010; Koen et al., 2017; Liang et al., 2017; Parra, 2017; Schneegans and Bays, 
2019). However, three separate studies using the “What was where?” task have reported 
results suggestive of hippocampal involvement in visual short-term memory binding. 
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Liang et al. found that smaller hippocampal volume was associated with increased 
binding errors in presymptomatic mutation carriers, but hippocampal volume was not 
associated with object or location recall (Liang et al., 2016). Two other studies of patients 
with medial temporal lobe damage due to voltage-gated potassium channel complex 
antibody-associated limbic encephalitis (Pertzov et al., 2013), and patients who had 
undergone anterior temporal lobectomy for treatment of pharmacoresistant epilepsy 
(Zokaei, Nour, et al., 2019) both reported that the patients had intact memory for object 
identity and location but a deficit in binding. 
The “What was where?” task has also provided evidence of interesting effects of the 
APOE-ε4 allele on short-term memory. In two studies comparing the performance of ε4-
carriers and non-carriers – one in middle-aged adults (mean age 45.7) and one in older 
adults (mean age 68.8) – an apparent advantage for APOE-ε4 carriers was observed in 
terms of more accurate recall for object locations after delays of a few seconds (Zokaei 
et al., 2017; Zokaei, Čepukaitytė, et al., 2019). In the older adults, this was in contrast to 
a long-term memory task where APOE-ε4 carriers had poorer recall for locations after a 
delay of about 20 minutes compared to non-carriers (Zokaei, Čepukaitytė, et al., 2019), 
a finding which is suggestive of subtle memory decline associated with preclinical AD, 
although no biomarker data were available in this study. The authors proposed two 
possible explanations for the apparent beneficial effect of APOE-ε4 on short-term 
localisation memory: (1) that it could reflect compensatory mechanisms whereby there 
may be increased activation in frontal and parietal regions that are not directly affected 
by prodromal AD pathology but are implicated in attention and short-term memory; (2) 
that it could reflect phenotypical effects of the APOE-ε4 allele whereby the ε4 allele may 
have some beneficial effects in earlier life which could explain its survival in the 
population (the principle of antagonistic pleiotropy, discussed in section 2.6.1). As the 
Insight 46 protocol includes both APOE genotyping and amyloid-PET imaging, this 
provides an opportunity to investigate potential independent effects of APOE-ε4 and β-
amyloid pathology on the “What was where?” task in more detail.  
In terms of factors that may predict between-subject differences in performance on the 
“What was where?” task, one study (n = 66) tested for sex differences and found none 
(Zokaei, Čepukaitytė, et al., 2019), although another (n = 60) reported that the beneficial 
effect of APOE-ε4 described above was specific to males (Zokaei et al., 2017). No 
studies so far have examined the effects of childhood cognitive ability, educational 
attainment, or socioeconomic position. Accounting for potential effects of these 
predictors may increase the sensitivity of “What was where?” outcomes to subtle effects 
of APOE-ε4 and β-amyloid pathology. 
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Following the structure of the previous chapter, the aims of this study were firstly to 
understand patterns of performance on the “What was where?” task and characterise 
associations between task performance and demographic and life-course predictors, 
and secondly to investigate associations between performance and biomarkers of brain 





5.2.1. Stimuli and Procedure 
 
The stimuli and procedure of the ‘What was where?’ task have been described in detail 
in previous papers (Pertzov et al., 2012, 2013, 2015; Liang et al., 2016). The participant 
was seated in front of a DELL Optiplex 9030 all-in-one touchscreen computer. The 
dimensions of the screen were 51.2 x 28.7 cm and the approximate distance from the 
subject’s eyes to the centre of the screen was 58 cm. 
The procedure for the “What was where?” task is presented in Figure 5-1. In each trial, 
one or three fractals were displayed on the screen in random locations, presented on a 
black background. Participants were asked to look at the fractals and to try to remember 
their identities and locations.  
1-fractal trials are referred to as ‘low load’ and 3-fractal trials are referred to as ‘high load’. 
The low load trials were displayed for 1 second whereas the high load trials were 
displayed for 3 seconds to allow time for encoding. This was followed by a blank screen 
for either a short or long delay (1 or 4 seconds), and then a test array appeared in which 
two fractals were displayed along the vertical meridian. One of these fractals had 
appeared in the memory array on the previous screen (the target) and the other was a 
foil or distractor. Participants were instructed to touch the fractal that they remembered 
seeing and drag it to the location where they think it was originally presented (Figure 
5-1). There was no time-limit for reporting the location – the tester pressed the space bar 
to initiate the next trial when the participant was ready. 
Previous studies using the “What was where?” task have administered at least 100 trials 
(Pertzov et al., 2012, 2013, 2015; Liang et al., 2016; Zokaei et al., 2017; Zokaei, 
Čepukaitytė, et al., 2019), but for Insight 46 a shortened version was used containing 24 
trials: 4 low load and 20 high load. Within each load condition, trials were equally likely 
to have a short or long delay. Therefore, there were four possible combinations of load 
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and delay (2 x low load with short delay; 2 x low load with long delay; 10 x high load with 
short delay; 10 x high load with long delay). The experiment was preceded by 4 practice 
trials – one of each of the load x delay combinations, and the tester ensured that the 
participant understood the task before continuing. 
All fractals including the foils were drawn from a pool of 60 fractals that were used across 
the experiment (rendered using http://sprott.physics.wisc.edu/fractals.htm, see Figure 
A1 in the Appendix). 
The locations of the fractals were generated in a pseudo-randomised manner by a 
MATLAB script (MathWorks, Inc). The script imposed the following restrictions which are 
necessary to allow analysis of localisation error which is a key outcome of this task: 
fractals were always at least 9o away from each other to avoid crowding and to ensure 
that there was a clear zone of 4.5o around each fractal which is necessary for the 
calculation of swap errors (see below), and fractals were at least 6.5o from the centre of 
the screen and 3.9o from the edges. The 24 trials were the same for all participants (i.e. 
the same fractals were presented in the same locations) but the trials were presented in 
a random order for each participant. The reason for using a random order is to avoid the 
results being confounded by practice effects on the one hand (familiarity with the 
procedure could cause performance to improve throughout the task) and by interference 
effects on the other hand (as fractals appear more than once during the task, the foil in 
the test array could be recognised from a previous trial, which could increase the 




Figure 5-1. The “What was where?” task  
Figure reprinted from Liang et al. (2016) under the terms of the Creative Commons Attribution 
License (CC BY). 
 
 
5.2.2. Outcome Variables 
 
Memory for object identification was defined as the percentage of trials in which the 
participant chose the correct fractal from the test array (Figure 5-2).  
Memory for object location was defined in two different ways. The first, gross 
localisation error, is the distance between the centre of the target in the location 
reported by the participant and its true location in the original memory array, measured 
in degrees of visual angle (Figure 5-2B). The second definition takes account of the fact 
that, in high load trials, participants may mislocalise the target to the location of a different 
(unprobed) object from the memory array (i.e. they make a swap error – see definition 
below). In this situation the gross localisation error could be very large. The nearest item 
control measure of localisation error accounts for this by subtracting out the effect of 
swap errors: it is defined as the distance between the location reported by the participant 
and the closest of the three original locations from the memory array (Figure 5-2C). 
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Localisation error was only analysed in trials where the participant identified the correct 
fractal.  
A swap error occurs when a participant correctly identifies the target fractal but they 
swap its location of the target with the location of another object (Figure 5-2C). If the 
target is positioned within 4.5o of the location of a different object from the memory array, 
this is counted as a swap error. 4.5o was used as the threshold to ensure that a location 
could not be attributed to more than one object, as objects were always at least 9o apart. 
Note that in the low load condition it is not possible to make a swap error as there is only 
one fractal in the memory array. For each participant, the percentage of swap errors (out 
of the number of trials in which they identified the correct fractal) was calculated. It is 
possible that swap errors could occur by chance, a possibility which is discussed and 






Figure 5-2. Outcome measures on the “What was where?” task   
Figure reprinted from Liang et al. (2016) under the terms of the Creative Commons Attribution 
License (CC BY). Green circles indicate the original location of the target fractal; red circles 
indicate the original locations of non-target fractals; blue line indicates measured localisation 
error. (A) Object identification: the participant is required to select the fractal that they remember 
seeing. (B) Gross localisation error is measured from the location reported by the participant to 
the original location of the target fractal. (C) ‘Nearest item control’ localisation error is measured 
from the location reported by the participant to the location of the closest fractal. If the reported 








Based on the literature discussed in section 4.1, I hypothesised that cognitively-normal 
Aβ+ participants would make a greater number of swap errors than Aβ- participants, 
indicating a subtle deficit in memory binding. 
I also aimed to test the hypotheses that APOE-ε4 carriers would perform better than non-
carriers on localisation memory, and that smaller hippocampal volume would be 




486 participants completed the “What was where?” experiment (see section 3.3). 
Participant characteristics are reported in section 3.6.  
 
5.2.5. Data Processing  
 
Each participant’s raw data file was processed using a MATLAB script which generated 
a score for each outcome variable in each of the four conditions (low load with short 
delay; low load with long delay; high load with short delay; high load with long delay).  
Six participants had one trial where the software did not record whether they selected 
the correct or incorrect fractal. I corresponded with Yoni Pertzov, the creator of the test, 
and he concluded that this was likely to be caused by the participant touching the screen 
exactly midway between the two fractals. These six individual trials were excluded and 
the mean scores for the relevant conditions were recalculated.  
One previous study excluded participants who had an object identification accuracy of 
less than 70%, to ensure that interpretations were not made based on performance at 
chance level (Liang et al., 2016). Thirty-six participants had an overall identification rate 
of less than 70%, of whom one performed below the 50% chance level with a score of 
46%. This participant was classified as cognitively normal (see section 3.2.3 for criteria). 
I decided not to exclude any participants from analysis based on their identification rate 
because other studies in healthy participants have not employed such exclusion criteria 
(Pertzov et al., 2012, 2015) whereas the study by Liang et al. included patients with 
symptomatic FAD, so adopting a 70% threshold was a way of excluding individuals with 
significant memory impairment whose data were not been pertinent to the research 




5.3. Patterns and predictors of performance  
 
5.3.1. Statistical Analyses 
 
Analysis of identification used a GEE logistic regression model for the odds of correctly 
identifying the fractal, with an independent correlation structure and robust standard 
errors to allow for the correlation between repeated measures of the same participant. 
The outcome was number of correct identifications, which was treated as a proportion of 
the total number of trials in each condition (2 x low load with short delay; 2 x low load 
with long delay; 10 x high load with short delay; 10 x high load with long delay). For the 
6 participants who had a trial excluded during the data cleaning process (see 5.2.5), the 
total number of trials in each condition was reduced accordingly. Results are expressed 
as odds ratios for ease of interpretation  
Regression models were fitted for the localisation error variables (gross error and 
‘nearest item control’) using GEE assuming a normal distribution for the dependent 
variable and an identity link (as with standard linear regression), but including an 
exchangeable correlation structure and robust standard errors. Localisation errors were 
first log-transformed as the distributions were positively skewed. 
Analysis of swap errors was carried out using the absolute measure rather than the 
corrected measures (see sections 5.2.2 and 5.3.2.3). The corrected measures are strict 
as they are based on the upper limit of swap errors that could be explained by chance, 
so they are more suitable for checking the validity of the absolute measures by 
confirming that the results cannot be explained by chance (see section 5.3.2.3). The 
absolute measure is more appropriate for cases in which performance of different 
participants is compared. A GEE logistic regression model was used for the odds of 
making a swap error, with an independent correlation structure and robust standard 
errors. The outcome was number of swap errors, which was treated as a proportion of 
the number of trials in which the participant identified the correct fractal in each condition 
(high load with short delay; high load with long delay). Results are expressed as odds 
ratios for ease of interpretation.  
Factors in the regression models were load (low vs. high), delay (short vs. long), age at 
assessment, sex, childhood cognitive ability, education, adult socioeconomic position 
and presence of a neurological or psychiatric condition (yes vs. no). 
As previous studies have found an interaction between load and delay whereby the 
detrimental effect of long delay was disproportionately greater when the load was high 
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(Pertzov et al., 2012, 2015), I tested for such an interaction on the identification and 
localisation outcomes. (This is not applicable to swap errors since swap errors cannot 
be made in the low load condition.) 
Previous studies have reported interactions between load and between-subjects 
predictors (such as clinical group, age at assessment, sex or APOE genotype). For 
example, Pertzov et al. found that patients with medial temporal lobe damage had 
disproportionately poorer localisation in the high load condition compared to controls 
(2013), and older adults had disproportionately poorer identification and localisation in 
the high load condition compared to younger adults (2015). Similarly, interactions 
between delay and between-subjects predictors have been reported; for example, 
Zokaei et al. (2017) reported that the detrimental effect of a longer delay on localisation 
performance was reduced in APOE-ε4 carriers compared to non-carriers. To investigate 
whether similar interaction effects were present among Insight 46 participants, I tested 
for interactions between load (low vs. high) and between-subject predictors (age, sex, 
childhood cognitive ability, adult socioeconomic position and presence of a neurological 




5.3.2. Results  
 
Descriptive statistics for the three outcome measures are shown in Table 5-1. Results of 
the multivariable regression models for the three primary outcomes are given in Table 
5-2. In addition, results of statistically significant interactions are reported in the text.  
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Table 5-1. Descriptive statistics for the “What was where?” task   
 
* In the low load condition, Nearest Item Control is the same as Gross Localisation Error 
because there is only one fractal so no swap errors can be made. IQR = interquartile range.  
  Low load High load 
  Short delay Long delay  Short delay Long delay 
Identification  
(% correct) 
Median 100 100 80 80 
IQR 100 - 100 100 - 100 70 - 90 70 - 90 




(degrees of visual 
angle) 
Median 2.05 2.38 7.65 7.36 
IQR 1.42 – 2.73 1.73 – 3.14 5.47 – 9.84 5.90 – 9.54 





(degrees of visual 
angle) * 
Median 2.05 2.38 3.09 3.43 
IQR 1.42 – 2.73 1.73 – 3.14 2.54 – 3.86 2.88 – 4.09 
Range 0.12 – 20.84 0.28 – 14.36 0.79 – 8.41 1.54 – 7.96 




IQR 11 - 29 11 - 29 
Range 0 – 100 0 – 75 
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Table 5-2. Associations between demographic and life-course predictors and 










(degrees of visual angle, 
log-transformed): 
coefficient and 95% CIs 
Swap errors: 
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Coefficients in bold are significant at p < 0.05 and asterisks indicate significance at p < 0.01. 
Multivariable regression models were used so each association is independent of all others. 
a See section 3.2.4 for definition of categories;  b See section 3.2.3 for definitions. 
 





5.3.2.1. Load and delay 
 
5.3.2.1.1. Identification 
As expected, identification performance was poorer in the high load condition compared 
to the low load condition (Table 5-1, Table 5-2, Figure 5-3). In contrast to previous studies 
that have reported poorer identification after a long delay than a short delay (Pertzov et 
al., 2012, 2015; Zokaei et al., 2017), there was no statistically significant effect of delay 
on identification performance (Table 5-2, Figure 5-3). However, there was an interaction 
between load and delay, whereby the long delay had a more detrimental effect on 
identification performance in the low load condition, compared to the high load condition 
(OR = 7.27, 95% CIs 4.22 to 12.51, p < 0.0001, Figure 5-3). This is contrary to previous 
studies which reported that the long delay had a disproportionately greater effect when 
there were more items to be remembered (Pertzov et al., 2015; Zokaei et al., 2017). 
 
 
Figure 5-3. Identification performance on the “What was where?” task, by load and 
delay: means and 95% confidence intervals 
Markers show unadjusted means and error bars show 95% confidence intervals. This figure 
illustrates that, although delay did not have a statistically significant effect overall, there was an 
interaction between load and delay. 
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5.3.2.1.2. Localisation error 
As expected, localisation error was greater in the high load condition than the low load 
condition (Table 5-1, Table 5-2, Figure 5-4). This applied to the ‘nearest item control’ 
measure as well as the gross error measure, showing that the increased localisation 
error in the high load condition cannot be explained by swap errors. Also, as expected, 
localisation error was greater after a long delay compared to a short delay, both on the 
gross error measure and on the ‘nearest item control’ measure (Table 5-2, Figure 5-4).  
In contrast to previous studies that have reported that the detrimental effect of a longer 
delay was exaggerated when there were more items to be remembered (Pertzov et al., 
2012, 2015; Zokaei et al., 2017), there was a significant interaction between load and 
delay in the opposite direction, such that the detrimental effect of a long delay was slightly 
reduced in the high load condition compared to the low load condition, on both the gross 
localisation error (regression coefficient = -0.15, 95% CIs -0.23 to -0.08, p < 0.0001) and 
‘nearest item control’ measure (regression coefficient = -0.07, 95% CIs -0.14 to -0.01, 
p = 0.018). However, the interaction effect appears minimal on visual inspection, as the 





Figure 5-4. Localisation error on the “What was where?” task, by load and delay: 
means and 95% confidence intervals 
Markers show unadjusted means and error bars show 95% confidence intervals. ‘Nearest item 
control’ accounts for the impact of swap errors – see section 5.2.2 for full definitions. (Note that 
swap errors cannot be made in the low load condition as there is only one fractal, so no ‘nearest 
item control’ is necessary.)   
 
 
5.3.2.1.3. Swap errors 
Delay had no significant effect on the proportion of swap errors (Table 5-2), in contrast 
to a previous study where healthy participants made more swap errors in the long delay 





5.3.2.2. Demographic and life-course predictors 
 
5.3.2.2.1. Childhood cognitive ability, education and adult 
socioeconomic position 
Higher childhood cognitive ability was associated with better identification performance 
(Table 5-2, Figure 5-5). There was evidence that this effect was exaggerated in the long 
delay condition compared to the short delay (OR = 1.14, 95% CIs 1.01 to 1.30, p = 0.037). 
There was no evidence of a statistically significant association between childhood 
cognitive ability and localisation error, either in the gross error measure nor the ‘nearest 
item control’ measure (Table 5-2). Participants with higher childhood cognitive ability 
tended to make fewer swap errors (Table 5-2, Figure 5-6).  
 
 
Figure 5-5. Association between childhood cognitive ability and identification 
memory on the “What was where?” task 
Solid line represents prediction from the multivariate regression model, adjusted for sex, age at 
assessment, education, adult socioeconomic position and presence of a neurological or 
psychiatric condition. Shaded area represents 95% confidence intervals. Markers show each 
participant’s identification rate across the experiment as a whole (combined across the different 






Figure 5-6. Association between childhood cognitive ability and swap errors on 
the “What was where?” task 
Solid line represents prediction from the multivariate regression model, adjusted for sex, age at 
assessment, education, adult socioeconomic position and presence of a neurological or 
psychiatric condition. Shaded area represents 95% confidence intervals. Markers show each 
participant’s swap error rate across the experiment as a whole (as a percentage of trials on which 
they identified the correct fractal). For an explanation of the childhood cognitive ability variable, 
see section 3.2.4. 
 
Educational attainment and adult socioeconomic position did not show evidence of 
associations with performance on any outcome measure (Table 5-2). 
 
5.3.2.2.2. Sex differences 
Males had slightly poorer identification memory than females on average, having 10% 
lower odds of identify the correct fractal (Table 5-2). However, males made smaller 
localisation errors than females on average, both in the gross measure (unadjusted 
means: 4.93o vs. 5.39o) and ‘nearest item control’ (unadjusted means: 2.78o vs. 3.10o) 
(Table 5-2). There was evidence that this sex difference was reduced in the high load 
condition compared to the low load condition (gross error: interaction coefficient = 0.09, 
95% CIs 0.01 to 0.18, p = 0.034; nearest item control: interaction coefficient = 0.09, 95% 
CIs 0.02 to 0.16, p = 0.012) and in the long delay condition compared the short delay 
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condition (gross error: interaction coefficient = 0.13, 95% CIs 0.05 to 0.20, p = 0.13; 
nearest item control: interaction coefficient = 0.09, 95% CIs 0.03 to 0.15, p = 0.004). The 
untransformed results for males and females are illustrated in Figure 5-7 for the ‘nearest 
item control’ measure, as an aid to the interpretation of these interaction effects. Overall, 
these results indicate that males tended to report the location of objects more accurately 
than females when the memory demands were easier, whereas sex differences were 
reduced when the memory demands were harder. 
There was no sex difference in the proportion of swap errors (Table 5-2). 
 
 
Figure 5-7. ‘Nearest Item Control’ localisation error on the “What was where?” task 
for males and females, by load and delay 
Markers show unadjusted means and error bars show 95% confidence intervals. 
 
 
5.3.2.2.3. Age at assessment 





5.3.2.2.4. Neurological and psychiatric conditions 
Participants with neurological and psychiatric conditions made slightly larger gross 
localisation errors than cognitively-normal participants, although this did not reach 
statistical significance in the ‘nearest item control’ measure (p = 0.067) (Table 5-2). There 
was no evidence that participants with neurological and psychiatric conditions differed 




5.3.2.3. Exploration of swap errors 
It is possible that swap errors could occur by chance – firstly the participant could guess 
the correct object by chance and secondly they could localise it to the location of a non-
target fractal by chance. To account for this, three measures were calculated to estimate 
the proportion of swap errors that may be expected due to chance for each participant, 
using the methods set out in previous studies (Pertzov et al., 2012, 2013). As there was 
no evidence of an effect of delay on the proportion of swap errors (see section 5.3.2.1.3), 
this was done based on each participant’s overall proportion of swap errors across the 
short and long delay conditions. 
Swap errors due to chance identification. If a participant could not remember the 
identity of the object and guessed it correctly by chance, but their memory for the 
locations of the objects was intact, they would be expected to localise the object around 
one of the three remembered locations. Therefore, in one third of cases they would be 
expected to localise it to the target location and in two thirds of cases they would be 
expected to localise it to one of the two non-target locations, which would be recorded 
as a swap error. Therefore, the upper limit of the number of swap errors that may be 
expected due to guessing the identity of the object correctly by chance can be calculated 
by multiplying each participant’s number of identification errors by two thirds. This gives 
a number of “swap errors due to chance identification”.  
Swap errors due to chance localisation. For every trial on which a swap error was 
observed, the probability that the swap error was obtained by chance despite the 
locations having been forgotten can be estimated by simulating all possible locations 
(using steps of 1o) that the target could have been placed with the same amplitude of 
error, and then calculating the proportion of these locations that would be classified as a 
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swap error (Figure 5-8). Combining these probabilities across all the trials gives a 
number of “swap errors due to chance localisation” for each participant. 
Swap errors due to chance identification and localisation can be calculated by 
combining the two measures described above. This represents the strictest upper limit 










Figure 5-8. Swap errors on the “What was where?” task 
Dashed green circles indicate the original location of the target fractal, dashed red circles indicate 
the original locations of non-target fractals. The left-hand image shows the location reported by 
the participant in this example. The right-hand image shows all potential locations that the fractal 
could be placed by chance, assuming the same amplitude. Blue lines are drawn to locations that 
would not be classified as a swap error, and orange lines are drawn to locations that would be 
classified as a swap error (i.e. within 4.5o of a non-target location). Therefore, the probability of 
obtaining this swap error by chance equals the number of orange lines divided by the total number 
of orange and blue lines. Reprinted from Pertzov et al. (2013) under the terms of the Creative 
Commons Attribution License (CC BY-NC 3.0).  
 
The mean and SD for the various swap error measures were as follows: observed swap 
errors = 20 ± 11%; swap errors expected due to chance identification = 9 ± 6%; swap 
errors expected due to chance localisation = 2 ± 2%; swap errors expected due to chance 
identification and localisation = 11 ± 6%. 
Paired sample t-tests were used to test the hypothesis that the observed proportion of 
swap errors was significantly greater than the proportion of swap errors expected due to 
chance. This hypothesis was supported (swap errors due to chance identification: t(485) 
= 26.5, p < 0.0001; swap errors due to chance localisation t(485) = 36.2, p < 0.0001; 
swap errors due to chance identification and localisation t(485) = 24.4, p < 0.0001). 
These results confirm that when participants did not remember the correct location of the 
target fractal, they did not report a random location but tended to mislocalise it around 




5.4. Associations with biomarkers and APOE-ε4 
 
Following the format laid out in section 3.5, the second part of this chapter aims to 
investigate associations between performance on the “What was where?” task and 
biomarkers of AD in cognitively-normal participants for whom complete biomarker data 
are available. The number of participants meeting these criteria who also had usable 
data from the “What was where?” task was 398 (see section 3.3). 
As explained in section 3.5.2.1, I wanted to derive some summary scores that capture 
the key aspects of performance on each task, to use for comparing results across the 
different cognitive tests in the Insight 46 battery (see Chapter 9). For the “What was 
where?” task I calculated the following three summary outcomes for each participant: 
i) Identification, defined as the percentage of trials on which the correct fractal 
was selected (out of 24 trials). This is a measure of memory for the identity of 
objects. 
ii) Mean ‘nearest item control’ localisation error, defined as above (see section 
5.2.2). The scores were log-transformed to more closely approximate the normal 
distribution. I chose the ‘nearest item control’ measure over the gross error 
measure (see section 5.2.2) because the gross error measure is heavily 
influenced by swap errors, whereas ‘nearest item control’ is a purer measure of 
memory for the location of objects. 
iii) Swap errors, defined as the percentage of trials on which a swap error was made 
(see definition in section 5.2.2). This is a measure of ‘misbinding’ of objects and 
locations in memory.  
Combining outcomes across the different conditions of load (low vs. high) and delay 
(short vs. long) was justified because my hypotheses about associations between AD 
pathology and “What was where?” outcome measures (see section 5.2.3) were general 
rather than specific to certain conditions. 
For each of the three summary outcomes, I tested for associations with the same 
biomarkers as in the previous chapter (see section 3.5.2). I also tested for associations 
between “What was where?” outcomes and hippocampal volume, in order to test the 
hypothesis that smaller hippocampal volume would be associated with increased swap 
errors. Hippocampal volume was generated using the Similarity and Truth Estimation 
for Propagated Segmentations (STEPS) automated segmentation method with 




5.4.1. Statistical Analyses 
 
As before, identification was analysed using a GEE logistic regression model for the 
odds of correctly identifying the fractal with an independent correlation structure and 
robust standard errors. The outcome was number of correct identifications, which was 
treated as a proportion of the total number of trials (24 for most people, but 23 for the 6 
participants who had a trial excluded during the data cleaning process – see 5.2.5). 
Results are expressed as odds ratios for ease of interpretation. 
Mean ‘nearest item control’ localisation error was analysed using a linear regression 
model. 
As before, a GEE logistic regression model was used for the odds of making a swap 
error, with an independent correlation structure and robust standard errors. The outcome 
was number of swap errors, which was treated as a proportion of the number of trials in 
which the participant identified the correct fractal. Results are expressed as odds ratios 
for ease of interpretation.  
All models included predictors of amyloid status (positive vs. negative), whole brain 
volume, WMHV and APOE genotype (ε4-carrier vs. non-carrier). To adjust for the 
correlation between whole brain volume and head size, total intracranial volume (TIV) 
was included in all models, as were the demographic factors investigated in section 6.3 
(sex, age at assessment, childhood cognitive ability, education and adult socioeconomic 
position).  
The models were additionally rerun replacing dichotomised amyloid status with SUVR to 
test whether increasing Aβ deposition was associated with differences in performance. 
To check whether associations between SUVR and cognition were sensitive to the 
inclusion of the imputed SUVR values (see section 3.2.2), the analyses were rerun 
excluding the 26 participants with imputed SUVR data. 
To test for associations between “What was where?” outcomes and hippocampal volume 
(total volume of left plus right hippocampus), I reran the above models with covariates of 
hippocampal volume, sex, age at assessment, childhood cognitive ability, education, 





5.4.2. Results  
 
Results of the regression models for the three outcomes are reported in Table 5-3. 
Results for the demographic and life-course factors (sex, age at assessment, childhood 
cognitive ability, education and adult socioeconomic position) are not reported as they 
are essentially unchanged from the first analysis section (5.3.2). 
 
Table 5-3. Associations between biomarkers and “What was where?” outcomes 
in cognitively-normal participants (n = 398) 
Predictor 
Identification: 
odds ratio and 
95% CIs 
Mean “Nearest Item 
Control” localisation 
error  
(degrees of visual angle,  
log-transformed): 
coefficient and 95% CIs 
Swap errors: 
odds ratio and 
95% CIs 
β-amyloid status  














Whole brain volume  

















Multivariable regression models were used so each association is independent of all others. In 
addition to the predictors listed, models also included sex, age at assessment, childhood cognitive 
ability, adult socioeconomic position, and total intracranial volume. 
Coefficients in bold are significant at p < 0.05 and asterisks indicate significance at p < 0.01.  
CI = confidence interval; WMHV = white matter hyperintensity volume 
 
On average, Aβ+ participants had slightly poorer identification memory than Aβ- 
participants (adjusted means from the multivariable regression model: 80% vs. 83% 
correct) (Table 5-3). There was no evidence of statistically significant differences 
between the amyloid groups in terms of localisation error or swap errors (Table 5-3). As 
an aid to interpretation, the unadjusted untransformed means are quoted as follows: 
‘nearest item control’ localisation error: Aβ+ = 3.19o; Aβ- = 3.21o; swap errors: Aβ+ = 
18.9%; Aβ- = 20.0%. 
When rerunning the models replacing dichotomous amyloid status with continuous 
SUVR, there were no statistically significant associations between SUVR and any of the 
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“What was where?” outcome variables (Identification: Odds ratio = 0.55, 95% CIs 0.23 
to 1.32, p = 0.18; Localisation error: regression coefficient = 0.08, 95% CIs -0.28 to 0.43, 
p = 0.67; Swap errors: Odds ratio = 0.73, 95% CIs 0.22 to 2.36, p = 0.59). These results 
were unchanged in a sensitivity analysis excluding the individuals with imputed SUVR 
values (see section 3.2.2).  
Although the raw unadjusted scores for object identification were slightly lower in APOE-
ε4-carriers compared to non-carriers (ε4-carriers = 82% correct; non-carriers = 84% 
correct), ε4-carriers were found to perform better than non-carriers on this measure after 
adjustment for amyloid status and all other covariates (Table 5-3). As the effect of APOE-
ε4 worked in the opposite direction to the effect of Aβ, this means that the best-
performing group were Aβ- ε4-carriers, and the worst-performing group were Aβ+ non-
carriers (Figure 5-9).  
 
 
Figure 5-9. Identification performance on the “What was where?” task by amyloid 
status and APOE genotype: means and 95% confidence intervals 
Markers show unadjusted means and error bars show 95% confidence intervals.  
 
APOE-ε4 carriers also had better localisation memory than non-carriers on average 
(Table 5-3), with a regression coefficient equivalent to -0.25 SD. A t-test using the raw 
unadjusted localisation error scores confirmed that this group difference was statistically 
110 
 
significant without adjusting for any other covariates (ε4-carriers = 3.0o error; non-carriers 
= 3.3o error, t(396) = 2.50, p = 0.013). As a previous study using the “What was where?” 
task reported that the beneficial effect of APOE-ε4 on localisation memory was only 
present in males (Zokaei et al., 2017), I tested for an interaction between sex and APOE 
genotype: there was no evidence of such an interaction (interaction coefficient = 0.02, 
95% CIs -0.08 to 0.13, p = 0.67).  
Whole brain volume and WMHV did not have any statistically significant effects on any 
of the “What was where?” outcomes (Table 5-3).  
There was no evidence of associations between hippocampal volume and any “What 
was where?” outcomes (Identification: OR = 1.00 per additional ml, 95% CIs 0.91 to 1.11, 
p = 0.93; Localisation error: -0.02, 95% CIs -0.06 to 0.03, p = 0.45; Swap errors: OR = 







The “What was where?” task measured memory for the identity and location of objects, 
and binding of these two features in memory. Subtle sex differences were observed for 
the first time on this task, with females performing better on the identification measure 
but males performing better on the localisation measure. Higher childhood cognitive 
ability was associated with better memory for the identity of objects and fewer binding 
errors. The results did not support the hypothesis that cognitively-normal Aβ+ 
participants would show subtle binding deficits, but there was evidence that Aβ+ 
participants had slightly poorer memory for object identity. As predicted, APOE-ε4 
appeared to have a beneficial effect on memory for locations, and a beneficial effect on 
memory for object identity was also observed. There was no evidence to support the 
hypothesis of an association between hippocampal volume and memory binding. 
 
5.5.2. Patterns of performance 
 
Performance on the three outcomes (identification, localisation and binding) was broadly 
similar to previous studies that have used this task in healthy adults (Pertzov et al., 2012, 
2015; Zokaei et al., 2017; Zokaei, Čepukaitytė, et al., 2019). Neither a ceiling nor a floor 
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effect was observed in terms of identification rate (mean = 83%; SD = 8.9) and the 
percentage of swap errors (mean = 20%) was in line with previous studies (Pertzov et 
al., 2012, 2015). 
Unexpectedly, the length of the delay before participants were asked to report the identity 
and location of the fractal had little impact on their performance. There was no evidence 
of a statistically significant effect of delay duration on identification, although localisation 
performance was a little poorer after the longer delay as expected. Furthermore, this 
study did not observe the expected interactions between load and delay, whereby the 
detrimental effects of a long delay on identification and localisation were expected to be 
disproportionately greater when there were more items to be remembered (high load) 
compared to the low load condition (Pertzov et al., 2012, 2015; Zokaei et al., 2017). One 
possible explanation for this could derive from the way that this shortened version of the 
task was adapted from the original version. The 24 trials in this version were randomly 
selected from the 100 trials in the original task, and it is possible that the ‘short delay’ 
and ‘long delay’ trials could have ended up unbalanced in terms of difficulty. Anecdotally 
the difficulty of individual trials can vary depending on the features of the fractals such 
as their relative salience, similarity and positions (for example, if the target and foil 
fractals in the test array happen to contain similar colours, it may be more difficult to 
choose between them). This variability in the appearance of the fractals is inherent to 
the task and is impossible to fully control for. Also, as 24 trials is a small number 
compared to many neuropsychology tests, the signal-to-noise ratio may not have been 
good enough to measure these effects. 
 
5.5.3. Demographic and life-course predictors 
 
5.5.3.1. Associations with childhood cognitive ability, education and adult 
socioeconomic position 
Higher childhood cognitive ability was associated with better memory for the identity of 
objects and fewer ‘misbinding’ errors. It is interesting that localisation memory did not 
show evidence of an association with childhood cognitive ability, especially given that 
the continuous nature of this measure (as opposed to a discrete correct vs. incorrect 
recall measure) makes it sensitive to small differences in performance (Pertzov et al., 
2013). I would speculate that the adoption of encoding strategies may possibly be 
relevant here; anecdotally, I observed that participants sometimes commented on trying 
out different encoding strategies for remembering the identity of the objects, for example 
“I tried to give the shapes a name in my head” or “I tried to remember the colours”, and 
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sometimes remarked on whether or not such strategies had been successful. I do not 
recall any participants commenting on strategies for remembering the locations and I 
would argue that the range of possible strategies for remembering precise locations on 
a blank screen may be more limited. I would speculate that the greater potential for 
adopting a range of strategies to encode object identities may be of relevance in 
explaining why the identification memory measure appears to be more related to general 
cognitive ability, as it introduces an element of problem-solving into the task, creating 
potential for participants to generate and adapt strategies throughout the task. Although 
fractal stimuli were used to reduce the likelihood of verbal encoding, it is interesting to 
note that such strategies are effectively an attempt to introduce a verbal memory 
component into the task (i.e. encoding the names of colours or shapes), allowing the 
object identities to be more easily rehearsed during the delay interval. 
Given that previous studies have reported the ‘swap error’ measure to be a sensitive and 
specific measure of memory binding impairment in individuals with presymptomatic FAD 
(Liang et al., 2016) and patients with medial temporal lobe damage (Pertzov et al., 2013; 
Zokaei, Nour, et al., 2019), the novel association reported here between higher childhood 
cognitive ability and fewer swap errors has implications for such studies. While most 
cohorts do not have access to data on childhood cognitive ability, interpretation of results 
should consider the fact that individual differences in memory binding ability may be 
partially driven by general cognitive ability as well as by pathology.  
 
5.5.3.2. Sex differences 
The finding that males had better memory for the location of objects is interesting in the 
context of a previous study using the “What was where?” task which reported an 
interaction between sex and APOE genotype on the localisation memory measure: male 
APOE-ε4 carriers were found to be at an advantage compared to male non-carriers in 
terms of localisation memory, but no such effect of APOE-ε4 was observed in females 
(Zokaei et al., 2017). As that study found no statistically significant overall difference 
between males and females on the localisation measure (although they did report a 
significant sex difference in terms of swap errors), the authors’ interpretation focussed 
on reasons why APOE-ε4 may have differential effects on men and women, rather than 
on reasons why there may be sex differences in localisation memory. However, the 
direction of their data appears to be consistent with the effect I report here, and their 
hypotheses about differential effects of APOE-ε4 were not supported by their later study 
which reported the same effect of APOE-ε4 in both males and females (Zokaei, 
Čepukaitytė, et al., 2019). Perhaps the lack of a statistically significant sex difference in 
localisation memory in these two studies could be explained by the fact that it is a very 
113 
 
subtle effect and those studies had much smaller sample sizes (n=60 and n=66 
respectively) and contained wider age ranges. 
As the male advantage for localisation was primarily driven by the conditions with easier 
memory demands (1 object to remember and 1-second delay), this suggests that the 
difference may lie in the precision of encoding and/or reporting locations, rather than in 
the rate of decay of representations in memory (in which case the opposite result would 
be expected, i.e. a greater sex difference after 4 seconds delay). One previous study 
conducted a detailed examination of sex differences in reporting of point locations within 
a blank circle and within photographs of complex natural scenes, and concluded that the 
sex differences may arise during encoding as the differences were present even when 
there was no retention interval (i.e. participants were asked to reproduce a location from 
an image on a screen onto a response sheet while the screen remained visible) (Holden, 
Duff-Canning and Hampson, 2015). The nature of the errors in this task revealed an 
interesting pattern from which the authors concluded that women were more likely to rely 
on categorical cues whereas men tended to rely on metric information. Within a blank 
circle, women were more likely to localise the point closer to the centre of one of the four 
quadrants that would be formed if the horizontal and vertical axes of the circle were 
drawn in. Similarly in the photographic scenes, they were more likely to localise the point 
closer to the centre of the section that the stimulus location was in, where the sections 
were defined by an algorithm using edge detection and shared perceptual features (e.g. 
the shadow on the side of a mountain). Both cases suggest an increasing tendency to 
categorise the image into regions of interest and to adopt a strategy of remembering 
which region the point is in. Anecdotally, this fits with my perception of watching 
participants complete the “What was where?” task, where I got the impression that some 
participants appeared to be recalling the locations using strategies such as “over by the 
right-hand edge” or “up towards the top-left corner”, as they sometimes seemed to make 
stereotyped errors such as locating the fractal as far towards the edge or corner as 
possible. 
There is a well-established literature on sex differences in spatial abilities, with males 
reported to outperform females on a range of tasks such as spatial navigation and mental 
rotation, in rats as well as humans (for meta-analyses see Voyer, Voyer and Bryden, 
1995; Jonasson, 2005; Voyer, Voyer and Saint-Aubin, 2017). Various explanations for 
sex differences in spatial abilities have been advanced, including hormonal (see 
Jonasson for a review in rats) and evolutionary factors (e.g. Ecuyer-Dab and Robert, 
2004). However, there is also evidence that sex differences in spatial abilities in humans 
are dependent on cultural factors. In a recent analysis of over 2.5 million people from all 
195 nation states who played a mobile-app-based game designed to measure spatial 
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navigation ability, there was a consistent sex difference across nations with males 
performing better, but the size of a nation’s sex difference was positively correlated with 
its level of gender inequality, as defined by the World Economic Forum’s Gender Gap 
Index  (Coutrot et al., 2018). Consistent with the evidence described above of a sex 
difference in preference for cues versus metric information, studies of spatial navigation 
have reported sex differences in navigation strategies, with females tending to place 
more emphasis on allocentric strategies (based on a perception of the positions of 
landmarks and their relationships to other landmarks) and males tending to rely more on 
egocentric strategies (based on an internal representation of spatial information from 
one’s own viewpoint) (Saucier et al., 2002; Jonasson, 2005).  
With respect to sex differences on object location memory tasks specifically, two meta-
analyses have concluded that women outperform men, but these meta-analyses 
focussed on specific types of task which require recall of categorical locations. The first 
meta-analysis included variations of a task where participants are asked to study an 
array of objects and then are presented with a new array in which some objects have 
moved and others are in the same places as before – the task is to identify which objects 
have switched places (Voyer et al., 2007). The second meta-analysis focussed on a task 
where participants are asked to memorize the locations of pairs of coloured dots hidden 
underneath flaps (similar to the ‘Pairs’ card game) (Voyer, Voyer and Saint-Aubin, 2017). 
It has been argued that the apparent female advantage on these sorts of location 
memory tasks may be dependent on non-spatial aspects of these tasks (Andreano and 
Cahill, 2009; Holden, Duff-Canning and Hampson, 2015), which may explain the 
discrepancy with tasks based on recall of absolute metric locations such as “What was 
where?”.  
This argument may also be relevant to my finding that females had slightly better memory 
for the identity of objects, as good performance on this measure may be aided by 
verbalisation strategies (as alluded to in section 5.5.3.1) rather than relying purely on 
visual memory. This result is in line with the results from the other memory tests in the 
Insight 46 battery (Logical Memory and FNAME – see Chapter 4) where females had 
higher scores on average. 
In summary, the finding of sex differences on the “What was where?” task is novel, but 
is consistent with a body of literature on sex differences in verbal and visuospatial 
abilities. This finding is noteworthy for the fact that both male and female advantages 




5.5.3.3. Associations with age 
Age effects have previously been observed on the “What was where?” task, whereby 
older adults had poorer memory for object identity and location compared to younger 
adults, although there was no age effect on memory binding (Pertzov et al., 2015). It is 
not surprising that no such evidence of associations between age and performance were 
seen among Insight 46 participants, given that the age range was so small (2.6 years- 




5.5.4. Associations with biomarkers and APOE-ε4 
 
Previous studies have suggested that visual memory binding may be one of the first 
aspects of memory to decline as AD pathology accumulates, as subtle binding deficits 
have been detected in presymptomatic FAD mutation carriers, at a stage when memory 
for the individual features was unaffected (Parra et al., 2010, 2011, 2015; Liang et al., 
2016). The results of this study contradict this as there was no evidence of a difference 
between cognitively-normal Aβ+ and Aβ- participants in terms of object-location binding, 
but Aβ+ participants did have slightly poorer memory for the identity of objects (as well 
as evidence of slightly lower scores on the Logical Memory Immediate recall task 
reported in Chapter 4). To my knowledge, associations between Aβ deposition and visual 
short-term memory binding have not been investigated before in cognitively-normal older 
adults, but binding deficits in MCI (Pietto et al., 2016; Parra et al., 2017) and AD are well-
established (Parra et al., 2009, 2010, 2011; Fernández et al., 2018), so further studies 
are needed to determine at what point such deficits may emerge. As the presymptomatic 
mutation carriers in the study by Liang et al. showed evidence of hippocampal atrophy 
which correlated with greater binding deficits, and Aβ deposition is understood to 
precede hippocampal atrophy by some years (Bateman et al., 2012; Jack et al., 2013) it 
is currently unclear whether binding deficits may be detectable before measurable 
neurodegeneration occurs. 
This is now the third independent cohort to report a beneficial effect of APOE-ε4 on 
memory for locations in the “What was where?” task (Zokaei et al., 2017; Zokaei, 
Čepukaitytė, et al., 2019). This is consistent with a recent review of the association 
between APOE-ε4 and cognition in younger adulthood, which highlighted spatial memory 
as one area of cognition in which APOE-ε4 carriers appear to be at an advantage, along 
with advantages in many aspects of physical fitness (Smith, Ashford and Perfetti, 2019). 
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The authors of this review acknowledged the issue of “transition from ε4-associated 
cognitive advantage to cognitive deficit” across the life span, but it is important to 
remember that beneficial effects of APOE-ε4 on cognition may not cease to operate in 
older age, even if outweighed on average by the detrimental effects of Aβ-pathology – 
as highlighted by the novel finding that APOE-ε4 carriers in Insight 46 had better memory 
for object identity on the “What was where?” task, once the detrimental effect of Aβ had 
been accounted for. Many studies comparing APOE-ε4 carriers and non-carriers in older 
age do not have access to biomarker data on Aβ levels, so it is possible that subtle 
independent effects of APOE-ε4 are being masked by Aβ. This could potentially explain 
why Zokaei et al. observed no effect of APOE-ε4 on memory for object identity, if this 
measure is more sensitive to Aβ-pathology as the results reported here suggest. It could 
also explain why the APOE-ε4 carriers in their study showed evidence of poorer memory 
on a delayed recall task, whereas in Insight 46 APOE-ε4 carriers performed better on a 
delayed recall task (Logical Memory – see Chapter 4) after the detrimental effect of Aβ 
was accounted for. This finding on the Logical Memory task further supports the 
hypothesis that the purported beneficial effect of APOE-ε4 is not specific to location 
memory. Furthermore, in light of evidence from studies of spatial navigation that have 
observed poorer performance in APOE-ε4 carriers, both in younger and older adults 
(Kunz et al., 2015; Coughlan et al., 2019), it is possible that the superior performance of 
APOE-ε4 carriers on the “What was where?” localisation measure could be primarily due 
to its demands on working memory and attention, rather than spatial abilities per se. This 
is discussed further in Chapter 10. 
 
5.5.5. Strengths and limitations 
 
Although anecdotally this was one of the tasks on which participants were most likely to 
report a perception of poor performance, it worked well with no floor or ceiling effects, 
and only one participant declining to complete the full task (see section 3.3). The results 
suggest that the adapted short form of the “What was where?” task used in Insight 46 is 
sufficient to measure the outcomes of interest, and suitable for detecting subtle 
differences in performance in this age group. This is encouraging as this version (24 
trials) takes approximately 8-10 minutes to complete, whereas the original version was 
much longer with 100 trials. For participants who did report finding this task particularly 
difficult, a much longer version could have been demoralising. However, more trials may 
be necessary for studies which aim to examine the effects of load and delay, as the small 
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number of trials may have affected our ability to detect differences between the 
conditions, especially since the low load condition only had 4 trials. 
The software had a limitation that resulted in occasional instances of the opposite fractal 
being selected to the one the participant intended. This happened when a participant 
selected a fractal and dragged it to their chosen location, passing through the unselected 
fractal on the way. This could generally be avoided by instructing the participant to tap 
their chosen fractal first and then tap the location, rather than doing both in one 
movement. It was not possible to record which trials this occurred on, but my estimate is 
that it affected 5-10% of trials for 1-5% of participants i.e. no more than 0.5% of trials in 
total. This means that a few participants may have received lower identification scores 
than they should have. Localisation error and swap error scores are unlikely to have 
been affected since they are calculated based on correct identifications only. I am 
confident that this has not affected the results and conclusions, but would recommend 
for future studies that the software is altered to require the identification step to be logged 
before moving onto the localisation step. 
Strengths and limitations that apply to all the analyses presented in this thesis, such as 





In summary, this sensitive computerised task allows precise measurement of multiple 
aspects of visual short-term memory, revealing an interesting pattern of sex differences 
and a novel dissociation between the effects of Aβ pathology and APOE-ε4, whereby Aβ 
was associated with a subtle deficit in object recognition memory whereas APOE-ε4 was 




6. CHOICE REACTION TIME 
 
6.1. Introduction  
 
Processing speed is an aspect of cognition in which age-related decline is particularly 
notable (Salthouse, 2000; Harrington et al., 2018), and also an area which becomes 
impaired early in the AD process. Evidence that decline in processing speed can be 
detected in the preclinical phase of AD comes primarily from studies that have reported 
a difference between cognitively-normal individuals with and without amyloid-β and tau 
pathology, on paper-and-pencil tasks such as the WAIS-Digit Symbol and Trail Making 
Test A (e.g. Baker et al., 2017; Ho and Nation, 2018). An aspect of processing speed 
which merits further investigation as a potential marker of subtle cognitive decline in 
preclinical AD is reaction time (RT) because it underpins many other cognitive processes 
and is of constant relevance to daily functioning. Simple RT tasks can be conceptualised 
as requiring sustained attention and the energisation and execution of a pre-planned 
motor or other response (Stuss et al., 2005). Choice RT tasks (which require selection 
of the correct response from two or more options) can be considered to additionally 
require monitoring a larger set of stimuli and inhibiting responses to non-target stimuli 
(Stuss et al., 2005). Choice RT may be a particularly informative measure because – 
compared to simple RT – it is more sensitive to age and cerebral dysfunction (Benton, 
1986; Der and Deary, 2006). As well as response speed itself, another interesting aspect 
of performance on such tasks is intra-individual variability (or inconsistency) in RT.  
It is well-established that Choice RT slows with age. Most evidence comes from cross-
sectional studies comparing younger and older adults (Deary and Der, 2005; Bugg et al., 
2006; Der and Deary, 2006; Garrett, Macdonald and Craik, 2012; Vincent et al., 2012; 
Nissan, Liewald and Deary, 2013; Woods et al., 2015), but longitudinal decline has also 
been reported (Ritchie et al., 2016). While there is a component of motor slowing, most 
of the age-related increase in RT is understood to be due to slower cognitive processing, 
which includes the specific steps of response selection and response generation 
(Salthouse, 1996; Godefroy et al., 2010; Woods et al., 2015), as well as to a decline in 
attention (Godefroy et al., 2010). Intra-individual variability in RT is also widely-reported 
to increase with age (Anstey et al., 2005; Deary and Der, 2005; Williams et al., 2005; 
Dykiert et al., 2012a; Nissan, Liewald and Deary, 2013). As intra-individual variability in 
RT is a function of overall response speed (i.e. variability increases as responses get 
slower), experimental studies often use normalised measures of intra-individual 
variability that account for each individual’s average RT. One such index is the 
“coefficient of variation”, defined as standard deviation / mean (e.g. (Der and Deary, 
2006) or interquartile range / median (e.g. (Phillips et al., 2013)).  
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Impaired RT and increased intra-individual variability in RT are common across a variety 
of neurological conditions including the dementias, traumatic brain injury, schizophrenia 
and attention deficit hyperactivity disorder (Benton, 1986; MacDonald, Nyberg and 
Bäckman, 2006). A number of diverse associations suggest that RT might be a general 
indicator of the integrity of the central nervous system (MacDonald, Nyberg and 
Bäckman, 2006), for example, RT correlates with a wide range of physical health 
measures such as grip strength, forced expiratory volume, corrected visual acuity and 
concentration of macular pigment (Anstey et al., 2005; Feeney et al., 2013). Insight 46 
participants have previously completed a Choice RT task at age 60-64, as part of the 
wider MRC National Survey of Health and Development (NSHD), and the results 
provided evidence that slower RT is associated with greater adiposity (waist 
circumference) (Masi et al., 2018) and impaired kidney function, partially accounted for 
by socioeconomic factors (Silverwood et al., 2014). 
Multiple studies have reported that patients with AD have slower and more variable RTs 
than controls (Hultsch et al., 2000; Burton et al., 2006; Phillips et al., 2013; Christ, 
Combrinck and Thomas, 2018). There is evidence that decline in RT can be detected 
before the onset of AD dementia, as patients with MCI are reported to have slower RTs 
than controls (Christensen et al., 2005; Ballesteros, Mayas and Reales, 2013; Phillips et 
al., 2013; Haworth et al., 2016). One study found that RT discriminated the MCI and 
control groups better than the commonly-used Trail-Making Test, another measure of 
information processing speed that arguably relies more on multiple high-level functions 
such as working memory, cognitive flexibility and set-shifting (Haworth et al., 2016).  
Intra-individual variability in RT has received relatively little attention as a potential 
marker of early cognitive decline in preclinical AD, but some studies have investigated 
intra-individual variability in RT in patients with MCI and reported mixed results. One 
study reported that patients with MCI were more variable than controls (Christensen et 
al., 2005), whereas another reported that patients with MCI had larger standard 
deviations of RT than controls but this was accounted for by their slower overall response 
speed (i.e. there was no difference in the coefficient of variation) (Phillips et al., 2013). A 
third study reported that MCI patients did not differ from controls in terms of intra-
individual variability on a simple RT task, but greater variability within the MCI group was 
predictive of developing dementia within a 2.5 year follow-up (Tales et al., 2012). To my 
knowledge, no studies have investigated associations between Choice RT (response 
speed and intra-individual variability) and biomarkers of AD pathology in cognitively-
normal older adults. 
If Choice RT and/or intra-individual variability in RT are to be useful measures in 
detecting and tracking subtle cognitive decline in the preclinical phase of AD, it is 
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important to disentangle disease-related decline from ageing effects, and also to account 
for other factors which may contribute to individual differences in RT, such as sex and 
prior cognitive ability. Factors associated with individual differences in RT are briefly 
reviewed below.  
The relationship between RT and intelligence has been widely investigated, with the aim 
of understanding how differences in cognitive ability may be underpinned by differences 
in the simple cognitive processes that support more complex information processing. 
Associations between higher intelligence and faster responses in Choice RT tasks have 
been reported across adulthood (e.g. Deary, Der and Ford, 2001; Sheppard and Vernon, 
2008; Deary, Johnson and Starr, 2010; Nissan, Liewald and Deary, 2013). Proposed 
explanations for this association include (1) intelligence is built up over time by the 
processing of information and RT is a measure of information processing efficiency 
(Vernon, 1983); (2) both are at least partially dependent on attention (Doebler and 
Scheffler, 2016); and (3) they share genetic predictive factors (Sheppard and Vernon, 
2008). Evidence from the Lothian Birth Cohort has shown that childhood cognitive ability 
is predictive of Choice RT at age 70 (Deary, Johnson and Starr, 2010).  
Higher intelligence has also been associated with lower intra-individual variability in RT, 
as reported in a recent meta-analysis (Doebler and Scheffler, 2016) – however this meta-
analysis did not adjust the variability measure for its dependence on overall response 
speed, which may account for most of the association with intelligence (Der and Deary, 
2017). Having access to data on Insight 46 participants’ childhood cognitive ability and 
educational attainment provides an (imperfect) way to account for differences in general 
mental ability, which may improve the sensitivity of the Choice RT task to potential effects 
of brain pathologies. It also provides a rare opportunity to examine whether childhood 
cognitive ability and educational attainment have independent effects on RT and intra-
individual variability in RT in older age. 
Some studies have found no sex differences on Choice RT tasks (e.g. (Woods et al., 
2015)), while others have reported that males tend to have faster and less variable RTs 
(Deary and Der, 2005; Der and Deary, 2006; Dykiert et al., 2012b; Vincent et al., 2012; 
Phillips et al., 2013; Haworth et al., 2016). Deary and Der suggest a possible hormonal 
explanation (Deary and Der, 2005), and proposed behavioural explanations include that 
females may show stronger learning effects and greater post-error slowing (Reimers and 
Maylor, 2006; Thakkar et al., 2014; Fischer et al., 2016). This is in contrast to perceptual 
processing speed tests (such as Digit-Symbol Substitution) where females tend to be 
faster (see Chapter 4). 
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Another factor that needs to be considered when interpreting individual differences in RT 
is speed-accuracy trade-offs. Standard practice in Choice RT studies is to analyse error 
rate separately to RT – an approach which allows comparisons of speed and accuracy 
between groups, but does not allow a direct analysis of the trade-offs between speed 
and accuracy on an individual level. Correlations between slower RT and greater 
accuracy on Choice RT tasks have been observed (Nissan, Liewald and Deary, 2013), 
but the opposite result has also been reported (i.e. slower responses being associated 
with poorer accuracy (Vaportzis, Georgiou-Karistianis and Stout, 2013), or no correlation 
between RT and accuracy (Bugg et al., 2006). 
Following the structure of the previous chapter, the aims of this study were firstly to 
understand patterns of performance on the Choice RT task and to characterise 
associations between task performance and demographic and life-course predictors, 
and secondly to investigate associations between performance and biomarkers of brain 




   
6.2.1. Stimuli and Procedure 
 
Two related experiments were combined into one task. This chapter concerns the first 
experiment, a Choice RT task. The second experiment is described in Chapter 7.  
The Choice RT task was presented on a DELL Optiplex 9030 all-in-one touchscreen 
computer, using SuperLab software. A response box with two buttons side by side was 
connected to the computer and placed on the table in front of the participant. The 
experiment had 2 blocks of 12 trials each. In block 1 the stimulus was an arrow pointing 
left or right, and in block 2 the stimulus was a word – ‘LEFT’ or ‘RIGHT’ (see Figure 6-1). 
All stimuli were displayed in the centre of the screen. At the beginning of each trial, there 
was an interval of 1000ms throughout which a cue was displayed (‘Arrow’ in Block 1, and 
‘Word’ in Block 2), before the stimulus appeared below it. The purpose of displaying the 
cue before the stimulus was to pace the experiment and to maintain a consistent format 
with the second experiment (see Chapter 7) where cues formed a necessary part of the 
instructions.  
Six practice trials preceded each block. The practice trials were followed by a gap of 
about 5 seconds before the main block started automatically. The order of trials was the 
same for all participants: LRRRLRLRLLRL in Block 1, and LLLLRRRLRRL in Block 2. 
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However, the software output indicated that 3 participants were presented with the trials 
in a different order (RLLLRLRLLRRR in Block 1, and RRLRRLLLLRRL in Block 2), which 
appeared to be an unexplained consequence of the tester accidentally omitting to 
complete the Session ID field when launching the experiment.  
Participants were instructed to press the correct button on the response box (left or right) 
as quickly as possible, according to the stimulus on the screen. They were asked to use 
the index and middle fingers of their dominant hand, with one finger on each button. If 
their response was correct, the next trial was initiated; if their response was incorrect, 
the stimulus remained on the screen and an error tone sounded to signal that they should 
respond again as quickly as possible. Regardless of whether their second attempt was 










Figure 6-1. The Choice Reaction Time task.  
The cue (“Arrow” or “Word”) appeared on its own for 1000ms before the stimulus appeared 
underneath. The XXX inside the arrow is not relevant for the response, but was included so that 
the appearance and visual complexity of both blocks were as similar as possible. 
 
 
6.2.2. Outcome variables 
 
Two variables were recorded for each response: RT (ms) and accuracy (correct or 
incorrect). All analyses were based on the initial response to each stimulus; second 
attempts were not analysed as their purpose was to reorient participants to the task. 
Standard practice across many different tasks measuring RT is to analyse RT for correct 
responses only (e.g. Aron et al., 2004; Forster and Lavie, 2008; Silverwood et al., 2014; 
Stoet, 2017). This is because the cognitive processes involved in making a correct 
response are assumed to be different to those involved in making an incorrect response: 
Block 1 Block 2 
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reasons for errors include anticipatory responses, attentional slips, and failures in 
understanding how to reach the correct answer. Therefore, restricting RT analyses to 
correct responses is a fairer way to compare individuals or groups (notwithstanding the 
fact that correct responses could also be achieved by anticipatory responses or chance). 
This approach was adopted here.  
The third outcome of interest was intra-individual variability in RT. Variability in RT is 
a function of overall response speed, therefore mean RT needs to be accounted for when 
investigating individual differences in intra-individual variability. This analysis adopts the 
commonly-used coefficient of variation, calculated by dividing each participant’s 
standard deviation by their mean RT (e.g. Hultsch et al., 2000; Der and Deary, 2006). As 
before, only correct responses are considered because the RT of incorrect responses is 
likely to vary depending on what led to the error (e.g. inattention, anticipation, difficultly 
working out the answer), whereas the variability in RT of correct responses is a purer 





Based on the literature, I hypothesised that higher childhood cognitive ability, higher 
educational attainment and male sex would be associated with faster and less variable 
RTs. 
I aimed to test the hypothesis that cognitively-normal Aβ+ participants would have slower 





All 502 participants completed the Choice RT task (see section 3.3). Participant 





6.2.5. Data processing 
 
The first trial in each block was not included in any analyses because participants did 
not always realise that the block had started and this affected RT. This limitation in the 
experimental design in discussed later (see section 6.5.5). 
In line with the policy of keeping the sample as representative as possible, the only 
reason to exclude participants with outlying performance was deemed to be a clear 
indication that they deviated from the protocol e.g. a fundamental misunderstanding of 
the instructions. One participant had a lifelong condition affecting cognition and was 
noted to have difficulty in understanding the task, in telling left from right, and in confusing 
the meaning of ‘right’ with ‘correct’. This participant was excluded from the analyses, 
leaving a sample of 501.  
If any participants were to have an error rate of >50%, i.e. suggestive of guessing at 
chance level, this would be grounds to consider excluding them from the analyses 
because it would indicate that they might not have understood the instructions, paid 
attention to the task or known their left from their right. Some Choice RT tasks adopt 
stricter exclusion criteria (e.g. 90% accuracy (Deary and Der, 2005) or 80% accuracy 
(Der and Deary, 2006). The majority of participants (75%) made no errors and the 
highest error rate was 27%, therefore no participants were excluded from analyses 
based on their error rate.  
Although only correct responses were considered for most of the analyses of RT (see 
section 6.3.1.1), RTs of incorrect responses were considered as part of the analysis of 
speed-accuracy trade-offs (see section 6.3.1.3). Therefore, for the purpose of checking 
for outlying RTs, I have considered all responses together, both correct and incorrect. 
The distribution of each participant’s mean RT shows that there were few participants 
with outlying slow RTs (Figure 6-2). One of these participants had a tremor but this was 
not grounds to exclude them from analyses because they performed the task according 
to the instructions and they were not fundamentally different to some other participants 
with motor symptoms whose performance was not outlying but was affected by their 






Figure 6-2. Box and whisker plot of mean reaction times (correct and incorrect 
responses) on the Choice Reaction Time task, before data cleaning 
 
Reaction times to individual trials were checked for outliers. Extremely fast RTs can be 
assumed to be invalid as there is a minimum amount of time required to process the 
stimulus. In a previous paper using a similar task, a threshold of 300ms was used as the 
fastest possible time for a genuine response (Aron et al., 2004) so I adopted the same 
criterion, although no trials had RTs of less than 300ms. There were a few outlying slow 
responses (Figure 6-3). Unusually slow responses are unlikely to reflect the participant’s 
ability – for example I observed instances of participants stopping to cough or drink water 
– so I considered three approaches to choosing a threshold for excluding the slowest 
trials:   
i) Excluding trials where the RT is more than 3 SD above the sample mean (i.e. > 
1208 ms). 
ii) Excluding trials where the RT is more than 3 SD above each participant’s own 
mean, as in (Anstey et al., 2005).  
iii) Excluding trials where the RT is above an arbitrary cut-off such as 4000 ms as in 
(Aron et al., 2004) or 1000 ms in (Anstey et al., 2005).  
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Approach (ii) was adopted as it is most likely to filter out trials that are not representative 
of an individual’s ability. As the range of mean RTs was wide, approach (i) could 
consistently exclude trials from participants who found the task difficult – possibly the 
very participants who may provide evidence to confirm the hypothesis that poor 
performance on this task is associated with brain pathologies. Approach (iii) is too 
arbitrary and would mainly exclude trials belonging to a few low-performing participants 
– again possibly the participants of particular interest to the hypothesis.  
Therefore, I excluded trials more than 3 SD above each participant’s own mean, which 
applied to 40 trials (0.4%) from 40 participants (1 trial each). This reduced the maximum 
RT to 1637 ms. 
 
 
Figure 6-3. Box and whisker plot of individual reaction times (correct and incorrect 






6.3. Patterns and predictors of performance 
 
Following the format laid out in section 3.5, in the first part of this chapter I aimed to 
describe patterns of performance across the various outcomes and conditions of the 
task, and to investigate the effects of demographic and life-course predictors on 
performance in the full Insight 46 sample. Specifically I aimed to investigate whether RT 
and error rate differ for word and arrow stimuli, explore speed-accuracy trade-offs, and 
describe intra-individual variability in RT. The demographic and life-course predictors 
(sex, age at assessment, childhood cognitive ability, educational attainment, adult 
socioeconomic position and presence of a neurological or psychiatric condition) are 
defined in sections 3.2.4 and 3.2.3 respectively. 
 
 
6.3.1. Statistical Analyses 
 
6.3.1.1. RT and error rate 
Rather than using summary scores for each participant (e.g. mean RT for arrows and 
mean RT for words), trial-by-trial responses to each individual stimulus were analysed to 
avoid losing information. RTs were first log-transformed so that the distribution more 
closely approximated the normal distribution.  
RT was analysed using a GEE model, assuming a normal distribution for the dependent 
variable and an identity link (as with standard linear regression), but including an 
exchangeable correlation structure and robust standard errors to allow for the correlation 
between repeated measures of the same participant.  
Response accuracy (correct vs. incorrect) was analysed using a GEE logistic regression 
model with an independent correlation structure and robust standard errors. Results are 
expressed as odds ratios for ease of interpretation. 
Predictors in the models were stimulus type (arrow vs. word), sex, age at assessment, 
childhood cognitive ability, education, adult socioeconomic position and presence of a 




6.3.1.2. Practice effects 
As the arrow block always preceded the word block, comparison between them could be 
confounded by practice effects. While this cannot be tested explicitly, exploring practice 
effects with the two blocks separately could give an indication of whether practice effects 
are generally observed on this test. Practice effects on RT and error rate were 
investigated by rerunning the models (see 6.3.1.1) with an additional factor of trial 
number (1 to 11). 
 
6.3.1.3. Speed-accuracy trade-offs  
Speed-accuracy trade-offs can be investigated both between-subject or within-subject. 
Between-subject analyses address questions such as: “Which participants are most 
likely to trade speed for accuracy?” or “Which participants tend to perform well on both 
speed and accuracy?”  Within-subjects analyses address questions such as “Are 
participants more likely to make an error when they respond more quickly, and which 
experimental conditions promote this response pattern?”  The between-subjects 
questions are my main focus in line with my research questions about whether this task 
can identify participants whose performance may be indicative of subtle cognitive 
decline, but the within-subject questions are also of interest in understanding more about 
general patterns of performance on this task.  
To address the between-subject questions, each participant’s mean RT for correct 
responses was compared to their error rate (percentage of incorrect responses), 
combined across arrow and word stimuli. This approach has been adopted in other 
studies, for example a study which investigated speed-accuracy trade-offs on a Choice 
RT experiment in participants with Huntington’s disease (Vaportzis et al., 2015a). 
The distribution of mean RTs had a positive skew. Two transformations were considered: 
log-transforming the mean RTs or calculating the mean of the log-transformed raw RTs. 
As neither of these removed the skew, the untransformed data were used for ease of 
interpretation. The distribution of error rates also had a strong positive skew due to a 
ceiling effect on accuracy. The relationship between mean RT and error rate was 
analysed using Spearman’s rank correlation. This nonparametric test was appropriate 
due to the non-linear relationship between the variables (see section 6.3.2.3), and 
because the main purpose of this section is a simple investigation of whether those who 
rank high in terms of speed tend to rank low in terms of accuracy.  
To address the within-subject trade-offs, trial-by-trial responses to each individual 
stimulus were analysed to investigate whether the speed of a response predicted 
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whether that response would be correct or incorrect. This was done by rerunning the 
GEE model for the odds of making errors (see 6.3.1.1), with RT included as an additional 
factor. RT was not log-transformed this time, to aid interpretability of its effects as a 
predictor (it was previously transformed to comply with the assumption of a normal 
distribution for linear regression when it was being modelled as an outcome). 
 
6.3.1.4. Intra-individual variability in RT 
As intra-individual variability in RT was normally distributed, a linear regression model 
was used to investigate its associations with sex, age at assessment, childhood cognitive 
ability, education, adult socioeconomic position and presence of a neurological or 
psychiatric condition (yes vs. no).  
Some studies have reported that variability in RT for correct responses is a function of 
error rate (Hultsch et al., 2000; Der and Deary, 2006), probably because the response 
following an error is typically slower. To investigate the extent to which intra-individual 
variability in RT (for correct responses only) may be predicted from error rate on this 




6.3.2.1. RT and error rate 
Descriptive statistics are presented in Table 6-1. Results of the multivariable regression 
models for RT and error rate are given in Table 6-2. 
 
Table 6-1. Descriptive statistics for the Choice Reaction Time task   





Median 741 789 768 
IQR 668 - 828 723 - 870 695 - 850 
Range 489 - 1586 503 - 1637 489 - 1637 
Error rate (%) 3.0 2.2 2.6 
 





Table 6-2. Associations between demographic and life-course predictors and 
Choice RT outcomes: RT and error rate (n = 501) 
Predictor 
RT a 
coefficient and 95% CIs 
Odds Ratio for making 
an error and 95% CIs 
Arrow stimulus 














































Coefficients in bold are significant at p < 0.05 and asterisks indicate significance at p < 0.01. a For 
the RT outcome, as the data were log-transformed, the coefficients are quoted in exponentiated 
form for ease of interpretation; for example, a coefficient of 1.05 would mean that the factor was 
associated with 5% longer response time. Multivariable regression models were used so each 
association is independent of all others. b See section 3.2.4 for definition of categories. c See 
section 3.2.3 for definitions.  
CI = confidence interval; RT = reaction time. 
 
On average, responses were 7% slower to words than arrows (Figure 6-4), and the odds 
of making an error were 28% lower for words than arrows. Taken together, this implies 




Figure 6-4. Box plot of reaction time for arrows and words on the Choice Reaction 
Time task 
 
On average, males responded 1% faster than females (adjusted means 767 vs. 777 ms) 
and were 14% more likely to make errors (adjusted mean error rates 2.7% vs 2.4%), but 
these differences were not statistically significant (Table 6-2).  
Older age at assessment was associated with slightly slower RT and fewer errors (3% 
slower RT, 19% less likely to make errors, per year of older age) (Table 6-2).  
Higher childhood cognitive ability was associated with slightly faster responses and 
substantially lower odds of making errors (Table 6-2).  
Education and adult socioeconomic position were not associated with RT or error rate 
(Table 6-2). 
Participants with neurological and psychiatric conditions did not differ from cognitively-
normal participants in terms of their RTs, but their odds of making an error were 54% 




6.3.2.2. Practice effects 
The comparison of RT and error rate for word and arrow stimuli reported above could 
potentially be confounded by practice effects, as the word block was always administered 
after the arrow block. This could partially explain the observation of lower error rates for 
word stimuli, or could mean that the finding of slower RTs for word trials underestimates 
the true effect (see 6.3.2.1). Practice effects were explored in the two blocks separately 
to give an indication of whether they are a feature of performance on this test. 
RT slightly decreased during the arrow block (regression coefficient = 0.996 per 
successive trial, 95% CIs 0.995 to 0.997, p < 0.0001) suggesting a practice effect, but 
slightly increased during the word block (regression coefficient = 1.002, 95% CIs 1.001 
to 1.003, p < 0.0001). This difference could be due to the fact that the arrow block came 
first so perhaps participants were still getting used to the task. There was no evidence of 
statistically significant practice effects in error rate (Arrow block: OR = 1.004, 95% CIs 
0.998 to 1.094, p = 0.063; Word block: OR = 0.987, 95% CIs 0.932 to 1.045, p = 0.656). 
Overall it does not appear that performance was strongly influenced by practice effects. 
 
6.3.2.3. Speed-accuracy trade-offs  
Slower mean RT was associated with lower error rate i.e. a speed-accuracy trade-off 
was observed (Spearman’s ρ = -0.28, p < 0.0001) (Figure 6-5). The correlation is weak 
as there is a ceiling effect with many participants having an error rate of zero regardless 
of their mean RT. However, it is striking that all of the participants with the highest error 
rates had relatively fast mean RTs, which suggests that those participants were trading 
accuracy for speed. Also, all of the slowest responding participants had very low error 




Figure 6-5. Error rate against mean reaction time on the Choice Reaction Time task  
  
 
Incorrect responses were 21% faster than correct responses on average (621ms vs. 783 
ms). The within-subjects analysis found that errors were less likely to occur with 
increasing RT, with a 2% reduction in the odds of making an error per additional 
millisecond (OR = 0.98, 95% CIs 0.98 to 0.98, p < 0.0001). With RT included in the 
model, the difference in error rate between word and arrow stimuli was reversed such 
that word stimuli were associated with greater odds of an error (adjusted error rates: 
words 3.9% vs arrows 2.0%, OR = 2.16, 95% CIs 1.68 to 2.78, p < 0.0001). This suggests 
that the earlier result of a higher error rate for arrows can be fully accounted for by speed-
accuracy trade-offs, since responses to arrows were faster (see section 6.3.2.1).  
 
 
6.3.2.4. Intra-individual variability in RT (for correct responses only) 
Intra-individual variability (IIV) scores were approximately normally distributed across 
Insight 46 participants (mean = 0.126, SD = 0.034). Figure 6-6 illustrates how the IIV 
scores are derived. Results of the multivariable regression models for RT and error rate 





Figure 6-6. Distribution of reaction times for three participants with the maximum, 
median and minimum intra-individual variability scores 
Each participant’s reaction times to the 22 trials are plotted (correct responses only). Intra-
individual variability (IIV) in RT (for correct responses only) is defined as the coefficient of variation 
(SD/mean). These three participants have been selected to illustrate the meaning of the IIV score 
and to put its magnitude in context: participant 1 has the maximum IIV, participant 2 has the 
median IIV and participant 3 has the minimum IIV. It can be seen that these three participants 
have similar mean RTs (774ms, 755ms and 763ms respectively) but the variability of their 





Table 6-3. Associations between demographic and life-course predictors and 
intra-individual variability in RT on the Choice RT task (n = 501) 
Predictor 
Intra-individual variability in RT a: 
coefficient and 95% CIs 
Sex (female as reference) 0.0046 
(-0.0106, 0.0013) 
Age at assessment (per year) 0.0085* 
(0.0043, 0.0128) 




Education (per category) b -0.0030 
(-0.0058, -0.0002) 
Adult socioeconomic position 
(per category) b 
0.0024 
(-0.0008, 0.0057) 
Neurological or psychiatric 
condition c 




Coefficients in bold are significant at p < 0.05 and asterisks indicate significance at p < 0.01. a 
Intra-individual variability in RT (for correct responses only) is defined as the coefficient of 
variation (SD/mean). Multivariable regression models were used so each association is 
independent of all others. b See section 3.2.4 for definition of categories. c See section 3.2.3 for 
definitions. RT = reaction time. 
 
 
On average, participants with neurological and psychiatric conditions had higher IIV than 
cognitively-normal participants (Table 6-3).  
There was an association between older age at assessment and greater IIV in RT (Table 
6-3, Figure 6-7).    
Higher educational attainment was associated with reduced IIV (Table 6-3). The effect 
size was relatively small: the predicted IIVs of the lowest and highest educational 
categories (with all other variables held at average values) were 0.133 and 0.121 
respectively, equivalent to a difference of 0.35 SD.  
There was no evidence of an association with childhood cognitive ability, sex or adult 




Figure 6-7. Intra-individual variability in reaction time against age at assessment  
Scatter plot shows the raw data. The solid line is the predicted line of best fit from the multivariate 
regression model (adjusted for sex, childhood cognitive ability, education, adult socioeconomic 
position and presence of a neurological or psychiatric condition), and the shaded grey area 
represents its 95% CIs. Intra-individual variability in RT (for correct responses only) is defined as 
the coefficient of variation (SD/mean). 
 
Adding error rate into the model confirmed that higher error rate was associated with 
greater intra-individual variability in RT for correct responses (regression coefficient = 
0.0021 per percentage point increase in error rate, 95% CIs 0.0014 to 0.0029, p < 
0.0001). This could be due to post-error slowing, where a more cautious response speed 




6.4. Associations with biomarkers and APOE-ε4 
 
Following the format laid out in section 3.5, the second part of this chapter investigates 
associations between Choice RT performance and biomarkers of AD in cognitively-
normal participants for whom complete biomarker data are available. The number of 
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participants meeting these criteria who also had usable data from the Choice RT task 
was 406 (see section 3.3). 
As explained in 3.5.2.1, I wanted to derive some summary scores that capture the key 
aspects of performance on each task, to use for comparing results across the different 
cognitive tests in the Insight 46 battery (see Chapter 9). For the Choice RT task, I 
calculated the following three summary outcomes for each participant, combined across 
word and arrow stimuli: 
i) Mean RT for correct responses  
ii) Error rate (% incorrect responses) 
iii) Intra-individual variability in RT for correct responses (SD / mean, as defined 
in section 6.3.1.4) 
Combining outcomes across the word and arrow stimuli is justified because the 
magnitude of differences in RT and error rate between the two stimulus types was small, 
and my hypotheses about associations between AD pathology and RT (see section 
6.2.3) were general rather than specific to certain types of stimuli.  
For each of these three outcomes, I tested for associations with the same biomarkers as 
in the previous chapter (see 3.5.2). I did also run analyses using the trial-by-trial data to 
check whether there were any interactions with stimulus type (arrow vs. word), but there 
were none, so I have only reported the analyses using the summary outcomes. 
 
6.4.1. Statistical Analyses 
 
Mean RTs were analysed using a linear regression model. The distribution of mean RTs 
had a positive skew. As above (see 6.3.1.3), two transformations were considered – log-
transforming the mean RTs or calculating the mean of the log-transforming raw RTs – 
but neither of these removed the skew so the untransformed data were used for ease of 
interpretation, and bootstrapping was used to produce bias-corrected and accelerated 
95% CIs from 2000 replications. 
Error rate was analysed using a GEE logistic regression model with an independent 
correlation structure and robust standard errors. The outcome was number of errors, 
which was treated as a proportion of the number of trials (22 for most people, but 21 for 
the 40 participants who had a trial excluded during the data cleaning process – see 
6.2.5). Results are expressed as odds ratios for ease of interpretation. 
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Intra-individual variability in RT was analysed using a linear regression model as before 
(see section 6.3.1.4). 
All models included predictors of amyloid status (positive vs. negative), whole brain 
volume, WMHV and APOE genotype (ε4-carrier vs. non-carrier). To adjust for the 
correlation between whole brain volume and head size, total intracranial volume (TIV) 
was included in all models, as were the demographic factors investigated in section 6.3 
(sex, age at assessment, childhood cognitive ability, education and adult socioeconomic 
position).  
The models were additionally rerun replacing dichotomised amyloid status with SUVR to 
test whether increasing Aβ deposition was associated with differences in performance. 
To check whether associations between SUVR and cognition were sensitive to the 
inclusion of the imputed SUVR values (see section 3.2.2), the analyses were rerun 
excluding the 26 participants with imputed SUVR data. 
 
 
6.4.2. Results  
 
Results of the regression models for the three outcomes are reported in Table 6-4. 
Results of interactions are reported in the text. Results for the demographic and life-
course factors (sex, age at assessment, childhood cognitive ability, education and adult 
socioeconomic position) are not reported as they are essentially unchanged from the 





Table 6-4. Associations between biomarkers and Choice RT outcomes in 
cognitively-normal participants (n = 406): mean RT, error rate and intra-individual 
variability in RT 
 
Predictor 
Mean RT (ms): 
coefficient 
(95% CIs) 
Odds ratio for 
making an 
error (95% CIs) 
Intra-individual 
variability in RT: 
coefficient (95% CIs) 




































Multivariable regression models were used so each association is independent of all others. In 
addition to the predictors listed, models also included sex, age at assessment, childhood cognitive 
ability, adult socioeconomic position and total intracranial volume. 
Coefficients in bold are significant at p < 0.05 and asterisks indicate significance at p < 0.01.  
CI = confidence interval; RT = reaction time; WMHV = white matter hyperintensity volume.  
 
On average, Aβ+ participants had greater intra-individual variability in RT (adjusted 
means from the regression model: 0.135 vs. 0.122, a difference of 0.37 SD) (Table 6-4, 
Figure 6-8). Aβ+ participants also had slightly slower mean RTs and higher error rates 
than Aβ- participants, but these differences were not statistically significant (RT: Aβ+ = 
789 ms; Aβ- = 777 ms;  error rate: Aβ+ = 3.1%; Aβ- = 2.3% ms) (Table 6-4). Given the 
evidence that performance was influenced by speed-accuracy trade-offs (see section 
6.3.2.3), I conducted a post-hoc analysis to investigate whether Aβ+ and Aβ- participants 
differed in their error rates after accounting for their mean RT, by rerunning the 
regression model for error rate with mean RT included as an additional co-variate. The 
results indicated that Aβ+ participants had 48% higher odds of making an error (95% CIs 
1.03 to 2.13, p = 0.035, adjusted means: Aβ+ = 3.3%; Aβ- = 2.3% ms) after adjustment 
for their mean RTs.  
When rerunning the models replacing dichotomous amyloid status with continuous 
SUVR, the same pattern emerged, as SUVR was associated with intra-individual 
variability in RT (regression coefficient = 0.062, 95% CIs 0.014 to 0.110, p = 0.012) but 
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not with mean RT (regression coefficient = 59.0 ms, 95% CIs -34.1 to 158.7, p > 0.10) 
or error rate (Odds ratio = 2.34, 95% CIs 0.25 to 21.45, p = 0.45). These results were 
unchanged in a sensitivity analysis excluding the individuals with imputed SUVR values 
(see section 3.2.2). 
Whole brain volume, WMHV and APOE genotype showed no evidence of associations 
with any of the outcomes, although there was a trend towards an association between 




Figure 6-8. Box plots of intra-individual variability in reaction time for β-amyloid 
negative (n=332) and β-amyloid positive (n=74) participants 














As hypothesised, cognitively-normal Aβ+ participants had greater intra-individual 
variability in Choice RT. To my knowledge, this is the first time this finding has been 
reported. However, there was no evidence in support of the hypothesis that Aβ positivity 
would be associated with slower RT. As expected, there were some effects of childhood 
cognitive ability and education on performance, but there was no evidence of the sex 
differences reported by others. Speed-accuracy trade-offs were identified as an 
important factor in interpreting response patterns. These results are discussed in greater 
detail in the following sub-sections. 
 
6.5.2. Patterns of performance 
 
Responses were slower to words than arrows. A possible explanation is that word stimuli 
place greater cognitive demands on the participant because they require higher-order 
processing of the concepts of left and right, whereas arrow stimuli simply require the 
participant to press the button on the same side as the arrow. A similar effect was found 
in a previous study which compared Choice RT to numbers and lights, and concluded 
that the slower responses to numbers could be attributed to the higher-order cognitive 
processing required (Nissan, Liewald and Deary, 2013). One might expect that stimuli 
requiring greater cognitive processing (and consequently slower RT) would also elicit a 
higher error rate. This was the case in the results of Nissan et al., but the opposite pattern 
was observed in this study – a higher error rate for arrows than words. My analyses 
suggest that this was due to a speed-accuracy trade-off (i.e. errors occurred with hasty 
responses – the classic pattern in decision-making) because after adjusting for RT, the 
relationship was reversed such that words were associated with a higher error rate than 
arrows. This illustrates the importance of considering speed-accuracy trade-offs when 
interpreting error rates in Choice RT tasks.  
The finding that incorrect responses were typically faster than correct responses 
suggests that some errors arose from anticipatory responses. This is consistent with the 
observation of a between-subjects speed-accuracy trade-off: the most error-prone 
participants tended to have fast mean RTs, and the slowest-responding participants 
tended to be highly accurate. Thus, the tendency to prioritise speed or accuracy was a 
relevant factor in explaining individual differences in performance, although its impact 
was limited by the ceiling effect on accuracy. Similar speed-accuracy trade-offs in Choice 
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RT tasks have been observed before (Nissan, Liewald and Deary, 2013) but other 
studies have reported the reverse (a correlation between speed and accuracy) 
(Vaportzis, Georgiou-Karistianis and Stout, 2013). I would hypothesise that the 
difference is most likely to be explained by the design of the experiment and the precise 
stimuli used, with easier tasks being more susceptible to speed-accuracy trade-offs, and 
more complex tasks tending to show speed-accuracy correlations (as in the following 
experiment, see Chapter 7). Regarding the factors which predict whether an individual 
tends to prioritise speed or accuracy, strategies have been reported to differ on a range 
of cognitive tasks by age (Brébion, 2001), sex (Reimers and Maylor, 2006; Thakkar et 
al., 2014), risk-aversion (Nagengast, Braun and Wolpert, 2011) and mental fatigue 
(Rozand et al., 2015). However, it should be noted that an individual may alter their 
speed-accuracy strategy during the task, which was not captured by the between-
subjects analysis. For example, after making an error participants may shift their strategy 
to place an increased priority on accuracy, or after a run of correct responses they may 
shift their strategy to place an increased priority on speed; toggling between the two 
priorities is a legitimate strategy for maximising both over the course of the experiment 
(Dang, Figueroa and Helton, 2018).  
 
6.5.3. Demographic and life-course predictors 
 
6.5.3.1. Associations with age at assessment 
The findings that older age was associated with slower RT, greater intra-individual 
variability in RT and lower error rate are consistent with the literature, where response 
times are widely-reported to become slower and more variable with age (Anstey et al., 
2005; Deary and Der, 2005; Williams et al., 2005; Bugg et al., 2006; Der and Deary, 
2006; Dykiert et al., 2012a; Garrett, Macdonald and Craik, 2012; Vincent et al., 2012; 
Nissan, Liewald and Deary, 2013; Woods et al., 2015). However, the fact that they were 
detected in the Insight 46 cohort was unexpected, since the age range is so narrow (69.2 
to 71.8 years – reflecting the time it took to collect the data, since participants were all 
born in the same week). To my knowledge no studies have investigated age effects on 
Choice RT over such a small interval, but estimates of the rate of decline per year have 
been reported in cross-sectional studies: a recent comparison of large-scale Choice RT 
studies concluded that RT increases by 2.0-3.4 ms per year after young adulthood 
(Woods et al., 2015), and another study of adults aged 60-85 estimated that processing 
speed declines by about 0.06 SD per year (Harrington et al., 2018). A longitudinal study 
which tested adults repeatedly at ages 70, 73 and 76 reported a decline of -0.096 SD 
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per year (Ritchie et al., 2016). The effect size reported here, which equates to an 
increase in RT of about 24ms per year, or 0.30 SD, is implausibly large in comparison.  
Regarding the association between older age and lower error rate, this is consistent with 
some previous reports that older people tend to reduce errors at the expense of speed 
(i.e. they adopt a more cautious balance on the speed-accuracy trade-off) (Brébion, 
2001)) but other studies contradict this (Vaportzis, Georgiou-Karistianis and Stout, 2014; 
Woods et al., 2015), and it may depend greatly on the precise characteristics of the task. 
As mentioned in Chapter 4 in the context of the apparent age effect on the Matrix 
Reasoning task, while it is conceivable that a genuine subtle effect of age may be 
detectable over a 2.6-year range, especially when carefully controlling for other factors 
that affect performance such as childhood cognitive ability and education, I considered 
the possibility of a recruitment bias whereby participants seen towards the beginning of 
the data collection period may have differed in some ways to those seen towards to the 
end. This is discussed in greater detail in Chapter 10. 
 
6.5.3.2. Associations with childhood cognitive ability, education and adult 
socioeconomic position 
Consistent with the literature on the relationship between RT and intelligence, higher 
childhood cognitive ability was associated with faster RT, but the effect size was small. 
Higher childhood cognitive ability was also associated with lower error rate, even though 
error rate did not vary much due to the ceiling effect on accuracy. Following on from my 
earlier conclusion that errors were likely to be anticipatory or hasty responses (section 
6.5.2), this may suggest a link between higher childhood cognitive ability and inhibition, 
which was assessed more directly in a related experiment presented in Chapter 7. 
Contrary to hypotheses, childhood cognitive ability was not associated with intra-
individual variability in RT. Conversely, educational attainment had no independent effect 
on RT and error rate, but was associated with reduced intra-individual variability in RT – 
an effect which is consistent with a previous report (Christensen et al., 2005) but was 
modest in magnitude and unlikely to be clinically meaningful. These findings are broadly 
consistent with the conclusion of Der and Deary (2017) that intra-individual variability in 
RT shows little association with mental ability when its dependence on mean RT is 
accounted for, as was the case in my analyses.  
Overall, the effects of childhood cognitive ability and education on this task were 
relatively small when compared to their effects on the standard cognitive tests discussed 
in the previous chapter. The fact that adult socioeconomic position was not a significant 
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predictor of performance on any outcome is not unexpected in light of previous analyses 
of predictors of cognition across adulthood in the NSHD, which have found adult 
socioeconomic position to be less important than childhood cognitive ability and 
education (Richards and Sacker, 2003; Richards et al., 2019). 
 
6.5.3.3. Sex differences 
Contrary to some previous studies (Deary and Der, 2005; Der and Deary, 2006; Dykiert 
et al., 2012b; Vincent et al., 2012; Phillips et al., 2013), in this study, which benefits from 
a large sample size, very narrow age range, and adjustment for confounding variables 
of prior cognitive ability, there was no evidence of sex differences on any outcome. 
 
6.5.4. Associations with biomarkers and APOE-ε4 
The second part of the analyses investigated associations between performance on the 
key summary outcomes of the Choice RT task and various neuroimaging and genetic 
biomarkers of AD pathology. The hypothesis that Aβ+ participants would have greater 
intra-individual variability in RT than Aβ- participants was supported, but there was no 
evidence for the hypothesis that their RT would be slower overall.  
To my knowledge, the literature on changes in response time and variability preceding 
the onset of AD dementia comes from investigation of individuals with MCI (Christensen 
et al., 2005; Tales et al., 2012; Phillips et al., 2013). As the Aβ+ participants in this 
analysis were all cognitively-normal and on average perhaps a decade or more away 
from the time when a significant proportion of them may be expected to develop 
dementia, this suggests the possibility that intra-individual variability in RT may be a 
particularly sensitive measure to accumulating AD pathology, whereas the slowing of 
mean RT may perhaps occur at a later stage. 
It is important to remember that changes in response speed and variability are by no 
means specific to AD. These measures appear to be general markers of the integrity of 
the central nervous system, vulnerable to disruption across a range of 
neurodegenerative diseases and brain injuries, and correlating with diverse physical 
health measures such as grip strength, forced expiratory volume and waist 
circumference (Anstey et al., 2005; MacDonald, Nyberg and Bäckman, 2006; Masi et al., 
2018). Further work is needed to investigate how changes in RT associated with AD 
pathology may relate to such physical health measures and to other brain pathologies 
that accumulate with age. One study comparing intra-individual variability of RT in 
patients with AD and Parkinson’s disease reported that the AD patients were more 
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variable, controlling for overall severity of cognitive impairment (Burton et al., 2006), but 
more research is needed to determine whether there is a pattern to the timing and nature 
of changes in RT (both response speed and variability) as AD pathology accumulates. 
There was a suggestion that Aβ pathology was associated with higher error rate on this 
task, as Aβ+ participants made more errors than Aβ- participants and this difference was 
statistically significant after adjustment for the trade-off between RT and error rate. As 
Aβ+ participants had slightly slower RTs on average (although this difference was not 
statistically significant), I would speculate that they might have been less likely to make 
errors due to responding in haste and more likely to make errors for other reasons, such 
as failures in the executive functions of monitoring and inhibition. However, this 
experiment was limited in its ability to measure subtle differences in accuracy due to the 
small number of trials, as discussed in the following section. 
No evidence was found of statistically significant associations between outcomes on this 
task and whole brain volume, white matter hyperintensity volume (WMHV) or APOE-ε4 
(accounting for amyloid status). In the previous chapter I reported the finding that Insight 
46 participants with smaller whole brain volumes and larger WMHV showed evidence of 
slightly slower perceptual processing speeds on the Digit-Symbol task (see Chapter 4), 
and discussed why the Digit-Symbol test may be particularly sensitive to overall brain 
health. As the detrimental effects of white matter disease on processing speed are well 
established (Prins and Scheltens, 2015) and compromised white matter integrity has 
been reported to predict slower and more variable RT (Fjell et al., 2011; Jackson et al., 
2012), the lack of an association between WMHV and Choice RT is probably due to the 
fact that the Insight 46 participants on the whole had very low levels of white matter 
disease.  
In summary, this study builds on the results of the previous chapter by providing further 
evidence that subtle differences in cognition can be detected cross-sectionally between 
cognitively-normal Aβ+ and Aβ- individuals in a large well-characterised sample, and that 
such differences are present in multiple cognitive domains.  
 
6.5.5. Strengths and limitations 
A strength of the experimental design is that RTs were collected for every response, in 
contrast to some RT experiments which only collect the mean RT, SD and error rate (for 
example the numbers-based device that has been widely used (e.g. (Der and Deary, 
2006)) including in the NSHD cohort when they were aged 60-64 (Silverwood et al., 
2014). By collecting data on individual responses, we were able to exclude extreme 
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responses thus reducing noise in the data, as well as being able to investigate within-
subject speed-accuracy trade-offs by comparing the RTs of correct and incorrect 
responses. Without this information it would have been difficult to interpret the fact that 
arrow stimuli had a higher error rate than word stimuli, which turned out to be explained 
by a speed-accuracy trade-off (see section 6.5.2). 
There were a number of limitations to the experimental design, the main one being the 
small number of trials (22). This had a particular impact on the error rate measure, as a 
single incorrect response corresponded to a large proportionate increase in error rate. 
The fact that odds of making an error were associated with childhood cognitive ability, 
age at assessment and presence of a neurological or psychiatric condition – despite the 
ceiling effect on accuracy – suggest that this measure may capture something 
meaningful about performance on this task, rather than just signifying random mistakes. 
The fact that errors tended to be faster than correct responses suggests that impulsivity 
or a lack of inhibition may be playing a role. The numbers of participants with each 
neurological or psychiatric diagnosis are too small to compare between them (see 
section 3.6), but some of the conditions have motor symptoms (e.g. Parkinson’s disease 
and multiple sclerosis) so motor errors could have been a contributing factor. The 
apparent difference in accuracy between cognitively-normal Aβ+ and Aβ- participants 
would be interesting to investigate further. The best strategy for replicating these results 
would be to repeat the experiment with a much greater number of trials. Any attempt to 
reduce the ceiling effect on accuracy by making the task more difficult (e.g. by changing 
the number of response options from two to three) could disrupt the phenomena being 
studied, since the ceiling effect is integral to the type of errors that are being captured 
(theoretically the only requirement for accuracy is to know one’s left from one’s right so 
errors are likely to be due to anticipations or occasional lapses of attention). 
It is worth noting that many Choice RT studies place little focus on error rates – and 
sometimes they are not even reported – since the interest is naturally in investigating 
RT, which is typically only analysed for correct responses. To study RT in as pure a form 
as possible, some studies exclude participants with high error rates, for example Der and 
Deary (2006) excluded participants with error rates of 20% or higher, noting that their 
performance “suggests problems in correctly carrying out the task”. However, for 
studying brain health in older age it might be the case that errors on Choice RT tasks 
could be a relevant indicator.  
There were a number of other limitations to the experimental design. Below is a list of 
recommendations (in no particular order) for how I think the task should ideally be altered 
to address these limitations.  
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i) The first trial of each block began automatically after a pause of about 5 seconds, 
following the practice trials. Although participants were warned about this, they 
were not always ready. This resulted in me having to exclude the first trial of each 
block. A better experimental design would be for the tester or participant to initiate 
the main block by pressing a button when ready, or to designate the first few trials 
of the block as warm-up trials, as in Aron et al. (2004). 
ii) Button presses of longer than a certain duration were registered as multiple 
presses. Although participants were instructed to press the button quickly, some 
had a tendency to hold the button down (e.g. for 500ms). If this happened for a 
correct response, it did not matter because the next trial would be immediately 
initiated after the first button press had registered, and any “extra” presses would 
fall during the cue of the next trial, when they would not be registered. However, 
if a participant held the button down for too long on an incorrect response, this 
meant that they would not have the chance to correct their error since their 
incorrect response registered as both the first and second attempt. Ideally a 
single button press should be registered until the button is released, however 
long that takes. 
iii) When the instructions were on the screen at the start of each block, it was 
possible for the participant to accidentally initiate the block by pressing one of the 
response buttons before the tester had finished explaining the task. Occasionally 
this happened when the participant held down the button too long when 
responding to the final stimulus of the previous block and it registered as a 
double-press (see point ii). Ideally an extra blank screen should be added before 
the instructions screen, and it should be impossible to initiate the block using the 
response buttons (e.g. by assigning a key on the keyboard instead). 
 
Strengths and limitations that apply to all the analyses presented in this thesis, such as 





In summary, this short Choice Reaction Time experiment has provided novel evidence 
that cognitively-normal older adults with Aβ pathology are, on average, less consistent 
in their response times. This adds to previous literature that has shown similar deficits in 
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individuals with MCI and AD, and suggests that this may be a sensitive measure of early 
cognitive changes that could be included in future studies and clinical trials targeting 








Executive function is a term that describes the higher-order cognitive processes – 
controlled by the prefrontal cortex – which are necessary for problem-solving, decision-
making, planning and focusing attention in an effortful manner to accomplish tasks (Otero 
and Barker, 2014). A key aspect of executive function is inhibitory control, which has 
both behavioural and cognitive dimensions. Behavioural inhibition describes the ability 
to resist impulsive actions (self-control), whereas cognitive inhibition describes the ability 
to selectively focus attention on stimuli or thought processes that are relevant for the 
current goal and to resist interference from irrelevant stimuli or thought processes that 
would interfere with achieving the goal (Diamond, 2013). Often this involves inhibiting 
automatic responses, which are habitual or “overlearned”. Inhibitory control is a vital skill 
for all aspects of life including health, social interactions and employment.  
Inhibitory control has been widely researched using response inhibition tasks, which 
create a conflict between an automatic (but incorrect) response and the correct 
response. An effective way of creating this conflict is to use incongruent stimuli, such as 
in the Stroop task (see MacLeod (1991) for a review) or the Simon task (Simon, 1969). 
In the Stroop task participants are presented with incongruent stimuli (e.g. the word 
“blue” printed in red-coloured ink) and congruent stimuli (e.g. the word “blue” printed in 
blue-coloured ink) and asked to name the colour of the ink. Responses to incongruent 
stimuli are typically slower and less accurate than responses to congruent stimuli. In a 
computerised version of the Simon task (e.g. Stoet, 2017), arrows are presented pointing 
left or right, on either the left-hand or right-hand side of the screen. If the direction of the 
arrow is incongruent with its position on the screen (e.g. arrow pointing left on the right-
hand side of the screen), participants are generally slower and less accurate at 
identifying the direction of the arrow. There are other methods of creating conflict 
between an automatic response and the required response; for example, the Stop-signal 
or Go/No-Go tasks (see Rey-Mermet and Gade, 2018) require participants to repeatedly 
press a button in response to a stimulus, except on rare occasions when a “stop signal” 
is presented. The response is difficult to inhibit because it has become automatic through 
repetition. The Insight 46 cognitive battery contained a response inhibition task with 
congruent and incongruent stimuli, somewhat akin to the Simon task. 
Impaired inhibitory control can be a feature of many neurodevelopmental and psychiatric 
conditions affecting the frontal lobes, including attention deficit hyperactivity disorder, 
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autism, schizophrenia, obsessive compulsive disorder and addictions, and is also seen 
subsequent to frontal lobe damage due to traumatic brain injury or neurodegenerative 
diseases including the dementias (Goldstein and Naglieri, 2014). It is a prominent and 
early feature of frontotemporal dementia – a spectrum of neurodegenerative diseases 
where the frontal and temporal lobes are subject to focal atrophy (O’Callaghan, Hodges 
and Hornberger, 2013). Although it is not generally considered to be a defining symptom 
of typical AD, a recent meta-analysis estimated that 17% of patients with AD show 
disinhibition, as rated by a care-giver on the Neuropsychiatric Inventory (Zhao et al., 
2016). There is some evidence that patients with AD show impairments on the response 
inhibition tasks described above: patients with mild AD have been reported to respond 
disproportionately slowly and inaccurately to incongruent stimuli on the Stroop task 
(Bélanger, Belleville and Gauthier, 2010) and the Simon task (Castel et al., 2007), as 
well as a similar interference task (Aschenbrenner et al., 2015). There is also some 
evidence to suggest that such impairments in inhibitory control may emerge prior to the 
onset of AD dementia, as individuals with MCI have been reported to show increased 
interference from incongruent stimuli compared to healthy older adults (Bélanger, 
Belleville and Gauthier, 2010).  
As to whether impairments in inhibitory control may emerge even earlier – in the 
preclinical stage of AD when individuals are cognitively-normal but have accumulating 
AD pathology – there has been little research to date. While there is growing evidence 
that subtle changes in executive function can be detected in the preclinical stage of AD 
and can predict progression to dementia diagnosis (i.e. in cognitively-normal individuals 
who show biomarker evidence of AD pathology) (Grober et al., 2008; Clark et al., 2012; 
Hassenstab et al., 2015; Baker et al., 2017; Duke Han et al., 2017; Mortamais et al., 
2017), executive function is a broad term with no consistent definition. The conclusions 
of these studies are based on diverse cognitive tests including processing speed (e.g. 
Digit-Symbol test, see Chapter 4), verbal fluency (e.g. generating items within a category 
such as animals or vegetables), cognitive flexibility (e.g. the Trail Making Test) and 
working memory (e.g. Digit Span). A small number of studies have specifically examined 
associations between inhibitory control and biomarkers of AD pathology in cognitively-
normal individuals. One such study reported that individuals with pathological β-
amyloid42/tau ratios (based on CSF sampling) tended to show greater interference on 
the Stroop task than controls (Harrington et al., 2013) and another study observed that 
interference on a different response inhibition task was correlated with quantity of β-
amyloid plaques (as measured by PET) and CSF levels of β-amyloid42 and tau 
(Aschenbrenner et al., 2015). 
151 
 
As I have argued in previous chapters, when investigating potential differences in 
inhibitory control that may be associated with AD pathology, it is important to account for 
other factors which may contribute to individual differences such as age effects, sex and 
prior cognitive ability. Factors associated with individual differences in inhibitory control 
are briefly commented on below.  
A recent meta-analysis of 176 studies comparing older and younger adults on response 
inhibition tasks (including the Stroop, Simon and stop-signal tasks) concluded that the 
prevailing hypothesis of a deficit in inhibitory control in older age was generally not 
supported, although there was some variation between tasks (Rey-Mermet and Gade, 
2018). 
In terms of sex differences on response inhibition tasks, the evidence is limited as most 
studies adjust for sex in their analyses without reporting whether it was associated with 
the outcomes. Sex differences are generally not observed on the Stroop task (MacLeod, 
1991). A recent review concluded that women may show greater interference on the 
Simon task (i.e. greater slowing of responses to incongruent stimuli), but the evidence is 
mixed (Stoet, 2017). 
As with many cognitive tests, there is some evidence of a relationship between education 
and performance on response inhibition tests, although it does not seem to have been 
widely investigated: one study reported an association between greater education and 
reduced interference (Aschenbrenner et al., 2015), and another study found that 
increased interference on the Stroop task was correlated with lower verbal IQ in older 
adults (Puccioni and Vallesi, 2012). 
As for the Choice Reaction Time task reported in the previous chapter, it is important to 
consider the relationship between speed and accuracy on response inhibition tasks, 
rather than only considering them as two separate outcomes. Speed-accuracy trade-offs 
have been reported on “stop-signal” tasks (Dang, Figueroa and Helton, 2018), so the 
speed of an individual’s response may dictate their ability to suppress interference from 
irrelevant properties of the stimulus. 
Following the structure of the previous chapter, the aims of this study were firstly to 
understand patterns of performance on the Response Inhibition task and characterise 
associations between task performance and demographic and life-course predictors, 
and secondly to investigate associations between performance and biomarkers of brain 





   
7.2.1. Stimuli and Procedure 
 
Two related experiments were combined into one task. The first experiment – a Choice 
Reaction Time task – was described in the previous chapter. This chapter concerns the 
second experiment which was a response inhibition task.  
The response inhibition task was presented on the same DELL computer with the same 
2-button response box (see section 6.2.1). All stimuli were displayed in the centre of the 
screen and consisted of an arrow pointing left or right with the word ‘LEFT’ or ‘RIGHT’ 
inside it. In 50% of trials, the arrow and the word were congruent (e.g. an arrow pointing 
left with the word ‘LEFT’ inside it) and in the other 50% of trials the arrow and the word 
were incongruent (e.g. an arrow pointing right with the word ‘LEFT’ inside it) (Figure 7-1). 
Each stimulus was preceded by a cue indicating whether the participant should respond 
to the arrow or to the word.  
There were 2 blocks of 48 trials each. In Block 1, the cue duration was 200ms (i.e. the 
cue was displayed on its own for 200ms before the stimulus appeared below it). In Block 
2 the cue duration was 1500ms. Throughout both blocks, the order of the trials was A-A-
A-W-W-W-A-A-A-W-W-W etc., where A indicates an arrow cue and W indicates a word 
cue. Thus, there were equal numbers of arrow cue and word cue trials. Within each A-
A-A and W-W-W sequence the trials are referred to as being in run-positions 1, 2 and 3. 
Within each block there were equal numbers of trials in each of the four possible 
combinations of congruency and cue type (congruent arrow, incongruent arrow, 
congruent word, incongruent word). However, these factors were not perfectly 
counterbalanced across each run-position; the number of trials in each combination of 
run-position x cue type x congruency varied from 2 to 6 within each block, because the 
order was random with respect to congruency. 
The order of trials was the same for all participants. Six practice trials preceded each 
block. The practice trials were followed by a gap of about 5 seconds before the main 
block started automatically.  
As in the Choice RT task (see Chapter 7), participants were instructed to press the 
correct button on the response box (left or right) as quickly as possible, using the index 
and middle fingers of their dominant hand. If their response was correct, the next trial 
was initiated; if their response was incorrect, the stimulus remained on the screen and 
an error tone sounded to signal that they should respond again as quickly as possible. 
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Regardless of whether their second response was correct or incorrect, no feedback was 










Figure 7-1. The Response Inhibition task 
The cue (“Arrow” or “Word”) appeared on its own for 200ms (Block 1) or 1500ms (Block 2) 
before the stimulus appeared underneath. 
 
 
7.2.2. Outcome variables 
 
Two variables were recorded for each response: RT (ms) and accuracy (correct or 
incorrect). All analyses were based on the initial response to each stimulus; second 
attempts were not analysed as their purpose was to reorient participants to the task. 
As explained in section 6.2.2, standard practice on tasks measuring RT is to analyse RT 
for correct responses only. This approach was adopted here. 
In the Choice RT task, an outcome of interest was intra-individual variability in RT. This 
would not be a very meaningful measure in the Response Inhibition task because there 
are large differences in RT depending on congruency, cue duration and cue type. A 
variability measure would be heavily influenced by the extent to which participants were 
affected by these factors, rather than capturing their variability in executing a repeated 
response. I considered calculating intra-individual variability for each combination of 
these factors separately, but there are not many trials in each and it is not the primary 
interest of this experiment. The primary interest is the ability to inhibit automatic 
responses to incongruent stimuli. 
 
Congruent trial Incongruent trial 
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7.2.3. Exploration of task-set switching 
 
This experiment is based on the paradigm used by Aron et al. (2004) which was designed 
to measure task-set switching – the ability to switch backwards and forwards between 
two different sets of instructions, or “task-sets”, within the same experiment. As in our 
experiment, they ordered the trials in groups of three (A-A-A-W-W-W-A-A-A-W-W-W etc. 
where A indicates an arrow cue and W indicates a word cue) and their aim was to 
examine task-set switching by comparing responses in run-positions 1, 2 and 3. They 
assessed whether responses were slower and less accurate to trials in run-position 1 
(i.e. trials where the cue was different to the previous trial, requiring a switch of task-set) 
compared to run-positions 2 and 3 (where the cue was the same as the previous trial). I 
was not involved in the design of the experiment for Insight 46, and when I came to 
analyse it, I came to the conclusion that it is not suitable for addressing the question of 
task-set switching because the experimental design differs from that of Aron et al. in 
several important ways.  
Firstly, in order to accurately assess task-set switching, trials should be excluded from 
analysis if the participant’s response to the preceding trial was incorrect, because their 
incorrect response may be due to adopting the wrong task-set. For example, if a trial in 
run-position 3 is an incongruent stimulus with the cue ‘arrow’, but the participant 
responds to the word (thus making an error), then the following trial (a trial in run-position 
1 with the cue ‘word’) would not actually require the participant to switch their task-set. 
Aron et al. excluded trials following an error on either of the preceding two trials for this 
reason. This was feasible because their experiment contained a large number of trials 
(288). This experiment only contained 96 trials due to time constraints, but contained a 
requirement for participants to make a second response if they received feedback that 
their first attempt was incorrect – a feature not present in the experiment of Aron et al. – 
which arguably functions as an alternative mechanism to ensure that participants were 
reoriented to the correct task-set before the next trial appeared. However, on reflection I 
do not think this modification is sufficient for the following reasons: 
i) To correct an incorrect response, all that is required is to press whichever button 
was not pressed on the first attempt. This may be cognitively different to having 
to process the cue and stimulus, so it cannot be assumed that correcting an error 
equates to being reoriented to the task.  
ii) Some participants may have got the second attempt wrong due to perseverating 
with the incorrect task-set despite the feedback that their first attempt was 
incorrect – anecdotally I believe I sometimes observed this happening when 
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administering the test. As no feedback was given for the second attempt, this 
would not be drawn to their attention. 
iii) As discussed in section 6.5.5, one limitation of the response box used for the 
Choice RT and Response Inhibition experiments was that button presses of 
longer than a certain duration registered as multiple presses. Although this issue 
only affected a minority of participants, it reduces confidence in the effectiveness 
of the second attempt for reorienting participants to the correct task-set. 
The second main reason that this experiment does not address task-switching in a 
comparable manor to Aron et al. is that their format made the A-A-A-W-W-W pattern 
obvious to participants by the position of the stimuli on the screen (see Figure 7-2) as 
run-positions 1, 2 and 3 appeared in different locations on the screen, moving round in 
a circle. This allowed the authors to conclude that task-switching was associated with a 
cost (slower and less accurate responses) even when each upcoming switch could be 
anticipated. In contrast, the design of the experiment used in Insight 46 meant that the 
A-A-A-W-W-W pattern was not made obvious to participants and, based on anecdotal 
observations, I suspect that few of them spotted it, although there may have been some 
implicit learning. Therefore, participants may have been more likely to respond to each 
trial with the same degree of surprise rather than allowing the task-set to become 









Figure 7-2. Run-position effect and task design in the experiment used by Aron 
et al.  
 
This figure is reprinted from Aron et al. (2004) with permission from Oxford University Press.  
(A) shows that run-position 1 elicited significantly slower and less accurate responses, indicating 
the presence of a task-set shifting effect. (B) shows that stimuli in the three run-positions were 
presented in different places on the screen, making it obvious when the shift of task-set would 
occur.  
CT = controls; LF = left frontal lesion patients; RF = right frontal lesion patients; RSI = duration of 
cue before stimulus appeared; pos = run-position.  
 
 
Thirdly, in the original study, the simple arrow and word trials (which the Insight 46 Choice 
RT experiment was based on – see Chapter 6) were not administered in a separate 
experiment but were mixed in with the congruent and incongruent trials, and were 
referred to as ‘neutral’ trials. By comparing neutral and congruent trials the authors were 
able to address a specific question about the processes involved in task-set switching 
because neither neutral nor congruent trials trigger any competing response which needs 
to be inhibited, yet there is typically a difference in RT between the two, with responses 
to congruent trials being slower than responses to neutral trials. As congruent stimuli 
contain elements that are associated with the irrelevant task-set (e.g. the presence of a 
word when the relevant task-set is ‘arrow’), this slowing of responses compared to 
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neutral trials can only be attributed to competition arising from endogenous activation of 
the irrelevant task-set. This is different to the activation of the irrelevant task-set that can 
be triggered exogenously by incongruent stimuli. Therefore, the original study was able 
to analyse both the endogenous and exogenous aspects of task-set shifting, whereas 
our experiment does not permit investigation of the endogenous aspect because of the 
lack of ‘neutral’ trials. 
In summary, I concluded that the Insight 46 Response Inhibition task could not provide 
a valid measure of task-set shifting. However, the fact that the trials were ordered in a 
pattern of groups of three (A-A-A-W-W-W, where A indicates an arrow cue and W 
indicates a word cue) meant that the influence of run-position on the results still needed 




For the purpose of assessing inhibitory control, the outcomes of interest were RT and 
error rate on incongruent trials, compared to congruent trials.  
Based on the literature, I hypothesised that higher childhood cognitive ability and 
educational attainment would be associated with greater inhibitory control i.e. the 
tendency to respond slower and less accurately on incongruent trials would be reduced. 
I aimed to test the hypothesis that cognitively-normal Aβ+ participants would show 





All 502 participants completed the Response Inhibition task, but one participant’s data-
file was not successfully saved (see section 3.3). Participant characteristics are reported 





7.2.6. Data processing 
 
As for the Choice RT task, the first trial in each block was excluded from analyses 
because participants did not always realise that the block had started and this affected 
RT (see sections 6.2.5 and 6.5.5).  
In line with the policy of keeping the sample as representative as possible, the only 
reason to exclude participants with outlying performance was deemed to be a clear 
indication that they deviated from the protocol e.g. a fundamental misunderstanding of 
the instructions. As mentioned in the previous chapter (see section 6.2.5), one participant 
had a lifelong condition affecting cognition and was noted to have difficulty in 
understanding the task, so this participant was excluded from the analyses, reducing the 
sample size to 500. 
As explained in the previous chapter (see section 6.2.5), an error rate of greater than 
50% in a 2-choice task would normally be suggestive of guessing at chance level, and 
this would be grounds to consider excluding participants from the analyses. However, 
this task contains incongruent trials where it is necessary for participants to inhibit 
incorrect responses which are prompted by the non-cued property of the stimulus. 
Therefore, an error rate of greater than 50% on incongruent trials would not necessarily 
be suggestive of guessing at chance level – it could indicate a failure to inhibit incorrect 
responses despite understanding the instructions. Anecdotally, from observing 
participants completing this task, I concluded that this was the case, so it would not be 
appropriate to exclude participants with error rates of greater than 50%. In fact, although 
no participants had an overall error rate of greater than 50%, 12 participants had an error 
rate of greater than 50% on incongruent trials alone (max 67%). Of these, three met 
criteria for a neurological or psychiatric condition and nine were classified as cognitively-
normal (see definitions in section 3.2.3) 
As in the previous chapter, I have considered both correct and incorrect responses for 
the purpose of checking for outlying RTs. The distribution of each participant’s mean RT 
shows that there a few participants with outlying slow RTs (Figure 7-3). Of those with a 
mean RT greater than 4000 ms, one met criteria for MCI (see section 3.2.3) and the 
other three were cognitively-normal. There was no evidence that any participants did not 
complete the task according to the instructions, so none were excluded based on their 
mean RT. 
Reaction times to individual trials were checked for outliers. As in the previous chapter 
(see section 6.2.5), I adopted a threshold of 300 ms as the fastest possible time for a 
valid response. Four participants had one response each excluded for being faster than 
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300ms. There were a few trials with extremely slow outlying RTs, up to 40 seconds 
(Figure 7-4). It is clear that some of these should be excluded as they are outside a 
reasonable time frame and correspond to notes made by the testers about deviations 
from the protocol; for example, I observed instances of participants stopping to cough or 
drink water. As in the previous chapter (see section 6.2.5) I excluded trials where the RT 
was more than 3 SD above each participant’s own mean. This applied to 558 trials (1.2%) 
from 379 participants, with between 1-4 trials each. After these exclusions, the slowest 
response was 13755 ms. Even though slower responses are more likely to occur in 
certain conditions (e.g. incongruent stimuli, short cue duration – see results section 
7.3.2.2.1) I concluded that it was fair to exclude this small minority of trials as a way of 
reducing noise in the data, especially as there are not enough trials in the different 
conditions to define outliers within each one.  
 
Figure 7-3. Box and whisker plot of mean reaction times (correct and incorrect 






Figure 7-4. Box and whisker plot of individual reaction times (correct and incorrect 
responses) on the Response Inhibition task, before data cleaning 
 
7.3. Patterns and predictors of performance 
 
Following the format laid out in section 3.5, in the first part of this chapter I aimed to 
describe patterns of performance across the various outcomes and conditions of the 
task, and to investigate the effects of demographic and life-course predictors on 
performance in the full Insight 46 sample. Specifically I aimed to investigate whether RT 
and error rate differ in the different conditions (word vs. arrow stimuli, congruency, cue 
duration) and explore the relationship between RT and error rate. The demographic and 
life-course predictors (sex, age at assessment, childhood cognitive ability, educational 
attainment, adult socioeconomic position and presence of a neurological or psychiatric 





7.3.1. Statistical Analyses 
 
7.3.1.1. Run-position and practice effects 
As described in section 7.2.3, the fact that trials were presented in an A-A-A-W-W-W 
sequence (where A indicates an arrow cue and W indicates a word cue) means that the 
speed and accuracy of a given response may potentially be affected by its position within 
this sequence. As the three experimental factors (congruency, cue type and cue 
duration) were not perfectly counterbalanced across the run-positions (see 7.2.1), the 
interpretation of the effects of these factors could be confounded by the influence of run-
position.  
Practice effects could also confound interpretation of the effects of these factors, 
particularly the effect of cue duration since the short cue block always preceded the long 
cue block, so the long cue block would theoretically benefit more from practice effects. 
As well as general improvement in speed and accuracy, practice effects could have led 
to implicit or explicit learning of the A-A-A-W-W-W sequence, which may have helped 
participants to improve their performance as the task went on. 
Therefore, to account for these issues, run-position (1, 2 or 3) and trial number (1 to 47 
within each block) were included in the analysis models as described below, and their 
effects are reported first (see section 7.3.2.1) to provide context for the other results 
which follow. 
 
7.3.1.2. RT and error rate 
Rather than using summary scores for each participant (e.g. mean RT for each 
condition), trial-by-trial responses were analysed to avoid losing information. 
As in the previous chapter, reaction times were analysed using a GEE model assuming 
a normal distribution for the dependent variable and an identity link (as with standard 
linear regression), with an exchangeable correlation structure and robust standard errors 
to allow for the correlation between repeated measures of the same participant. RTs 
were first log-transformed so that the distribution more closely approximated the normal 
distribution.  
As in the previous chapter, response accuracy (correct vs. incorrect) was analysed using 
a GEE logistic regression model with an independent correlation structure and robust 
standard errors. Results are expressed as odds ratios for ease of interpretation. 
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Predictors in the models were cue type (arrow vs. word), congruency (congruent vs. 
incongruent), cue duration (short vs. long), run-position (1, 2 or 3), trial number (1 to 47), 
sex, age at assessment, childhood cognitive ability, education, adult socioeconomic 
position and presence of a neurological or psychiatric condition (yes vs. no). 
To investigate how cue type, congruency and cue duration combine to affect 
performance, I tested for interactions between these variables. I also tested for 
interactions between these variables and each between-subject predictor (sex, 
education etc.). In the case of congruency, these interaction tests allowed me to assess 
differences in inhibitory control, in accordance with my hypotheses. In the case of cue 
type and cue duration, these interaction tests were exploratory as I did not have prior 
hypotheses about how the between-subject predictors may be associated with 
differences in the degree to which participants would be disadvantaged by the short cue 
duration (compared to the long duration) or differences in performance on arrow and 
word trials. 
 
7.3.1.3. Relationship between speed and accuracy 
As in the previous chapter, I investigated the relationship between speed and accuracy 
both between-subjects and within-subject, to determine whether there was a trade-off 
between speed and accuracy as there was on the Choice Reaction Time task (see 
sections 6.3.1.3 and 6.3.2.3).  
To address the between-subject questions (e.g. are the fastest-responding participants 
likely to make the most errors?), each participant’s mean RT for correct responses was 
compared to their error rate (percentage of incorrect responses). 
As in the Choice RT task, the distributions of mean RTs and error rates both had a 
positive skew. Two transformations were considered for mean RT: log-transforming the 
mean RTs or calculating the mean of the log-transformed raw RTs. As neither of these 
removed the skew, the untransformed data were used for ease of interpretation and for 
consistency with the analysis of the Choice RT data (see section 6.3.1.3). Spearman’s 
rank correlation was used to examine the relationship between mean RT and error rate. 
As in the Choice RT task, the within-subjects questions were addressed by analysing 
the trial-by-trial data to see whether the speed of a response predicted whether that 
response would be correct or incorrect. This was done by rerunning the GEE model for 
the odds of making errors (see 7.3.1.2) with RT included as an additional covariate. RT 
was not log-transformed this time, to aid interpretability of its effects as a predictor (it was 
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previously transformed to comply with the assumption of a normal distribution for linear 





Descriptive statistics are presented in Table 7-1. 
 
Table 7-1. Descriptive statistics for the Response Inhibition task 
  Congruent Incongruent 
Congruent and 
Incongruent combined 
RT for correct 
responses (ms)  
Median 1491 1645 1560 
IQR 1111 - 1936 1225 - 2185 1161 - 2052 
Range 513 - 12273 353 - 13755 353 – 13755 
Error rate (%) 0.8 10.7 5.6 
 
Statistics are based on 500 participants who each completed 94 trials. Results for congruent and 




7.3.2.1. Run-position and practice effects 
Run-position effects on RT are illustrated in Figure 7-5. Correct responses got faster with 
increasing run-position (regression coefficient = 0.982 (i.e. 1.8% decrease in RT per run-
position), 95% CIs 0.978 to 0.986, p < 0.0001). As this effect was independent of the 
effect of trial number, it cannot be explained by the fact that run-positions 2 and 3 would 
benefit more on average from the general practice effect. Therefore, it is likely that some 
implicit and/or explicit learning of the A-A-A-W-W-W pattern facilitated faster responses 
across each group of three trials. It is worth noting that this does not constitute a “task-
set switching” effect as described by Aron et al. (see 7.2.3), as pairwise comparisons of 
consecutive run-positions revealed that RT improved steadily from position 1 to 2 
(regression coefficient = 0.982 (i.e. 1.8% decrease in RT), 95% CIs 0.974 to 0.989, p < 
0.0001) and position 2 to 3 (regression coefficient = 0.985 (i.e. 1.5% decrease in RT), 
95% CIs 0.980 to 0.991, p < 0.0001), whereas a task-set switching effect would manifest 





Figure 7-5. Mean reaction time at each run-position in the short cue and long cue 
blocks of the Response Inhibition task 
Markers show unadjusted means and error bars show 95% confidence intervals.  
 
Run-position effects on error rate are illustrated in (Figure 7-6). The odds of making an 
error decreased with increasing run-position (OR = 0.935, 95% CIs 0.890 to 0.982, p = 
0.007). However, there were contrasting profiles in the short cue duration and long cue 
duration blocks: in the short cue duration block there was no main effect of run-position 
(OR = 0.954, 95% CIs 0.893 to 1.019, p = 0.16), whereas in the long cue duration block 
error rate decreased with increasing run-position (OR = 0.862, 95% CIs 0.801 to 0.928, 
p < 0.0001). The lack of a consistent relationship between run-position and error rate is 
probably due to the fact that error rate was heavily influenced by congruency and 
stimulus cue (arrow vs. word) (see 7.3.2.2.1) and these factors were not counterbalanced 
across the run-positions (see 7.2.1). Again, there is no evidence of the task-set switching 
effect described by Aron et al. (which would be indicated by substantially higher error 





Figure 7-6. Error rate at each run-position in the short cue and long cue blocks of 
the Response Inhibition task 
Markers show unadjusted means and error bars show 95% confidence intervals. 
 
Practice effects on RT are illustrated in Figure 7-7. There was a general practice effect 
whereby RT got slightly faster with increasing trial number (regression coefficient = 0.999 
(i.e. 0.1% decrease in RT per trial), 95% CIs 0.998 to 0.999, p < 0.0001). However, when 
analysing the ‘short cue’ and ‘long cue’ blocks separately, it is clear that this effect derives 
from the short cue block (regression coefficient = 0.997 (i.e. 0.3% decrease in RT per 
trial), 95% CIs 0.997 to 0.997, p < 0.0001), and there is no statistically significant effect 
in the long cue block (regression coefficient = 1.000, 95% CIs 0.999 to 1.000, p = 0.42). 
This could be partly because the long cue duration block was administered after the short 
cue duration block, so participants may have already had sufficient practice to reach their 
optimum level of performance, but also because the long cue duration block is easier 






Figure 7-7. Mean Reaction Time for each trial in the short cue and long cue blocks 
of the Response Inhibition task 
There were 47 trials within each condition. The long cue block was always administered first. 
 
 
Practice effects on error rate are illustrated in Figure 7-8. A slight practice effect (i.e. a 
reduction in error rate with increasing trial number) was observed overall (OR = 0.993, z 
= -4.54, p < 0.0001). As with RT, this was observed in the short cue block (OR = 0.982, 
z = -7.62, p < 0.0001) but not the long cue duration block, which had evidence of a slight 
worsening of performance over time (OR = 1.008, z = 3.09, p = 0.002).  
Overall, run-position and trial number had small independent effects on RT and error rate 
so it is justified to account for them in the following analyses, but there is no cause to be 
concerned that the comparison between the short and long cue durations will be 






Figure 7-8. Error rate for each trial in the short cue and long cue blocks of the 
Response Inhibition task 






7.3.2.2. RT and error rate 
 
7.3.2.2.1. Cue duration, congruency and cue type 
Results of the multivariable regression models for RT and error rate are given in Table 
7-2 and Table 7-3 respectively, along with results of interaction tests between predictors.  
Responses were 39% slower on average when the cue was of short duration compared 
to long duration (Table 7-2), and also 1.65 times more likely to be incorrect (Table 7-3). 
This is as expected, because the long cue duration gives people more time to prepare 
the appropriate task set for their response. As mentioned above, a contribution of 
practice effects to this result cannot be ruled out, as the long cue duration block came 
after the short cue duration block.  
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Incongruent trials were associated with 13% slower responses than congruent trials 
(Table 7-2) and the odds of making an error were 17.17 times greater (Table 7-3).  
Responses were slightly slower (6%) to arrow cues than word cues (Table 7-2) and also 
5.32 times more likely to be incorrect (Table 7-3). 
Several interaction effects were observed between these factors; as an aid to the 
interpretation of these interaction effects, described below, mean RT and error rate for 
each combination of cue duration, congruency and cue type are shown in Figure 7-9 and 
Figure 7-10. 
The slowing of responses and the increased error rate associated with incongruent trials 
were both disproportionately greater when the cue type was arrow rather than word 
(Table 7-2, Table 7-3, Figure 7-9, Figure 7-10). The slowing of responses associated 
with incongruent trials was slightly reduced when the cue was of short duration compared 
to long duration (Table 7-2, Figure 7-9), but there was no evidence that the increase in 
error rate on incongruent trials differed between the short and long cue duration 
conditions (Table 7-3, Figure 7-10). Finally, the slowing of responses and the increased 
error rate associated with arrow cues were both disproportionately greater when the cue 
was of short duration compared to long duration (Table 7-2, Table 7-3, Figure 7-9, Figure 
7-10).  
Overall these results show that both RT and error rate were influenced by all three 
experimental factors, with the most difficult combination being an arrow cue of short 
duration for an incongruent stimulus. The biggest influence on RT was cue duration 
whereas the biggest influence on error rate was congruency. It is clear from Figure 7-10 
that the error rate for congruent trials was extremely low, regardless of cue duration and 
cue type, whereas incongruent trials were much more error-prone, especially when 
participants were cued to respond to the arrow. This suggests that the word was the 







Table 7-2. Associations between demographic and life-course predictors and RT 
























































































































Coefficients in bold are significant at p < 0.05 and asterisks indicate significance at p < 0.01. 
Multivariable regression models were used so each association is independent of all others. a As 
the data were log-transformed, the coefficients are quoted in exponentiated form for ease of 
interpretation; for example, a coefficient of 1.05 would mean that the factor was associated with 
5% longer response time. b See section 3.2.4 for definition of categories. c See section 3.2.3  for 
definitions. 




Table 7-3. Associations between demographic and life-course predictors and error 
























































































































Coefficients in bold are significant at p < 0.05 and asterisks indicate significance at p < 0.01. 
Multivariable regression models were used so each association is independent of all others.  
a See section 3.2.4 for definition of categories. b See section 3.2.3 for definitions. 
  






Figure 7-9. Mean reaction time by congruency, cue type (arrow vs. word) and cue 
duration (short vs. long) on the Response Inhibition task 





Figure 7-10. Error rate by congruency, cue type (arrow vs. word) and cue duration 
(short vs. long) on the Response Inhibition task 
Markers show unadjusted means and error bars show 95% confidence intervals. 
 
 
7.3.2.2.2. Demographic and life-course predictors  
Results of the multivariable regression models for RT (correct responses only) and error 
rate are given in Table 7-2 and Table 7-3 respectively, along with results of interaction 
tests between predictors. 
On average, males responded 8% faster than females (1640 vs. 1788 ms, Table 7-2). 
There was evidence of an interaction between sex and cue type, such that the tendency 
to respond more slowly to arrow cues than words cues was reduced in males, i.e. their 
RTs to arrows and words were more similar. There was no evidence of statistically 
significant sex differences in overall error rates (males = 6.0%; females = 5.3%) nor in 
the extent to which accuracy was influenced by cue duration, congruency or cue type 
(Table 7-3). 
Older age at assessment was associated with slightly slower RT (5% slower per year), 
an effect which appeared to generalise across all conditions of the task as there was no 
evidence of interactions between age and cue duration, congruency or cue type (Table 
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7-2). There was no evidence of a general ageing effect on error rate, but the tendency 
to make more errors in response to arrow cues (as opposed to word cues) was 
exaggerated in older participants (Table 7-3). 
Participants with higher childhood cognitive ability tended to respond faster overall (5% 
faster per z-score unit of childhood cognitive ability) and had a reduced tendency to 
respond more slowly to incongruent stimuli, i.e. their RTs to congruent and incongruent 
stimuli were more similar, indicating better inhibitory control (Table 7-2). While higher 
educational attainment and higher adult socioeconomic position did not have a 
statistically significant effect on RT overall, these factors were also associated with a 
reduction in the tendency to respond more slowly to incongruent stimuli, indicating better 
inhibitory control (Table 7-2).  
Childhood cognitive ability, education and adult socioeconomic position all had notable 
independent effects on error rate (odds of making an error reduced by 30% per unit z-
score of childhood cognitive ability, reduced by 18% per category of educational 
attainment, and reduced by 13% per category of adult socioeconomic position, Table 
7-3, Figure 7-11). There was no evidence of interactions between these factors and the 
tendency to make more errors on incongruent trials, although as error rates in the 
congruent condition were so low it should be noted that the overall error rates were driven 
almost entirely by errors on incongruent trials. There was also no evidence of interactions 
between these factors and the tendency to make more errors when the cue was of short 
duration, but there were interaction effects with cue type such that those with higher 
childhood cognitive ability and higher education attainment made relatively more errors 
in response to arrow cues (as opposed to word cues). In other words, their accuracy 
advantage was greater when they were required to respond to the word.  
There was no evidence of any statistically significant differences between participants 
with neurological or psychiatric conditions and cognitively-normal participants in terms of 





Figure 7-11. Association between childhood cognitive ability and error rate on the 
Response Inhibition task 
Error rate is represented as a proportion between 0 and 1. Solid line indicates predictions from 
the multivariate regression model, adjusted for sex, age at assessment, education, adult 
socioeconomic position and presence of a neurological or psychiatric condition. Shaded area 
represents 95% confidence intervals. For an explanation of the childhood cognitive ability 
variable, see section 3.2.4. 
 
 
7.3.2.3. Relationship between speed and accuracy 
Figure 7-12 illustrates the relationship between mean RT and accuracy. There was a 
ceiling effect on accuracy with many participants having an error rate close to zero 
regardless of their speed, but there was a positive association (rather than a trade-off) 
between speed and accuracy, such that slower mean RT for correct responses was 





Figure 7-12. Scatter plot of each participant’s mean reaction time against their 
error rate on the Response Inhibition task 
Transparent markers have been used so that the density is visible where there are markers on 
top of each other. Solid line indicates line of best fit. 
 
The within-subjects analysis of trial-by-trial responses found that errors were more likely 
to occur with increasing RT, with a 2% increase in the odds of making an error per 
additional 100 milliseconds (OR = 1.02, 95% CIs 1.01 to 1.03, p < 0.0001). To put this in 
context, the mean RTs for correct and incorrect responses were 1712 ms and 2175 ms 
respectively. The predictors of higher error rate remained unchanged when adjusting for 
RT: incongruent stimuli (OR = 16.21, 95% CIs 12.19 to 21.54, p < 0.0001), short cue 
duration (OR = 1.48, 95% CIs 1.31 to 1.66, p < 0.0001), and arrow cues (OR = 5.11, 
95% CIs 4.16 to 6.26, p < 0.0001). This provides evidence that RT and error rate were 
mainly dependent on the properties of the stimuli (i.e. certain conditions were more 
difficult which had a detrimental effect on both speed and accuracy), rather than errors 




7.4. Associations with biomarkers and APOE-ε4 
 
Following the format laid out in section 3.5, the second part of this chapter aims to 
investigate associations between performance and biomarkers of AD in cognitively-
normal participants for whom complete biomarker data are available. The number of 
participants meeting these criteria who also had usable data from the Response 
Inhibition task was 405 (see section 3.3). 
As explained in section 3.5.2.1, I wanted to derive some summary scores that capture 
the key aspects of performance on each task, to use for comparing results across the 
different cognitive tests in the Insight 46 battery (see Chapter 9). As a test of response 
inhibition, the outcome of primary interest in this task is how well participants can inhibit 
incorrect responses when presented with incongruent stimuli. This is the dimension of 
the task which my hypotheses relate to, rather than the other factors that were varied 
across the experiment, namely cue duration and cue type (arrow vs. word). The results 
reported above support the idea that congruency is the aspect on which interesting 
differences in RT between participants are observed, as the extent to which RT was 
slowed on incongruent stimuli varied by childhood cognitive ability, education and adult 
socioeconomic position, whereas the effects of cue duration and cue type on RT did not 
vary by any of the predictors tested (except a small interaction between sex and cue type 
(see section 7.3.2.2.2).  
Based on this, I decided to calculate summary scores that quantify the extent to which 
RT and accuracy were compromised on incongruent trials, compared to congruent trials. 
This approach is commonly adopted on response inhibition tasks. For example on the 
Simon task, the ‘Simon effect’ is the difference between mean RT for congruent trials 
and mean RT for incongruent trials (e.g. Stoet, 2017), and the ‘Stroop effect’ is usually 
defined as the total time to complete the incongruent condition of the Stroop task minus 
the total time to complete the congruent condition (MacLeod, 1991). I calculated the 
following two summary outcomes for each participant: 
i) “Incongruent cost” to RT, defined as the mean RT for incongruent trials minus 
the mean RT for congruent trials, divided by the mean RT for congruent trials. 
This is a measure of the relative increase in RT for incongruent trials. I chose to 
calculate the relative difference, rather than the absolute difference, because it 
may be more meaningful given the large range of RTs and because it more 
closely approximates the normal distribution. 
ii) “Incongruent cost” to error rate, defined as the percentage of incorrect 
responses on incongruent trials minus the percentage of incorrect responses on 
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congruent trials. I considered whether to normalise this outcome to each 
participant’s performance in the congruent condition (i.e. to calculate the relative 
difference in error rate rather than the absolute difference) but this was 
problematic because it would require dividing by zero for the vast majority of 
participants (83%) who made no errors on congruent trials. Because of this 
ceiling effect on accuracy for congruent trials, this outcome is essentially a 
measure of error rate on incongruent trials, but one that attempts to minimise the 
influence of anticipations or lapses of attention – the most likely explanation for 
making errors in the congruent condition. 
For each of these two outcomes, I tested for associations with the same biomarkers as 
in the previous chapter (see section 3.5.2).  
 
 
7.4.1. Statistical Analyses 
 
“Incongruent cost” to RT and “incongruent cost” to error rate were both analysed 
using multivariable linear regression models. For the error rate variable, bootstrapping 
was used to produce bias-corrected and accelerated 95% CIs from 2000 replications, as 
it had a positive skew. 
All models included predictors of amyloid status (positive vs. negative), whole brain 
volume, WMHV and APOE genotype (ε4-carrier vs. non-carrier). To adjust for the 
correlation between whole brain volume and head size, total intracranial volume (TIV) 
was included in all models, as were the demographic factors investigated in section 6.3 
(sex, age at assessment, childhood cognitive ability, education and adult socioeconomic 
position).  
The models were additionally rerun replacing dichotomised amyloid status with SUVR to 
test whether increasing Aβ deposition was associated with differences in performance. 
To check whether associations between SUVR and cognition were sensitive to the 
inclusion of the imputed SUVR values (see section 3.2.2), the analyses were rerun 







Results of the regression models for the two outcomes are reported in Table 7-4. Results 
for the demographic and life-course factors (sex, age at assessment, childhood cognitive 
ability, education and adult socioeconomic position) are not reported as they are 
essentially unchanged from the first analysis section (7.3.2). 
There was no evidence of any associations between any biomarkers and either of the 
two outcomes. 
 
Table 7-4. Associations between biomarkers and Response Inhibition outcomes 
in cognitively-normal participants (n = 405) 
Predictor 
Coefficients and 95% CIs 
“Incongruent cost” to 
RT a 
“Incongruent cost” to 
error rate b 
β-amyloid status  










Whole brain volume  












Multivariable regression models were used so each association is independent of all others.  
In addition to the predictors listed, models also included sex, age at assessment, childhood 
cognitive ability, adult socioeconomic position and total intracranial volume. 
 
Coefficients in bold are significant at p < 0.05 and asterisks indicate significance at p < 0.01.  
a “Incongruent cost” to RT is the relative increase in RT for incongruent trials, defined as the mean 
RT for incongruent trials minus the mean RT for congruent trials, divided by the mean RT for 
congruent trials. b “Incongruent cost” to error rate is defined as the percentage of incorrect 
responses on incongruent trials minus the percentage of incorrect responses on congruent trials. 









This study investigated inhibitory control on a task where incongruent stimuli were used 
to create a conflict between the automatic (but incorrect) response and the correct 
response. As hypothesised, there was evidence that higher childhood cognitive ability 
and education were associated with increased inhibitory control, as evidenced by a lower 
error rate and a reduction in the tendency to respond more slowly to incongruent stimuli. 
There was evidence of a similar effect of higher adult socioeconomic position. There was 
no evidence to support the hypothesis that Aβ+ participants would show reduced 
inhibitory control. There was no evidence of speed-accuracy trade-offs; rather there was 
a positive association between speed and accuracy. These results are discussed in 
greater detail in the following sub-sections. 
 
 
7.5.2. Patterns of performance 
 
As expected, responses were slower when the stimuli were incongruent and when 
participants had less time to prepare for their response (i.e. the cue was of short 
duration). Responses were also slightly slower when the cue instructed participants to 
respond to the arrow rather than the word. This may be explained by the fact that reading 
words is an automatic or “overlearned” process, and would naturally take precedence 
over attending to the direction of the arrow – this is the phenomenon behind the well-
established Stroop effect (see 7.1). The results of the Choice RT experiment reported in 
the previous chapter support this explanation, because in the Choice RT experiment 
(where arrows and words were presented alone, not combined together as in the 
Response Inhibition experiment) responses were slightly faster to arrows than words, 
suggesting that in the Response Inhibition task it was indeed the presence of the 
irrelevant word that slowed down responses to arrows. In the experiment by Aron et al. 
(2004) on which this one was based, cue type was not considered as a factor in the 
analyses so it is not possible to compare my results with theirs in this respect.  
The finding that the fastest-responding participants tended to make the fewest errors, is 
the opposite of the relationship observed in the Choice RT experiment reported in the 
previous chapter, where there was a trade-off between speed and accuracy. Similarly, 
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the observation that incorrect responses were typically slower than correct responses 
was the opposite of the Choice RT experiment. In my discussion of those results (section 
6.5.2), I hypothesised that the complexity of the task is the key factor in determining the 
relationship between speed and accuracy, as errors in a more complex task may arise 
primarily from making an incorrect judgement, whereas on a more simple task errors 
may arise primarily from anticipatory or hasty responses. 
 
 
7.5.3. Demographic and life-course predictors 
 
7.5.3.1. Associations with age at assessment 
As on the Choice RT experiment reported in the previous chapter, there was an 
association between older age and slower RT. However, there was no evidence of an 
age effect on inhibitory control, as the tendency to respond more slowly to incongruent 
stimuli was independent of age. This agrees with the conclusion of a recent meta-
analysis which concluded that there is little evidence that inhibitory control declines with 
age (Rey-Mermet and Gade, 2018), although the very narrow age range of Insight 46 
participants (2.6 years – reflecting the time it took to collect the data, since all participants 
were born in the same week) means that I was not expecting to observe age effects in 
general. As discussed previously (see sections 4.5.2.3 and 6.5.3.1) I considered the 
possibility of a recruitment bias whereby participants seen towards the beginning of the 
data collection period may have differed in some ways to those seen towards to the end, 
and this is discussed in greater detail in Chapter 10. 
 
7.5.3.2. Associations with childhood cognitive ability, education and adult 
socioeconomic position  
Error rate on this task showed strong independent associations with childhood cognitive 
ability, education and adult socioeconomic position. As error rates for congruent stimuli 
were extremely low, these associations are driven by errors in the incongruent condition, 
which occurred primarily when participants were required to ignore the word and respond 
to the direction of the arrow (see 6.5.2). Higher childhood cognitive ability, higher 
educational attainment and higher adult socioeconomic position also independently 
predicted a reduced tendency to slow down when the stimuli were incongruent, indicating 
better inhibitory control. These results are consistent with previous studies that have 
described an effect of education on response inhibition tasks (Puccioni and Vallesi, 2012; 
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Aschenbrenner et al., 2015), but to my knowledge this is the first study to report 
independent effects of these factors on inhibitory control in older age.  
Consistent with the results of the Choice RT experiment reported in the previous chapter, 
higher childhood cognitive ability was associated with faster RT overall, whereas there 
was no evidence for associations between RT and education or adult socioeconomic 
position. As discussed in the previous chapter, associations between RT and general 
cognitive ability are widely reported in the literature.  
 
7.5.3.3. Sex differences 
There was evidence of a sex difference in RT whereby males generally responded faster. 
In the previous chapter I discussed the fact that the lack of evidence for sex differences 
on the Choice RT experiment was contrary to some previous studies which had reported 
that males tended to respond faster on Choice RT tasks  (Deary and Der, 2005; Der and 
Deary, 2006; Dykiert et al., 2012b; Vincent et al., 2012; Phillips et al., 2013). While this 
task was primarily designed to measure inhibitory control, it can still be considered as a 
Choice RT task, albeit one with an extra layer of demands due to the congruent and 
incongruent stimuli. One theory of relevance that could explain this finding is the 
hypothesis that females may show greater post-error slowing (Thakkar et al., 2014; 
Fischer et al., 2016), so I plan to conduct further analyses to see if this was indeed the 
case. 
This study did not find any evidence of a sex difference in inhibitory control, which is 
consistent with the literature on the Stroop task where sex differences in inhibitory control 
are not generally observed (MacLeod, 1991) but contrary to the results of a previous 
study which reported that males had reduced interference on the Simon task (Stoet, 
2017). I would speculate that a possible reason for the discrepancy could be related to 
the design of the task, because the incongruity in the Simon task comes from the 
direction of an arrow and its location, whereas the incongruity in the Stroop task comes 
from a word and colour, and in the task used in Insight 46 it comes from a word and the 
direction of an arrow. As discussed in Chapter 5 in the context of the observation that 
males had slightly better memory for the location of objects in the “What was where?” 
task, there is evidence for sex differences in spatial abilities, so this could perhaps play 
a role in the result reported on the Simon task. However, it should also be noted that the 




7.5.4. Associations with biomarkers and APOE-ε4 
On the two summary outcomes chosen as measures of inhibitory control on this task, 
there was no evidence of differences between cognitively-normal Aβ+ and Aβ- 
participants, nor of any associations with whole brain volume, WMHV or APOE genotype. 
Given that I have found evidence that β-amyloid deposition is associated with subtly 
poorer performance on a range of other cognitive measures covering a variety of 
cognitive domains (see Chapters 4 to 6), this may suggest that inhibitory control is not 
an area in which such early changes are seen. That would be contrary to the conclusion 
of a previous study which suggested that decline in inhibitory control may be evident 
before memory impairment, as they found that individuals with pathological β-
amyloid42/tau ratios showed greater interference on the Stroop task but did not differ from 
controls on any other cognitive measure (Harrington et al., 2013). The participants in that 
study were slightly older and the sample size was small (mean age 76 for controls, n = 
36; mean age 78 for those with pathological β-amyloid42/tau ratios, n = 34). While the 
evidence for impaired inhibitory control in MCI and AD dementia is more well-established 
(e.g. Castel et al., 2007; Bélanger, Belleville and Gauthier, 2010) further studies are 
needed to understand the timing of declines in this area and how this may relate to 
accumulation of AD pathology. It still remains to be understood how potential declines in 
inhibitory control may relate to changes in other executive functions such as processing 
speed, cognitive flexibility, attention and working memory, where there is accumulating 
evidence for subtle declines in the preclinical stage of AD (Grober et al., 2008; Clark et 
al., 2012; Hassenstab et al., 2015; Baker et al., 2017; Duke Han et al., 2017; Mortamais 
et al., 2017).  
 
7.5.5. Strengths and limitations 
This task worked well as a measure of inhibitory control, in that it detected substantial 
differences between participants in terms of their ability to deal with incongruent stimuli. 
However its design was complex, arising from the fact that it was initially based on a 
task-set shifting experiment, but I concluded that its suitability for measuring task-set 
shifting was too limited (see 7.2.3). In order to measure task-set shifting, the experiment 
would need a greater number of trials, and for trial types to be properly counterbalanced. 
In the previous chapter I made three recommendations to improve the design of the 
Choice RT experiment (see section 6.5.5). The same three recommendations apply to 
the Response Inhibition experiment. The fact that the first trial of each block had to be 
dropped (see first recommendation) had an additional consequence on the Response 
Inhibition task because it meant that the number of trials was no longer perfectly 
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counterbalanced for congruency, cue type (arrow / word) and cue duration (long / short), 
so there is an additional motivation to address that issue. 
The experiment contained two blocks of a long and short cue duration, but I did not have 
prior hypotheses about whether certain groups of participants would perform differently 
depending on the cue duration, and in fact there were no differences between 
participants in this regard. This feature of the design could be removed without affecting 
the ability of the task to measure inhibitory control. Similarly, I did not have prior 
hypotheses about whether certain groups of participants would perform differently 
depending on whether they were cued to respond to the word or the arrow, so it was 
difficult to interpret these effects (for example, I observed that the tendency to respond 
more slowly to arrow cues than words cues was exaggerated in female participants and 
in older participants), and it should be remembered that some of the findings may be due 
to chance. For a future study, I would recommend either simplifying the design of this 
experiment to focus purely on inhibition, or using a different inhibition task. The Stroop 
task and Simon task (see section 7.1) are both good candidates. If the Stroop task is 
administered in a computerised format with a microphone to record the verbal responses 
(e.g. Bélanger, Belleville and Gauthier, 2010), then it offers the same advantages as the 
Simon task in terms of allowing the RT and accuracy of each individual response to be 
recorded.  
Strengths and limitations that apply to all the analyses presented in this thesis, such as 




The results of this Response Inhibition task have provided evidence that childhood 
cognitive ability, education and adult socioeconomic position each have independent 
effects on the ability to resist interference from irrelevant stimuli in older age. This task 




8. CIRCLE-TRACING AND SERIAL SUBTRACTION 
8.1. Introduction 
 
Many common daily activities such as eating, getting dressed or driving depend on the 
ability to combine visuoperceptual and motor skills. In particular, visual information often 
has to be continuously integrated with motor output – this is referred to as visuomotor 
integration. This is similar to the concept of hand-eye coordination which describes the 
ability to use visual information to guide hand movements, for example when reaching 
or grasping objects. Visuomotor integration encompasses situations where the visual 
feedback is either direct or indirect. Direct visual feedback means that the visual 
information required to carry out the movement can be gathered by observing the 
movement directly. For example, when someone is hand-writing or using a fork to pick 
up food, they watch their hand as they complete the action. Indirect visual feedback 
means that the visual information is derived from an indirect source. For example, when 
someone is using a computer mouse, they look at the screen rather than the mouse itself 
and continuously interpret the movement of the pointer on the screen to guide their hand 
movements, or when reversing a car, they may look in the mirrors to guide their 
movement of the steering wheel. Visuomotor integration is difficult to assess using paper-
and-pencil tests but is a good candidate for novel computerised assessments that allow 
real-time capture of movement data. 
Visuoperceptual difficulties can be a varied, complex and debilitating aspect of many 
types of dementia, for example causing problems with detecting movement, recognising 
objects, and judging distances (Alzheimer’s Society, 2016b). The posterior parietal 
cortex is understood to be particularly important for visuomotor integration as it is 
involved in spatial perception and coordinating information about eye and hand 
movements through its connections with the frontal cortex (Tippett and Sergio, 2006), 
and it is vulnerable to early damage in AD (Hawkins and Sergio, 2014). Visuomotor 
integration has received relatively little attention in AD research but there is some 
evidence that it may become impaired early in the disease process. Several studies 
using a visuomotor integration task with nonstandard visual feedback (e.g. rotated with 
respect to the plane of movement) have reported impairments in AD patients, even those 
with otherwise mild cognitive deficits (Tippett and Sergio, 2006; Tippett, Krajewski and 
Sergio, 2007; Tippett, Sergio and Black, 2012) and in those at high risk of AD (strong 
family history or MCI) (Hawkins and Sergio, 2014). Other studies have observed that AD 
patients are slower to initiate and carry out goal-directed hand movements compared to 
controls (Verheij et al., 2012; de Boer et al., 2016) and less likely to move their eyes in 
an anticipatory manner when carrying out a sequential tapping task (Verheij et al., 2012). 
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There has been little investigation to date of whether visuomotor integration tasks could 
be sensitive markers of subtle cognitive decline in preclinical AD, but one recent study 
with a small sample size found that cognitively-normal individuals with CSF evidence of 
elevated amyloid deposition (n=19) performed slower than controls (n=47) on a reaction 
time task with a visuomotor component (Mollica et al., 2017). Interestingly, the presence 
of abnormal amyloid and tau biomarkers has been reported to predict decline in an 
annual on-road driving test in cognitively-normal individuals (Roe et al., 2017, 2018).  
A circle-tracing task has detected subtle impairments in visuomotor integration in 
presymptomatic carriers of the mutation for Huntingdon’s disease – an autosomal 
dominant inherited disorder with progressive motor, cognitive and psychiatric symptoms 
– up to a decade before estimated symptom onset (Say et al., 2011). Compared to 
healthy controls, presymptomatic gene carriers traced less accurately, particularly when 
the visual feedback was indirect (see Figure 8-1). I previously analysed the results of a 
study which administered this same circle-tracing task to presymptomatic FAD mutation 
carriers and found a similar result, with presymptomatic carriers tracing less accurately 
than controls (Macpherson et al., 2017). This circle-tracing task was included in the 
Insight 46 battery to investigate whether it might be sensitive to subtle visuomotor 
integration deficits associated with amyloid deposition. 
If it is to have potential as a useful marker of cognitive decline, it is important to be able 
to account for other factors which predict differences in performance between individuals, 
such as sex and education. To my knowledge, no studies have investigated the effects 
of these factors on the specific circle-tracing task used here, but sex differences were 
assessed on a different circle-tracing task which involves pursuing a moving target 
around a circle, with the finding that females were less accurate than males in some age 
groups but not in other age groups (Stirling et al., 2013). Studies of associations between 
visuomotor integration and educational attainment have tended to focus on the 
development of handwriting skills in children, since handwriting requires visuomotor 
integration and is an important skill for performance at school (e.g. (Van Hoorn et al., 
2010)), but effects of educational attainment on visuomotor integration in later life have 
received little attention. Insight 46 offers a novel opportunity to assess potential effects 
of childhood cognitive ability, education and adult socioeconomic position on visuomotor 
integration at age 70.  
Another factor which is important to consider when interpreting the results of visuomotor 
integration tasks is the impact of speed-accuracy trade-offs, which have already been 
discussed in the context of the Choice Reaction Time task (see Chapter 6). Speed-
accuracy trade-offs are highly relevant to motor tasks and have been studied in the 
context of sport, for example to optimise bowling in cricket (Freeston and Rooney, 2014). 
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Speed-accuracy trade-offs have been observed on the circle-tracing task previously, with 
the participants who traced fastest being more error-prone  (Vaportzis, Georgiou-
Karistianis and Stout, 2014). 
Following the structure of previous chapters, the aims of this study were to understand 
patterns of performance on the circle-tracing task, characterise associations between 
task performance and demographic and life-course predictors, and investigate 
associations between performance and biomarkers of brain pathologies among 




8.2.1. Stimuli and Procedure 
The circle-tracing task was presented on a Lenovo ThinkPad X61 tablet laptop, placed 
horizontally on the table in front of the participant, with an additional vertically placed 
monitor behind it for the indirect condition (Figure 8-1). The monitor was at a distance of 
about 60cm from the participant. On the laptop, the display showed a 90mm diameter 
circle and 5mm thick annulus; on the monitor, the display showed a 143mm diameter 
circle and 9mm thick annulus. Although the actual size of the circle was larger on the 
monitor than the laptop, the visual angle was comparable – about 13o in each case – 
because the monitor was at a greater distance from the eyes. 
Participants were instructed to trace clockwise round the circle using a stylus as quickly 
and accurately as possible (trying to stay within the annulus) without leaning their hand 
on the screen, starting from the vertical apex of the circle. A thin blue line appeared on 
the display to show their tracing path. In the direct condition, participants could see their 
hand and the path they were tracing on the tablet screen (Figure 8-1). In the indirect 
condition, the laptop was covered by an upturned box with the front open to allow the 
participant to put their hand inside. The participant wore a long cape which completely 
covered both their arms so they had no direct visual feedback while they were drawing, 
but they could view a copy of the circle and the tracing path on the monitor (Figure 8-2). 
The length of each trial was 45 seconds. There were three trials of each feedback 
condition, administered in the order Direct, Indirect, Indirect, Direct, Direct, Indirect. Two 
practice trials – one direct and one indirect – were administered approximately one hour 
before the main experiment, so that participants could familiarise themselves with the 
procedure, but with a long enough delay to mitigate against immediate practice effects. 
Some previous studies have randomised or counterbalanced the order of presentation 
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of trials (Lemay et al., 2005; Say et al., 2011) but others have administered them in a 
fixed order to allow participants to start with an easier direct trial and build up experience 
for the more difficult indirect trial (Vaportzis, Georgiou-Karistianis and Stout, 2014; 
Vaportzis et al., 2015b).  
The task was administered in a dual-task format with a concurrent task of serial 
subtraction, as has been done in previous studies (Vaportzis, Georgiou-Karistianis and 
Stout, 2014; Vaportzis et al., 2015b). Participants were asked to count backwards in 
threes from a given starting number while performing each circle-tracing trial. Starting 
numbers across the six trials were the same for all participants as follows: 99, 98, 97, 
96, 95 and 94. Participants were instructed that, if they reached zero or near zero, they 
should begin again from the starting number. The tester wrote down the sequence of 
numbers called out by the participant.  
In December 2016 (approximately half-way through the data collection period) the 
procedure was modified to add an additional two circle-tracing trials (Direct, Indirect) to 
the end of the experiment. These two trials were performed as a single task without serial 
subtraction, so that I could compare circle-tracing performance in the dual and single 
task conditions in a sub-sample of participants, to investigate how tracing speed and 
accuracy were influenced by having to attend to the concurrent subtraction task (the 














Figure 8-1. Circle-tracing apparatus 
This figure is reprinted from Say et al. (2011) with permission from Elsevier. The additional box 









8.2.2. Outcome Variables 
 
8.2.2.1. Circle-tracing 
For each trial, the following outcome measures were derived: 
i) Number of rotations completed in 45 seconds, as an index of tracing speed. This 
was recorded by the software to 14 decimal places.  
ii) Number of errors per rotation, as an index of tracing accuracy. An error was 
recorded whenever the stylus deviated outside of the annulus (either beyond its inner 
or outer edge) for more than 100 ms.  
iii) Error time per rotation (milliseconds) defined as the time spent tracing outside of the 
annulus. This variable was split by a factor of direction: when the stylus was moving 
away from the annulus this was classified as error detection, when the stylus was 
moving back towards the annulus this was classified as error correction.  
iv) For the sub-sample of participants who completed the additional ‘single task’ trials 
(circle-tracing without concurrent serial subtraction), dual-task cost for tracing speed 
was calculated, which is a measure of the extent to which tracing speed was 
compromised by having to attend to the subtraction task. Dual-task cost was defined 
as: (single speed – dual speed) / single speed, where speed is the number of 
rotations completed in 45 seconds, as above. 
 
8.2.2.2. Serial Subtraction 
For each trial, the following outcome measures were derived: 
i) Subtraction rate (responses per second), calculated by dividing the number of 
responses by the duration of the trial (45 seconds). 




Based on the results of previous studies (Lemay et al., 2005; Say et al., 2011; Vaportzis, 
Georgiou-Karistianis and Stout, 2014; Vaportzis et al., 2015b), I expected that the 
indirect condition (indirect visual feedback) would be associated with slower tracing, 
reduced accuracy, and a disproportionately longer time spent on error detection relative 
to error correction. I also expected to observe speed-accuracy trade-offs whereby 
participants who traced more quickly would tend to deviate outside the circle more often.  
190 
 
Given that education is associated with better performance on most cognitive tasks 
across a wide range of cognitive domains, and analyses from the NSHD have 
consistently reported associations between childhood cognitive ability, education and 
cognition during adulthood (Richards and Sacker, 2003; Richards et al., 2019), I 
anticipated that higher childhood cognitive ability and educational attainment would be 
associated with better performance on this task. However, because the two main 
outcomes are in competition with each other (speed vs. accuracy), “better performance” 
is difficult to define and I did not have specific hypotheses about the effects of these 
predictors on individual outcome measures. 
I aimed to test the hypothesis that cognitively-normal Aβ+ participants would show 
evidence of subtle impairments along the same lines as pre-symptomatic Huntington’s 
gene carriers i.e. disproportionately poorer tracing accuracy in the indirect condition (Say 
et al., 2011). 
Although the experimental design was not ideal for measuring “dual-task cost” (see 
discussion in section 8.5), I hypothesised that Aβ+ participants would have a greater 




483 participants completed the dual-task circle-tracing (see section 3.3), of whom 209 
also completed the single-task circle-tracing. Participant characteristics are reported in 
section 3.6. The proportion of participants who were right-handed was 91%. 
 
8.2.5. Data processing 
 
8.2.5.1. Circle-tracing 
The data were generated in xml format (one file per participant) and I processed them 
using the HD-CAB Data Analyzer software application PxAnalyze, which produced a 
single spreadsheet of outcome variables for all participants.  
Certain trials were excluded from analysis according to the following criteria:  
i) A ‘tracing time’ variable was generated as part of the software output; it should 
be 45 seconds (i.e. the duration of the trial) but could be less if the trial was not 
completed perfectly, for example if the participant lifted the pen off the screen 
during the trial, they pressed too hard with the stylus such that no trace was 
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recorded temporarily, or they failed to begin tracing immediately upon initiating 
the trial. The maximum time in this dataset was exactly 44 seconds rather than 
45 seconds as expected. I corresponded with the research group in Monash 
University who wrote the software and they did not have an explanation for this 
discrepancy, as the author of the source code was not available. I chose a 
threshold of three standard deviations below the mean (34.7 seconds) as a 
minimum acceptable tracing time. Thirty-two participants had one trial excluded 
for being below this threshold, an additional three participants had two trials 
excluded, and an additional one participant had four trials excluded (Figure 8-3). 
After these exclusions, the number of participants with usable single-task data 
dropped to 208 and the number with usable dual-task data remained at 483.  
 
Figure 8-3. Dot plot showing total tracing time on the circle-tracing task 
Red line shows the threshold below which trials were excluded (3 standard deviations 
below the mean). 
 
ii) An additional two participants had one indirect trial excluded because the output 
showed a negative number of rotations (-0.07 and -0.08). I corresponded with the 
research group in Monash University who wrote the software and they did not 
have an explanation for these odd results. I considered if this could be caused by 
initially tracing anti-clockwise out of the red box (see Figure 8-1) but when I tested 
this myself, the results were normal. However, I identified that if all rotations are 
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completed anti-clockwise (contrary to instructions) this outputs a negative 
number. I highly doubt that any testers would have failed to correct a participant 
who was tracing anti-clockwise, but it is possible. It is slightly concerning not to 
know how these results arose, but it only affects 0.07% of trials.  
 
iii) Two previous studies using the circle-tracing task excluded trials where the speed 
or error rate was more than 3.5 standard deviations from the individual’s mean  
(Vaportzis, Georgiou-Karistianis and Stout, 2014; Vaportzis et al., 2015b). 
However, they used 18 trials lasting 20 seconds each, whereas this task uses 6 
trials lasting 45 seconds each (plus two additional trials for those who completed 
the single-task). Given the smaller number of trials and the fact that speed and 
accuracy vary between the direct and indirect conditions, it would be 
inappropriate to consider each participant’s six trials as a distribution. Therefore, 
I decided not to follow such a method for data cleaning, but simply to check that 
none of the speed or error rates looked impossible. The number of rotations 
ranged from 0.37 to 50.62 and the number of errors per rotation ranged from 0 to 
49, which are all plausible.  
 
iv) An additional issue was considered, which could affect the validity of analyses 
comparing error detection and error correction. Sixteen participants had one trial 
where they were recorded as having traced outside of the annulus only in one 
direction, e.g. they recorded an ‘error detection time’ for tracing away from the 
annulus, but they have no corresponding ‘error correction time’. The most likely 
explanations for this are either that the participants lifted the pen off the screen 
and placed it back inside the annulus, or that they had a temporary issue with the 
tracing pressure such that there was a break in the line due to them pressing too 
hard or too lightly with the stylus. I decided not to exclude these trials because 
the data probably reflect the participant’s true performance, rather than being due 
to a software error. Also, other trials could have been affected by the same 
irregularities in tracing but within the annulus, which is not apparent from the 
software output. 
 
In line with the policy of keeping the sample as representative as possible, the only 
reason to exclude participants with outlying performance was deemed to be a clear 
indication that they deviated from the protocol e.g. a fundamental misunderstanding of 
the instructions. To identify any participants whose performance was outlying overall, I 
calculated each participant’s mean speed and error rate, then applied transformations to 
reduce the skew of the distributions (log-transform for speed, square-root for accuracy). 
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As there are trade-offs between speed and accuracy, outlying values of either could 
represent a valid extreme of prioritising speed or accuracy, so the most valid way to 
identify outliers is to consider speed and accuracy together. I plotted speed and error 
rate against each other, doing this separately for the dual and single tasks because I 
expected that the relationship between speed and accuracy might differ between the 
two, and because the single task was only performed on a sub-sample.  
In the dual task, the two participants with the highest error rates appear to be outlying 
from the distribution, whereas the participants with the fastest and slowest speeds 
appear to conform to the normal pattern of speed-accuracy trade-offs (Figure 8-4). Both 
outlying participants have a diagnosis of Parkinson’s disease so it is reasonable to 
suppose that their high error rates are due to their motor symptoms. This is not grounds 
to exclude these participants from analyses because they performed the task according 
to the instructions and they are not fundamentally different to some other participants 
with milder motor symptoms (e.g. other forms of tremor) whose performance was not 
outlying but was affected by their symptoms nonetheless. 
  
Figure 8-4. Speed-accuracy trade-offs on the circle-tracing dual task  
Each participant's mean speed is plotted against their mean error rate. This graph is presented 
on the same scale as Figure 8-5 to facilitate visual comparison. 
 
In the single task, two participants appeared to be outlying from the distribution in terms 
of high performance, as they achieved unusually fast tracing with an error rate of around 
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average (Figure 8-5). Their results are plausible and there were no grounds to exclude 
them.  
 
Figure 8-5. Speed-accuracy trade-offs on the circle-tracing single task  
Each participant's mean speed is plotted against their mean error rate. This graph is presented 
on the same scale as Figure 8-4 to facilitate visual comparison. 
 
 
8.2.5.1.1. Comparison of dual and single task 
An ideal experimental design for comparing single vs. dual task would have equal 
numbers of single and dual trials, equally divided between the direct and indirect 
conditions, and the order of trials would be counterbalanced to control for practice 
effects. As our design did not achieve this (see Table 8-1), a simple average of speed or 
accuracy on dual vs. single trials might not be the fairest comparison because there were 
unequal numbers of trials (6 dual and 2 single) and the single-task trials always came at 
the end of the experiment where they may benefit more from practice effects. Therefore, 
I examined the pattern of responses across each trial before deciding which would be 
the best trials to use for comparison of single and dual task.  
Figure 8-6 shows the mean speed and accuracy for each trial, for the 208 participants 
with usable data for both the dual and single tasks. Tracing speed improved on 
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successive trials within both the direct and indirect conditions of the dual-task, but the 
gains were relatively small in magnitude so an average of speed across the dual-task 
might be a fair reflection of tracing speed ability (Figure 8-6A). However, error rate was 
much more variable from one trial to another, specifically in the indirect condition. The 
highest error rates on the dual task were recorded on the two indirect trials that 
immediately followed a direct one (trials 2 and 6), suggesting that switching to the indirect 
visual feedback was initially difficult and required some adjustment each time, whereas 
performance was much improved when completing a second consecutive indirect trial 
(trial 3) (Figure 8-6B). Therefore, I decided that a fair comparison between the dual and 
single task should use trials which are matched for these factors as much as possible. 
 
Table 8-1 Order and description of circle-tracing trials 
Trial Number Condition Task 
1 Direct Dual 
2 Indirect Dual 
3 Indirect Dual 
4 Direct Dual 
5 Direct Dual 
6 Indirect Dual 
7 Direct Single 
8 Indirect Single 
 
 
I considered the following options for comparing the dual and single tasks. 
Option 1: compare trials 1 and 2 against 7 and 8 
 Advantage: none of these trials are preceded by another trial in the same 
condition, so there would not be any confounding practice effects due to 
performing consecutive trials in one condition.  
 Disadvantage: Practice effects across the whole experiment may depress the 
dual task results (trials 1 and 2) – especially in terms of accuracy as trial 2 (the 




Option 2: compare trials 5 and 6 against 7 and 8 
 Advantage: Theoretically this minimises the influence of general practice effects 
as it uses trials from the end of the experiment. 
 Disadvantage: Trial 5 (dual task, direct condition) is preceded by another trial in 
the same condition, whereas none of the others are. This means it may have 
benefitted more from practice effects, which could explain why trial 5 had faster 
tracing and a slightly lower error rate than trial 4 (although the difference in error 
rate was not statistically significant) (Figure 8-6B). This may inflate the dual task 
results.  
 
Option 3: compare trials 4 and 6 against 7 and 8 
 Advantage: All trials are alike in that they are preceded by a trial in the opposite 
condition (direct or indirect).  
 Advantage: Theoretically this almost minimises the influence of general practice 
effects as it uses trials from towards the end of the experiment. 
 
Option 4: Compare the average of all direct dual task trials (1/4/5) and all indirect 
dual task trials (2/3/6) against trials 7 and 8. 
 Advantage: This might improve the reliability of the dual-task results because it 
would minimise the impact of any individual outliers. 
 Disadvantage: By including trials from the beginning of the experiment, this fails 
to minimise the impact of practice effects so may depress the dual-task results. 
Conversely, as it includes trials 3 and 5 which benefit from being in the same 
condition their preceding trials, this may inflate the dual-task results. 
 
I decided to choose Option 3 as it gives the best match between the circumstances of 
the dual and single-task trials, so I only included trials 4, 6, 7 and 8 in analyses comparing 
the dual and single tasks. Of the 208 participants who completed the dual and single 
tasks, nine did not have usable data for all four of these trials because their tracing time 
had been less than 34.53 seconds on at least one trial – see point (1) in section 8.2.5.1 
– so these participants were excluded from analyses involving the single task, leaving a 






























Figure 8-6. Means and 95% confidence intervals for circle-tracing speed and 
accuracy on each trial. A = speed. B = accuracy.  
Asterisks indicate statistically significant difference in pairwise comparisons between successive 
dual-task trials within the direct or indirect condition (p < 0.05). The means and confidence 
intervals were generated from the transformed data (log transformed for speed, square-root 
transformed for error rate) as these are the variables that were used in the regression models 











8.2.5.2. Serial Subtraction 
When processing the serial subtraction task, I decided to exclude trials where the 
concurrent circle-tracing data had been excluded, as these exclusions were mostly due 
to the tracing time being significantly less than expected (see section 8.2.5.1) indicating 
a problem with performing the circle-tracing. I observed that when such problems arose, 
the participant invariably paused their subtraction while trying to address it. This resulted 
in 34 participants having one trial excluded and an additional two participants having two 
trials excluded. I examined the distributions of subtraction rates and error rates to check 
for implausible outliers. Some participants found this task very challenging, as evidenced 
by a minimum subtraction rate of 0.12 responses per second and a maximum error rate 
of 49% (to calculate these values, each participant’s performance was averaged across 
the six subtraction trials, see section 8.3.1.2.1). This is not unexpected, especially as the 
dual task design meant that participants could not give the subtraction task their full 
attention. Notes from the testing sessions reported that some participants struggled with 
this task but there was no indication that they did not understand the instructions or 




In ter  
8.3. Patterns and predictors of performance 
 
Following the format laid out in section 3.5, the first part of this chapter aims to describe 
patterns of performance across the various outcomes and conditions of the task, and to 
investigate the effects of demographic and life-course predictors on performance in the 
full Insight 46 sample. The demographic and life-course predictors (sex, age at 
assessment, childhood cognitive ability, educational attainment, adult socioeconomic 
position and presence of a neurological or psychiatric condition) are defined in sections 




8.3.1. Statistical Analyses 
 
8.3.1.1. Circle-tracing 
8.3.1.1.1. Speed and accuracy  
All main circle-tracing analyses were carried out using the data from the six dual-task 
trials completed by 483 participants.  
To improve data distribution, a log transformation was applied to the speed variable 
(number of rotations) and square-root transformations were applied to the accuracy and 
error time measures. The transformed data were used in all statistical analyses. 
Regression models were fitted for the transformed speed (number of rotations) and 
accuracy (number of errors per rotation) variables using GEE, assuming a normal 
distribution for the dependent variable and an identity link (as with standard linear 
regression), but including an exchangeable correlation structure and robust standard 
errors to allow for the correlation between repeated measures of the same participant. 
Predictors in the models were condition (direct / indirect), age at assessment, sex, 
childhood cognitive ability, adult socioeconomic position, education and presence of a 
neurological or psychiatric condition (yes / no). Handedness (left / right) was included as 
an additional covariate because anecdotally it can be more difficult to trace clockwise for 
left-handed people. 
As I was interested in identifying factors that predict disproportionately poorer 
performance in the indirect condition, I tested for interactions between these predictors 
and circle-tracing condition. 
 
 
8.3.1.1.2. Practice Effects 
The order of trials (D-I-I-D-D-I) is such that the indirect trials have a higher average 
position in the order than the direct trials. Therefore, comparisons of circle-tracing and 
serial subtraction outcomes between the direct and indirect conditions may be 
confounded by practice effects. While this cannot be tested explicitly, exploring practice 
effects within the direct and indirect trials separately could give an indication of whether 
practice effects are generally observed on this test. Practice effects on speed and 
accuracy across the dual-task trials have already been described for the sub-sample of 
participants who also completed the single task, using pairwise comparisons of 
successive trials within the direct and indirect conditions (section 8.2.5.1.1). For each 
pair of trials, these comparisons were conducted by fitting the GEE regression models 
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for speed and accuracy with trial number as a predictor, also including the usual 
predictors of sex, age at assessment, childhood cognitive ability, education, adult 
socioeconomic position, handedness and presence of a neurological or psychiatric 
condition. These comparisons were repeated for the full sample of 483 participants.  
 
8.3.1.1.3. Error detection time versus error correction time 
A similar GEE model was used for the error time outcome, including an additional 
predictor of tracing direction (away from the circle / towards the circle) in order to 
compare detection time with correction time. The software output gives the total error 
time per trial, split into detection and correction, but does not provide any information 
about the duration of individual errors. The total error time is sufficient for making 
comparisons between error detection time versus error correction time, but not for 
drawing conclusions about whether some participants detected and corrected errors 
more quickly than others – to answer that question the number of errors should be taken 
into account. This was not done in the original paper (Say et al., 2011) and therefore 
their conclusion that “premanifest and early Huntington’s disease groups required longer 
to detect and correct errors (than the control group)" could alternatively be explained by 
the fact that the Huntington’s disease groups made a greater number of errors, so 
naturally their total error time would be greater even if each individual error was of a 
comparable duration to the errors made by the control group. To exclude this alternative 
explanation, I adjusted for the number of errors per rotation (square-root transformed). 
In summary, the outcome was error time (ms) and the predictors were tracing direction 
(away / towards), number of errors per rotation (square-root transformed), condition 
(direct / indirect), age at assessment, sex, childhood cognitive ability, adult 
socioeconomic position, education, handedness, and presence of a neurological or 
psychiatric condition. 
As for the speed and accuracy variables above, I tested for interactions between these 
predictors and circle-tracing condition (direct vs. indirect). I also tested for interactions 
between the predictors and error direction (detection / correction), to identify predictors 
of spending a relatively longer time on either detecting or correcting. 
 
8.3.1.1.4. Speed-accuracy trade-offs 
As discussed in the context of the Choice Reaction Time task (see Chapter 6) speed-
accuracy trade-offs can be investigated between-subject or within-subject. Between-
subject analyses address questions such as: “Which participants are most likely to trade 
speed for accuracy?” or “Which participants tend to perform well on both speed and 
201 
 
accuracy?”. These questions are relevant to my hypotheses about whether this task can 
identify participants who may show evidence of subtle cognitive decline, as differences 
may become apparent when considering speed and accuracy together, rather than as 
separate outcomes. Within-subjects analyses address questions such as “Are quick 
responses more quickly to be inaccurate?” which was of interest in the Choice Reaction 
Time task, but are not appropriate in the context of these circle-tracing and serial 
subtraction tasks, since we do not have information on the timing of individual errors 
within the circle-tracing task, nor the latency of individual subtraction responses. 
Therefore within-subjects speed-accuracy trade-offs were not investigated. 
To address the between-subjects questions for the circle-tracing task, each participant’s 
mean number of rotations was compared to their mean number of errors per rotation 
using Pearson’s correlation. Initially I did this separately for the direct and indirect 
conditions, to examine whether the pattern of speed-accuracy trade-offs differed 
between the two. As patterns of trade-offs were similar across both (see section 
8.3.2.1.4) I calculated each participant’s average speed and accuracy combined across 
both conditions, to more easily assess overall differences between individuals. I did this 
by averaging the means for the direct and indirect conditions, rather than simply 
averaging across all the trials – this was to avoid an unfair outcome for the participants 
who had one or more trials excluded (n=36, see section 8.2.5.1). For example, if a 
participant was missing an indirect trial, a simple average of their scores would be 
weighed towards direct trials (known to be easier) and the average score would look 
better than it should.  
As speed logically precedes accuracy, I wanted to investigate whether any of the effects 
on accuracy investigated in the primary analyses (section 8.3.1.1.1) could be explained 
by speed-accuracy trade-offs. It is possible that having a higher-than-expected error rate 
(higher than predicted at a given speed) may be a more sensitive indicator of visuomotor 
integration problems than having a high error rate per se. A linear regression model was 
fitted with an outcome of mean number of errors per rotation (square-root transformed) 
and predictors of mean number of rotations (log-transformed), age at assessment, sex, 
childhood cognitive ability, adult socioeconomic position, education and presence of 
neurological or psychiatric condition (yes / no). Robust standard errors were used 
because of heteroscedasticity in the data (the variance in error rate is not constant across 





8.3.1.1.5. Comparison of Dual and Single Task  
In order to compare tracing speed in the dual and single tasks, I calculated each 
participant’s “dual-task cost” in terms of tracing speed (number of rotations). Dual-task 
cost was defined as: 
(mean single-task speed – mean dual-task speed) / mean single-task speed  
For example, a dual-task cost of 0.4 would mean that tracing speed in the dual task was 
40% slower than in the single task. As explained in section 8.2.5.1.1, only the data from 
trials 4, 6, 7 and 8 were used. A regression model was fitted with an outcome of dual-
task cost and predictors of age at assessment, sex, childhood cognitive ability, adult 
socioeconomic position, education, handedness and presence of a neurological or 
psychiatric condition.  
Dual-task cost for error rate was not calculated, since accuracy was actually higher on 
the dual task due to a speed-accuracy trade-off (see section 8.3.2.1.5).  
 
8.3.1.2. Serial Subtraction 
 
8.3.1.2.1. Speed and accuracy 
A regression model was fitted for subtraction rate using GEE assuming a normal 
distribution for the dependent variable and an identity link (as with standard linear 
regression), but including an exchangeable correlation structure and robust standard 
errors to allow for the correlation between repeated measures of the same participant.  
Subtraction error rate was analysed using a GEE logistic regression model with an 
independent correlation structure and robust standard errors. The outcome was the 
number of incorrect subtractions responses on each trial, which was treated as a 
proportion of the total number of subtraction responses on each trial. Results are 
expressed as odds ratios for ease of interpretation. 
Predictors in the models were condition (direct / indirect), age at assessment, sex, 
childhood cognitive ability, adult socioeconomic position, education, handedness and 
presence of a neurological or psychiatric condition (yes / no). 
 
8.3.1.2.2. Relationship between speed and accuracy  
Each participant’s mean subtraction rate was compared to their overall error rate using 
Spearman’s correlation. Mean subtraction rate was calculated by averaging the 
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subtraction rate across all trials. If the same approach were used for calculating mean 
error rate, this would mean that errors committed on trials where subtraction was slower 
would be weighted more heavily than errors committed on trials where subtraction was 
faster; to avoid this, error rate was calculated as the total number of incorrect responses 
summed across all trials, divided by the total number of responses summed across all 
trials. 
 
8.3.1.2.3. Practice effects 
Practice effects on subtraction rate and accuracy were investigated by rerunning the 





Descriptive statistics for the circle-tracing and serial subtraction outcome variables are 
provided in Table 8-2.  
  
Table 8-2. Descriptive statistics for circle-tracing and serial subtraction 
outcomes in the dual task  
    Median Interquartile range Range 
Tracing speed (number of 




                  Direct 5.73 3.93 – 8.25 0.59 – 50.63 
                  Indirect 3.09 2.09 – 4.46 0.37 – 36.52 
Tracing accuracy (number 
of errors per rotation)  
 
 
                  Direct 0.59 0.20 – 1.16 0 – 10.27 
                  Indirect 0.84 0.27 – 1.80 0 – 24.04 
Error time per rotation (ms)  
 
 
      Error detection    
                  Direct 85 19 - 201 0 – 5682 
                  Indirect 149 23 - 413 0 – 13174 
      Error correction    
                  Direct 94 22 - 205 0 – 5556 
                  Indirect 149 25 - 399 0 – 9654 
Subtraction rate (responses 
per second)  
 
 
                  Direct 0.51 0.38 – 0.64 0.04 – 1.22 
                  Indirect 0.47 0.36 – 0.58 0.07 – 1.04 
Subtraction error rate (%)  
 
 
                  Direct 0 0 – 3.13 0 – 77.78 







8.3.2.1.1. Speed and accuracy 
Results of the multivariable regression models for speed and accuracy are reported in 
Table 8-3, along with results of interaction tests between each predictor and tracing 






Table 8-3. Associations between demographic and life-course predictors and 




Speed (number of 
rotations) a: 
coefficient and 95% CIs 
 Accuracy (number of errors 
per rotation) 
(square-root transformed) b: 
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Coefficients in bold are significant at p < 0.05 and asterisks indicate significance at p < 0.01. 
Multivariable regression models were used so each association is independent of all others.  
 a For the circle-tracing speed outcome, as the data were log-transformed, the coefficients are 
quoted in exponentiated form for ease of interpretation; for example, a coefficient of 1.5 would 
mean that the factor was associated with 50% faster tracing. b The coefficients for the square-
root transformed error rate are not easily interpretable as a back-transformation would not be 
meaningful. c See section 3.2.4 for definition of categories. d See section 3.2.3 for definitions. 




As expected, the indirect condition was associated with slower tracing than the direct 
condition (54% fewer rotations in the adjusted model) and poorer accuracy (Table 8-2, 
Table 8-3). 
On average, males traced slightly faster and made slightly more errors, but these 
differences were not statistically significant (Table 8-3).  
There was a significant main effect of age on speed and accuracy, with older participants 
tracing faster (15% more rotations per year of older age) (Table 8-3) but making more 
errors (Table 8-3).  
Higher educational attainment was not associated with speed but was associated with 
fewer errors per rotation (Table 8-3). 
Childhood cognitive ability and adult socioeconomic position were not associated with 
speed or accuracy (Table 8-3).  
Participants with neurological and psychiatric conditions did not differ from cognitively-
normal participants in terms of tracing speed but they made more errors per rotation 
(Table 8-3) (unadjusted untransformed means: cognitively-normal participants = 0.79 
errors per rotation, participants with neurological and psychiatric conditions = 1.02 errors 
per rotation).  
There was no evidence of a statistically significant difference between left and right-
handed participants in terms of their overall speed and accuracy, but there was an 
interaction between handedness and circle-tracing condition such that left-handed 






Figure 8-7. Number of errors in the direct and indirect conditions of the circle-
tracing task, by handedness 
There were 438 right-handed and 45 left-handed participants. Markers show the predicted means 
from the multivariate regression model and error bars show the 95% confidence intervals. The 
model included adjustment for tracing direction (away / towards), condition (direct / indirect), 
number of errors per rotation, age at assessment, sex, childhood cognitive ability, adult 
socioeconomic position, education, handedness, and presence of a neurological or psychiatric 
condition. 
 
Apart from handedness, there was no evidence of interactions between any other 
predictors and circle-tracing condition, so the detrimental effect of the indirect condition 
on speed and accuracy appeared to be fairly universal.  
 
 
8.3.2.1.2. Practice Effects 
Practice effects on speed and accuracy across the dual-task trials have already been 
described for the sub-sample of participants who completed the single task (section 
8.2.5.1.1). The analyses were repeated for the full sample of 483 participants and the 
same pattern of effects was observed, so results are not reported again but their 
implications are briefly discussed below.  
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The finding of practice effects on speed (speed improved in successive trials within the 
direct and indirect conditions) could affect the comparison between the direct and indirect 
conditions. Although the indirect condition was associated with substantially slower 
tracing (section 8.3.2.1.1), the true effect of indirect visual feedback could be 
underestimated in this study as the indirect trials had a higher average position in the 
trial order so would theoretically benefit more from practice effects.  
 
 
8.3.2.1.3. Error detection time versus error correction time 
As all analyses of error time controlled for the number of errors per rotation, the outcome 
is an index of how quickly participants detected and corrected errors, rather than just a 
correlate of how many errors were made.  
As expected, error time was longer in the indirect condition than the direct condition 
(regression coefficient = 1.22 (ms, square-root transformed), 95% CIs 0.90 to 1.55, p < 
0.0001). While there was no overall difference in time spent on error detection compared 
to correction (regression coefficient = 0.03, 95% CIs -0.06 to 0.12, p = 0.52), there was 
an interaction between condition and error direction (regression coefficient = 0.29, 95% 
CIs 0.12 to 0.47, p = 0.001). This interaction arose from opposite profiles being observed 
in the direct and indirect conditions: in the indirect condition participants spent a little 
more time on detection than correction, which is consistent with a previous study (Say et 
al., 2011), whereas in the direct condition there was a small difference in the opposite 
direction (error correction taking longer than detection) (Table 8-2, Table 8-4). Previous 
studies have reported no difference between detection and correction time in the direct 
condition (Lemay et al., 2005; Say et al., 2011). 
In light of this, the effects of each predictor on error time were analysed in the direct and 
indirect conditions separately and are reported in Table 8-4, along with results of 




Table 8-4. Associations between demographic and life-course predictors and 
circle-tracing error time (n = 483) 
 Coefficients and 95% confidence intervals 
(milliseconds, square-root transformed) 
 
Predictor 



























































































































Coefficients in bold are significant at p < 0.05 and asterisks indicate significance at p < 0.01. 
Multivariable regression models were used so each association is independent of all others. In 
addition to the predictors listed, models were additionally adjusted for number of errors per 
rotation (square-root transformed). The units of the coefficients are not easily interpretable as a 
back-transformation would not be meaningful. a See section 3.2.4 for definition of categories. b 
See section 3.2.3 for definitions.  
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There was no evidence of sex differences in error time in the direct condition but males 
had a shorter error time per rotation in the indirect condition (Table 8-4, Figure 8-8) 
suggesting that they were able to detect and correct errors slightly more quickly. There 
was no evidence of sex differences in the relative times spent on detection and correction 
in either condition (Table 8-4, Figure 8-8). 
 
 
Figure 8-8. Error detection and error correction time of males and females on the 
direct and indirect condition of the circle-tracing task  
Markers show the predicted means from the multivariate regression model and error bars show 
the 95% confidence intervals. The model included adjustment for tracing direction (away / 
towards), condition (direct / indirect), number of errors per rotation, age at assessment, sex, 
childhood cognitive ability, adult socioeconomic position, education, handedness, and presence 
of a neurological or psychiatric condition. Error time is the total time spent tracing outside the 
annulus during a 45 second trial, split into error detection (tracing away from the annulus) and 
error correction (tracing back towards the annulus). 
 
Age was not associated with error time in either condition and there was no evidence of 
age effects on the relative times spent on error detection and correction in either 
condition (Table 8-4). This indicates that, although older participants tended to make 
more errors per rotation (see section 8.3.2.1.1), they did not differ in terms of the time 
required to detect and correct errors on average.  
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Childhood cognitive ability was not associated with error time in the direct condition but 
higher childhood cognitive ability predicted shorter error time in the indirect condition 
(Table 8-4). In the direct condition, there was no evidence of an interaction between 
childhood cognitive ability and error direction, so the tendency to spend slightly longer 
on error correction in the direct condition applied across the range of childhood cognitive 
abilities (Table 8-4, Figure 8-9). However, in the indirect condition, there was an 
interaction between childhood cognitive ability and error direction such that with 
increasing childhood cognitive ability, error detection and correction times were more 
similar i.e. the tendency to spend longer on error detection was reduced (Table 8-4, 
Figure 8-9). Overall these results suggest that, although participants with higher 
childhood cognitive ability did not make fewer errors overall (see 8.3.2.1.1), they were 
able to detect and correct their errors more quickly in the indirect condition, with a 
particular advantage in the time taken to detect errors.  
  
Figure 8-9. Difference between error detection time and error correction time 
across the range of childhood cognitive abilities, for the direct and indirect 
conditions of the circle-tracing task 
Solid lines represent predictions from the multivariate regression models, holding all other 
predictors at average values, and shaded areas represent 95% confidence intervals. y=0 
represents no difference between error detection and correction. Positive values of y indicate 
spending longer on detection than correction. Negative values of y indicated spending longer on 
correction than detection. The model included adjustment for tracing direction (away / towards), 
condition (direct / indirect), number of errors per rotation, age at assessment, sex, adult 
socioeconomic position, education, handedness, and presence of a neurological or psychiatric 




Education and adult socioeconomic position were not associated with error time in either 
condition and there was no evidence of these variables being associated with differences 
in the relative times spent on error detection and correction (Table 8-4). 
Compared to cognitively-normal participants, participants with neurological and 
psychiatric conditions had a greater error time in both conditions, but these differences 
were not statistically significant (Table 8-4). They followed the same pattern as 
cognitively-normal participants in terms of the relative times spent on detection and 
correction in each condition, as there was no evidence of interactions between error 
direction and presence of a neurological or psychiatric condition (Table 8-4). 
Handedness was not associated with error time in either condition and there was no 
evidence of differences between right-handed and left-handed participants in terms of 
the relative times spent on error detection and correction in either condition (Table 8-4). 
This indicates that, although left-handed participants tended to make more errors in the 
indirect condition (see 8.3.2.1.1), they did not differ in terms of the time required to detect 
and correct errors on average.   
 
 
8.3.2.1.4. Speed-accuracy trade-offs 
Speed-accuracy trade-offs were initially examined in the direct and indirect conditions 
separately. Figure 8-10 shows that a trade-off was observed in both conditions i.e. faster 
tracing was associated with a higher number of errors per rotation (Direct: Pearson’s r = 




Figure 8-10. Speed-accuracy trade-offs in the direct and indirect conditions of the 
circle-tracing task 
Each participant has one point plotted for each condition, showing their mean speed and mean 
error rate. Transparent markers have been used so that the density is visible where there are 
markers on top of each other. Solid lines indicate lines of best fit. 
 
 
Examination of the residual error rates (vertical distance to the line of best fit in Figure 
8-10) revealed that participants were fairly consistent between the two conditions in 
terms of how far their error rate deviated from that which would be predicted given their 
speed (Figure 8-11). This is consistent with results reported above, where there was no 
evidence that any particular groups of participants (according to sex, age, education etc.) 
performed disproportionately worse in the indirect condition (section 8.3.2.1.1). 
Therefore, I decided that averaging each participant’s performance across the two 
conditions was justified as a way of examining overall between-subject differences in the 




Figure 8-11. Residual error rate in the direct condition against residual error rate 
in the indirect condition of the circle-tracing task 
Residual error rate was calculated from a linear regression of mean speed against mean error 
rate (see Figure 8-10). A positive residual indicates that the participant made more errors than 
would be predicted from their mean speed. Residual error rates in the direct and indirect 
conditions were correlated (Pearson’s r = 0.41, p < 0.0001). Transparent markers have been used 
so that the density is visible where there are markers on top of each other. 
 
 
Figure 8-12 shows the speed-accuracy trade-off across the direct and indirect conditions 
combined. The correlation appears relatively weak among participants who traced more 
slowly, but it is evident that none of the fastest-tracing participants managed to maintain 




Figure 8-12. Speed-accuracy trade-offs combined across the direct and indirect 
conditions of the circle-tracing task 
Each participant has one point plotted, showing their mean speed and mean error rate. Solid 
line indicates predictions from the multivariate model adjusted for sex, age at assessment, 
childhood cognitive ability, education, adult socioeconomic position, handedness, and presence 
of a neurological or psychiatric condition. Shaded areas represent 95% confidence intervals. 
 
In the earlier analysis of circle-tracing accuracy, which did not account for tracing speed, 
predictors of higher error rate were lower education, older age at assessment, and 
presence of a neurological or psychiatric condition (section 8.3.2.1.1). Results of the 
regression model for error rate accounting for speed revealed that participants with 
neurological or psychiatric conditions still had higher error rates at a given speed 
(regression coefficient = 0.22 (number of errors per rotation, square-root transformed), 
95% CIs 0.04 to 0.41, p = 0.019) and higher educational attainment was still associated 
with lower error rates at a given speed (regression coefficient = -0.03, 95% CIs -0.06 to 
-0.00, p = 0.035). However, the effect of age was much reduced and was no longer 
statistically significant, suggesting that the higher error rates of older participants can be 
explained by their faster tracing speed (regression coefficient = 0.03, 95% CIs -0.01 to 
0.08, p = 0.15).  
Sex, childhood cognitive ability, adult socioeconomic position and handedness were not 




8.3.2.1.5. Comparison of Dual and Single Task  
In the sub-sample of 199 participants who completed both the dual and single tasks, the 
mean dual-task cost to circle-tracing speed was 0.24 (i.e. 24% fewer rotations on 
average in the dual task, compared to the single task). 13% of participants had a negative 
“dual-task cost”, meaning that they traced more slowly in the single task than the dual 
task (Figure 8-13). 
 
 
Figure 8-13. Dual-task cost to circle-tracing speed 
Dual-task cost is a measure of the extent to which tracing was slower in the dual task compared 
to the single task (for full definition see section 8.3.2.1.5). 
 
Dual-task cost to circle-tracing speed did not show any statistically significant 
associations with sex, age at assessment, education, adult socioeconomic position, 
handedness or presence of a neurological or psychiatric condition (Table 8-5). There 
was a trend towards an association between higher childhood cognitive ability and 
smaller dual-task cost, suggesting that participants with higher childhood cognitive ability 




Table 8-5. Associations between demographic and life-course predictors and 
dual-task cost (n =208) 
Predictor 
Coefficient 
(95% confidence interval) 
p 
Sex  
(female as reference category) 
0.03 (-0.04, 0.11) 0.41 
Age at assessment (per year) 0.05 (-0.08, 0.18) 0.44 
Childhood cognitive ability  
(per z-score) 
-0.06 (-0.12, 0.00) 0.06 
Education (per category) a 0.02 (-0.02, 0.05) 0.33 
Adult socioeconomic position 
(per category) a 
0.01 (-0.03, 0.05) 0.65 
Neurological or psychiatric 
condition b 
(cognitively-normal as reference 
category) 
-0.08 (-0.22, 0.06) 0.27 
Handedness 
(right-handed as reference category) 
0.05 (-0.07, 0.17) 0.43 
 
Multivariable regression models were used so each association is independent of all others.  
a See section 3.2.4 for definition of categories. b See section 3.2.3 for definitions. 
 
Dual-task cost to circle-tracing accuracy was not calculated, since error rate was 
actually slightly higher on the single task on average (mean errors per rotation: single = 
1.08; dual = 0.99), with 53% of participants having a higher mean error rate in the 
single task than the dual task.  
 
 
8.3.2.2. Serial subtraction 
 
8.3.2.2.1. Speed and accuracy 
Results of the multivariable regression models for speed and accuracy are reported in 
Table 8-6, along with results of interaction tests between each predictor and circle-tracing 




Table 8-6. Associations between demographic and life-course predictors and 





coefficient (responses per 
second) and 95% CIs 
 Odds ratio for making a 

























































































































Coefficients and Odds Ratios in bold are significant at p < 0.05 and asterisks indicate significance 
at p < 0.01. Multivariable regression models were used so each association is independent of all 
others. a See section 3.2.4 for definition of categories. b See section 3.2.3 for definitions 
 




Participants subtracted more slowly when the concurrent circle-tracing task was in the 
indirect condition (indirect visual feedback) compared to direct condition (Table 8-2, 
Table 8-6). The effect size was small, equivalent to 1.8 fewer responses on average over 
the 45-second period. On average, participants made slightly more subtraction errors 
during the indirect condition of the circle-tracing task, compared to the direct condition, 
but this difference was not statistically significant (p = 0.08) (Table 8-2, Table 8-6).  
Predictors of faster and more accurate subtraction were male sex, higher childhood 
cognitive ability, higher educational attainment, and absence of a neurological or 
psychiatric condition (Table 8-6). The mean values for males and females were as 
follows: females = 0.45 responses per second, 3.5% error rate; males = 0.55 responses 
per second, 2.2% error rate.  
For subtraction accuracy, these effects appeared to apply equally in both the direct and 
indirect conditions of the concurrent circle-tracing task, as there was no evidence of 
interactions between the predictors and circle-tracing condition (Table 8-6). For 
subtraction rate, there were interactions with circle-tracing condition whereby the effects 
of sex, childhood cognitive ability and education were slightly reduced in the indirect 
condition compared to the direct condition (Table 8-6). This suggests that participants 
were on a more equal footing in terms of their subtraction speed when they were doing 
the more difficult concurrent task (indirect circle-tracing). However the detrimental effect 
of neurological or psychiatric conditions on subtraction rate (equivalent to 3.6 fewer 
responses over the 45-second period) was not reduced in the indirect condition (Table 
8-6).  
There was an interaction between handedness and circle-tracing condition such that left-
handed participants subtracted disproportionately slowly in the indirect condition (Table 
8-6, Figure 8-14). This mirrors the earlier finding that left-handed participants traced 
disproportionately less accurately in the indirect condition, which I believe was due to the 
set-up of the equipment being less convenient for them (see section 8.3.2.1.1). This 
provides further evidence that subtraction tended to be slower when the circle-tracing 
was more difficult, whether because the visual feedback was indirect or because of some 
other problem. 
Age at assessment and adult socioeconomic position were not associated with 







Figure 8-14. Subtraction rate of right-handed (n = 438) and left-handed (n = 45) 
participants in the direct and indirect conditions of the concurrent circle-tracing 
task 
Markers show the predicted means from the multivariate regression model and error bars show 
the 95% confidence intervals. The model included adjustment for age at assessment, sex, 
childhood cognitive ability, adult socioeconomic position, education, and presence of a 
neurological or psychiatric condition. 
 
 
8.3.2.2.2. Relationship between speed and accuracy  
Faster subtraction rate was associated with lower error rate (Spearman’s ρ = -0.51, p < 
0.0001) i.e. the opposite of a speed-accuracy trade-off (Figure 8-15). The relationship is 
non-linear due to a ceiling effect on subtraction accuracy. It is evident that all of the 
fastest-subtracting participants also achieved low error rates, whereas participants who 




Figure 8-15. Speed against accuracy on the serial subtraction task 
Each participant has one point plotted, showing their mean subtraction rate (an index of speed) 
and mean error rate across the six subtraction trials. Transparent markers have been used so 




8.3.2.2.3. Practice effects 
Trial-by-trial performance on serial subtraction is shown in Figure 8-16. There was 
evidence of a small practice effect on subtraction rate, equivalent to an improvement of 
0.006 responses per second on each successive trial (95% CIs 0.005 to 0.008, p < 
0.0001). Therefore the finding that subtraction was slower when the concurrent circle-
tracing task had indirect visual feedback 8.3.2.2.1 could be an underestimate of the true 
effect, as the indirect trials had a higher average position in the trial order so would 
theoretically benefit more from practice effects.  
There was a slight improvement in subtraction accuracy on successive trials but this was 
not statistically significant (OR for making an error per successive trial = 0.97, 95% CIs 





























Figure 8-16. Means and 95% confidence intervals for subtraction speed and 
accuracy on each trial  








8.4. Associations with biomarkers and APOE-ε4 
 
Following the format laid out in section 3.5, the second part of this chapter aims to 
investigate associations between performance and biomarkers of AD in cognitively-
normal participants for whom complete biomarker data are available. The number 
meeting these criteria who also had usable data from the circle-tracing task was 392 for 
the dual task and 165 for the single task. 
As explained in section 3.5.2.1, I wanted to derive some summary scores to capture the 
key aspects of performance on this task. In the Choice RT, Response Inhibition and 
“”What was where?” tasks (see Chapters 5 to 7), it was appropriate to create summary 
outcomes by averaging responses across all trials (mean RT, overall identification rate 
etc.) because, although performance levels did vary according to the conditions of the 
task (e.g. in the Choice RT task, RT tended to be faster for words rather than arrows), 
the magnitude of these differences were small. By contrast, in the circle-tracing task, the 
magnitude of differences in performance between the direct and indirect conditions was 
large, with speed differing by approximately a factor of two. Therefore, while a simple 
average would still be valid as a way of comparing participants’ tracing speed, it would 
have limited meaning as a representation of typical performance. Also, there is a 
theoretical reason to focus on the difference in performance between the two conditions 
(which would be masked by a simple average), because the outcome that was sensitive 
to early changes in Huntington’s disease was the interaction between tracing condition 
and clinical group (Huntington’s gene carriers were disproportionately disadvantaged in 
the indirect condition (Say et al., 2011)). Therefore, I decided to investigate the 
associations between biomarkers and circle-tracing outcomes using the trial-by-trial data 
as I did in the previous section (8.3), and then to use these results to inform the selection 
of the most promising summary scores.  
I focused on the speed and accuracy variables, rather than the error time variable, 
because speed and accuracy are the main dimension of the task and exploring the error 
time variable was more a way of understanding the nature of errors. I also investigated 
dual-task cost because deficits in dual-tasking have been reported in presymptomatic 
FAD mutation carriers at a stage when their episodic memory was unimpaired 
(MacPherson et al., 2012), so it has potential as a marker of subtle cognitive change 








8.4.1.1.1. Speed and accuracy  
GEE regression models were fitted as above for tracing speed and accuracy (see section 
8.3.1.1.1) including predictors of amyloid status, whole brain volume, WMHV and APOE 
genotype. I tested for interactions between these factors and circle-tracing condition. As 
in previous chapters, total intracranial volume was included to adjust for the correlation 
between whole brain volume and head size, as were the demographic factors 
investigated in section 8.3 (sex, age at assessment, childhood cognitive ability, education 
and adult socioeconomic position).  
The models were additionally rerun replacing dichotomised amyloid status with SUVR to 
test whether increasing Aβ deposition was associated with differences in performance. 
To check whether associations between SUVR and cognition were sensitive to the 
inclusion of the imputed SUVR values (see section 3.2.2), the analyses were rerun 
excluding the 26 participants with imputed SUVR data. 
 
8.4.1.1.2. Comparison of Dual and Single Task  
A regression model was fitted with an outcome of “dual-task cost” as above (see section 
8.3.1.1.5) including predictors of amyloid status, whole brain volume, WMHV and APOE 
genotype. As above, total intracranial volume was included to adjust for the correlation 
between whole brain volume and head size, as were the demographic factors 
investigated in section 8.3 (sex, age at assessment, childhood cognitive ability, education 
and adult socioeconomic position). The model was additionally rerun replacing 
dichotomised amyloid status with SUVR, and a sensitivity analysis was run excluding the 
26 participants with imputed SUVR data. 
 
 
8.4.1.2. Serial subtraction 
 
GEE regression models were fitted as above for tracing speed and accuracy (see section 
8.3.1.2.1) including additional factors of amyloid status, whole brain volume, WMHV and 
APOE genotype, and tested for interactions between these factors and circle-tracing 
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condition. As in previous chapters, total intracranial volume was included as to adjust for 
the correlation between whole brain volume and head size, as were the demographic 
factors investigated in section 8.3 (sex, age at assessment, childhood cognitive ability, 
education and adult socioeconomic position). 
The model was additionally rerun replacing dichotomised amyloid status with SUVR, and 





8.4.2.1.1. Speed and accuracy 
Results of the multivariable regression models for speed and accuracy are reported in 
Table 8-7, along with results of interaction tests between each predictor and tracing 
condition (direct vs. indirect). As these regression models used log-transformed and 
square-root transformed data, descriptive statistics on the untransformed data for Aβ+ 
and Aβ- participants are provided in Table 8-8 to aid interpretation of the results. Results 
for the demographic and life-course factors (sex, age at assessment, childhood cognitive 
ability, education and adult socioeconomic position) are not reported as they are 




Table 8-7. Associations between biomarkers and circle-tracing speed and 




Speed (number of 
rotations) a: 
coefficient and 95% CIs 
 Accuracy (number of errors 
per rotation) 
(square-root transformed) b: 




































































Multivariable regression models were used so each association is independent of all others. In 
addition to the predictors listed, models also included sex, age at assessment, childhood cognitive 
ability, adult socioeconomic position, handedness and total intracranial volume. 
Coefficients in bold are significant at p < 0.05 and asterisks indicate significance at p < 0.01.  
a For the circle-tracing speed outcome, as the data were log-transformed, the coefficients are 
quoted in exponentiated form for ease of interpretation; for example, a coefficient of 1.5 would 
mean that the factor was associated with 50% faster tracing. b The coefficients for the square-root 
transformed error rate are not easily interpretable as a back-transformation would not be 
meaningful.  






Table 8-8. Descriptive statistics for circle-tracing speed and accuracy, by 
amyloid status 
Outcome variable 
mean, median, (range) 
amyloid positive (n = 72) amyloid negative (n = 320) 
Speed (number of 
rotations) 
  
Direct condition 6.8, 5.7, (1.0 to 31.7) 6.7, 5.6, (0.6 to 44.1) 
Indirect condition 3.8, 3.1, (0.8 to 15.7) 3.6, 3.1, (0.4 to 33.1) 
Accuracy (number 
of errors per 
rotation) 
  
Direct condition 0.7, 0.5, (0 to 5.5) 0.7, 0.6, (0 to 9.6) 
Indirect condition 1.4, 1.2, (0 to 9.2) 1.1, 0.7, (0 to 12.2) 
 
 
There were no statistically significant differences between Aβ+ and Aβ- participants in 
terms of their overall accuracy, but the detrimental effect of the indirect condition was 
greater in Aβ+ participants (Table 8-7, Figure 8-17). As a post-hoc exploration of this 
interaction, the models were rerun in the direct and indirect conditions separately. In the 
direct condition alone, the difference between Aβ+ and Aβ- participants was minimal and 
not statistically significant (regression coefficient = 0.01 errors per rotation (square-root 
transformed), 95% CIs -0.10 to 0.11, p = 0.92), but in the indirect condition Aβ+ 
participants made significantly more errors (regression coefficient = 0.18, 95% CIs 0.05 
to 0.31, p = 0.008).  
When rerunning the models replacing dichotomous amyloid status with continuous 
SUVR, the same pattern emerged, as SUVR did not have a statistically significant 
association with error rate (regression coefficient = 0.50 errors per rotation (square-root 
transformed), 95% CIs –0.06 to 1.06, p = 0.08) but there was evidence of an interaction 
between higher SUVR and circle-tracing condition, with higher SUVR predicting 
disproportionately poorer accuracy in the indirect condition (regression coefficient = 0.88, 
95% CIs 0.22 to 1.54, p = 0.009). These results were unchanged in a sensitivity analysis 
excluding the individuals with imputed SUVR values (see section 3.2.2). 
Overall these results suggest that Aβ deposition was associated with greater difficulty in 
tracing accurately with indirect visual feedback, consistent with subtle deficits in 
visuomotor integration.  
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In terms of tracing speed, there was no statistically significant difference between Aβ+ 
and Aβ- participants, nor a statistically significant interaction between Aβ and circle-
tracing condition (Table 8-7).  
When rerunning the models replacing dichotomous amyloid status with continuous 
SUVR, there was no evidence of an association between SUVR and tracing speed 
(regression coefficient = 1.25, 95% CIs 0.50 to 3.09, p = 0.63) and there was no 
statistically significant interaction between SUVR and circle-tracing condition (regression 
coefficient = 1.26, 95% CIs 0.96 to 1.67, p = 0.10). These results were unchanged in a 




Figure 8-17. Tracing accuracy in the direct and indirect conditions of the circle-
tracing task, by amyloid status 
Markers show the predicted means from the multivariate regression model and error bars show 
the 95% confidence intervals. The model included adjustment for sex, age at assessment, 
childhood cognitive ability, adult socioeconomic position, education, handedness, white matter 





Larger whole brain volume was associated with faster tracing, equivalent to 2% more 
rotations per 10ml (Table 8-7, Figure 8-18). There was no evidence that this effect 
differed between the direct and indirect conditions (Table 8-7). There was no evidence 
of any relationship between whole brain volume and tracing accuracy (Table 8-7). 
 
 
Figure 8-18. Association between whole brain volume and circle-tracing speed 
Solid line represents prediction from the multivariate regression model, holding all other predictors 
at average values, and shaded area represents 95% confidence intervals. The model included 
adjustment for age at assessment, sex, adult socioeconomic position, education, handedness, 
amyloid status, white matter hyperintensity volume, APOE-ε4 genotype and total intracranial 
volume. Markers show each participant’s mean speed combined across the direct and indirect 
conditions. TIV = total intracranial volume. 
 
There was a trend towards an association between greater WMHV and slower tracing (p 
= 0.07), but no evidence that this effect differed between the direct and indirect conditions 
(Table 8-7). For tracing accuracy, there was no overall association with WMHV but there 
was evidence of an interaction between WMHV and circle-tracing condition, such that 
greater WMHV was associated with disproportionately poorer accuracy in the indirect 
condition (Table 8-7). As a post hoc exploration of this interaction, the models were rerun 
in the direct and indirect conditions separately, and WMHV was not associated with 
tracing accuracy in either condition alone (Direct: regression coefficient = -0.02 errors 
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per rotation (square-root transformed) per 10 ml, 95% CIs -0.10 to 0.06, p = 0.68; 
Indirect: regression coefficient = 0.07, 95% CIs -0.02 to 0.17, p = 0.13). 
APOE-ε4 was not associated with any circle-tracing outcomes (adjusting for amyloid 
status and all other covariates) (Table 8-7). 
 
  
8.4.2.1.2. Comparison of Dual and Single Task  
Larger whole brain volume was associated with smaller dual-task cost (regression 
coefficient = -0.01 per 10 ml, 95% CIs -0.02 to -0.00, p = 0.023), meaning that participants 
with larger brain volumes tended to be less influenced (slowed) in their tracing speed by 
the concurrent subtraction task (Figure 8-19). The units represent proportional decrease 
in speed in the dual task compared to the single task (see 8.3.1.1.5) so the regression 
coefficient is equivalent to a reduction of 1 percentage point for every additional 10ml of 
brain volume. 
Amyloid status, WMHV and APOE-ε4 genotype showed no evidence of associations with 
dual-task cost. When the models were rerun replacing amyloid status with SUVR, it also 
showed no association with dual-task cost, and this was unchanged when excluding the 
participants with imputed SUVR values. 
Results for the demographic and life-course factors (sex, age at assessment, childhood 
cognitive ability, education and adult socioeconomic position) are not reported as they 





Figure 8-19. Association between whole brain volume and dual-task cost to 
circle-tracing speed 
Solid line represents prediction from the multivariate regression model, holding all other predictors 
at average values, and shaded area represents 95% confidence intervals. The model included 
adjustment for age at assessment, sex, adult socioeconomic position, education, handedness, 
amyloid status, white matter hyperintensity volume, APOE-ε4 genotype and total intracranial 
volume. Markers show each participant’s mean dual-task cost against whole brain volume 






8.4.2.2. Serial subtraction 
 
Results of the multivariable regression models for subtraction speed and accuracy are 
given in Table 8-9. Results for the demographic and life-course factors (sex, age at 
assessment, childhood cognitive ability, education and adult socioeconomic position) are 
not reported as they are essentially unchanged from the first analysis section (8.3.2.2). 
 
 
Table 8-9. Associations between biomarkers and subtraction speed and accuracy 





coefficient (responses per 
second) and 95% CIs 
 Odds ratio for making a 




































































Multivariable regression models were used so each association is independent of all others. In 
addition to the predictors listed, models also included sex, age at assessment, childhood cognitive 
ability, adult socioeconomic position, handedness and total intracranial volume.  
Coefficients and Odds Ratios in bold are significant at p < 0.05 and asterisks indicate significance 
at p < 0.01.  




On average, Aβ+ participants subtracted more slowly than Aβ- participants (Table 8-9). 
The effect size is equivalent to 2.3 fewer responses in the 45 second period (predicted 
means: Aβ+ = 20.6 responses in 45 seconds, Aβ- = 22.9 responses in 45 seconds). 
There was no evidence that this effect differed according to whether the concurrent 
circle-tracing task was in the direct or indirect condition (Table 8-9).  
When rerunning the models replacing dichotomous amyloid status with continuous 
SUVR, the results followed the same pattern: there was an association between higher 
SUVR and slower subtraction rate (regression coefficient = -0.23, 95% CIs -0.42 to -0.04, 
p = 0.018) and no statistically significant interaction between SUVR and circle-tracing 
condition (regression coefficient = 0.03, 95% CIs -0.03 to 0.09, p = 0.38). These results 
were unchanged in a sensitivity analysis excluding the individuals with imputed SUVR 
values (see section 3.2.2). 
There was no evidence of a statistically significant difference between Aβ+ and Aβ- 
participants in subtraction error rate (unadjusted means: Aβ+ = 3.1%; Aβ- = 2.6%) (Table 
8-9). 
Larger whole brain volume was associated with slightly faster subtraction rate but was 
not associated with subtraction accuracy (Table 8-9). 
WMHV was not associated with subtraction rate or accuracy overall (Table 8-9). 
However, for subtraction accuracy there was an interaction between WMHV and circle-
tracing condition such that the tendency to make more subtraction errors in the indirect 
condition (compared to the direct condition) was reduced in participants with greater 
WMHV. As a post-hoc exploration of this interaction, the models were rerun in the direct 
and indirect conditions separately, which revealed that greater WMHV predicted a 
greater likelihood of making subtraction errors in the direct condition (OR = 1.45 per 10 
ml, 95% CIs 1.07 to 1.96, p = 0.02), but WMHV was not associated with subtraction 
accuracy in the indirect condition (OR = 1.03 per 10 ml, 95% CIs 0.78 to 1.37, p = 0.81).  
APOE-ε4 was not associated with any subtraction outcomes (adjusting for amyloid status 
and all other covariates) (Table 8-9). 
 
  
8.4.2.3. Selection of summary outcome variables 
I decided that the following two summary outcomes would be the most meaningful 
representation of the circle-tracing effects described above. They are based on the six 
dual-task trials completed by all participants. 
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Difference in error rate between indirect and direct conditions. This was defined by 
calculating each participant’s mean error rate in the direct and indirect conditions 
separately (the mean number of errors per rotation across the three trials within each 
condition) and subtracting the former from the latter. This is an index of the extent to 
which participants’ tracing accuracy was affected by the indirect visual feedback. As the 
circle-tracing task was designed to assess visuomotor integration ability, this outcome 
reflects the core demands of the task better than overall error rate, and captures the 
aspect of performance that showed a difference between Aβ+ and Aβ- participants. I 
considered whether to normalise this outcome to each participant’s performance in the 
direct condition i.e. to calculate the relative difference in error rate rather than the 
absolute difference. However, this was problematic because it would require dividing by 
zero for some participants who made no errors in the direct condition. As the error rate 
variable is already expressed per rotation, large differences between participants have 
already been eliminated and its range is relatively small (-1.58 to 9.9 errors per rotation), 
therefore I decided that the absolute difference was appropriate. 
Overall tracing speed. This was defined as the mean number of rotations across all six 
dual-task trials (combined across direct and indirect conditions). This is the same 
outcome that was used to examine speed-accuracy trade-offs (see sections 8.3.1.1.4 
and 8.3.2.1.4). I chose this outcome, rather than the difference in speed between the 
direct and indirect conditions, as it captures a wide and meaningful variation between 
individuals (range 0.6 to 35.8 rotations in 45 seconds) and is the aspect of performance 
which was associated with whole brain volume. 
For the serial subtraction task, the summary outcomes are obvious: mean subtraction 
rate (responses per second) and overall error rate, as defined earlier 8.3.1.2.2. 
These summary outcomes will be used when comparing performance across different 






This study reported the results of a circle-tracing and serial subtraction task which were 
administered concurrently. The serial subtraction task showed evidence of sex 
differences (males subtracting faster and more accurately) and relatively strong 
associations with childhood cognitive ability and educational attainment, whereas circle-
tracing performance was generally less associated with these factors. As hypothesised, 
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cognitively-normal Aβ+ individuals showed evidence of subtle deficits in visuomotor 
integration, indicated by disproportionately poorer tracing accuracy when visual 
feedback was indirect. There was also evidence of an association between Aβ pathology 
and slower subtraction rate. Speed-accuracy trade-offs were an important feature of 
circle-tracing performance. 
 
8.5.2. Patterns of performance 
 
8.5.2.1. Patterns of performance on the circle-tracing task 
Performance of Insight 46 participants on the circle-tracing task was consistent with 
previous studies in that tracing was slower and less accurate in the condition of indirect 
visual feedback compared to the direct condition. A trade-off between speed and 
accuracy was observed, with the participants who traced more quickly tending to make 
more errors per rotation. As discussed earlier in the context of the Choice Reaction Time 
task (see section 6.5.2), it is worth noting that a person may alter their speed-accuracy 
strategy during the task, which is not captured by a between-subjects analysis.  
The speed-accuracy trade-off showed a surprising relationship with age at assessment 
whereby older participants traced faster and less accurately, despite the age range being 
so narrow (2.6 years – reflecting the time taken to collect the data as all participants were 
born in the same week). There is no obvious explanation for this finding. The nature of 
the trade-off means that performance was not better or worse with age – just different. 
Age effects on this circle-tracing task have been investigated in one study which 
compared older and younger adults and found that they did not differ in their tracing 
accuracy but the older adults traced more slowly (Vaportzis, Georgiou-Karistianis and 
Stout, 2014). In another study which recruited adults aged from 21 to 95, strong 
associations were observed between older age and decreasing accuracy on a different 
circle-tracing task which involved pursuing a moving target around a circle, but speed 
was not reported (Stirling et al., 2013). As mentioned in previous chapters (4, 6 and 7) 
where “age effects” were observed, I considered the possibility of a recruitment bias 
whereby participants seen towards the beginning of the data collection period may have 
differed in some ways to those seen towards to the end. This is discussed in greater 
detail in Chapter 10. One factor of potential relevance to differences in speed-accuracy 
trade-offs is risk sensitivity, as one study has reported that risk-seeking individuals are 
more likely to prioritise speed whereas risk-averse individuals are more likely to prioritise 
accuracy on a task of motor control (Nagengast, Braun and Wolpert, 2011). 
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In the sub-sample of participants who completed two additional single-task circle-tracing 
trials (without the concurrent subtraction task), the majority traced more quickly in the 
single task compared to the dual. According to the influential multiple-component working 
memory system proposed by Baddeley (Baddeley and Hitch, 1974; Baddeley, 2000), 
healthy individuals show little interference when performing dual tasks that rely on 
different components of working memory, such as processing verbal and visuospatial 
information (e.g. (MacPherson et al., 2012)), but these results suggest that the circle-
tracing and serial subtraction tasks were competing for the same attentional and working 
memory resources. Anecdotally, I often observed participants slowing down or even 
pausing their tracing on the dual task when they were struggling to work out the next 
subtraction response. However, tracing accuracy was poorer in the single task, which is 
consistent with a previous study using the same experiment (Vaportzis, Georgiou-
Karistianis and Stout, 2014) and can be explained by speed-accuracy trade-offs. It 
appears that the influence of the subtraction task in slowing down participants’ tracing 
prevented them from adopting a fast and inaccurate tracing style, whereas when free to 
focus entirely on the circle-tracing task they could prioritise speed at the expense of 
accuracy. Limitations of this experiment for measuring dual-task abilities are discussed 
in section 8.5.5. 
 
8.5.2.2. Patterns of performance on the serial subtraction task 
There was wide variability between participants in terms of their subtraction rates, with 
the fastest participant subtracting 10 times faster than the slowest, while error rates were 
generally low. There was a correlation, rather than a trade-off, between speed and 
accuracy, with the highest error rates recorded by participants with the slowest 
subtraction rates. A possible explanation for this is that arithmetic is a task where speed 
has to be adjusted to maintain accuracy, because each response is either correct or 
incorrect, so – unless one is prepared to simply guess the answer – one has to take as 
much time as necessary to work out each answer. This explanation is consistent with 
the fact that subtraction rate – but not subtraction accuracy – was affected by the 
demands of the concurrent circle-tracing task, with slower subtraction rates while tracing 
with indirect visual feedback compared to direct visual feedback. Another piece of 
evidence in support of this idea that only subtraction rate (but not accuracy) is influenced 
by external demands is the observation that left-handed participants subtracted more 
slowly than right-handed participants in the indirect condition – where circle-tracing was 
disproportionately difficult for them – but did not perform worse than right-handed 
participants on subtraction accuracy. 
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The finding that subtraction rate was slower while tracing with indirect visual feedback is 
somewhat analogous to the concept of “dual-task cost” discussed earlier, as it could be 
explained by the fact that the indirect condition placed a greater demand on cognitive 
resources, leaving less resources available to allocate to the subtraction task. 
 
8.5.3. Demographic and life-course predictors 
 
8.5.3.1. Predictors of performance on the circle-tracing task 
Participants with neurological or psychiatric conditions traced less accurately than 
cognitively-normal participants, but the fact that this effect was observed with both direct 
and indirect visual feedback suggests that motor problems or more distributed cognitive 
deficits may have been the main contributing factors rather than a difficulty with 
integrating non-standard visual feedback. 
On the whole, the circle-tracing task was relatively free from associations with childhood 
cognitive ability, educational attainment and adult socioeconomic position, with the 
exception that higher educational attainment predicted more accurate tracing. This is 
perhaps surprising given the importance of these predictors for most cognitive tests 
including tests with a speed component such as Digit-Symbol Substitution (see Chapter 
4). One speculative explanation for this could be that the circle-tracing task relies on fine 
motor control, which is more affected by physical health factors at this age, such as 
tremors and arthritis. Although childhood cognitive ability was not associated with tracing 
speed or accuracy, analysis of error times revealed a specific effect whereby participants 
with higher childhood cognitive ability were able to detect and correct their errors more 
quickly in the condition of indirect visual feedback, with a particular advantage for error 
detection. To my knowledge, this is the first study to report associations between 
childhood cognitive ability, educational attainment and performance on a visuomotor 
integration task in older age, and this evidence provides important context for interpreting 
any decline in visuomotor integration that may be associated with accumulating brain 
pathologies.  
The finding that left-handed participants traced disproportionately less accurately in the 
indirect condition is likely to reflect a difficulty with drawing left-handed under the 
constraints of the equipment that was used to cover the tablet screen, rather than that 
left-handed participants were disproportionately disadvantaged by the indirect visual 
feedback. The fact that left-handed participants also subtracted disproportionately slowly 
in the indirect condition supports this view. The box used to cover the tablet screen was 
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rather small, so I believe that left-handed participants were more restricted in how they 
could angle their arm to draw clockwise.  
 
8.5.3.2. Predictors of performance on the serial subtraction task 
Sex differences of a moderate magnitude were observed on the subtraction task, with 
males subtracting more quickly and more accurately. A male advantage in mathematics 
has been widely reported and its basis is the subject of some controversy. While some 
argue that it may be underpinned by biological differences in visuospatial abilities, others 
have pointed to environmental and cultural factors (Halpern et al., 2007). For example, 
an analysis of quarter of a million students from 40 countries found that sex differences 
in mathematical test performance were eliminated in countries with high levels of gender 
equality (Guiso et al., 2008). Other predictors of faster and more accurate subtraction 
were higher childhood cognitive ability, higher educational attainment and absence of a 
neurological or psychiatric condition. As the subtraction task was not administered alone 
(without concurrent circle-tracing), it is not possible to determine whether these 
predictors apply to subtraction in general, or were specific to this dual-task format. This 
issue is discussed in greater detail in section 8.5.5. 
 
 
8.5.4. Associations with biomarkers and APOE-ε4 
 
8.5.4.1. Circle-tracing 
To my knowledge, this is the first study to evaluate the effects of β-amyloid pathology on 
visuomotor integration in cognitively-normal older adults. These results support the 
hypothesis that β-amyloid deposition is associated with subtle deficits in visuomotor 
integration, as Aβ+ participants had disproportionately poorer circle-tracing accuracy 
with indirect visual feedback. This mirrors the result reported in presymptomatic 
Huntington’s mutation carriers (Say et al., 2011) and builds on my previous analysis of 
the same circle-tracing task in presymptomatic FAD mutation carriers, who were an 
average of 7 years before estimated age of symptom onset (Macpherson et al., 2017). 
The mutation carriers (n = 19) traced less accurately than controls (n = 12) across the 
experiment as a whole and there was a suggestion that this effect was exaggerated in 
the indirect condition but the interaction was not statistically significant. The results are 
also consistent with previous studies that have described visuomotor integration deficits 
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in patients with AD dementia (Tippett and Sergio, 2006; Tippett, Krajewski and Sergio, 
2007; Tippett, Sergio and Black, 2012; Verheij et al., 2012; de Boer et al., 2016). 
While loss of motor control is a major symptom of Huntington’s disease, it is not a 
prominent feature of AD, particularly in the early stages where memory deficits tend to 
dominate. This result is of considerable interest in understanding more about the subtle 
cognitive decline that may accompany the accumulation of Alzheimer’s pathology during 
the preclinical stage of the disease. However, one must of course remain mindful of the 
fact that Aβ positivity does not necessarily predict progression to AD on an individual 
basis (Brookmeyer and Abdalla, 2018). 
It is interesting that the outcome that was sensitive to Aβ positivity (disproportionate 
decrease in accuracy in the indirect condition) also showed evidence of being sensitive 
to white matter disease burden. This is consistent with the sensitivity of this outcome to 
presymptomatic Huntington’s disease, as white matter damage has been documented 
as an early feature of Huntington’s disease (McColgan et al., 2017). This outcome was 
not associated with any of the demographic and life-course predictors (sex, age at 
assessment, childhood cognitive ability, education, adult socioeconomic position – with 
the exception of left-handedness which I believe was an artefact of the experimental 
design (see section 8.5.2.1)), suggesting that it may be specifically sensitive to brain 
pathology rather than general cognitive ability. 
This study did not find any evidence of an association between β-amyloid deposition and 
dual-task cost. However the measurement of dual-task cost was subject to limitations in 
the experimental design, discussed in section 8.5.5. 
The association between greater whole brain volume and faster tracing speed is 
consistent with my earlier finding of a similar association on the Digit-Symbol processing 
speed test (see Chapter 4) and the association with subtraction speed, discussed below. 
 
8.5.4.2. Serial subtraction 
I did not have prior hypotheses about associations between amyloid deposition and 
performance on the serial subtraction task, as the subtraction task was initially chosen 
as a way to examine the impact of a dual task on circle-tracing, rather than as a primary 
outcome of interest in its own right. The finding that Aβ+ participants subtracted more 
slowly is interesting but not easy to interpret because the experiment did not contain a 
measure of “pure” subtraction ability (i.e. subtraction as a single task without the 
concurrent circle-tracing task). Impaired calculation ability, or dyscalculia, is known to 
occur in AD and to have significant functional consequences (Girelli and Delazer, 2001). 
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Like visuomotor integration, it is understood to be associated with parietal damage, 
specifically the left inferior parietal lobule (Hirono et al., 1998). Research studies that 
assess calculation tend to focus on errors rather than speed (e.g. (Martin et al., 2003), 
although assessments usually have time limits so an error would be recorded if a 
response is too slow (e.g. the arithmetic sub-test of the Wechsler Adult Intelligence Scale 
– Revised (Wechsler, 1981)).  
As subtraction rate was dependent on the demands of the concurrent circle-tracing task 
(see 8.3.2.2.1 and 8.5.3.2), the slower subtraction rate of Aβ+ participants could 
potentially stem from greater interference from the concurrent circle-tracing task, rather 
than a difficulty with subtraction per se. Unfortunately, this theory cannot be tested with 
these data. Also, this subtraction task was not designed to probe differences in 
calculation ability, as subtracting in 3s is not challenging for the majority of people and 
there was a strong ceiling effect, so a more difficult test would be required to properly 
probe differences in calculation ability between Aβ+ and Aβ- individuals. 
The finding of an association between whole brain volume and subtraction rate mirrors 
its association with circle-tracing speed and information processing speed as assessed 
by the Digit-Symbol test (see Chapter 4), indicating that the effect of brain volume on 
speed applies across a range of cognitive domains and task demands – this is discussed 




There were a number of limitations to the experimental design. The most significant was 
regarding its suitability for assessing “dual-task cost” – the extent to which performance 
on a task is compromised by having to perform a second task concurrently. There was 
no measure of subtraction ability as a single task, which made it difficult to interpret the 
effects of predictors that were associated with subtraction rate and accuracy, since it was 
impossible to know the extent to which the dual-task aspect was driving performance, 
rather than the core demands of the subtraction task. Less than half of participants had 
a measure of circle-tracing ability as a single task, as this part of the protocol was added 
later. However, the size of this sub-sample (n=208) was still large in comparison to most 
neuropsychological studies. The more potentially limiting issue was the fixed order and 
unequal numbers of the trials (6 dual-task trials, followed by 2 single-task trials), coupled 
with the complex practice effects, which made it difficult to decide how best to compare 
the dual and single tasks. Ideally there would be five conditions with equal numbers of 
trials administered in a randomised order: circle-tracing with direct visual feedback; 
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circle-tracing with indirect visual feedback; serial subtraction; circle-tracing with direct 
visual feedback plus serial subtraction; circle-tracing with indirect visual feedback plus 
serial subtraction.  
Although the circle-tracing task has been administered in a dual-task format before 
(Vaportzis, Georgiou-Karistianis and Stout, 2014; Vaportzis et al., 2015b), it is not a 
straight-forward choice for measuring dual-tasking ability as it is hard to define optimum 
performance on the task, since speed and accuracy are in competition with each other. 
If participants adopt a different balance of speed and accuracy on the dual and single 
tasks, this can result in a negative dual-task cost on either outcome alone, as observed 
in this study. To probe dual-tasking ability more easily, it may be better to use a task less 
susceptible to speed-accuracy trade-offs, such as a tracking task (Della Sala et al., 2010; 
MacPherson et al., 2012) or a simple reaction time task (Logie et al., 2007).  
Another limitation of the analyses is that mild motor symptoms such as action tremor 
were not controlled for. While I do not think this was a major issue in this study, this 
potential confounder could be accounted for using scores from the Unified Parkinson’s 
Disease Rating Scale (UPDRS), which was administered to all Insight 46 participants. 
There were a number of other limitations to the experimental design. Below is a list of 
recommendations (in no particular order) for how I think the task should ideally be altered 
to address these limitations.  
i) If a participant traces quickly and completes many rotations, the blue line showing 
their tracing path can begin to obscure the annulus. I suspect this makes further 
errors more likely, so ideally the tracing path should fade during each rotation so 
that by the time the participant reaches the top of the circle, they have a clean 
circle for the next rotation.  
 
ii) As the speed-accuracy trade-off is an important feature of this task, it would be 
useful to check its influence more explicitly. This could be done by adding a 
condition where participants are asked to prioritise accuracy, tracing as slowly as 
is necessary to achieve their best accuracy, as was done in one previous study 
(Lemay et al., 2005). 
 
iii) The set-up for the indirect condition should be improved so that it does not 
disadvantage left-handed people. This could be done by using a bigger box to 
obscure the screen, or possibly allowing left-handed people to trace anticlockwise 




iv) The software output for error time was sufficient for comparing error detection 
with error correction, but for a more accurate analysis of error time – for example, 
to investigate whether certain groups of were particularly slow to detect or correct 
errors – it would be better to have fine-grained data on the duration of each error. 
I suspect that this information is recorded in the raw data-files but do not know 
how to extract it. 
 
v) In light of the interesting association between amyloid deposition and subtraction 
rate, it would be informative to compare this with a more challenging calculation 
task, as well as conducting the subtraction task on its own without circle-tracing. 
It is possible that the slower subtraction observed in this study could be indicative 
of general decline in calculation ability, which might be detectable as errors on a 
more challenging task. 
Strengths and limitations that apply to all the analyses presented in this thesis, such as 





In summary, this study has provided novel evidence that Aβ+ cognitively-normal older 
adults may have subtle deficits in visuomotor integration. The finding of an association 
between Aβ pathology and slower subtraction rate merits further investigation and should 





9. INTEGRATION OF RESULTS ACROSS THE COGNITIVE 
BATTERY, AND POTENTIAL APPLICATIONS 
 
So far in this thesis each cognitive test has been considered separately. In order to view 
the results as a whole and draw broader conclusions from them, I aimed to 1) summarise 
the results reported in previous chapters; 2) evaluate which combination of cognitive 
measures may be most sensitive to amyloid status; 3) reflect on potential applications of 
these results. The rationale, methods and results for each of these three aims are 
reported in the following three sub-sections.  
 




In order to draw conclusions about patterns of performance across all the tests, I aimed 
to summarise and compare the effects of the various predictors (demographic 
characteristics, biomarker measures etc.) across the different cognitive measures and to 
examine correlations between the cognitive measures. 
   
9.1.2. Methods 
 
While the paper-and-pencil tests all had simple outcomes (total number of items correct), 
the computerised tests had a variety of outcome measures that could be analysed on a 
trial-by-trial basis or summarised across the various different conditions of the task. The 
selection of two or three key summary outcomes for each computerised test was 
explained in previous chapters (see section 3.5.2.1). For the purposes of comparison 
across tests, all outcomes were framed such that a higher score indicates better 
performance and converted into z-scores based on all participants. Transformations 
were applied to skewed outcomes where helpful to enable the data to more closely 
approximate the normal distribution. Table 9-1 summarizes the 19 cognitive outcomes 







Table 9-1. List of cognitive outcome measures from the Insight 46 battery 
Name of cognitive 
measure 
Brief descriptor How score was derived 
MMSE 
(see Chapter 4) 
Screening test for cognitive 
impairment, covering 
multiple cognitive domains 
Total score (max. 30)  
standardised into z-score. 
Matrix Reasoning 
(see Chapter 4) 
Non-verbal reasoning 
Total score (max. 32)  
standardised into z-score. 
FNAME-total  
(see Chapter 4) 
Associative memory for 
face-name and face-
occupation pairs 
Total score of names and 
occupations (max. 96)  
standardised into z-score. 
Logical Memory 
Immediate 
(see Chapter 4) 
Immediate recall for a short 
story  
Total score (max. 25)  
standardised into z-score. 
Logical Memory 
Delayed 
(see Chapter 4) 
Recall for a short story after 
approximately 20 minutes 
Total score (max. 25)  
standardised into z-score. 
Digit-Symbol 
(see Chapter 4) 
Processing speed  
Total score (max. 93)  
standardised into z-score. 
PACC 
(see Chapter 4) 
Composite measure of 
MMSE, FNAME-total, 
Logical Memory Delayed 
and Digit Symbol 
Mean of the following four z-
scores: MMSE, Logical 





(see Chapter 5) 
Memory for the identity of 
objects in the “What was 
where?” task 
Proportion of correct 





(see Chapter 5) 
Memory for the location of 
objects in the “What was 
where?” task 
Mean localisation error for 
correctly identified items  
log-transformed  multiplied 




(see Chapter 5) 
Measure of “swap errors” 
where objects and locations 
are “mis-bound” in the “What 
was where?” task 
Proportion of swap errors 
within correctly identified items 
 multiplied by -1  
standardised into z-score 
Choice RT 
(see Chapter 6) 
Mean response time in the 
2-choice RT task 
Mean RT (ms) for correct 
responses  multiplied by -1 
 standardised into z-score 
Choice RT 
accuracy 
(see Chapter 6) 
Accuracy in the 2-choice RT 
task 
Percentage of correct 




(see Chapter 6) 
Consistency of response 
times in the 2-choice RT 
task 
Intra-individual variability in RT 
for correct responses (SD / 
mean)  multiplied by -1  
standardised into z-score 
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Name of cognitive 
measure 




cost” to RT 
(see Chapter 7) 
Proportional difference in 
response time between 
conditions of congruent and 
incongruent stimuli 
(Mean RT for incongruent 
trials) minus (mean RT for 
congruent trials)  divided by 
mean RT for congruent trials 
 multiplied by -1  




cost” to accuracy 
(see Chapter 7) 
Difference in accuracy 
between conditions of 
congruent and incongruent 
stimuli  
(Error rate for incongruent 
trials) minus (error rate for 
congruent trials)  multiplied 




(see Chapter 8) 
Speed of circle-tracing while 
concurrently completing 
serial subtraction 
Mean number of rotations  
log-transformed  
standardised into z-score 
Circle-tracing 
“indirect cost” to 
accuracy 
(see Chapter 8) 
Difference in circle-tracing 
accuracy between 
conditions of indirect and 
direct visual feedback, while 
concurrently completing 
serial subtraction 
(Mean number of errors per 
rotation in indirect trials) minus 
(mean number of errors per 
rotation in direct trials)  
standardised into z-score 
Subtraction 
speed 
(see Chapter 8) 
Speed of subtracting in 3s 
while concurrently complete 
circle-tracing 
Number of responses per 




(see Chapter 8) 
Accuracy of subtracting in 3s 
while concurrently complete 
circle-tracing 
Percentage of incorrect 
responses  square-root 
transformed  multiplied by -1 
 standardised into z-score 
 
FNAME = Face-name associative memory exam; MMSE = Mini Mental State Examination; 
PACC = Preclinical Alzheimer Cognitive Composite; RT = reaction time 
 
 
Multivariable regression models were fitted for each cognitive outcome, with sex, age at 
assessment, education, childhood cognitive ability, adult socioeconomic position, 
amyloid status, WMHV, whole brain volume and APOE genotype (ε4-carrier or non-
carrier) included as predictors. As in previous analyses, bootstrapping was used to 
produce bias-corrected and accelerated 95% CIs from 2000 replications for outcomes 
with skewed distributions (MMSE, Matrix Reasoning, “What was where?” Identification, 
Choice RT, Choice RT accuracy, Serial subtraction accuracy, Response Inhibition 
“incongruent cost” to RT, and Response Inhibition “incongruent cost” to accuracy). 
In chapters 4 to 8, associations between cognitive outcomes and the demographic and 
life-course predictors (sex, age at assessment, education, childhood cognitive ability, 
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adult socioeconomic position, presence of a neurological or psychiatric condition) were 
reported based on all 502 participants, whereas associations between cognitive 
outcomes and the biomarker predictors (β-amyloid, WMHV, whole brain volume, APOE) 
were reported based on the sub-sample of cognitively-normal participants with complete 
biomarker data (n = 406). For the purpose of summarising all the predictors together in 
the current chapter, only the sub-sample of cognitively-normal participants with complete 
biomarker data were included. This explains why the regression coefficients for the 
demographic and life-course predictors (and the R-squared values for the models) are 
not identical to those reported in previous chapters.  
Correlations between cognitive outcomes were measured using Pearson’s correlation 
coefficient, or Spearman’s correlation coefficient if either or both of the outcomes had a 
skewed distribution (as per the list above). The PACC was not included in these 
correlation analyses because its sub-tests were already included as outcomes in their 
own right, so correlations between the PACC and its own sub-tests are present by 
definition and are not informative. 
 
9.1.3. Results and commentary 
 
Results of the multivariable regressions for each cognitive outcome are shown in Table 
9-2. Some observations on the patterns of results are presented below, but a fuller 
discussion is provided in Chapter 10 which summarizes the findings of this thesis and 
interprets them in the context of the literature. 
Overall it appears that sex differences were more evident on the standard paper-and-
pencil tests and the serial subtraction task (with a consistent advantage for females, 
especially on memory-based tests, and a substantial advantage for males on subtraction 
speed), whereas sex differences on the computerised tests were much smaller in 
magnitude and not statistically significant (Table 9-2). (In Chapter 5 I reported sex 
differences on the “What was where?” computerised test when the full sample of 502 
participants was included, which are now in the same direction but not statistically 
significant).  
Childhood cognitive ability influenced performance on at least one outcome of every 
cognitive test (Table 9-2). (For the circle-tracing task, although it did not have a significant 
effect on the summary outcomes reported in this chapter, it was associated with 
differences in the time taken to detect and correct errors – see section 8.3.2.1.3.)  
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Education also had a consistent effect on many cognitive outcomes, whereas 
socioeconomic position was a much less notable predictor (Table 9-2).  
Most cognitive outcomes did not have any association with age at assessment, which 
was as expected given the extremely narrow age range of Insight 46 participants (2.6 
years – see section 3.6). However unexpected age effects were observed on the Matrix 
Reasoning, Choice RT and Circle-tracing tasks, as detailed in the relevant chapters (4, 
6, 8). Possible reasons for these findings are discussed in Chapter 10. 
Aβ+ participants consistently performed worse than Aβ- participants across a range of 
cognitive domains, with the greatest differences in Matrix Reasoning and Choice RT 
consistency (Table 9-2, Figure 9-1). On the eight measures where the difference was 
statistically significant, the effect size was reasonably consistent at around -0.3 SD. 
Larger whole brain volume (adjusted for total intracranial volume) was associated with 
better performance on three cognitive measures which all have a speed component – 
Digit-Symbol, Circle-tracing speed, and Subtraction speed – with the largest effect on 
Digit-Symbol (Table 9-2, Figure 9-2). It is interesting that this relationship between whole 
brain volume and speed was shown on three tasks that all have very different demands 
in terms of what the participant is asked to do. WMHV was only associated with Digit-
Symbol processing speed, and APOE-ε4 was associated with superior short-term 
memory on the Logical Memory and “What was where?” tasks. These findings are 























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 9-2. Associations between whole brain volume and cognition 
Solid lines indicate predictions from the multivariate models adjusted for total intracranial volume, 
sex, age at assessment, childhood cognitive ability, education, adult socioeconomic position, 
APOE-ε4, amyloid status and white matter hyperintensity volume (WMHV). Dashed lines 
represent 95% confidence intervals. TIV = total intracranial volume. 
 
Correlations between the cognitive outcomes are shown in Table 9-3. As a general rule, 
the standard paper-and-pencil tests were moderately correlated with each other, but the 
computerised tests were less so. This could be because, by having multiple metrics on 
the computerised tests, these metrics tend to hone in on more specific aspects of 
cognition, and hence reflect less of task-general demands. It could also be related to 
other properties of the tests, for example the standard tests all involved the participant 
responding verbally to the tester (with the exception of Digit-Symbol) and I would argue 
that the potential for adopting different approaches was relatively limited, whereas my 
impression from administering the computerised tests is that they offered more scope for 
adopting different strategies. 
Within the six memory measures (FNAME-total, Logical Memory Immediate, Logical 
Memory Delayed, “What was where?” identification, “What was where?” localisation, and 
“What was where?” binding), correlations were only moderate at best (apart from the 
expected strong correlation between Logical Memory Immediate and Delayed, which not 
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only assessed similar cognitive processes but were based on identical test stimuli). 
Clearly these various memory tests encompassed a range of demands (visual, verbal, 
differing delay times etc.), so the specific set of cognitive processes that underlie 
performance on each test are different, and all are relevant to different aspects of 
memory in daily living. It is also likely that the tests were affected to differing degrees by 
other factors such as attention and confidence; anecdotally I observed that some 
participants commented that they experienced mind-wandering during the “What was 
where?” task, and some commented that they expected to perform poorly on the FNAME 
task. This highlights the value of including multiple measures of memory in a cognitive 
battery and illustrates the need for cautious interpretation of results, for example when 
using limited memory measures to define “amnestic” cognitive impairment or when 























































Logical Memory Immediate 
Logical Memory Delayed 
Digit-Symbol 
“What was where?” identification 
“What was where?” localisation 
“What was where?” binding 
Choice RT 
Choice RT accuracy 
Choice RT consistency 
Response Inhibition “incongruent 
cost” to RT 
Response Inhibition “incongruent 
cost” to accuracy 
Circle-tracing speed 













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































As discussed in section 2.5.1, cognitive composites are increasingly being used as 
outcome measures in research studies in preclinical AD, based on evidence that a 
combination of cognitive measures covering different cognitive domains may be more 
sensitive to subtle decline than any single measure. Given that I have identified group 
differences between Aβ+ and Aβ- participants on a range of different cognitive measures, 
this leads to the question: which combination of these cognitive measures is most 
sensitive to amyloid status?  It is possible that there is an optimum combination of 
measures sufficient to detect differences in cognition between the groups, beyond which 
the addition of further measures is redundant. I aimed to investigate this by modelling 
amyloid status as a function of different combinations of cognitive measures from the 
Insight 46 battery, plus relevant demographic and genetic predictors. 
As age and APOE-ε4 are by far the biggest risk factors for Aβ positivity (ARUK Dementia 
Statistics Hub; Prince et al., 2014), the strongest predictor in a model of amyloid status 
among Insight 46 participants, all approximately the same age, will clearly be APOE-ε4. 
As I have reported that the differences in cognition between Aβ+ and Aβ- participants 
were very subtle with overlapping distributions, and by definition all participants included 
in these analyses were cognitively-normal, it is unrealistic to expect that the results of a 
cognitive assessment alone could be a good predictor of dichotomous amyloid status on 
an individual level. However, it is still reasonable to hypothesise that a model which 
includes sensitive cognitive measures could fit the distribution of amyloid status better 
than a model based purely on APOE genotype and demographic factors, and to use this 
approach to evaluate which combination of cognitive measures adds the most value. 
One motivation for developing this approach as part of my PhD work is that once the 
Insight 46 follow-up assessments are completed and the cognitive measures can be 
expressed in terms of change over a ~2-year interval, this type of model may be useful 
for determining the combination of cognitive tests that is most sensitive to Aβ-related 
cognitive decline. There is consistent evidence that accelerated decline in cognition can 
be detected in Aβ+ individuals over time, on the PACC and other measures, (see 
sections 2.3 and 4.1) and the question of which combination of cognitive tests is most 
sensitive to such decline is a pertinent one for clinical trials.  
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As discussed in section 2.5.1, cognitive composites are generally constructed using one 
of two approaches: measures can either be selected based on their face validity and 
prior evidence for their sensitivity – as in the case of the PACC (Donohue et al., 2014), 
or they can be selected using a data-driven approach (e.g. Ayutyanont et al., 2014; 
Langbaum et al., 2014; Tariot et al., 2018). Both approaches require informed decisions 
to be made about which cognitive measures should be considered in the first place, but 
the first approach allows a higher priority to be placed on selecting tests that cover a 
range of cognitive domains and on accounting for practical considerations such as the 
time, equipment and expertise required to administer the assessments, depending on 
the intended application. Given that I have already used my judgment to define the most 
relevant summary outcomes for each cognitive test in the Insight 46 battery, and I have 
already drawn conclusions about the sensitivity of each cognitive measure to amyloid 
status, I decided to use this information to propose several combinations of cognitive 
measures and to compare them against each other, rather than comparing every 
possible combination of the measures. (With 19 summary outcome measures, the 
number of possible combinations of any number of them is over 500,000!) 
As the PACC has emerged as a front-running outcome measure in therapeutic trials in 
preclinical AD (Weintraub et al., 2018), I decided to frame my analyses in terms of 
starting with the PACC and testing whether the step-wise addition of other promising 
cognitive measures into the model yields improvements. After evaluating this and 
selecting the best combination of cognitive measures, I aimed to quantify how much this 
combination of cognitive measures could improve the prediction of an individual’s 
amyloid status compared to a prediction based simply on their APOE genotype and 
demographic characteristics.  
   
9.2.2. Methods 
 
The first step in choosing which measures to add, and in which order, was to exclude 
those tests which form a part of the PACC composite, since performance on those tests 
is already captured by inclusion of the PACC in the model. Note that although the PACC 
contains only the delayed recall score from the logical memory test (not the immediate 
recall score), I excluded the immediate recall score from consideration as well, as it 
overlaps very closely with the delayed in terms of what it measures (Abikoff et al., 1987). 
From the remaining outcomes, I considered only those for which there was a statistically 
significant difference between Aβ+ and Aβ- participants and ordered these by the effect 
size of the association with amyloid status (see Table 9-2, Figure 9-1). The outcome with 
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the largest effect size would be added to the model first, followed by step-wise addition 
of the other outcomes in decreasing order of effect size. I decided to make one alteration 
to this order based on the pragmatic fact that the serial subtraction and circle-tracing 
tasks are administered concurrently, so once subtraction speed is added, the circle-
tracing outcome could be added with no extra time or effort for the tester or participant. 
Therefore, I moved the circle-tracing outcome up one place in the list, which seemed 
justified since its effect size was virtually identical to the next largest effect size (“What 
was where?” identification).  
This yielded the following list, (see Table 9-1 for definitions of each outcome):  
1. Matrix Reasoning (d = -0.40) 
2. Choice RT consistency (d = -0.37) 
3. Subtraction speed (d = -0.32) 
4. Circle-tracing “indirect cost” to accuracy (d = -0.29) 
5. “What was where?” identification (d = -0.30) 
I also considered the cognitive domains that are covered by these measures and 
concluded that there is no reason to assume that any measures would be redundant 
since they all tap into different abilities and processes.  
This gave me 7 models to test, where the outcome is amyloid status and the predictors 
are as follows: 
Model A: sex, age at assessment, childhood cognitive ability, education, adult 
socioeconomic position, APOE-ε4 (carrier or non-carrier) 
Model B: model A + PACC 
Model C: model B + Matrix Reasoning 
Model D: model C + Choice RT consistency 
Model E: model D + Subtraction speed 
Model F: model E + Circle-tracing “indirect cost” to accuracy  
Model G: model F + “What was where?” identification 
 
To compare how well these models predict amyloid status, I adopted a cross-validation 
approach. Cross-validation is a technique often used in machine-learning to evaluate the 
quality of a model in a relatively unbiased way by splitting the dataset into groups, called 
‘folds’, and using these to generate multiple estimates of the model’s accuracy. This has 
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advantages over simply evaluating a model’s goodness-of-fit across the whole dataset 
because such an approach is vulnerable to over-fitting, meaning that the model may not 
generalise well to other datasets and will be of limited usefulness for predicting new 
results. Cross-validation is less likely to over-estimate a model’s accuracy and can give 
increased confidence in the generalisability of the results (Brownlee, 2018).  
I conducted k-fold cross-validation, which involves splitting the dataset into k folds, where 
k is a number to be decided depending on the properties of the dataset (see below). The 
principle of the process is that one fold is left out and the model is fitted on the remaining 
k-1 folds and its accuracy evaluated, then this process is then repeated a total of k times, 
leaving out a different fold each time. Comparing the model’s accuracy across each 
repetition allows relatively unbiased conclusions to be drawn about its accuracy. 
When deciding how many folds to split the data into, the optimum number depends on 
the sample size and the distribution of the outcome to be predicted. A large number of 
folds is desirable for reducing bias, as the sub-sample used for each repetition (the k-1 
folds) is increasingly likely to be representative of the whole sample. However, a larger 
number of folds incurs extra computational burden and means that the sub-samples used 
for each repetition increasingly overlap with each other and become basically equivalent 
to the full sample, so are similarly vulnerable to overfitting (Brownlee, 2016). I used 10 
folds as this is widely accepted as the default recommended number (Brownlee, 2018).  
In order to compare the 7 different models, I used an information criterion and a measure 
of accuracy, as explained below.  
Information criteria measure how much information is lost by using the model to 
represent the “true” processes that generated the data and are commonly used for 
selecting a statistical model from several candidates. I used the Akaike information 
criterion (AIC), which balances goodness-of-fit against complexity to give an overall 
measure of the quality of a model. Balancing these two factors is desirable because 
goodness-of-fit nearly always improves with the addition of extra parameters but this 
extra complexity can lead to over-fitting – simpler models are generally preferred as they 
are more robust and generalisable (Bozdogan, 1987). AIC is defined as follows: 
AIC = 2k – 2(ln L)        (Equation 1) 
where k is the number of parameters and L is the likelihood function (a measure 
of goodness-of-fit) 
Thus, AIC penalises complexity by including a term that increases with the number of 
parameters. A lower value of AIC indicates a better model, one that minimises the 
information loss. The AIC values of two models can be compared to calculate the 
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probability that one minimises the information loss better than the other. For example, if 
model X has a lower AIC value than model Y, the probability that model Y minimises the 
information loss better than model X is:  
 𝑒((𝐴𝐼𝐶𝑋−𝐴𝐼𝐶𝑌)/2)       (Equation 2) 
While AIC allows models to be compared against each other, it does not provide an 
absolute measure of a model’s quality. In order to quantify how accurately each model 
can predict an individual’s dichotomous amyloid status, I used Receiver Operating 
Characteristic (ROC) curves, a common technique for assessing the accuracy of 
diagnostic tests where the classification is either positive or negative. A ROC curve plots 
the detection rate (rate of ‘true positives’) against “Type 1 errors” (rate of ‘false positives’) 
for every possible cut-point. In this case the possible cut-points are predicted 
probabilities of being Aβ+. The area under the curve (AUC) is a measure of the accuracy 
of the model, with an area of 0.5 representing a useless model (one that classifies 
individuals no better than chance) and an area of 1 representing a perfect model (one 
that correctly classifies all individuals).  
Therefore, my strategy for selecting the best model was to minimise AIC and maximise 
AUC. 
As explained earlier, after identifying the best model, I aimed to test how well this model 
can predict an individual’s amyloid status. To avoid circularity, I reserved a proportion of 
the sample – hereafter referred to as the “validation set” – before conducting the cross-
validation so that I could carry out this predictive testing using data that had played no 
part in the model selection process. 
A summary of the methods is presented in Figure 9-3, with explanatory notes in the text 
below. Out of the 406 cognitively-normal participants with complete biomarker data, 21 
were missing data for one or more of these cognitive measures so were excluded from 
this section of the analyses, leaving a sample of 385. As the missing data were mostly 
due to random technical problems (see section 3.3), excluding these individuals is 
unlikely to bias the sample, whereas including them would mean that models A to G were 















Figure 9-3. Flow-chart illustrating methods for cross-validation 
 
Note 1. I chose to assign 20% of the sample to the validation set as this is a sufficient 
proportion to be representative of the dataset but allows the majority of the sample to be 
used in selecting the best model. It was important to ensure that each group contained 
a representative proportion of Aβ+ participants, since this is the outcome being modelled. 
I also balanced the groups for sex and childhood cognitive ability since these were the 
strongest and most consistent predictors of individual differences in cognition (see 
section 9.1). To achieve this, I ordered the dataset by amyloid status then sex then 
childhood cognitive ability, and applied the following repeating sequence to the dataset 
from top to bottom to assign each participant to a group: V, F1, F2, F3, F4, V, F5, F6, 
F7, F8, V, F9, F10, F1, F2, V, F3, F4, F5, F6, V, F7, F8, F9, F10. (V = validation set; F = 
fold). 
Note 2. In this context, “fit the models” means run a logistic regression model with an 
outcome of amyloid status and predictors as specified earlier for models A to G. All 
Reserve 20% of the data as a validation set and 
split the remaining dataset into 10 equally-sized 
folds, ensuring that all groups are balanced for 
important variables (see Note 1). 
Leave out one fold and fit models A, B, C, D, E, F 
and G using the remaining 9 folds (see Note 2). 
Generate measures of the goodness-of-fit and 
accuracy of each model (see Note 3). 
Using the information generated by all 10 
repetitions, conclude which model is best (see 
Note 4). 
Evaluate how well this model can predict the 
amyloid status of individuals in the validation set 
(see Note 5). 
Repeat a total of 
10 times, leaving 




cognitive predictors were in the form of z-scores with a higher score indicating better 
performance (see Table 9-1).  
Note 3. As explained earlier, the goodness-of-fit measure was Akaike’s Information 
Criterion (AIC) and the accuracy measure was the area under the ROC curve (AUC).  
Note 4. For each of models A to G, I calculated the mean AIC and mean AUC across 
the ten repetitions, and the standard errors of these means. I then chose the best model 
based on the aim to minimise AIC and maximise AUC (as explained above).  
Note 5. The probability that an individual is amyloid positive can be predicted from the 
logistic regression model using an equation of the following form: 
𝑝(Aβ+) = 1/(1 + 𝑒−(constant + coef1.predictor1 + coef2.predictor2… )) 
         (Equation 3) 
where p(Aβ+) is the probability of being amyloid positive, and ‘coef’ is the regression 
coefficient that corresponds to each predictor.  
I fitted the chosen model to all ten folds to get the values for the constant and coefficients, 
then for each participant in the validation set I used the equation to predict their 
probability of being Aβ+. To assess the accuracy of these predictions, I compared them 
to the actual classifications of amyloid status derived from the PET scans. As the 
probability scores had a skewed distribution, I used a non-parametric test (Wilcoxon’s 
rank sum) to determine whether the predicted probabilities were higher for the Aβ+ group 














Table 9-4. Characteristics of the validation set and the 10 folds 






Validation set 77 50.7 18.2 0.41 35.1 
Fold 1 31 48.4 16.1 0.43 25.8 
Fold 2 31 51.6 19.4 0.34 32.3 
Fold 3 31 51.6 19.4 0.39 38.7 
Fold 4 31 51.6 19.4 0.44 25.8 
Fold 5 31 51.6 19.4 0.51 38.7 
Fold 6 31 48.4 19.4 0.42 38.7 
Fold 7 31 45.2 19.4 0.36 16.1 
Fold 8 31 45.2 19.4 0.43 25.8 
Fold 9 30 46.7 16.7 0.41 30.0 
Fold 10 30 46.7 16.7 0.44 23.3 
 
 
9.2.3.1. Selection of best model 
Table 9-5 shows the results for each model in each of the ten repetitions. An example of 
the ROC curves for models A to G is provided in Figure 9-4, illustrating results from the 
first repetition. Figure 9-5 summarises the AUC and AIC statistics for each model 
averaged across the ten repetitions.  
In each of the ten repetitions, the area under the curve (AUC) slightly increased from 
Models A to G (Table 9-5). This is consistent with the hypothesis that adding additional 
cognitive measures would improve the accuracy of the model. As illustrated in Figure 
9-5, the rise in AUC value was greatest between models A and D, after which further 
gains appeared to be minimal. However, there was no evidence that these differences 
in accuracy were statistically significantly, as the confidence intervals of the AUCs of 
models A to G overlapped in each repetition.  
Regarding Akaike’s Information Criterion (AIC), each of the ten repetitions showed a 
consistent pattern whereby AIC increased slightly from model A to B, then decreased 
from model B to D (Table 9-5, Figure 9-5). Between models D to G the AIC values were 
more variable but remained broadly similar (Table 9-5, Figure 9-5). As a lower value of 
AIC is preferred, this suggests that the inclusion of the first three additional cognitive 
measures (PACC, Matrix Reasoning, Choice RT consistency) improved the quality of the 
266 
 
model (in spite of the fact that AIC is designed to penalize the number of parameters). 
The magnitude of these differences in AIC values is not negligible; for example, by 
comparing the mean AIC values for models A and D, using Equation 2 (page 262) above, 
we can conclude that the probability of model A being better than model D is only 5%. 
Based on these results, there was no evidence that the addition of further cognitive 
measures (Subtraction speed, Circle-tracing “indirect cost” to accuracy, and “What was 
where?” identification) improved the quality of the model.  
In summary, the AUC and AIC statistics suggest that a model for amyloid status can be 
improved by the addition of cognitive measures (on top of demographic characteristics 
and APOE). These results tentatively suggest that model D appears the most promising, 
as adding additional cognitive measures beyond those included in model D may not yield 
improvements, and may not merit the extra time and effort involved in generating these 
measures (both for participants and researchers). However, it is important to note that 
these results are not conclusive and must be interpreted with caution given the lack of 






Table 9-5. Results of the cross-validation process 
Repetition Model AOC (95% CIs) AIC 
1 
A 0.78 (0.71, 0.84) 242.6 
B 0.78 (0.72, 0.84) 243.6 
C 0.80 (0.47, 0.85) 240.9 
D 0.80 (0.75, 0.86) 239.9 
E 0.80 (0.75, 0.86) 241.9 
F 0.81 (0.76, 0.87) 240.3 
G 0.81 (0.76, 0.87) 242.3 
2 
A 0.77 (0.70, 0.84) 240.2 
B 0.79 (0.73, 0.85) 241.0 
C 0.80 (0.75, 0.86) 236.3 
D 0.82 (0.77, 0.88) 230.8 
E 0.82 (0.77, 0.88) 232.8 
F 0.83 (0.77, 0.88) 232.0 
G 0.83 (0.77, 0.88) 233.0 
3 
A 0.79 (0.72, 0.85) 237.3 
B 0.80 (0.74, 0.86) 237.3 
C 0.82 (0.76, 0.87) 232.5 
D 0.83 (0.77, 0.88) 229.4 
E 0.83 (0.77, 0.88) 231.1 
F 0.83 (0.78, 0.88) 231.2 
G 0.83 (0.78, 0.88) 233.1 
4 
A 0.77 (0.71, 0.84) 238.9 
B 0.79 (0.73, 0.85) 239.3 
C 0.81 (0.76, 0.87) 233.6 
D 0.82 (0.77, 0.87) 232.9 
E 0.82 (0.77, 0.88) 234.3 
F 0.83 (0.78, 0.88) 232.7 
G 0.83 (0.78, 0.88) 233.9 
5 
A 0.77 (0.71, 0.84) 240.4 
B 0.78 (0.72, 0.84) 241.7 
C 0.80 (0.74, 0.86) 237.1 
D 0.82 (0.77, 0.88) 232.9 
E 0.82 (0.76, 0.88) 234.8 
F 0.83 (0.77, 0.88) 233.6 
G 0.83 (0.78, 0.88) 235.0 
6 
A 0.78 (0.71, 0.84) 241.1 
B 0.79 (0.73, 0.85) 242.3 
C 0.80 (0.75, 0.86) 238.5 
D 0.82 (0.77, 0.88) 232.6 
E 0.82 (0.77, 0.88) 234.1 
F 0.83 (0.77, 0.88) 234.5 
G 0.83 (0.77, 0.88) 235.9 
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Repetition Model AOC (95% CIs) AIC 
7 
A 0.78 (0.71, 0.84) 240.5 
B 0.79 (0.72, 0.85) 241.0 
C 0.79 (0.74, 0.85) 240.1 
D 0.81 (0.75, 0.87) 235.3 
E 0.81 (0.75, 0.87) 237.1 
F 0.81 (0.76, 0.87) 236.3 
G 0.82 (0.76, 0.87) 237.1 
8 
A 0.78 (0.72, 0.85) 238.5 
B 0.79 (0.73, 0.85) 239.8 
C 0.81 (0.75, 0.86) 234.4 
D 0.82 (0.76, 0.87) 233.6 
E 0.82 (0.76, 0.87) 235.6 
F 0.83 (0.78, 0.89) 229.6 
G 0.83 (0.78, 0.88) 231.3 
9 
A 0.77 (0.70, 0.83) 245.7 
B 0.77 (0.71, 0.84) 245.7 
C 0.79 (0.73, 0.85) 243.6 
D 0.80 (0.75, 0.86) 241.4 
E 0.80 (0.75, 0.86) 243.3 
F 0.81 (0.75, 0.87) 241.4 
G 0.81 (0.76, 0.87) 234.3 
10 
A 0.76 (0.69, 0.83) 244.6 
B 0.78 (0.72, 0.84) 244.4 
C 0.79 (0.73, 0.85) 243.3 
D 0.80 (0.75, 0.86) 240.5 
E 0.80 (0.75, 0.86) 242.5 
F 0.81 (0.75, 0.86) 242.0 
G 0.81 (0.76, 0.87) 243.4 
 
Repetition numbers correspond to the fold that was left out (e.g. in repetition 1 the models were 
fitted using all participants in folds 2-10). See section 9.2.2 for details of the predictors included 
in models A to G.  




Figure 9-4. Receiver Operating Characteristic (ROC) curves for models A to G in 
repetition 1  
Repetition 1 involved fitting the models to folds 2-10. Areas under the curves are quoted in 




Figure 9-5. Mean AUC and AIC values for Models A to G 
AUC (navy circles) is plotted on the left-hand y-axis. AIC (maroon squares) is plotted on the right-
hand y-axis. Markers show the mean value across the ten repetitions of each model, and error 
bars show the standard error of the mean. A preferred model maximises AUC and minimises AIC. 
See section 9.2.2 for details of the predictors included in models A to G.  
AUC = Area under the curve; AIC = Akaike’s Information Criterion 
 
 
9.2.3.2. Prediction of amyloid status in validation set 
Based on the above results I selected model D for testing in the validation set (the group 
of 77 individuals whose data were not included in the model-selection process). I used 
model D to calculate a probability score for each participant – their predicted probability 
of being Aβ+ according to the model (see Note 5 of Figure 9-3).  
The predicted probabilities were higher for Aβ+ (mean = 36%) than Aβ- participants 
(mean = 19%), although the difference was not statistically significant (z = -1.73, p = 
0.08). To examine whether the model was doing any better than simply accounting for 
APOE-ε4, I compared the predicted probabilities for Aβ+ and Aβ- participants in the ε4-
carrier and non-carrier groups separately. In the ε4-carrier group, the predicted 
probabilities were higher on average for Aβ+ participants than Aβ- participants (z = -3.10, 
p =0.002), but in the non-carrier group the predicted probabilities did not differ between 




Figure 9-6. Probabilities of β-amyloid positivity for participants in the validation 
set, based on predictions from Model D  
Box plots show the distribution of probability scores, which are predictions of the probability that 
an individual is β-amyloid positive. These probability scores were calculated based on the 
equations for Model D that were derived from the cross-validation process (see Note 5 of Figure 
9-3). APOE-ε4 carriers and non-carriers are plotted separately, further separated into Aβ+ and 
Aβ- (the true amyloid status according to PET scan). Numbers of participants in each group are 





In summary, it is not possible to conclude from these results that one combination of 
cognitive measures was more sensitive to dichotomous amyloid status than another. 
There was an indication that sensitivity (true positives) was improved by the inclusion of 
additional cognitive measures (Matrix Reasoning and Choice RT consistency) compared 
to the PACC alone, but the evidence was inconclusive due to the lack of statistically 
significant differences in accuracy between the various models. This is not unexpected 
given that the differences in cognition between Aβ+ and Aβ- participants were so subtle 
and the majority of variance in cognitive performance was unexplained (see 9.1.3), so 
cognitive scores are not a strong predictor of amyloid status on an individual level at age 
70. Once follow-up data have been collected and changes in cognitive performance over 
272 
 
time can be used as predictors in the model, I would like to repeat this approach to 
investigate the most sensitive combination of measures for detecting Aβ-related decline 
in cognition.  
The results from testing the chosen model in the validation set confirmed that the chosen 
model does not accurately predict dichotomous amyloid status on an individual level. On 
a group level (i.e. does the model predict amyloid status better than predictions purely 
based on APOE genotype?), the results were in the expected direction for ε4-carriers, 
but again do not constitute convincing evidence, and statistical comparisons were limited 
by the small sample size of the validation set. The question of whether these sorts of 
predictive models may have practical applications is explored in the following section.  
 
 
9.3. Potential applications for clinical practice and clinical trials 
 
The final section of this chapter focuses on potential applications of the results reported 
in this thesis. I decided to approach this in two ways. Firstly, it could be of value in a 
clinical setting to estimate the likelihood of Aβ positivity for an individual who does not 
meet criteria for dementia or MCI but falls into an “impaired” range on one or more 
cognitive tests. Secondly, eligibility for future therapeutic trials in preclinical AD is likely 
to be based on having an Aβ+ PET scan. This was the case in the first clinical trial in 
preclinical AD, the A4 trial (Sperling et al., 2014), which is currently still ongoing, as well 
as in the Janssen EARLY trial 
https://clinicaltrials.gov/ct2/show/NCT02569398?term=JNJ-54861911, which was 
terminated in 2018 due to liver toxicity https://www.janssen.com/update-janssens-bace-
inhibitor-program. It would be valuable to know whether the addition of a cognitive 
assessment into the screening process could improve efficiency by reducing the number 
of PET scans required to recruit the desired number of Aβ+ individuals. These two 
potential applications are explored in the following two sub-sections. This section is 
purely exploratory and partly a vehicle for me to reflect on the meaning of the analyses 




9.3.1. Application for clinical practice 
 
9.3.1.1. Rationale 
In clinical neuropsychology, the standard definition of cognitive impairment is below the 
fifth percentile of the normal healthy population. If an individual shows evidence of 
cognitive impairment on a clinical neuropsychological assessment, the next steps in the 
diagnostic process will be guided by evidence about the likelihood of possible causes. I 
decided to investigate the prevalence of Aβ positivity in the lowest-performing five 
percent of Insight 46 participants, as this could be of potential use to clinicians when 
dealing with patients who show similar evidence of possible cognitive impairment. I 
hypothesised that Aβ+ participants would be more likely to fall into the “impaired” range. 
 
9.3.1.2. Methods 
Before defining the fifth percentile of performance on each test, participants with 
dementia (n=3) were excluded. Participants with other neurological and psychiatric 
conditions (see section 3.2.3) were not excluded as the criteria for those conditions were 
primarily designed for analyses involving biomarkers (to ensure exclusion of potentially 
confounding comorbidities) and do not necessarily imply clinical symptoms or cognitive 
impairment. As this analysis aims to be relevant to the general population who may 
present to clinic without having had prior neuroimaging or screening for MCI, the sample 
was kept as representative as possible. From the sub-sample of dementia-free 
participants with complete biomarker data (n=443), participants who performed below 
the fifth percentile on each cognitive outcome were identified (see Table 9-1 for 
definitions of the 19 different outcomes). For each cognitive outcome, a chi-square test 
was conducted to assess whether the prevalence of Aβ positivity among individuals in 
this “impaired” group was higher than in the “non-impaired” group (those whose 
performance was greater than or equal to the fifth percentile).  
For each participant, I totalled up the number of cognitive measures on which their 
performance was below the fifth percentile. As some participants were missing data for 
one or more cognitive tests (mostly due to technical problems – see section 3.3), this 
total was converted into a proportion by dividing it by the number of tests completed. 
Wilcoxon’s rank sum test was used to assess whether Aβ+ participants tended to fall into 





The lowest-performing five percent of participants equates to approximately 22 
individuals in this sample, but the exact number varies from one cognitive test to another 
depending on the distribution of scores.   
In sixteen out of the nineteen cognitive outcomes, the prevalence of Aβ positivity in the 
lowest-performing five percent of participants was greater than 18.3%, which was the 
prevalence in the sample as a whole (Figure 9-7). However, these differences were not 
statistically significant, with the exception of the Matrix Reasoning test, on which the 
prevalence of Aβ positivity in the “impaired” group (38%) was significantly higher than in 
the “non-impaired” group (χ2 = 6.0, p = 0.014). 
On average, Aβ+ participants performed below the fifth percentile on a greater proportion 
of tests than Aβ- participants (Aβ+ median = 0.05; Aβ- median = 0; z = -2.24, p = 0.02). 
For Aβ+ participants, the median value is equivalent to performing below the fifth 
percentile on one out of nineteen tests.  
 
9.3.1.4. Conclusions 
With the exception of the Matrix Reasoning test, these results do not support the 
hypothesis that Aβ+ participants were more likely to fall into the “impaired” range on 
cognitive tests, although statistical comparisons between the “impaired” and “non-
impaired” groups were limited by the small sample size of the “impaired” group. It is 
interesting that Matrix Reasoning was the test on which Aβ+ participants were most likely 
to fall into the “impaired” range, as this complements the results of the main analyses 
where the Matrix Reasoning stood out as the test with the largest group difference 
between Aβ+ and Aβ- participants (see section 9.1). However it is important to note that 
Matrix Reasoning scores were generally high in Insight 46 as discussed previously (see 
Chapter 4) so it may be misleading to refer to the lowest 5% of scores as an “impaired” 
range relative to the wider population. Further studies would be needed to validate 























































































































































































































































9.3.2. Application for clinical trial recruitment 
 
9.3.2.1. Rationale 
The second application I chose to explore is whether a sensitive battery of cognitive 
measures may improve the efficiency of screening for a clinical trial in preclinical AD, 
where eligibility is conditional on having an Aβ+ PET scan. As the prevalence of Aβ 
positivity is still relatively low in healthy older adults who would be the target population 
for such a trial (Jansen et al., 2015), screening is a time-consuming and expensive 
process (~£1500 per PET scan) with a low success rate. Cognitive assessment is non-
invasive and cheap, so could potentially be used to pre-screen large numbers of people, 
in order to decide which individuals should proceed to have a PET scan. The purpose of 
the pre-screening process would be to exclude individuals who are highly likely to be 
Aβ-. A recent analysis of three large cohorts concluded that a pre-screening algorithm 
for Aβ positivity based on cognitive, genetic and socio-demographic predictors could 
reduce recruitment costs by about 20% by reducing the number of PET scans required 
(Ansart et al., 2019). 
In section 9.2 I concluded that the optimum combination of cognitive measures for 
detecting Aβ positivity was the following three, with the caveat that this model was not 
conclusively better than the others: PACC, Matrix Reasoning, Choice RT consistency. In 
this section, I aimed to quantify the extent to which this cognitive battery might improve 
the efficiency of the screening process and provide an estimate of cost-effectiveness. I 
decided to investigate this question in a scenario where APOE genotype is unknown, 
since that is the most realistic scenario for clinical trial recruitment. Although commercial 
companies offering APOE genotyping have appeared in the last few years, APOE testing 
is not available clinically due to its low prognostic value on an individual level, and is 
generally not recommended (National Institute on Aging, 2015; Alzheimer’s Society, 
2016a), so the vast majority of people do not know their APOE genotype. To date, clinical 
trials targeting Aβ+ cognitively-normal older adults – the A4 trial (Sperling et al., 2014) 
and the Janssen EARLY trial 
https://clinicaltrials.gov/ct2/show/NCT02569398?term=JNJ-54861911 – have used Aβ-







I imagined a clinical trial which aims to recruit 100 Aβ+ individuals, and compared two 
screening scenarios: 1) no pre-screening; 2) pre-screening with a cognitive assessment.  
In the “no pre-screening” scenario, the number of individuals who should have a PET 
scan to meet the recruitment target can be estimated from the prevalence of Aβ positivity 
among cognitively-normal participants in the Insight 46 sample (18.3%). 
For the “pre-screening scenario” I conducted a Receiver Operating Characteristic (ROC) 
analysis to select an optimal cut-point that would be used as a threshold for determining 
whether or not participants proceeded to have a PET scan. The outcome was amyloid 
status, and the model included the following cognitive measures as predictors: PACC, 
Matrix Reasoning and Choice RT consistency (see Table 9-1 for definitions). The sample 
was the 406 cognitively-normal participants with complete biomarker data.  
I chose an optimal cut-point by maximising Youden’s index, which is defined as follows: 
Youden’s index = Sensitivity + Specificity – 1  
Youden’s index falls between 0 for a useless model (predicts the outcome no better than 
chance) and 1 for a perfect test (predicts the outcome perfectly). 
For any screening test we have a 2x2 table as follows: 
 TEST 
TRUE Positive Negative 
Positive true positive (TP) false negative (FN) 
Negative false positive (FP) true negative (TN) 
 
 
These values relate to the ROC analysis according to the following three equations: 
1. Sensitivity = TP / (TP + FN) 
2. Specificity = TN / (TN + FP) 
3. Accuracy = (TP + TN) / (TP + TN + FN + FP) 
 
At any given cut-point, values are defined for the model’s sensitivity, specificity and 
accuracy (proportion of subjects correctly classified). Therefore if a clinical trial needs to 
recruit 100 Aβ+ individuals, the value of “true positives” is set to 100 and the other three 
values (false negative, false positive, true negative) can be determined by 
simultaneously solving the three equations. The number of individuals required at each 
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stage of the screening process to achieve the recruitment target can then be calculated 
as follows:  
Number required for pre-screening = TP + FN + TN + FP 
Number who would proceed from pre-screening to PET scan = TP + FP 
 
To evaluate cost-effectiveness I assumed that a PET scan costs £1500 and a cognitive 
assessment costs £50 (similar to the estimated cost assumed in Ansart et al. (2019)). 
 
9.3.2.3. Results 
A ROC curve for the pre-screening scenario is shown in Figure 9-8, with the chosen cut-
point. Note that the lower bound of the 95% confidence intervals for the area under the 
curve is greater than 0.5, which is evidence that the cognitive assessment enables 
amyloid status to be predicted better than chance – this can also be concluded from the 





Figure 9-8. ROC curves for pre-screening scenario 
Area under the curve = 0.63 (95% confidence intervals 0.55 to 0.70). Black cross indicates the 
chosen cut-point, which maximises Youden’s index. Youden’s index can be visualised as the 
vertical distance from the cross to the reference line.  
 
 
The equation for the model takes the form of Equation 3 (page 264), and is given below: 
𝑝(Aβ+) = 1/(1 + 𝑒(1.52+ 0.17∗P+ 0.23∗M+0.28∗R)) 
         (Equation 4) 
where p(Aβ+) is the probability of being amyloid positive; P = PACC score; M = 
Matrix Reasoning z-score; R = Choice Reaction Time consistency z-score 
 
The chosen cut-point (see Figure 9-8) corresponds to a 20% probability of being Aβ+, 
meaning that participants with a probability of less than 20% would not proceed to a PET 




Table 9-6. Solution of the equations for the number of individuals required for 









Number of people required for pre-screening 1069 
Number of people proceeding to PET scan 324 
 
See 9.3.2.2 for explanation of the solution of the simultaneous equations for sensitivity, specificity 
and accuracy. TP = true positives; FN = false negatives; TN = true negatives; FP = false positives.  
 
Based on the prevalence of Aβ positivity in the Insight 46 sample, if no pre-screening 
were conducted then 548 individuals would need to be scanned to meet the recruitment 
target of 100 Aβ+ individuals. By pre-screening 1069 individuals with the cognitive 
assessment, 324 PET scans would be required – a reduction of 41%. This would be 
cost-effective as the £53,450 cost of conducting the cognitive assessments would be 
outweighed by the £336,000 reduction in scan costs. 
 
9.3.2.4. Conclusions 
In this section I explored the potential application of a cognitive assessment to as part of 
the screening process for therapeutic trials in preclinical AD, where the target population 
is cognitively-normal older adults with elevated β-amyloid. The results suggested that my 
chosen battery of cognitive measures was able to predict an individual’s amyloid status 
better than chance in the Insight 46 sample, and therefore including a cognitive 
assessment in the pre-screening process may be worth considering in the future as it 
could improve efficiency and cost-effectiveness by reducing the number of expensive 
PET scans required.  
This was an exploratory analysis conducted primarily as a demonstration of method, and 
there are a number of factors that limit its relevance to real-word therapeutic trials. Firstly, 
as the sample only contains 69- to 71-year-olds, and increasing age is associated with 
both cognitive decline and increasing likelihood of Aβ positivity, the model would not 
generalise to a wider age range. Secondly, my approach was to choose a cut-point that 
optimised the accuracy of the predictive model and then to evaluate its cost-
effectiveness, but if cost-effectiveness was the primary goal then it may be preferable to 
281 
 
choose a cut-point that minimised cost rather than maximising accuracy (as was done in 
(Ansart et al., 2019)). Alternatively for a screening test it may be most important to 
optimise sensitivity (i.e. to minimise false negatives). 
In summary, while it is clear that a cross-sectional cognitive assessment is not a good 
predictor of amyloid status on an individual basis (within cognitively-normal older adults), 
it may be of potential use in a clinical trial recruitment scenario for identifying individuals 




10. GENERAL DISCUSSION 
 
10.1. Summary  
In this large population-based sample of older adults of approximately the same age, I 
investigated predictors of performance on a range of cognitive measures, including some 
standard paper-and-pencil tests and some more novel computerised tests. My key 
findings are summarised as follows, with reference to the overarching hypotheses stated 
in section 2.7.2: 
i) As expected, higher childhood cognitive ability was strongly associated with 
better performance on almost all cognitive tests, and there were independent 
effects of educational attainment and socioeconomic position on some cognitive 
outcomes. 
 
ii) As hypothesised, subtle sex differences in cognition were detected on a range of 
cognitive measures. On average, women performed better on measures of 
memory and processing speed, whereas men tended to be faster at serial 
subtraction, more accurate at reporting the locations of objects, and slightly faster 
at responding to a complex reaction time task.  
 
iii) Consistent with the hypothesis that cognitively-normal participants with elevated 
Aβ deposition would show evidence of subtle cognitive deficits, Aβ+ participants 
performed less well than Aβ- participants on a range of cognitive measures. 
Importantly, these subtle deficits covered a range of cognitive domains – not just 
memory – and included some measures where such differences have not been 
reported before. Differences between the group means were of the order 0.3 SD. 
The continuous measure of Aβ (SUVR) also showed associations with poorer 
performance on some cognitive measures. 
 
iv) In general, white matter pathology and whole brain volume were not strongly 
associated with cognitive performance, but there was evidence of some specific 
associations that are consistent with previous studies: greater whole brain 
volume was associated with faster performance on three different timed 
measures and greater white matter hyperintensity volume (WMHV) was 
associated with slower processing speed.  
 
v) The hypothesis that composite and computerised cognitive measures would be 
more sensitive to brain pathology than standard paper-and-pencil cognitive tests 
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was not supported overall. There was evidence that some computerised 
measures were among the most sensitive to Aβ, but some of the non-
computerised measures performed similarly and the most sensitive measure in 
this study was in fact Matrix Reasoning (a standard test of non-verbal reasoning). 
The Preclinical Alzheimer’s Cognitive Composite (PACC) was not better at 
discriminating Aβ+ and Aβ- individuals than some of the individual tests.  
Regarding associations between APOE-ε4 and cognition (about which I did not make an 
overarching hypothesis), there was no evidence of a detrimental effect of APOE-ε4 on 
cognition after accounting for Aβ pathology, but rather there was evidence that APOE-
ε4 was associated with better performance on measures of short-term memory. 
These results are discussed in more detail below, followed by a discussion of the 
strengths and limitations of this study, and directions for future work.  
 
 
10.2. Key results and interpretation 
 
10.2.1. Effects of childhood cognitive ability, education and adult 
socioeconomic position 
The association between higher childhood cognitive ability and better cognitive 
performance more than 60 years later was seen across most cognitive measures, 
covering a wide range of cognitive domains, and is consistent with previous NSHD 
analyses (Richards and Sacker, 2003; Richards et al., 2004, 2019; Davis et al., 2017; 
Philippou et al., 2018). The finding that educational attainment and adult socioeconomic 
position were associated with many cognitive outcomes, independent of childhood 
cognition, is also consistent with previous NSHD analyses (Richards and Sacker, 2003; 
Richards et al., 2019), which have concluded that these factors are only moderately 
correlated (see section 2.4.2). Clearly educational and occupational attainment are 
affected by many factors other than cognitive ability; among Insight 46 participants one 
of these factors was sex, as males had on average 2 years more education (likely a 
reflection of cultural norms at the time) and were more likely to work in jobs with a higher 
occupational complexity, despite there being no sex difference in childhood cognitive 
ability. Other predictors of education and adult socioeconomic position in NSHD are 
mother’s education and father’s socioeconomic position (Richards and Sacker, 2003; 
Richards et al., 2019). As most studies of ageing and neurodegenerative disease do not 
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have access to measures of prior cognitive ability, educational attainment is often used 
as a proxy, but the results reported in this thesis highlight the limitations of this.  
The independent effects of education and adult socioeconomic position on later-life 
cognition are consistent with evidence that cognitive ability is not fixed from birth but is 
shaped by various influences throughout life (Richards and Deary, 2013). A recent meta-
analysis of the effects of education on IQ reported an increase of approximately 1 to 5 
IQ points per additional year of education, and found that these effects persisted into 
older age (Ritchie and Tucker-Drob, 2018). Another analysis from the NSHD found that 
education and training undertaken during adulthood was associated with higher cognitive 
ability at age 53, after accounting for childhood cognitive ability and educational 
attainment up to age 26 (Hatch et al., 2007).  
The evidence for independent effects of childhood cognitive ability, education and adult 
socioeconomic position on cognitive performance at age ~70 is also consistent with 
evidence that these factors may be protective against cognitive decline in later life. 
Multiple longitudinal studies have reported an association between higher childhood 
cognitive ability and reduced risk of dementia (Snowdon et al., 1996; Whalley et al., 2000; 
McGurn et al., 2008; Russ et al., 2017; Huang et al., 2018). Higher educational and 
occupational attainment are similarly associated with a reduced risk of AD, and have 
been identified as potentially modifiable factors that could be considered as targets for 
intervention (Stern, 2012; Norton et al., 2014; Xu et al., 2015). Paradoxically, it has been 
reported that highly-educated cognitively-normal older adults tend to have a greater 
burden of Aβ pathology (Jansen et al., 2015; Arenaza-Urquijo et al., 2017) and 
neurodegeneration (Pettigrew et al., 2016). The concept of ‘cognitive reserve’ has been 
proposed to account for this, positing that individual differences in the way that cognitive 
tasks are performed allow some individuals to tolerate a greater burden of pathology 
than others before they experience cognitive decline, and that this resilience or ‘reserve’ 
can be increased by factors such as education, stimulating activities, healthy lifestyle 
and social support (Stern, 2012; Chan et al., 2018; Russ, 2018). There was no evidence 
of this divergence occurring in Insight 46, as the Aβ+ and Aβ- groups did not differ in 
their childhood cognitive ability, educational attainment or adult socioeconomic position 
(see section 3.6). However, as rates of cognitive impairment are extremely low at age 
70, it may be that differences in resilience to pathology become apparent in future when 




10.2.2. Sex differences 
The sex differences in cognition detected in this study are consistent with typical patterns 
of sex differences reported in the literature. Women performed better than men on 
measures of verbal memory (Logical Memory immediate and delayed recall, recall for 
face-name and face-occupation associations on the FNAME-12 task). A female 
advantage on verbal tasks is well-documented, with one proposed explanation being 
differences in cognitive strategies: women are reported to show an increased tendency 
to cluster items to be remembered according to semantic and phonological categories 
(Andreano and Cahill, 2009), and to engage in elaborative processing of the meaning of 
information to be remembered (Wirth et al., 2007). Another proposed explanation is a 
sex difference in distribution of language processing across the brain, with some studies 
reporting that women show more bilateral activity whereas men show more left-
lateralised activity (Andreano and Cahill, 2009), although others do not find such 
differences (Sommer et al., 2004).  
Sex differences in verbal encoding could also explain my finding of a subtle advantage 
for women on recalling the identity of objects on the “What was where?” visual short-
term memory binding task, as I noted from anecdotal reports that participants were 
adopting verbalisation strategies (Andreano and Cahill, 2009). Verbal encoding has also 
been proposed as an explanation for the consistent finding – replicated here in Insight 
46 – of superior performance for women on the Digit-Symbol substitution task (Royer, 
1978; Majeres, 1983). However, a review of sex differences in processing speed tasks 
(including Digit-Symbol Substitution) concluded that memory does not play a big role in 
performance and suggested that the effect may be underpinned by female superiority in 
reading and writing skills, although the concept of processing speed itself remains poorly 
defined (Roivainen, 2011). 
The measures on which male participants showed superior performance – serial 
subtraction speed, location memory in the “What was where?” task, and response times 
in the Response Inhibition task – are also consistent with the literature. A male advantage 
has been widely reported on mathematical (e.g. (Hyde and Mertz, 2009)), visuospatial 
(e.g. (Andreano and Cahill, 2009; Voyer, Voyer and Saint-Aubin, 2017)) and reaction 
time tasks (e.g. (Der and Deary, 2006; Roivainen, 2011)). As discussed in Chapters 5 
and 8 respectively, the superior performance of males in mathematics and visuospatial 
abilities is reduced in countries with greater gender equality (Hyde and Mertz, 2009; 
Coutrot et al., 2018), but biological explanations have also been proposed.  
In summary, a predictable pattern of sex differences has emerged across the Insight 46 
cognitive battery, and differences between males and females were in the region of 0.5 
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SD on average. This highlights the importance of accounting for sex differences when 
seeking to detect and track subtle cognitive decline in the preclinical stages of AD, as 
average differences between men and women in this study were often larger than 
differences between Aβ+ and Aβ- groups (typically ~0.3 SD). Once Insight 46 follow-up 
assessments are completed, it will be important to see whether any sex differences 
emerge in terms of changes in cognition over the ~2 year interval, as a similar study that 
conducted longitudinal assessment of 755 cognitively-normal older adults on the 
Preclinical Alzheimer Cognitive Composite (PACC) found that, although sex was not a 
direct predictor of cognitive decline, Aβ+ women declined faster than Aβ+ men (Buckley 
et al., 2018).  
 
10.2.3. Age effects 
Despite the very narrow age range of Insight 46 participants (2.6 years – due to the time 
taken to collect the data, as all participants were born during the same week), 
unexpected associations between age and cognition were observed on three cognitive 
tests. Older participants tended to score lower on the Matrix Reasoning task and to have 
slower and more variable reaction times on the Choice RT task. Both these findings 
follow the expected direction of age effects but the magnitudes are significantly greater 
than could be expected (see discussions in sections 4.5.2.3 and 6.5.3.1). On the Choice 
RT task, the slower RT of older participants was accompanied by higher accuracy, which 
can be explained by a speed-accuracy trade-off. Conversely, on the circle-tracing task, 
older participants tended to trace more quickly and to make correspondingly more errors 
– an effect which has no obvious explanation (see discussion in section 8.5.3.1).  
I considered the possibility of a recruitment bias i.e. that participants tested towards the 
end of the data collection period may have differed in some ways to those seen earlier. 
While participants were invited in a random order, inevitably some participants delayed 
their visits due to health problems, life circumstances or being initially undecided about 
taking part. However we did not find any evidence of differences in childhood cognitive 
ability, education or adult socioeconomic position (which were controlled for in analyses 
anyway), or in general health based on measures of self-rated health status and overall 
disease burden (see (James et al., 2018) for a description of these measures). In terms 
of biomarker measures, older age was associated with greater white matter disease 
burden and smaller whole brain volume, but again the age effects on cognition were 




10.2.4. Associations with β-amyloid pathology 
Investigating associations between dichotomous amyloid status and cognition was the 
primary focus of my research. As hoped, this work has produced novel evidence that 
contributes to the understanding of subtle cognitive changes that may be associated with 
preclinical AD pathology. These results are discussed below, followed by a discussion 
of their potential implications for clinical trials. 
 
10.2.4.1. Evidence for differences between Aβ+ and Aβ- groups 
The dominant narrative is that episodic memory is the first cognitive function to decline 
in AD (e.g. (Grober et al., 2008; Mortamais et al., 2017; Farrell et al., 2018; Landau et 
al., 2018)), although a closer examination of the literature reveals a nuanced picture, with 
reports of early declines in several areas including episodic function and visuospatial 
ability (e.g. (Baker et al., 2017; Duke Han et al., 2017) – see section 2.3). One particularly 
notable feature of my results is that statistically significant differences were observed 
between cognitively-normal Aβ+ and Aβ- on eight different outcomes covering a wide 
range of cognitive domains: MMSE; Logical Memory immediate recall; Matrix Reasoning 
test of non-verbal reasoning; intra-individual variability in reaction time (RT) on the 
Choice RT task; memory for object identity on the “What was where?” task; serial 
subtraction speed; and visuomotor integration on the circle-tracing task (the difference 
in accuracy between the conditions of direct and indirect visual feedback). To my 
knowledge, some of these have not been reported before – particularly Matrix 
Reasoning, intra-individual variability in RT, visuomotor integration and serial subtraction 
speed – and such a wide range of differences has not been reported before in a single 
study. 
It is also worth noting that the results were in the predicted direction (poorer performance 
for Aβ+ participants) on the vast majority of other measures: face-name associative 
memory exam (FNAME-12); Logical Memory delayed recall, Digit-Symbol Substitution; 
object location memory on the “What was where?” task; mean Choice RT, accuracy on 
the Choice RT task; difference in accuracy between the congruent and incongruent 
conditions of the Response Inhibition task; subtraction accuracy. While these results 
should not be over-interpreted, this is consistent with the overall picture of the literature, 
where differences between Aβ+ and Aβ- groups are not consistently detected cross-
sectionally but emerge more clearly when comparing longitudinal change scores (Baker 
et al., 2017; Duke Han et al., 2017; Mormino et al., 2017).  
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In fact, it would not have been overly surprising if no cross-sectional differences had 
been observed at all in Insight 46, especially given the relatively young age of the cohort: 
one meta-analysis of cross-sectional differences between Aβ+ and Aβ- groups 
concluded that differences in episodic memory and executive function were statistically 
significant only in samples aged 75 years and above (Baker et al., 2017). It is likely that 
the availability of unusually rich data on our participants’ prior cognitive ability, plus the 
ability to adjust for other brain pathologies and APOE-ε4, increased the sensitivity of 
analyses to detect subtle effects of Aβ pathology, as other sources of intra-individual 
variation in cognition were accounted for more robustly than usual. As mentioned earlier, 
accounting for prior cognitive ability may be particularly necessary when investigating 
differences in high-performing individuals (Rentz et al., 2004, 2007). With the important 
caveats that Aβ positivity is not sufficient to meet criteria for preclinical AD (tau pathology 
is also needed – see section 2.2.1) and that not all Aβ+ individuals are expected to 
develop symptoms in their life-times (see section 2.2.2), these results make a novel 
contribution to growing evidence that preclinical AD is accompanied by subtle cognitive 
decline in a broad range of cognitive domains, and that this decline begins many years 
before the onset of symptoms. 
 
10.2.4.2. Implications for clinical trials in preclinical AD 
The results of one of the first clinical trials in preclinical AD (currently ongoing) rest upon 
the Preclinical Alzheimer Cognitive Composite, since this is the primary outcome 
measure on which Aβ+ individuals on active treatment and placebo will be compared 
(Sperling et al., 2014). My analyses have provided novel information about life-course 
determinants of the PACC – childhood cognitive ability, educational attainment and adult 
socioeconomic position – which should be considered when interpreting any differences 
between groups. In addition, the results reported in this thesis can be interpreted both to 
support and challenge the argument for using the PACC as an outcome measure in such 
trials, i.e. the argument that composites may be sensitive to deficits which are too subtle 
to be detected on individual cognitive tests. On the one hand, I identified a large number 
of tests whose results appeared to suggest subtle non-statistically significant deficits in 
Aβ+ individuals, including three of the four tests which make up our version of the PACC 
(Logical Memory delayed recall, Digit-Symbol Substitution; FNAME). Therefore, the fact 
that a statistically significant difference between the Aβ+ and Aβ- groups was detected 
on the PACC is due to the additive contributions of these small effects on its sub-tests. 
However, the effect size of the difference on the PACC (0.17 SD) was less than half of 
that of the most sensitive individual measures (Matrix Reasoning and intra-individual 
variability in Choice RT – see section 9.1.3) suggesting that the PACC could be improved 
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and it may be important to widen the focus from episodic memory and executive function 
to consider a broader range of cognitive domains. 
However, as the PACC was designed to measure change in cognitive performance over 
time, it will be important to see how these other measures compare to the PACC in terms 
of longitudinal performance once the Insight 46 follow-up data have been collected. 
Rates of cognitive decline may differ from one cognitive domain to another (Cloutier et 
al., 2015), and also different tests are differentially influenced by practice effects and 
test-retest reliability, so measures that appear promising cross-sectionally may not 
perform best for tracking longitudinal change. 
Looking ahead to future clinical trials in preclinical AD, my results suggest that it may be 
cost-effective to include cognitive assessment in the screening process, to exclude 
individuals who are highly likely to be Aβ- and thus reduce the number of PET scans 
required to recruit the required number of Aβ+ individuals. However, my data do not allow 
me to recommend a specific screening process for several reasons: 1) my analyses were 
inconclusive with respect to which combination of cognitive tests was most sensitive to 
amyloid status; 2) the results cannot be generalised to participants outside this very 
narrow age range; 3) a more robust cost-effectiveness analysis would be needed to 
weigh up the feasibility of different options, including, for example, whether certain 
cognitive tests could be administered remotely.  
 
 
10.2.5. Associations with whole brain volume, white matter pathology and 
APOE-ε4 
While my main aim was to study Aβ, I also investigated whether cognition was 
independently associated with whole brain volume, global WMHV and APOE-ε4. Some 
interesting results emerged, with each of these variables showing specific associations 
with particular cognitive domains. The consistency of effects across tests, and their 




In general, APOE-ε4 was not associated with cognition after adjustment for amyloid 
status, consistent with evidence that APOE-ε4 confers increased risk of cognitive decline 
primarily by increasing the likelihood of accumulation of Aβ plaques (Kline, 2012). 
However, on the “What was where?” task my analyses replicated two previous studies 
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in identifying an advantage for ε4-carriers in reporting the locations of objects (Zokaei et 
al., 2017; Zokaei, Čepukaitytė, et al., 2019). In addition, I found evidence of advantages 
for ε4-carriers in recalling the identities of objects on this task, and in immediate recall of 
the Logical Memory story (after adjustment for Aβ positivity, which was associated with 
poorer performance on these same measures); these results have not been reported 
before to my knowledge. These tasks are both measures of short-term memory after 
delays of a few seconds and rely heavily on attention. Logical Memory delayed recall 
(delay of ~20 minutes) showed a trend in the same direction (p = 0.06) – unsurprising 
given its strong correlation with the immediate recall score – but there was no evidence 
of an effect of APOE-ε4 on the other memory test in the Insight 46 battery (face-name 
associative memory exam (FNAME)).  
These results could be interpreted to support the hypothesis of antagonistic pleiotropy, 
whereby the APOE-ε4 allele is associated with both beneficial and detrimental effects 
(see section 2.6.1). Investigation of this phenomenon tends to focus on the transition 
from beneficial to detrimental effects with age (Duke Han and Bondi, 2008; Tuminello 
and Duke Han, 2011; Smith, Ashford and Perfetti, 2019), but my results highlight the 
possibility that beneficial effects may persist, albeit often counteracted by Aβ, such that 
ε4-carriers who avoid accumulation of significant Aβ pathology may be the most 
cognitively advantaged on certain measures. This is consistent with evidence that among 
clinically-normal individuals aged ~90 years and above (i.e. those who have survived 
dementia-free beyond the prime ages for developing dementias), the cognitive 
performance of ε4-carriers appears to be at least as good as non-carriers (see review in 
(Tuminello and Duke Han, 2011)). The model of antagonistic pleiotropy accounts for 
evidence that ε4-carriers show increased brain activation in task-relevant regions, 
particularly frontal and parietal regions in tasks of short-term memory and attention (Duke 
Han and Bondi, 2008; Tuminello and Duke Han, 2011; Rusted et al., 2013), and further 
suggests that this increased activation may be pronounced in older age as individuals 
preferentially recruit frontal brain regions to compensate for preclinical AD pathology in 
other regions (Duke Han and Bondi, 2008; Tuminello and Duke Han, 2011; Scheller et 
al., 2017).  
This study was limited in its ability to study the effects of APOE-ε4 by the fact that we 
combined all participants into two categories (ε4-carriers and non-carriers), an approach 
that was taken due to the rarity of the ε4/ε4 genotype and the desire not to exclude 
participants with ε2 alleles, since the main focus of the analyses was on Aβ. Further 
studies are required to investigate the effects of APOE-ε4 and Aβ in large groups of older 




10.2.5.2. White matter hyperintensity volume 
My finding of an association between greater WMHV and slower processing speed (as 
measured by the Digit-Symbol Substitution task) is consistent with the results of previous 
studies (Gunning-Dixon and Raz, 2000; Oosterman et al., 2004; Prins et al., 2005; van 
Dijk et al., 2008). As discussed in Chapter 4, this has implications for the interpretation 
of the PACC as an outcome measure in research studies and clinical trials, and it is 
important to remember that processing speed is a sensitive but non-specific measure of 
brain function which is compromised in many disorders (Jaeger, 2018). There was also 
an indication of an association between greater WMHV and poorer visuomotor 
integration (as evidenced by disproportionately inaccurate circle-tracing under the 
condition of indirect visual feedback – see Chapter 8). Aside from this, these results 
indicate that WMHV appear to have little effect on the cognitive performance of 
cognitively-normal older adults with a generally low burden of white matter disease.  
 
10.2.5.3. Whole brain volume 
As expected for 70-year-olds, there did not appear to be evidence of significant brain 
atrophy among Insight 46 participants (excluding individuals with major neurological and 
psychiatric conditions), although inferences about atrophy based on cross-sectional 
measures of brain volume are limited by the variability that exists between individuals. 
The finding that larger whole brain volume was associated with faster performance on 
three different timed measures is consistent with previous studies (Jackson et al., 2012; 
Magistro et al., 2015; Takeuchi et al., 2017) and is notable for the diversity of these 
measures: Digit-Symbol Substitution, serial subtraction rate, and circle-tracing speed. 
However, as serial subtraction and circle-tracing were administered concurrently, 
performance on each task was affected by the other so further studies would be needed 
to test whether these findings are replicated if the tasks are administered separately. 
 
10.3. Strengths and limitations 
This study has a number of major strengths, foremost of which is the very small age 
range. Neurodegenerative diseases are notoriously difficult to disentangle from so-called 
normal or healthy ageing, since ageing is accompanied by increasing brain pathologies 
and neurodegeneration (Jack et al., 2014; Parnetti et al., 2019), and decline in most 
cognitive abilities (Glisky, 2007). This age-homogenous sample allowed hypotheses 
about the effects of brain pathologies to be clearly tested with this confound all but 
eliminated. Another major strength is the prospective collection of cognitive and 
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demographic data from birth, which provided the rare opportunity to investigate the 
effects of childhood cognitive ability on cognitive performance more than 60 years later. 
Thirdly, the large sample size made it possible to detect subtle effects including sex 
differences, differences between Aβ+ and Aβ- participants and associations with whole 
brain volume and WMHV. A large sample size was particularly important to the 
comparison of Aβ+ and Aβ- groups, since there was a difference in numbers of 
participants in the these groups – in line with expectations of the proportion of Aβ+ 
individuals at this age (Jansen et al., 2015) – which reduced statistical power to detect 
differences between them.  
As an investigation of preclinical AD, the main limitation of this study was the absence of 
tau-PET imaging. Since standard criteria for preclinical AD are based on the presence 
of both Aβ and tau pathology (see section 2.2), it was not possible to identify participants 
who meet criteria for preclinical AD, nor to investigate how Aβ and tau pathology may 
interact to affect cognition. Based on previous studies, somewhere around 30% of Aβ+ 
70-year-olds would be expected to have tau pathology (Jack et al., 2017; Kern et al., 
2018), and tau pathology will be present in some Aβ- individuals as well (possibly around 
15-20% (Jack et al., 2017)). As subtle cognitive deficits are reported to be greater in 
individuals with both pathologies, as opposed to those with Aβ alone (Soldan et al., 2016; 
Duke Han et al., 2017; Bilgel et al., 2018; Ho and Nation, 2018; Sperling et al., 2018), 
the associations between Aβ and poorer cognition reported in this thesis may be partially 
explained by tau pathology. 
Another limitation of the study is that the computerised cognitive tests were all shortened 
versions that contained relatively few trials compared to most neuropsychological 
research studies, which limited the potential for detailed examination of patterns of 
performance on any individual test. However, this was a necessary trade-off when 
designing a ~90-minute cognitive battery that could be incorporated into a busy 
assessment day, and on the whole these results indicate that the battery was highly 
successful at capturing subtle differences in cognitive performance across a wide range 
of domains, as well as being well-tolerated by participants.  
The generalisability of findings from this study rests on the extent to which the sample is 
representative of the population. This is a source of both strengths and limitations, which 




10.3.1. Representativeness of the NSHD and Insight 46 
The NSHD sample was originally designed to be representative of the general 
population, with the following caveats: 1) only single babies were included (not twins or 
multiples); 2) the sample was stratified by social class, taking all babies whose fathers 
had an agricultural or non-manual occupation, and one in four babies whose fathers had 
a manual occupation; 3) only babies born to married mothers were included, since the 
stratification by social class was based on the father’s occupation (and in the 1940s it 
was relatively uncommon for unmarried couples to co-habit) (Wadsworth et al., 2006). A 
comparison with census data when study members were aged 43 concluded that the 
cohort remained broadly representative of the UK population of British-born adults of the 
same age (Wadsworth et al., 1992), and a similar comparison at ages 60-64 concluded 
that the cohort was representative in terms of socioeconomic position and rates of 
unemployment, although they were more likely to own a home and less likely to have 
limiting illness (Stafford et al., 2013). As a native-born cohort reflecting the general British 
post-war population, all NSHD participants are white, so do not represent the more 
contemporary ethnic and cultural diversity of the wider population.  
Inevitably, there is a bias for healthier study members to still be alive and participating in 
the cohort. At age 69, active NSHD participants (52% of the original cohort) were more 
likely to have higher childhood cognitive ability, higher educational attainment, a non-
manual occupation, and better health status than those no longer active (Kuh et al., 2016; 
Richards et al., 2019). Despite their better health status on average, it is notable that 
only 15% of NSHD participants had no clinical disorders at age 60-64 (based on a list of 
15 disorders e.g. cancer, hypertension, diabetes), and the average was 2 disorders each 
– a telling illustration of population ageing (Pierce et al., 2012).  
By drawing participants from the NSHD, Insight 46 is likely to be more representative 
than most studies in dementia research which recruit convenience samples or recruit 
through memory clinics and which may be biased towards those with higher education, 
higher socioeconomic position, and better cognition (Hultsch et al., 2002; Brodaty et al., 
2014). Convenience samples of so-called healthy controls have been reported to have 
a higher prevalence of a family history of AD (Brodaty et al., 2014) and higher rates of 
hippocampal atrophy than population-based samples (Whitwell et al., 2012). In addition, 
the inclusive recruitment criteria and wide geographical area (participants came from 
across England, Wales and Scotland) distinguish Insight 46 from most research and 
clinical trial cohorts which tend to recruit participants who live near major urban centres 
(Tanner et al., 2015) and have strict exclusion criteria for physical health problems and 
neurological or psychiatric conditions. Insight 46 participants, however, were required to 
be willing and able to attend a research visit in London, and on average had slightly 
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higher education and socioeconomic position than those who decided not to participate 
or were ineligible (James et al., 2018). Within Insight 46, participants with missing 
neuroimaging data were more likely to be obese and to have mental health problems 
(James et al., 2018). As obesity and depression are associated with increased dementia 
risk (Norton et al., 2014), this raises the possibility that individuals with brain pathology 
and associated subtle cognitive decline may be underrepresented in these analyses.  
 
10.4. Future directions 
Questions about the nature and timing of cognitive decline in the preclinical stages of AD 
can best be answered with longitudinal cognitive assessment. Insight 46 participants are 
currently undergoing follow-up assessments (interval = ~2 years) which will be 
completed in summer 2020, so it will then be possible to assess changes in performance 
on each cognitive task, and to investigate whether Aβ pathology at baseline is predictive 
of relatively poorer cognition at follow-up. Declines relative to baseline are expected, 
since numerous studies have reported an association between Aβ positivity and 
cognitive decline over a similar interval (see (Baker et al., 2017; Duke Han et al., 2017) 
for meta-analyses), but practice effects are also anticipated to play a role (Hassenstab 
et al., 2015; Vemuri et al., 2015; Machulda et al., 2017). Predictive effects of baseline 
WMHV, whole brain volume and APOE-ε4 will also be explored. 
Models of cognitive trajectories will also be able to incorporate measures of cognition 
across adulthood in the NSHD (see Table 3-2), which will allow examination of 
relationships between life-course cognition and later-life brain pathology. 
It will also be important to examine changes in levels of brain pathologies over the ~2-
year interval and how these relate to changes in cognition. As discussed in section 2.3.2, 
“amyloid accumulators” – individuals whose levels of Aβ are rising from an initially normal 
level – may be a group of particular importance for identifying the earliest changes in 
cognition and may be a suitable target group for future clinical trials (McMillan and 
Chételat, 2018).  
Investigation of a broader range of biomarkers is also planned, including blood-based 
biomarkers, cortical thickness (a biomarker for neurodegeneration specified in the NIA-
AA criteria for preclinical AD (Jack et al., 2018)), microstructural neuroimaging measures, 
a polygenic risk score that incorporates other genetic risks for AD in addition to APOE-
ε4, and measures of Aβ and tau pathology in CSF (as approximately 35% of the cohort 
have so far agreed to have a lumbar puncture at their follow-up assessment). Looking 
further ahead, approximately one third of Insight 46 participants have agreed to post-
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mortem brain donation, which will ultimately allow direct investigation of pathologies and 
their relationship with cognition during life. 
 
10.5. Closing summary 
These results add to growing evidence of subtle cognitive decline associated with 
preclinical AD pathology and contribute novel data, with differences in cognition between 
Aβ+ and Aβ- groups reported in an unusually wide range of cognitive domains including 
some that have so far received little attention. These differences were detectable at an 
age when those who are destined to develop dementia are still likely to be many years 
from symptoms. The rich historical data available on this cohort enabled predictable 
variation between individuals to be accounted for in a manner unique among 
neuroimaging studies in the field of preclinical AD research, as well as making possible 
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Figure A1. Fractals used in the “What was where?” task 
Figure reprinted from Liang et al. (2016) under the terms of the Creative Commons Attribution 
License (CC BY). 
